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Transition metal-catalyzed allylic substitution has emerged as a powerful method 
for stereoselective C-N bond formation. Chiral iridium-phosphoramidite complexes have 
proven especially effective as catalysts for regio- and enantioselective allylic amination, 
but are limited to aryl-substituted π-allyl electrophiles. With commercially available π-
allyliridium C,O-benzoates, which are stable to air, water and SiO2 chromatography, and 
are well known to catalyze allylic acetate mediated carbonyl allylation, highly regio- and 
enantioselective electrophilic allylation of aliphatic amines, primary and secondary 
aromatic or heteroaromatic amines were demonstrated. Furthermore, indoles and related 
azoles can also undergo the amination and generate enantiomerically enriched N-allyl 
indoles with completely N-selective and exclusive branched regioselectivity, which are 
an unmet challenge in this field. Moreover, indoles and related azoles are prevalent 
structural motifs in clinical candidates and FDA approved drugs, so these results also 
show the utility and importance of asymmetric allylic alkylation. 
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Chapter 1: Intermolecular Late Transition Metal Catalyzed 
Enantioselective Allylic Amination 
 
1.1 Introduction 
Since the pioneering work of Tsuji and Trost on allylic substitution reactions 
catalyzed by late transition metals, diverse synthetic methodologies for enantioselective 
allylic substitution have emerged over the last decades.1 With the use of suitable chiral 
ligands around the catalyst metal center, enantioselective allylic substitution allows for 
the construction of covalent bonds between carbon and various other elements in a 
stereocontrolled fashion. A wide range of carbon-carbon and carbon-heteroatom bonds 
have been constructed via enantioselective allylic substitutions catalyzed by late 
transition metals. In particular, enantioselective allylic aminations have been highlighted  
 
 
Figure 1.1 Examples of Bioactive Molecules Bearing α-Chiral Amines. 
 2 
as one of the most powerful methods to provide enantiomerically enriched allylic amine 
products. The efficient enantioselective construction of this synthetically useful motif can 
streamline the approaches for natural products, semisynthetic and synthetic 
pharmaceutical and agrochemical ingredients. 
In this review, we summarize intermolecular enantioselective allylic aminations 
employing racemic allylic derivatives, dienes, allenes, and alkynes fragments as allyl 
donors catalyzed by late transition metals. Literature is organized by transition metal 
catalyst. Asymmetric hydrogenations, enantio- and diastereospecific allylic aminations 
are not discussed. Cyclic allylic proelectrophiles and symmetric allylic derivatives are not 
explicitly depicted. 
 
1.2 Intermolecular Iridium Catalyzed Enantioselective Allylic Amination 
The formation of branched chiral allylic amines has been greatly enabled by late 
transition metal catalyzed enantioselective allylic amination. Since the seminal work of 
Tsuji and Trost, iridium catalysts feature prominently in these transformations. In 1997, 
the first iridium catalyzed allylic amination was reported by Takeuchi.2 Using 
[Ir(COD)Cl]2 and triphenyl phosphite, high levels of regioselectivity for branched 
products were observed, which is distinct from that of palladium catalyzed reactions, 
which give linear products from nucleophilic attack of the amine on the less substituted 
terminus of the allylic group. Utilizing this complementary regioselectivity, the first 
iridium catalyzed enantioselective allylic alkylation was reported by Helmchen in 1997,3 
opening a new avenue for the construction of synthetically useful chiral products utilizing 
catalysts modified by chiral ligands. A series of studies by Helmchen and Takeuchi 
aimed at better understanding iridium catalyzed allylic substitutions have initiated the 
 3 
large expansion of this enantioselective allylic amination chemistry over the past decade 
to form chiral branched allylic amines. 
 
1.2.1 Allylic Carbonate 
In 2001, Takeuchi reported the very first iridium catalyzed allylic amination, 
generating racemic branched allylic amine products.4 Subsequent to this effort, in 2002, 
Hartwig reported the first iridium catalyzed enantioselective allylic amination (Scheme 
1.1).5 Using the Feringa ligand 1.4, which was used for enantioselective conjugate 
additions and known for its π-accepting properties,6 primary and secondary aliphatic 
amines reacted with allylic carbonates to form enantiomerically enriched allylic amines 
with high yields, and excellent regio- and enantioselectivities. Further mechanistic 
investigations revealed that the active species was the cyclometalated iridacycle formed 
from base mediated C–H activation of the initial iridium complex coordinated by the 
phosphoramidite ligand (Scheme 1.2).7,8 For this reason, weak nucleophiles, such as 
aniline, were not strong enough to enable this cyclometallation process to occur and 
therefore did not furnish the product of chiral allylic amines. To address this issue, 
Hartwig demonstrated that adding a catalytic amount of additional base such as DABCO 
plays a key role in this activation process and enforces the formation of branched allylic 
aryl amines with high regio- and enantioselectivity.9 Another approach to generate this 
cyclometalated complex is the in situ preparation where heating of [Ir(COD)Cl]2, 
phosphoramidite ligand, and N-propylamine in THF at 50 oC, followed by vacuum 
evaporation, yields the active catalyst. Many of the following works have exploited these 
in situ conditions for the generation of catalytically competent catalyst. 
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Scheme 1.3 Iridium Catalyzed Enantioselective Allylic Amination to Form Highly 
Functionalized Chiral Branched Amines. 
 
 In 2004, Helmchen reported the iridium catalyzed regio- and enantioselective 
allylic amination of linear dienyl carbonates (Scheme 1.3).10 Using iridium catalysts 
modified by a chiral phosphoramidite ligand, excellent levels of regio- and 
enantioselectivity of highly functionalized branched amines were observed. One year 
later, it was shown that the loading of the iridium catalyst could be decreased with the use 
of catalytic amounts of Pb(II) salts and tetrahydrothiophene (THT). These additives were 
effective in helping to vacate coordination sites at the iridium complex, allowing for 
oxidative addition of allylic proelectrophiles and significantly enhancing reaction rate.11  
In 2005, using an iridium pre-catalyst and the chiral phosphoramidite ligand 1.13 
developed by Alexakis,12 Helmchen reported an enantioselective allylic amination of 
sulfonamides in good yields with high regio- and enantioselectivity, although reactions 
with alkyl-substituted allylic proelectrophiles yielded incomplete regioselectivities 
(Scheme 1.4).13 Use of base to generate anionic N-nucleophiles resulted in slightly higher 
yields and enantioselectivities. A year later, the scope of these conditions was extended 
with the use of phthalimide and ortho-nosylamine as nucleophiles.14 The allylic amine 
products can be readily transformed into enantiomerically enriched primary amine 
hydrochloride salts. This method was later extended to other carboxamide for the 









Scheme 1.5 Sequential Catalytic Isomerization and Enantioselective Allylic 
Amination. 
 
In 2006, Hartwig reported a sequential, two catalytic process using a palladium 
catalyst and then an iridium catalyst modified by the phosphoramidite ligand 1.1716 
which was developed to enforce both yield and selectivity (Scheme 1.5).17 Iridium 
catalyzed allylic amination with racemic branched allylic proelectrophiles represents a 
challenge due to low levels of enantioselectivity typically observed.18 To broaden the 
scope of electrophiles for this transformation, a sequence of palladium catalyzed 
isomerization followed by iridium catalyzed allylic amination was developed, allowing 
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the formation of branched allylic amines in good yields with high regio- and 




Scheme 1.6 Iridium Catalyzed Enantioselective Allylic Aminations with Premetalated 
Nucleophiles. 
 
In 2007, Hartwig developed an enantioselective allylic amination using di-tert-
butyliminodicarboxylate and trifluoroacetamide as ammonia surrogates to form allylic 
amines in high yields with good regio- and enantioselectivity (Scheme 1.6).19 Although 
the generation of stoichiometric premetalated nucleophiles and metallic byproducts, from 
treatment of amide with stoichiometric potassium and lithium salts was inevitable, the 
resulting products could be easily transformed to the enantiomerically enriched allylic 
carbamates or primary amines. In an analogous manner, the enantioselective allylic 
amination of sodium benzotriazolide was reported by Zhao in 2012.20 Using an iridium 
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catalyst modified by a Feringa ligand, excellent yields and enantioselectivity were 
observed, although the branched N1 and N2 regioselectivities were modest. 
A few years later, to streamline such stepwise processes, the direct allylation of 
ammonia and primary carbamates were disclosed (scheme 1.7).21 Enantioselective 
monoallylation of ammonia generally poses an intrinsic limitation for two reasons. First, 
an ammonia molecule bounded to a metal complex is no longer catalytically competent. 
These ammonia molecules can displace chiral ligands around the metal, resulting in the 
formation of an achiral complex. Second, the monoallylated product is more nucleophilic 
than ammonia, which promotes further allylation. Using ethylene ligated cyclometalated 
iridium catalysts modified by a chiral phosphoramidite ligand, which are stable to excess 
ammonia, both aryl and alkyl-substituted allylic carbonates react with ammonia to form 
monoallylation products in good yields with excellent levels of enantioselectivity. In an 
analogous manner, primary carbamates also participate in enantioselective iridium 








Throughout extensive studies towards enantioselective allylic aminations, it has 
been found that the most active iridium catalyst species are those generated from 
[Ir(COD)Cl]2 and chiral phosphoramidite ligands with the use of bases (DABCO, TBD or 
nPrNH2). However, formation of the cyclometalated iridacycle is very sensitive to the 
presence of either oxygen or water. To address these issues, air stable iridium catalysts 
derived from a chiral phosphoramidite ligand and dibenzo[a,e]cyclooctatetraene (dbcot), 
which displays strong binding affinity to iridium, were reported by Helmchen in 2008.23 
Taking advantage of this air stable catalyst, which avoids the need for Schlenk techniques 
and requirement for an inert atmosphere, Nelson and Marsdena reported iridium 
catalyzed allylic amination reactions of highly functionalized amines. The resulting 
products have the physicochemical properties, which can be useful drug-like space (Not 
shown).24 In 2013, You reported an air stable iridium complex derived from 
dinaphthocyclooctatetraene (dncot) and a phosphoramidite ligand (Scheme 1.8).25 
Remarkably, using the more stable iridium catalysts derived from dbcot and dncot, 
 
 
Scheme 1.8 Air Stable Iridium Catalysts Derived from Other Diene Ligands. 
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regioselectivity was considerably improved for substrates which showed incomplete 
regioselectivity from the cod complex.  
In 2009, Hartwig reported an iridium catalyzed enantioselective N-allylation of 
imidazole, benzimidazole, and purine heterocycles (Scheme 1.9).26 Using an ethylene 
ligated cyclometalated iridium complex that was proven effective for such 
transformations,8 high yields and good to excellent levels of regio- and 
enantioselectivities were observed. Notably, the process was deployed for the formal 
synthesis of a JNK3 inhibitor, which represents the utility of enantioselective allylic 
amination in synthesis applications. This method was later extended to the use of 
indoles.27 In general, the C3 position of indole is the most reactive site for electrophilic 
aromatic substitution, which poses intrinsic challenges to undertake N-substitution due to 
largely weak acidity of N-H. In this process, installing electron withdrawing groups on 
the indole core increases the acidity of N-H, enabling enantioselective N-allylation of 
indoles with high regio- and enantioselectivity, although incomplete regioselectivity of 
alkyl-substituted allylic carbonates was observed. 
 
 
Scheme 1.9 Iridium Catalyzed Enantioselective Allylic Amination with Indoles and 
Azoles. 
 11 
 In 2012, You developed the synthesis of N-allylindoles through a one-pot reaction 
involving an iridium catalyzed enantioselective allylic amination of indoline, followed by 
DDQ mediated oxidation (Scheme 1.10).28 Using iridium catalysts, which were proven 
effective as more stable iridium species,23 indoline reacts with allylic carbonates and the 
subsequent oxidation forms α-chiral indole derivatives with excellent levels of regio- and 
enantioselectivity, although incomplete regioselectivity upon use of alkyl-substituted 
allylic proelectrophiles was observed. Two years later, to broaden scope of indole 
derivatives, You disclosed another approach to the synthesis of enantiomerically enriched 
N-allylindoles.29 N-allylation of 2-(phenylethynyl)aniline in the presence of an iridium 
catalyst modified by a chiral phosphoramidite ligand, followed by a gold catalyzed 
cyclization reaction, led to the enantiopure indole derivatives in good yields with high 




Scheme 1.10 Iridium Catalyzed Enantioselective Allylic Aminations to Form α-Chiral 





Scheme 1.11 Sequential Allylic C-H Functionalization and Enantioselective Allylic 
Amination. 
 
In 2013, Hartwig reported a sequence of two catalytic processes: allylic C–H 
functionalization and allylic amination (Scheme 1.11).30 Using 4,5-diazafluorenone as a 
ligand, which reportedly promotes allylic C-H acetoxylation,31 and using tert-butyl 
perbenzoate as the oxidant and source of the benzoate group, the linear allylic ester was 
formed with a high linear-to-branched ratio. Subsequent allylic amination provides α-
branched chiral allylic amines using both aliphatic and aromatic amines, and azoles.  
 
  




In 2015, You reported an enantioselective allylic amination of 2-pyridones 
(Scheme 1.12).32 Despite competition between O- and N-alkylation when using iridium 
catalysts modified by an Alexakis ligand, high levels of regio- and enantioselectivity 
were achieved for N-allylated 2-pyridones.  
In 2016, You developed iridium catalyzed enantioselective allylic aminations with 
a N-aryl phosphoramidite ligand (Scheme 1.13).33 In general, iridium catalysts modified 
by a Feringa type ligand provide excellent regio- and enantioselectivity for a variety of 
substrates, although ortho-substituted phenyl allylic proelectrophiles were found to lead 
to a decrease in either yield or regio- and enantioselectivity in many cases. To address 
this issue, a series of N-aryl phosphoramidite ligands were identified that provided 
superior results to previously reported asymmetric allylic aminations of ortho-substituted 
cinnamyl carbonates. Presumably, the cyclometalated iridium complex formed through 
C-H (indicated in Scheme 1.13) activation of the ligand 1.50 is less sterically hindered in 
comparison with those derived from a Feringa type ligand, leading to high regio- and 









1.2.2 Allylic Ester 
In 2015, Evans reported a highly regio- and enantioselective allylic amination of 
the sulfur stabilized aza-ylide, diphenylsulfilimine (Scheme 1.14).34 An iridium complex 
modified by ligand 1.53 catalyzed the formation of chiral allylic sulfilimines, which 
readily undergo cleavage with acid to afford enantiomerically enriched primary amine 
hydrochloride salts. Whereas carbonate leaving groups are generally used with aryl-
substituted allylic proelectrophiles for high regio- and enantioselectivity, allylic benzoate 




Scheme 1.14 Enantioselective Iridium Catalyzed Allylic Aminations of 
Diphenylsulfilimine. 
 
In 2018, the Krische group found that neutral π-allyliridium C,O-benzoates 
modified by SEGPHOS, which are well-known to catalyze nucleophilic carbonyl 
allylations,35 promote highly regio- and enantioselective allylic aminations of branched 
allylic acetates bearing linear alkyl groups using primary aliphatic amines (Scheme 
1.15).36 Whereas the iridium phosphoramidite catalyzed allylic substitutions occur by 
way of cationic π-allylmetal intermediates, these π-allyliridium-C,O-benzoates react by 
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Scheme 1.15 Enantioselective Iridium Catalyzed Electrophilic Allylations of Alkyl-
Substituted Allylic Acetates. 
 
way of neutral π-allylmetal intermediates, which may account for their amphiphilic 
character. Notably, these aminations enable complete branched regioselectivity, 
overcoming a significant limitation associated with previously reported iridium-
phosphoramidite catalysts, which display incomplete regioselectivity for alkyl-substituted 
allylic proelectrophiles. A year later, Krische showed that the corresponding tol-BINAP-
modified iridium catalyst provides a significant expansion in scope, enabling highly 
enantioselective aminations of branched alkyl-substituted allylic acetates with 
electronically diverse primary and secondary aryl amines, including site-selective 
reactions of bis(amine) nucleophiles.37 Mechanistic studies involving amination of the 
enantiomerically enriched, deuterium labeled acetate corroborates C-N bond formation 
via outer-sphere addition. Remarkably, the tol-BINAP-modified iridium C,O-benzoates 
catalyze highly enantioselective N-allylations of indoles and related azoles.38 This 
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reaction complements previously reported metal catalyzed indole allylations, enabling 
complete levels of N- versus C3-, and branched versus linear regioselectivity. 
 
1.2.3 Allylic Alcohol 
Whereas significant progress has been made in the formation of chiral allylic 
amines via iridium catalyzed allylic amination of allylic carbonate and ester, the use of 
allylic alcohols remains a challenge. Generally, these allylic proelectrophiles are made 
from the corresponding allylic alcohol; hence, direct use of allylic alcohols could 
streamline synthetic sequences. In 2007, Hartwig reported an enantioselective allylic 
amination with allylic alcohols (Scheme 1.16).39 Using niobium ethoxide or triphenyl 
borane as an activator of the allylic alcohol, iridium catalysts modified by the ligand 1.17 
formed branched allylic amines with high regio- and enantioselectivity, using primary 




Scheme 1.16 Enantioselective Allylic Aminations of Allylic Alcohols Activated by 
Lewis Acids. 
 
A new approach to allylic amination was discovered in 2007 by the Carreira 
group.40 Branched allylic alcohols have excellent reactivity under acidic conditions. With 
the use of iridium complex modified by phosphine-olefin ligands, branched allylic amines 
were formed regioselectively. Compared to iridium-phosphoramidite systems derived 
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from a Feringa type ligand, the η3-allyliridium complex derived from two phosphine-
olefin ligands is more electrophilic in character, which enables highly facile electrophilic 
allylic substitution. Subsequent to these efforts, an enantioselective allylic amination of 
racemic secondary allylic alcohols was achieved in 2012 by Carreira (Scheme 1.17).41 
Chirally modified phosphine-olefin ligands were used, which allow the reaction to occur 
in a non-stereospecific fashion, probably due to displacement of the π-bond of (σ+π)-allyl 
(enyl) iridium intermediates by the tethered olefin of the phosphoramidite ligand. A 
diverse range of protected chiral allylic amines, all with high regio- and 
enantioselectivity, was observed. In 2019, Carreira demonstrated highly reactive or 
unstable nucleophiles such as hydrazines or N-hydroxylamines also participated in the 
enantioselective allylic amination reactions.42 While numerous transition metal catalyzed 
reactions require anhydrous systems to maintain their efficiency, utilizing commercially 





Scheme 1.17 Enantioselective Allylic Aminations by Iridium Complex Modified by 




1.2.4 Allylic Phosphate 
 Whereas the pioneering reactions of enantioselective allylic substitution to form 
chiral branched allylic amines was catalyzed by an iridium-phosphoramidite complex, 
Takemoto applied a chiral Pybox ligand to the enantioselective allylic aminations of 
allylic phosphates in 2004 (Scheme 1.18).43 Using an iridium catalyst modified by a 
chiral Pybox ligand, the chiral branched product was isolated with good yield and 
enantioselectivity. Notably, 1-naphthyl-substituted allylic proelectrophile could improve 
regioselectivity up to >95:5 branched to linear ratio. This method was later extended to 
the use of guanidines.44 With electron withdrawing groups on the guanidines, products of 
monoallylation were observed in good yield with high enantioselectivity, albeit with 




Scheme 1.18 Enantioselective Allylic Aminations of Allylic Phosphate Proelectrophiles 




In 2011, You and Helmchen reported enantioselective allylic aminations of allylic 
phosphates with ortho-amino styrenes (Scheme 1.19).45 Due to the highly electrophilic π-
allyl iridium complex, sequential allylic vinylation and amination reactions were 
inevitable. To suppress the undesired pathway, the allylic phosphate was exploited, which 
led to exclusive N-allylation of amino styrenes with excellent levels of chemo-, regio-, 
and enantioselectivity. Notably, the amination product was transformed into 1,2-


















1.3 Intermolecular Rhodium Catalyzed Enantioselective Allylic Amination 
1.3.1 Allylic Derivatives 
 In 2012, Nguyen reported rhodium catalyzed regio- and enantioselective 
aminations of racemic tertiary allylic trichloroacetimidates with aryl amines via dynamic 
kinetic asymmetric transformation (DYKAT) (Scheme 1.20).46 Whereas rhodium 
catalyzed allylic substitutions of allylic derivatives to form chiral allylic amines have 
largely focused on stereospecific processes47 or kinetic resolution48, a rhodium catalyst 
modified by a chiral diene ligand allows the formation of branched chiral allylic amines 
using racemic secondary allylic carbonates and a wide range of aniline nucleophiles.49-52 
DYKAT of tertiary allylic trichloroacetimidates promotes ionization of the allylic 
proelectrophile to form diasteromeric π-allylrhodium species. The matched π-
allylrhodium intermediates enable facile substitution by anilines to form the preferred 
enantiomer of the product whereas a chirally modified rhodium complex could decrease 




Scheme 1.20 Rhodium Catalyzed Formation of Enantiomerically Enriched Allylic 
Amines Bearing α-Tetrasubstituted Tertiary Carbons. 
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 In 2016, Breit reported rhodium catalyzed dynamic kinetic asymmetric allylations 
of 2-hydroxypyridines with alkyl-substituted allylic carbonates (Scheme 1.21).53 The 
combination of a rhodium catalyst with chiral DTBM-SEGPHOS ligand led to excellent 
levels of asymmetric induction for the N-allylation of 2-hydroxypyridines. The collective 
data corroborate a mechanism involving rhodium(I)-mediated allylic carbonate oxidative 
addition, which operates through a formal SN2' mechanism to form a σ-allylrhodium 
complex. Releasing methanol and CO2, the phenolate bound π-allylrhodium complex 
undergoes reductive elimination to form the N-selective allylation product. A year later, 
this was extended to the use of quinazolinones.54 Using a rhodium catalyst modified by 
DTB-MeO-BIPHEP, quinazolinones reacted with both alkyl- and aryl-substituted allylic 
carbonates to form enantiomerically enriched allylic amines in good yields with high 





Scheme 1.21 Enantioselective Synthesis of Branched Allylic Amines via Rhodium 
Catalyzed Allylic Substitution. 
 22 
1.3.2 C-H Functionalization 
Formation of α-chiral allylic amines via enantioselective hydroamination is a 
highly attractive and atom economical approach. In 2012, Breit reported an 
enantioselective rhodium catalyzed synthesis of chiral allylic amines (Scheme 1.22).55 
Using a rhodium catalyst modified the Josiphos ligand 1.94, cyclohexylallene reacts with 
a variety of anilines to form chiral allylic amines. The proposed mechanism involves a 
rhodium(I)-mediated aniline oxidative addition followed by reversible hydrometallation 
of the terminal allene double bond to form a π-allylrhodium complex, which upon 
reductive elimination releases the branched allylic amine. This method was later extended 
to the use of imidazoles,56 2-pyridones,57 4-pyridones,58 pyrazoles,59 purines,60 
tetrazoles,61 2-aminothiazoles,62 and pyridazineones,63 leading to regio-, chemo- and 
enantioselective N-allylation of these heterocycles, which are all useful building blocks 









Scheme 1.23 Rhodium Catalyzed Enantioselective Synthesis of Branched Allylic 
Amines Using a Variety of Nucleophiles. 
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In 2016, Breit developed a one-pot procedure for an enantioselective synthesis of 
indole derivatives (Scheme 1.24).64 Using a rhodium catalyst modified by DTBM-
SEGPHOS, various aryl hydrazines were coupled with terminal allenes, generating 
selective N-allylated hydrazines. The more acidic N-H bond at N1 compared to N2 
promotes facile oxidative addition to the rhodium complex, which could differentiate 
nitrogen selectivity. Products through regio- and enantioselective allylation of aryl 
hydrazines were subjected to Fischer indolization, allowing the construction of α-chiral 
indole derivatives with high yields and enantioselectivity. 
 
 
Scheme 1.24 Sequential Allylic C-H Functionalization and Fischer Indole Synthesis. 
 
On the basis of Breit’s prior observation that alkyne could serve as precursors to 
form π-allylrhodium species,65 a rhodium catalyzed enantioselective coupling of indolines 
with internal alkyne using a rhodium catalyst modified by JoSPOphos was reported by 
Dong in 2015 (Scheme 1.25).66 An allene intermediate was formed via rhodium hydride 
mediated alkyne isomerization, which upon hydroamination releases allylic amines 
instead of the enamine or imine product which are competing side products of alkyne 
mediated hydroamination. It was found that acidic additives play a key role to afford high 
regioselectivity of branched allylic amines in good yields with high enantioselectivity. 
Two years later, Dong disclosed a method for the hydrofunctionalization of 1,3-dienes 
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with indolines.67 It was found that conjugated dienes could generate analogous π-
allylrhodium complexes which are typically generated by hydrometallation of an allene 
or alkyne. Using a rhodium catalyst modified by JoSPOphos, the enantioselective 
coupling of indolines with 1,3-dienes afforded N-allylated indolines with good yields 




Scheme 1.25 Rhodium Catalyzed Hydrofunctionalization to Form Chiral Allylic 
Amines. 
 
In 2016, Breit developed a regio- and enantioselective allylic amination of 
pyrazoles with internal alkynes in an atom-economic manner using a rhodium catalyst 
modified by JosPOphos (Scheme 1.26).68 The reaction displays a broad substrate range of 
substituted pyrazoles and alkynes to provide chiral pyrazole derivatives in good yields 
along with good regio- and enantioselectivities. To note, both allenes and terminal 
alkynes also participate in the enantioselective synthesis of branched allylic amines 
which represents a highly flexible approach via an interconverting π-allyl and σ-allyl 
haptomers from allenes, internal and terminal alkynes. In a similar manner, Breit 
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expanded the scope of internal alkyne with triazoles while the synthesis of N-allylated 
trizoles in combination with the desired N-selectivity, high branched regio- and 
enantioselectivity remains uncommon. Using a modified rhodium catalyst with 





Scheme 1.26 Rhodium Catalyzed Hydrofunctionalization to Form Chiral Allylic 
Amines via Alkyne Isomerization. 
 
1.4 Intermolecular Palladium Catalyzed Enantioselective Allylic Amination 
      While numerous iridium and rhodium catalyzed allylic aminations of allylic 
proelectrophiles with one terminal substituent to form branched products with excellent 
regio- and enantioselectivity have been documented, palladium catalyzed allylic 
amination forming chiral branched products remains less developed. Here, we mainly 
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summarized examples of palladium catalyzed allylic amination forming branched 
products via unsymmetrical π-allyl palladium species. 
 
1.4.1 Allylic Epoxide, Aziridine, Cyclic Carbonate and Carbamate 
 In 2001, Trost performed a dynamic kinetic asymmetric transformation (DYKAT) 
with commercially available butadiene monoxide (Scheme 1.27).70 Using a palladium 
catalyst modified by a Trost type ligand, vinylglycinol products were formed in high 
yields with excellent regio- and enantioselectivity. Coordination of the pronucleophile to 
the oxygen leaving group via intramolecular hydrogen bond would help to deliver the 
nucleophile to the adjacent carbon. This allows high levels of the regioselective branched 
product despite the regio-control problem since nucleophilic attack in such systems are 
normally favored at the less substituted carbon.71 This method was later extended to use 
of a variety of nucleophiles including hydrazines, hydroxylamines, isatin derivatives, and 
purines (not shown).72-74 Taking advantage of ring strain to facilitate ring opening, the 
analogous vinyl aziridines were employed for hetereocycles bearing chiral 1,2-diamines 
using biologically active pyrroles and indoles.75 In these processes, the amide anion 
leaving group in the π-allylpalladium intermediate was sufficiently basic enough to 
deprotonate the N-H from the nucleophiles and facilitate the transformation. N-allylated 
pyrroles and indoles were observed in good yields with high regio- and 
enantioselectivity, although a strong electron withdrawing group was necessary to give 





Scheme 1.27 Palladium Catalyzed Dynamic Kinetic Asymmetric Transformation of 
Butadiene Monoxide and Vinyl Aziridine. 
 
In 2003, Trost disclosed the asymmetric cycloaddition of isocyanates to vinyl 
aziridines (Scheme 1.28).76 High yields and enantioselectivities were obtained for a broad 
array of imidazolidin-2-ones upon use of a palladium catalyst modified by a Trost ligand. 
To note, acidic additives are required to achieve high enantioselectivity since protonating 
the nitrogen upon opening of the aziridine which slows the cyclization rate. This allows 
π-σ-π interconversion of the diastereomeric π-allyl palladium intermediates, which can 
ultimately compete with product formation. In a similar manner, Zhang recently 
developed an efficient method for the enantioselective construction of vinylglycinol 
derivatives bearing α-tetrasubstituted tertiary carbons through decarboxylative 
cycloaddition of vinylethylene carbonates with isocyanates.77 Using a palladium catalyst 






Scheme 1.28 Palladium Catalyzed Dynamic Kinetic Asymmetric Cycloadditions of 
Isocyanates. 
 
In 2006, Trost reported a palladium catalyzed asymmetric allylic alkylation of 
meso- and dl-divinylethylene carbonates (Scheme 1.29).78 Using a palladium catalyst 
modified by a Trost ligand, only the syn-diastereomer was formed in good yields and 
high enantioselectivity, which was unexpected based on the well-established double 
inversion mechanism.79 Due to the Curtin-Hammett type effects where the rapid and 
reversible matched ionization is unproductive, mismatched ionization followed by rapid 
π-σ-π interconversion to relieve steric repulsion between the substrate and asymmetric 




Scheme 1.29 Palladium Catalyzed Enantioselective Allylic Aminations of 
Divinylethylene Carbonate. 
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In 2013, Liu and Zhang found an efficient palladium catalyzed allylic amination 
of vinyl cyclic carbonates followed by the cleavage of phthalimide group, forming a 
series of chiral β-aryl-α,β-unsaturated amino alcohols (Scheme 1.30).80 Using a palladium 
catalyst modified by a planar chiral ferrocene-based phosphinooxazoline (PHOX) ligand, 
products with good yields and high regio- and enantioselectivity were shown. In 2016, 
Kleij reported a palladium catalyzed regio- and enantioselective synthesis of allylic aryl 
amines bearing α-tetrasubstituted tertiary carbons using vinyl cyclic carbonates.81 The 
combination of a palladium catalyst and a Feringa chiral phosphoramidite ligand enabled 
DYKATs where the π-σ-π interconversion occurs faster than the subsequent nucleophilic 
attack. While it is generally known that palladium catalyzed allylic substitution 
undergoes through an outer sphere process which leads to formation of linear products, it 
is demonstrated density functional theory (DFT) calculations and mechanistic studies 
corroborate chelation assisted amine nucleophilic attack via inner sphere process which 




Scheme 1.30 Palladium Catalyzed Enantioselective Allylic Aminations of Vinylic 
Cyclic Carbonate. 
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 In 2017, Lu reported a palladium catalyzed enantioselective allylic amination of 
vinyl benzoxazinones (Scheme 1.31).83 While the branched products in such substrates 
were usually generated with limited enantiocontrol, presumably due to the steric 
repulsion between the ortho substituent and the metal complex,5,14,23,26,33 this protocol 
using the directing effect of the hydrogen bond presented chiral allylic amines with a 




Scheme 1.31 Palladium Catalyzed Enantioselective Allylic Amination of Vinyl 
Benzoxazinones. 
 
1.4.2 Allylic Ester and Carbonate 
In 2001, Hou and Dai reported a palladium catalyzed allylic amination of mono-
substituted allylic acetates (Scheme 1.32).84 Employing a palladium catalyst modified by 
the ferrocene P,N-ligand 1.145, good yields with high regio- and enantioselectivity were 
observed. In the amination reaction, a hydrogen bond between the amine and the free OH 
in the ligand might direct intramolecular nucleophilic attack, leading to high levels of 
regioselective ratio of branched to linear products. It was later found that the ferrocene 
modified palladium complex was highly efficient for enantioselective allylic aminations 
of both alkyl- and aryl-substituted dienyl esters.85 In a similar manner, using a ferrocene 
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based ligands SIOCPhos, Hou recently reported regio- and enantioselective allylic 
aminations of mono-substituted allylic proelectrophiles with N-Boc-O-
methylhydroxylamine (not shown).86 In 2017, Kleij developed a palladium catalyzed 
allylic amination of allylic proelectrophiles and aliphatic amines, providing allylic amines 




Scheme 1.32 Palladium Catalyzed Enantioselective Allylic Aminations of Allylic 
Proelectrophiles. 
 
While the formation of branched products at the sterically more hindered position 
of allylic substrates is challenging in palladium catalyzed transformations, a palladium 
catalyzed enantioselective allylic amination of acyclic Morita-Baylis-Hillman (MBH) 
adducts using a variety of anilines as nucleophiles was reported in 2012 by Liu, Wang 
and Ding (Scheme 1.33).88 Using a palladium catalyst modified by a spiroketal-based 
bisphosphine ligand, optically active β-arylamino acid esters were formed in good yields 
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with high regio- and enantioselectivities. Further mechanistic investigation revealed that 
the ligand plays a bifunctional role in the process: one P atom forms a carbon-phosphine 
σ-bond with the terminal carbon atom of the allyl moiety, and the other P atom 
coordinates to palladium, leading to an uncommon regioselective formation of the 
branched product.89 This method was later extended to other N-heterocyclic nucleophiles, 




Scheme 1.33 Palladium Catalyzed Enantioselective Allylic Aminations of Racemic 
Morita-Baylis-Hillman Adducts. 
 
 In 2017, Liu and Zhang reported a synthesis of chiral α,β-unsaturated γ-amino 
esters via enantioselective allylic amination reactions (Scheme 1.34).91 Using a palladium 
catalyst modified by DTBM-SEGPHOS, high yields with excellent regio- and 
 34 
enantioselectivities were observed. Notably, control experiments found that the 
regioselectivity of aminated products might depend on steric hindrance on the right side 




Scheme 1.34 A Palladium Catalyzed Synthesis of Chiral α,β-Unsaturated γ-Amino 
Esters. 
 
 In 2016, Diaz and Castillon reported a palladium catalyzed asymmetric allylic 
amination of linear allylic carbonates (Scheme 1.35).92 Using a palladium catalyst 
modified by a Trost ligand, optically active vinylglycines were observed in good yields 
with high regio- and enantioselectivities. In this process, the excellent control of 
regioselectivity was shown to be due to hydrogen bonding interactions between the 
hydroxyl group in the substrate and the DACH-naphthyl ligand in the palladium 
complex, as absence of the hydroxyl group led to the opposite regioselectivity. In 2019, 
Zhang reported a method for the synthesis of N-substituted 2-pyridones via a palladium 
catalyzed regio- and enantioselective allylic amination of hydroxyl-containing allylic 
carbonates.93 Complete levels of chemo-, regio- and enantioselectivities were observed 
upon use of a palladium complex modified by a chiral phosphoramidite ligand. Control 
experiments determined that the hydrogen bond interaction between a π-allylpalladium 
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intermediate and 2-hydroxypyridine played a crucial role in resultant high levels of 
branched regioselectivity accompanied by high yields. 
 
 
Scheme 1.35 Palladium Catalyzed Regio- and Enantioselective Allylic Aminations of 2-
Pyridones. 
 
1.4.3 Allylic Alcohol 
In 2014, Beller disclosed an enantioselective allylic amination of racemic allylic 
alcohols (Scheme 1.36).94 A palladium catalyst modified by a phosphoramidite ligand in 
combination with a chiral phosphoric acid promoted formation of a variety of 
functionalized amines in high yields with complete levels of regio- and 
enantioselectivities, using racemic cyclic and acyclic alkyl-substituted allylic alcohols. 
Mechanistic studies involving amination of the deuterium labeled allylic alcohol found 
that the rate of σ-π-σ interconversion of allylic palladium intermediates is slower than the 
rate of a nucleophilic attack, which enables the highly regioselective formation of 
branched allylic amines. 
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Scheme 1.36 Cooperative Catalysis by Palladium and a Chiral Phosphoric Acid 
Promoted Regio- and Enantioselective Allylic Aminations. 
    
1.4.4 C-H Functionalization 
In 2001, Hartwig reported a palladium catalyzed hydroamination of 
cyclohexadiene with arylamines using a palladium catalyst modified by a Trost ligand 
(Scheme 1.37).95 Good yields with high enantioselectivities were achieved although 
amine nucleophile scopes were limited to aryl amines. Mechanistic studies later showed 
that hydropalladation of the cyclohexadiene generates a π-allylpalladium complex 
followed by outer sphere amine addition to form the resulting ammonium salts which 
oxidatively protonate palladium to regenerate palladium hydride species.96 In 2017, 
Malcolmson applied a PHOX ligand in palladium catalyzed allylic aminations of acyclic 
1,3-dienes.97 Using aliphatic amines, good yields of chiral allylic amines with excellent 
levels of regio- and enantioselectivity were reported. Interestingly, the electron deficient 
PHOX ligand was required for high regiomeric ratios of chiral branched to achiral linear 
products. Subsequent to these efforts, Malcolmson recently disclosed the development of 
palladium catalyzed hydroaminations of 1,4-disubstituted acyclic dienes with both 
aliphatic and aromatic amines.98 Whereas enantioselective intermolecular 
hydrofunctionalizations of dienes are largely limited to terminal 1,3-dienes, this protocol 
using palladium complexes with a noncoordinating BArF4 counteranion promoted the 
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hydroamination of internal 1,3-dienes to form chiral allylic amines in good yields along 




Scheme 1.37 Palladium Catalyzed Enantioselective Hydroamination of 1,3-Dienes. 
 
 In 2012, Rhee reported a palladium catalyzed intermolecular hydroamination of 
alkoxyallenes (Scheme 1.38).99 In an extension of their reported work,100 using a 
palladium catalyst modified by a Trost ligand, hydroamination products were observed in 
excellent yield and enantioselectivity, which upon a subsequent ring-closing metathesis 




Scheme 1.38 Palladium Catalyzed Regio- and Enantioselective Hydroaminations of 
Terminal Allenes. 
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Recently, Wang and Ding found an enantioselective alkoxycarbonylative amination of 
terminal allenes to form β-arylamino acid esters in good yields with high regio- and 
enantioselectivities.101 On the basis of their prior work (Scheme 1.33),88 using a palladium 
catalyst modified by an aromatic spiroketal based diphosphine ligand, the corresponding 
phosphonium palladium intermediate IV was generated, presumably via methoxy 
carbonylpalladation of the allene and subsequent intramolecular rearrangement. The rest 
of the catalytic cycles proceeded in the presence of a copper salt as an oxidant. This 
protocol would effectively promote straightforward access to chiral α-methylene-β-
arylamino acid esters, avoiding the tedious synthesis of MBH adducts. 
 
1.5 Intermolecular Ruthenium Catalyzed Enantioselective Allylic Amination 
      Whereas transition metal catalyzed enantioselective allylic aminations have been 
developed largely by effective palladium and iridium catalysts, such transformations 
catalyzed by ruthenium catalysts remain uncommon. In 2001, Takahashi reported the first 
example of enantioselective allylic aminations catalyzed by the planar-chiral 
cyclopentadienyl ruthenium complex 1.185, allowing the formation of branched products 
with high regioselectivity and up to 74% enantioselectivity (Scheme 1.39).102 Of note, it 
is the pioneering work toward asymmetric induction by planar-chiral complexes of late 
transition metals. Subsequent to this work, the same planar-chiral ruthenium complex 
was used for asymmetric auto tandem catalysis.103 Regio- and enantioselective allylic 
substitution reactions of mono-substituted allylic halides with carboxamides produced 
enantiomerically enriched branched allylic amines in good yields with excellent levels of 
regio- and enantioselectivity. Further investigation found that the allylic substitution 
reaction followed by atom transfer radical cyclization formed optically active γ-lactams 
in a one pot process. In 2014, Kawatsura and Itoh reported regio- and enantioselective 
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allylic aminations of racemic mono-substituted allylic esters with cyclic secondary 
amines.104 Using a ruthenium catalyst modified by (S,S)-ip-Pybox, enantiomerically 













Enantioselective late transition metal catalyzed allylic aminations have become a 
widely applicable reaction for the synthesis of enantiomerically enriched allylic amines, 
which are versatile building blocks for natural products, semisynthetic and synthetic 
pharmaceutical and agrochemical ingredients. The improvement of ligand design in the 
catalyst has allowed a wide range of amine nucleophiles with mono- and di-substituted 
allylic electrophiles. As illustrated in this review, late transition metal catalyst has been 
proven efficient for the formation of highly regio- and enantioselective allylic amines 
with good functional group tolerance, which have been applied in asymmetric total 
synthesis of a variety of complex chiral molecules. Like any other synthetic methodology 
though, there are still some limitations to the use of late transition metal catalyzed allylic 
amination. For example, the use of tri-substituted allylic electrophiles and alkyl-
substituted allylic derivatives remains challenging. Thus, to address these issues, future 
developments will be expected to provide more unforeseen aspects for late transition 












Chapter 2:  Asymmetric Allylation of Glycidols Mediated by Allyl 
Acetate via Iridium Catalyzed Hydrogen Transfer * 
 
2.1 Introduction 
Epoxides are important building blocks in chemical synthesis, including the 
construction of polyketide natural products where they also appear as native structural 
motifs.1 Accordingly, several methods have been reported for the asymmetric allylation2 
of glycidic aldehydes using reagents based on boron,3,4 tin,5,6 silicon,7,8 indium,9 and 
magnesium.10 These methods have proven effective in certain contexts;3−10 however, due 
to pronounced match−mismatch effects, only one diastereomer of the secondary 
homoallylic glycidol is generally accessible in highly diastereomerically enriched form.11 
Additionally, indirect formation of secondary homoallylic glycidols via enantioselective 
allylation of α,β-unsaturated aldehydes followed by Sharpless asymmetric epoxidation is 
problematic, as modest diastereoselectivities are evident in reactions of secondary (Z)-
allylic alcohols.12 By harnessing the native reducing ability of alcohols, we have 
discovered a new, redox-economic class of C−C bond formations that merge the 
characteristics of carbonyl addition and transfer hydrogenation.13 These hydrogen auto 
transfer processes utilize alcohol oxidation to drive reductive generation of transient 
organometallic nucleophiles. The resulting carbonyl−organometal pair combines to 
furnish products of addition, directly converting lower alcohols to higher alcohols. Based 
on this pattern of reactivity, diverse enantioselective alcohol C−H functionalizations have 
been developed including the C−H allylation14 and crotylation15,16 of primary alcohols to 
 
*This chapter is based on the published work: 
Kim, S. W.; Lee, W.; Krische, M. J. Org. Lett. 2017, 19, 1252.  
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form secondary homoallylic alcohols. In the present account, this allylation method is 
applied to the conversion of primary glycidols to secondary homoallylic glycidols. 
 
2.2 Reaction Development and Scope 
Initial studies were focused on the allylation of glycidol 2.1a, which is prepared 
through Sharpless asymmetric epoxidation of geraniol.17 For the sake of convenience, the 
cyclometalated π-allyliridium C,O-benzoate catalysts were generated in situ from 
commercial components. Thus, glycidol 2.1a was exposed to allyl acetate in the presence 
of [Ir(cod)Cl]2, a series of 4-substituted 3-nitro-benzoic acids, assorted axially chiral 
chelating phosphine ligands, and various inorganic bases. A small set of optimization 
experiments quickly led to the identification of effective conditions. Thus, using the 
iridium catalysts (R)- or (S)-Ir-I modified by SEGPHOS, the diastereomeric secondary 
homoallylic glycidols 2.2a and epi-2.2a were obtained in excellent yields and 
diastereoselectivities, respectively (Table 2.1). Notably, unlike the corresponding 
allylborations,11 the enantiomeric catalysts delivered 2.2a and epi-2.2a with roughly 
equivalent levels of catalyst directed diastereoselectivity (2.2a/epi-2.2a  = 11:1 vs 1:12), 
suggesting the present iridium catalysts are insensitive to match−mismatch effects. 
Indeed, using an achiral iridium catalyst modified by dppf, a 1:1 mixture of 
diastereomeric secondary homoallylic glycidols 2.2b and epi-2.2b was obtained. The 
identification of favorable conditions for the asymmetric C−H allylation of glycidol 2.1a 
prompted a more detailed investigation into the scope of this process (Table 2.1). cis-
Glycidols 2.1b−2.1e were specifically selected for study as the corresponding secondary 
homoallylic glycidols 2.2b−2.2e and epi-2.2b−epi-2.2e are inaccessible using 
conventional allylation methods2−10 due to the modest diastereoselectivities reported in 
Sharpless asymmetric epoxidations of secondary (Z)-allylic alcohols12 along with the 
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stereochemically labile nature of (Z)-α,β-unsaturated aldehydes. In the event, cis-
glycidols 2.1b−2.1e were converted to the secondary homoallylic glycidols 2.2b−2.2e 
and epi-2.2b−epi-2.2e, respectively, in good yields and good levels of catalyst-directed 
diastereoselectivity. In certain cases, the iridium catalysts (R)- or (S)-Ir-II modified by 
Cl,MeO-BIPHEP were found to enforce higher yields and diastereoselectivities than the 
iridium catalysts (R)- or (S)-Ir-I modified by SEGPHOS. To complete this study, the 
allylation of trans-glycidol 2.1f was explored. Whereas secondary homoallylic glycidol 
2.2f was formed with excellent levels of catalyst-directed diastereoselectivity, the 
isomeric glycidol epi-2.2f was formed in low yield with less pronounced levels of 
stereocontrol. These data suggest match−mismatch effects may be more important in 
reactions of trans-glycidols. Finally, it is worth noting that due to the Horeau principle, 
all major reaction products derived from 2.1a, 2.1b, and 2.1f, are obtained in >99% 














Table 2.1 Iridium catalyzed C-H allylation of glycidols 2.1a-2.2f to form adducts 




aCited yields are of material isolated by silica gel chromatography. ArCO2H refers to 4-cyano-3-
nitrobenzoic acid. Diastereomeric ratios were determined by 1H NMR of crude reaction mixtures. See 
Supporting Information for further experimental details. b1 mmol scale.of material isolated by silica gel 
chromatography. All reactions were conducted using enantiomerically enriched starting materials. See 





The direct C−H allylation of primary glycidols 2.1a−2.1e is both step-economic 
and redox-economic as it avoids discrete formation and isolation of less tractable glycidic 
aldehydes. Nevertheless, under certain circumstances it may be desirable to conduct the 
allylation from the aldehyde oxidation level. To assess the feasibility of utilizing glycidic 
aldehydes as reactants, the reductive coupling of allyl acetate with dehydro-2.1a was 
performed using 2-propanol as the terminal reductant under otherwise standard 
conditions (eq 2.1). The respective secondary homoallylic glycidols 2.2a and epi-2.2a 
were formed in good yields with excellent levels of catalyst-directed diastereoselectivity. 
The efficiencies observed in the reactions of glycidic aldehyde dehydro-2.1a were 
roughly equivalent to those observed using the corresponding glycidol 2.1a (Table 2.1). 
To illustrate how the present method may be applied to polyketide construction, 
secondary homoallylic glycidol 2.2c was subjected to conditions for regioselective 
epoxide ring opening using AlMe3-n-BuLi (eq 2.2).
19 The desired adduct 2.3c, which was 
obtained in 77% yield, embodies a propionate-based stereotetrad spanning C17−C23 of 
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dictyostatin, a marine macrolide that displays antimitotic activity against multidrug-




In summary, we report that glycidols prepared through Sharpless asymmetric 
epoxidation participate in direct carbinol C−H allylation with excellent levels of catalyst-
directed diastereoselectivity. This method is redox- and step-economic, as it avoids 
discrete formation of less tractable glycidic aldehydes. Further, this method overcomes 
limitations evident in corresponding allylations of glycidic aldehydes using allylboron 
reagents.3a,b,11 Finally, as Sharpless asymmetric epoxidations of secondary (Z)-allylic 
alcohols display low levels of diastereoselectivity,12 indirect formation of the present 
secondary homoallylic glycidols through an asymmetric enal allylation−epoxidation 
sequence is not feasible. Future studies will focus on the use of α-olefins22 as 






2.5 Experimental Details 
 
General Information 
All reactions were run under an atmosphere of argon. Sealed tubes (13x100 mm) 
were purchased from Fischer Scientific (catalog number 14-959-35C) and were flame 
dried followed by cooling in a desiccator. Tetrahydrofuran was distilled from sodium-
benzophenone immediately prior to use. Dichloromethane was distilled from calcium 
hydride under a nitrogen atmosphere prior to use. Anhydrous solvents were transferred 
by oven-dried syringes. Analytical thin-layer chromatography (TLC) was carried out 
using 0.25 mm commercial silica gel plates (Dynanmic Absorbents F254). Visualization 
was accomplished with UV light followed by dipping in potassium permanganate or p-
anisaldehyde stain solution and then heating. Purification of reactions was carried out by 
flash chromatography using Silacycle silica gel (40-63 μm, unless indicated specifically). 
Potassium carbonate was purchased through Fisher Chemical, flame dried prior to use, 
and stored in a desiccator. 
 
Spectroscopy, Spectrometry and Data Collection  
Infrared spectra were recorded on a Perkin-Elmer 1600 spectrometer. High-
resolution mass spectra (HRMS) were obtained on a Karatos MS9 and are reported as 
m/z (relative intensity). Specific optical rotations were recorded on an Atago AP-300 
automatic polarimeter at the sodium line (589 nm) in CHCl3. Solution concentrations are 
given in the units of 10–2 g mL–1. Accurate masses are reported for the molecular ion (M-
H, M, M+H, M+Na, or M+K), or a suitable fragment. 1H nuclear magnetic resonance 
spectra were recorded on an Agilent MR (400 MHz). Chemical shifts are reported as 
parts per million (ppm) relative to residual CHCl3 δH (7.26 ppm). 
13C nuclear magnetic 
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resonance spectra were recorded on an Agilent MR (100 MHz) for CDCl3 solutions, and 
chemical shifts are reported as parts per million (ppm) relative to residual CDCl3 δC (77.0 
ppm).  
 
Experimental Details and Spectral Data 
Glycidols 2.1a,1,2 dehydro-2.1a,3 2.1b,1,4 2.1c,5 2.1d4,6 and 2.1e6 were prepared 






To a flame dried round-bottomed flask charged with dry 4 Å molecular sieves (1 g) under 
an argon atmosphere was added CH2Cl2 (33 mL, 0.1 M with respect to allylic alcohol). 
The reaction vessel was placed in -40 ºC bath and Ti(OiPr)4 (1.93 mL, 6.54 mmol, 200 
mol%) was added followed by D-(–)-diisopropyl tartrate (1.70 mL, 8.1 mmol, 250 
mol%). The mixture was stirred vigorously for 30 minutes, at which point tert-butyl 
hydrogen peroxide (1.2 mL, 5.0-6.0 M in decane, 6.54 mmol, 200 mol%). After 30 
minutes a solution of allylic alcohol7 (0.8 g, 3.27 mmol) in dry CH2Cl2 (17 mL, 0.2 M) 
was added slowly and the mixture was stirred for 40 h. The reaction vessel was 
transferred to an ice batch. Water (30 mL) and NaOH (30 mL, 10% aqueous solution) 
were added to the reaction mixture. The mixture was allowed to stir for 2 hours. The 
reaction mixture was filtered (celite) with the aid of CH2Cl2 (50 mL) and the filtrate was 
transferred to a separatory funnel. The organic layer was extracted with CH2Cl2 (50 mL × 
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2) and the combined organic layers were washed with brine (100 mL), dried (MgSO4), 
filtered and concentrated under reduced pressure. The resulting oily residue was 
subjected to flash column chromatography (SiO2, hexanes: ethyl acetate = 10:1–7:1) to 
furnish the title compound as a colorless oil (690 mg, 2.65 mmol) in 81% yield. The 
spectral data were identical to those reported for the corresponding racemate.7 
 
TLC (SiO2) Rf  = 0.29 (hexanes/ethyl acetate = 4:1).  
1H NMR (400 MHz, CDCl3): δ = 3.94 (m, 2H), 3.77 (dd, J = 11.9, 4.1 Hz, 1H), 3.62 (dq, 
J = 12.2, 3.8 Hz, 1H), 3.13 (m, 2H), 1.05 (m, 21H). 
13C NMR (100 MHz, CDCl3): δ = 62.8, 61.3, 56.0, 55.7, 17.8, 11.9. 
HRMS (ESI) Calculated for C13H28O3Si [M+Na
+] = 283.1700, Found 283.1701.  
FTIR (neat) 3432, 2942, 2865, 1463, 1112, 1065, 995, 881, 779, 681 cm–1. 
[α]
D
𝟐𝟖: +16.33 (c 1.0, CHCl3). 
HPLC: Enantiomeric excess was determined by HPLC analysis of the benzoate 
derivative of the product (Chiralcel OD-H column, hexanes:i-PrOH = 97:3, 1.00 mL/min, 




























Detailed Procedures  
 
From alcohol oxidation level: An oven-dried pressure tube equipped with a magnetic stir 
bar was charged with [Ir(cod)Cl]2 (3.4 mg, 0.005 mmol, 2.5 mol%), (R)-SEGPHOS (6.1 
mg, 0.01 mmol, 5 mol%), 4-CN,3-NO-benzoic acid (3.8 mg, 0.02 mmol, 10 mol%), 
alcohol 1a (34 mg, 0.2 mmol, 100 mol%) and K2CO3 (13.8 mg, 0.1 mmol, 50 mol%). 
The vessel was purged with argon for 5 minutes. Anhydrous THF (0.5 mL, 0.4 M) and 
allyl acetate (43 µL, 0.4 mmol, 200 mol%) were sequentially added via syringe. The 
reaction vessel was sealed and the reaction mixture was allowed to stir at 100 ˚C for 48 h. 
After reaching ambient temperature, the reaction mixture was concentrated in vacuo. The 
residue was subjected to flash column chromatography (SiO2, hexanes: ethyl acetate = 
15:1–10:1) to furnish the title compound as a colorless oil (35.7 mg, 0.17 mmol, anti:syn 




From alcohol oxidation level: An oven-dried pressure tube equipped with a magnetic stir 
bar was charged with [Ir(cod)Cl]2 (17 mg, 0.025 mmol, 2.5 mol%), (R)-SEGPHOS (30.5 
mg, 0.05 mmol, 5 mol%), 4-CN,3-NO-benzoic acid (19.0 mg, 0.1 mmol, 10 mol%), 
alcohol 1a (170 mg, 1.0 mmol, 100 mol%) and K2CO3 (69.0 mg, 0.5 mmol, 50 mol%). 
The vessel was purged with argon for 5 minutes. Anhydrous THF (2.5 mL, 0.4 M) and 
allyl acetate (0.22 mL, 2.0 mmol, 200 mol%) were sequentially added via syringe. The 
reaction vessel was sealed and the reaction mixture was allowed to stir at 100 ˚C for 48 h. 
After reaching ambient temperature, the reaction mixture was concentrated in vacuo. The 
residue was subjected to flash column chromatography (SiO2, hexanes: ethyl acetate = 
15:1–10:1) to furnish the title compound as a colorless oil (171 mg, 0.17 mmol, anti:syn 
= 10:1) in 81% yield. 
 
From aldehyde oxidation level: An oven-dried pressure tube equipped with a magnetic 
stir bar was charged with [Ir(cod)Cl]2 (3.4 mg, 0.005 mmol, 2.5 mol%), (R)-SEGPHOS 
(6.1 mg, 0.01 mmol, 5 mol%), 4-CN,3-NO-benzoic acid (3.8 mg, 0.02 mmol, 10 mol%), 
aldehyde dehydro-1a (0.2 mmol, 100 mol%) and K2CO3 (13.8 mg, 0.01 mmol, 50 mol%). 
The vessel was purged with argon for 5 minutes. Anhydrous THF (0.5 mL, 0.4 M) and 
allyl acetate (43 µL, 0.4 mmol, 200 mol%) were sequentially added via syringe. The 
reaction vessel was sealed and the reaction mixture was allowed to stir at 100 ˚C for 48 h. 
After reaching ambient temperature, the reaction mixture was concentrated in vacuo. The 
residue was subjected to flash column chromatography (SiO2, hexanes: ethyl acetate = 
15:1–10:1) to furnish the title compound as a colorless oil (34.1 mg, 0.16 mmol, anti:syn 




Spectral data is reported for the major isomer. 
 
TLC (SiO2) Rf  = 0.62 (hexanes/ethyl acetate = 2:1).  
1H NMR (400 MHz, CDCl3): δ = 5.86 (m, 1H), 5.19 (m, 2H), 5.08 (m, 1H), 3.52 (td, J = 
8.1, 3.9 Hz, 1H), 2.66 (d, J = 8.1 Hz, 1H), 2.5 (m, 1H), 2.30 (m, 1H), 2.08 (m, 2H), 1.90 
(brs, 1H), 1.66 (m, 4H), 1.59 (m, 3H), 1.47 (m, 1H), 1.35 (s, 3H).  
13C NMR (100 MHz, CDCl3): δ = 133.6, 132.0, 123.4, 118.7, 68.8, 64.8, 61.4, 39.6, 38.5, 
25.6, 23.7, 17.6, 16.5.  
HRMS (ESI) Calculated for C13H22O2 [M+Na
+] = 233.1512, Found 233.1506.  
FTIR (neat) 3435, 2927, 2358, 1436, 1384, 1072, 986, 914, 819 cm–1. 
[α]
D
























Detailed Procedures  
 
From alcohol oxidation level: An oven-dried pressure tube equipped with a magnetic stir 
bar was charged with [Ir(cod)Cl]2 (3.4 mg, 0.005 mmol, 2.5 mol%), (S)-SEGPHOS (6.1 
mg, 0.01 mmol, 5 mol%), 4-CN,3-NO-benzoic acid (3.8 mg, 0.02 mmol, 10 mol%), 
alcohol 1a (34 mg, 0.2 mmol, 100 mol%) and K2CO3 (13.8 mg, 0.1 mmol, 50 mol%). 
The vessel was purged with argon for 5 minutes. Anhydrous THF (0.5 mL, 0.4 M) and 
allyl acetate (43 µL, 0.4 mmol, 200 mol%) were sequentially added via syringe. The 
reaction vessel was sealed and the reaction mixture was allowed to stir at 100 ˚C for 48 h. 
After reaching ambient temperature, the reaction mixture was concentrated in vacuo. The 
residue was subjected to flash column chromatography (SiO2, hexanes: ethyl acetate = 
15:1–10:1) to furnish the title compound as a colorless oil (36.1 mg, 0.17 mmol, anti:syn 
= 1:12) in 86% yield. 
 
From aldehyde oxidation level: An oven-dried pressure tube equipped with a magnetic 
stir bar was charged with [Ir(cod)Cl]2 (3.4 mg, 0.005 mmol, 2.5 mol%), (S)-SEGPHOS 
(6.1 mg, 0.01 mmol, 5 mol%), 4-CN,3-NO-benzoic acid (3.8 mg, 0.02 mmol, 10 mol%), 
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aldehyde dehydro-1a (0.2 mmol, 100 mol%) and K2CO3 (13.8 mg, 0.01 mmol, 50 mol%). 
The vessel was purged with argon for 5 minutes. Anhydrous THF (0.5 mL, 0.4 M) and 
allyl acetate (43 µL, 0.4 mmol, 200 mol%) were sequentially added via syringe. The 
reaction vessel was sealed and the reaction mixture was allowed to stir at 100 ˚C for 48 h. 
After reaching ambient temperature, the reaction mixture was concentrated in vacuo. The 
residue was subjected to flash column chromatography (SiO2, hexanes: ethyl acetate = 
15:1–10:1) to furnish the title compound as a colorless oil (34.9 mg, 0.17 mmol, anti:syn 
= 1:11) in 83% yield. 
 
Spectral data is reported for the major isomer. 
 
TLC (SiO2) Rf  = 0.50 (hexanes/ethyl acetate = 2:1).  
1H NMR (400 MHz, CDCl3): δ = 5.82 (m, 1H), 5.23–5.10 (m, 2H), 5.06 (m, 1H), 3.55 
(td, J = 7.5, 5.9 Hz, 1H), 2.74 (d, J = 7.9 Hz, 1H), 2.42–2.25 (m, 3H), 2.08 (m, 2H), 1.69 
(m, 4H), 1.60 (m, 3H), 1.41 (m, 1H), 1.29 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ = 133.4, 132.1, 123.4, 118.1, 69.6, 66.4, 61.9, 38.7, 38.6, 
25.6, 23.7, 17.6, 17.3. 
HRMS (ESI) Calculated for C13H22O2 [M+Na
+] = 233.1512, Found 233.1514.  
FTIR (neat) 3435, 2924, 2362, 1435, 1383, 1043, 997, 914, 822 cm–1. 
[α]
D















Detailed Procedures  
 
An oven-dried pressure tube equipped with a magnetic stir bar was charged with 
[Ir(cod)Cl]2 (3.4 mg, 0.005 mmol, 2.5 mol%), (R)-Cl-MeO-BIPHEP (6.5 mg, 0.01 mmol, 
5 mol%), 4-CN,3-NO-benzoic acid (3.8 mg, 0.02 mmol, 10 mol%), alcohol 1b (39 mg, 
0.2 mmol, 100 mol%) and K2CO3 (13.8 mg, 0.1 mmol, 50 mol%). The vessel was purged 
with argon for 5 minutes. Anhydrous THF (1.0 mL, 0.2 M) and allyl acetate (43 µL, 0.4 
mmol, 200 mol%) were sequentially added via syringe. The reaction vessel was sealed 
and the reaction mixture was allowed to stir at 100 ˚C for 48 h. After reaching ambient 
temperature, the reaction mixture was concentrated in vacuo. The residue was subjected 
to flash column chromatography (SiO2, hexanes: ethyl acetate = 5:1–3:1) to furnish the 
title compound as a colorless oil (35.6 mg, 0.15 mmol, anti:syn = 9:1) in 76% yield. 
 
Spectral data is reported for the major isomer. 
 
TLC (SiO2) Rf  = 0.42 (hexanes/ethyl acetate = 2:1).  
1H NMR (400 MHz, CDCl3): δ = 7.32 (m, 5H), 5.88 (m, 1H), 5.17 (m, 2H), 4.58 (m, 
2H),  3.83 (dd, J = 10.9, 6.0 Hz, 1H), 3.67 (dd, J = 10.8, 5.7 Hz, 1H), 3.50 (td, J = 7.8, 
4.8 Hz, 1H), 3.26 (td, J = 5.9, 4.3 Hz, 1H), 2.96 (dd, J  = 8.0, 4.3 Hz, 1H), 2.60 (brs, 1H), 
2.49 (m, 1H), 2.38 (m, 1H).  
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13C NMR (100 MHz, CDCl3): δ = 137.2, 133.4, 128.5, 128.0, 127.9, 118.2, 73.6, 68.9, 
68.4, 57.9, 54.1, 39.3. 
HRMS (ESI) Calculated for C14H18O3 [M+Na
+] =257.1148, Found 257.1151.  
FTIR (neat) 3454, 2921, 1718, 1453, 1271, 1075, 1028, 918, 698 cm–1. 
[α]
D





























Detailed Procedures  
 
An oven-dried pressure tube equipped with a magnetic stir bar was charged with 
[Ir(cod)Cl]2 (3.4 mg, 0.005 mmol, 2.5 mol%), (S)-Cl-MeO-BIPHEP (6.5 mg, 0.01 mmol, 
5 mol%), 4-CN,3-NO-benzoic acid (3.8 mg, 0.02 mmol, 10 mol%), alcohol 2.1b (39 mg, 
0.2 mmol, 100 mol%) and K2CO3 (13.8 mg, 0.1 mmol, 50 mol%). The vessel was purged 
with argon for 5 minutes. Anhydrous THF (1.0 mL, 0.2 M) and allyl acetate (43 µL, 0.4 
mmol, 200 mol%) were sequentially added via syringe. The reaction vessel was sealed 
and the reaction mixture was allowed to stir at 100 ˚C for 48 h. After reaching ambient 
temperature, the reaction mixture was concentrated in vacuo. The residue was subjected 
to flash column chromatography (SiO2, hexanes: ethyl acetate = 5:1–3:1) to furnish the 
title compound as a colorless oil (37.0 mg, 0.16 mmol, anti:syn = 1:8) in 79% yield. 
 
Spectral data is reported for the major isomer. 
 
TLC (SiO2) Rf  = 0.35 (hexanes/ethyl acetate = 2:1).  
1H NMR (400 MHz, CDCl3): δ = 7.32 (m, 5H), 5.80 (m, 1H), 5.15 (m, 2H), 4.58 (m, 
2H), 3.72 (dd, J = 11.2, 4.1 Hz, 1H), 3.63–3.53 (m, 2H), 3.31 (dt, J = 6.5, 4.3 Hz, 1H), 
3.02 (dd, J = 7.4, 4.5 Hz, 1H), 2.36 (m, 2H), 2.13 (brs, 1H). 
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13C NMR (100 MHz, CDCl3): δ = 137.6, 133.1, 128.4, 127.8, 127.8, 118.5, 73.3, 69.0, 
68.1, 59.2, 56.0, 38.7.  
HRMS (ESI) Calculated for C14H18O3 [M+Na
+] =257.1148, Found 257.1155.  
FTIR (neat) 3421, 2926, 1737, 1365, 1229, 1094, 1027, 918, 700 cm–1. 
[α]
D































Detailed Procedures  
 
An oven-dried pressure tube equipped with a magnetic stir bar was charged with 
[Ir(cod)Cl]2 (3.4 mg, 0.005 mmol, 2.5 mol%), (R)-Cl-MeO-BIPHEP (6.5 mg, 0.01 mmol, 
5 mol%), 4-CN,3-NO-benzoic acid (3.8 mg, 0.02 mmol, 10 mol%), alcohol 2.1c (51 mg, 
0.2 mmol, 100 mol%) and K2CO3 (13.8 mg, 0.1 mmol, 50 mol%). The vessel was purged 
with argon for 5 minutes. Anhydrous THF (1.0 mL, 0.2 M) and allyl acetate (43 µL, 0.4 
mmol, 200 mol%) were sequentially added via syringe. The reaction vessel was sealed 
and the reaction mixture was allowed to stir at 100 ˚C for 48 h. After reaching ambient 
temperature, the reaction mixture was concentrated in vacuo. The residue was subjected 
to flash column chromatography (SiO2, hexanes: ethyl acetate = 6:1–3:1) to furnish the 








Spectral data is reported for the major isomer. 
 
TLC (SiO2) Rf  = 0.36 (hexanes/ethyl acetate = 2:1).  
1H NMR (400 MHz, CDCl3): δ = 7.27 (m, 2H), 6.88 (m, 2H), 5.86 (m, 1H), 5.21 (m, 
2H), 4.48 (s, 2H), 3.80 (s, 3H), 3.52 (m, 3H), 2.88 (m, 2H), 2.56 (m, 1H), 2.34 (m, 1H), 
1.93 (brs, 1H), 1.79 (m, 1H), 1.10 (d, J = 6.9 Hz, 3H).  
13C NMR (100 MHz, CDCl3): δ = 159.1, 133.4, 130.5, 129.1, 119.1, 113.7, 73.0, 72.9, 
68.0, 59.6, 58.1, 55.2, 40.0, 33.2, 13.8.  
HRMS (ESI) Calculated for C17H24O4 [M+Na
+] = 315.1567, Found 315.1561.  
FTIR (neat) 3438, 2962, 2362, 1612, 1513, 1247, 1088, 1034, 820 cm–1. 
[α]
D
























Detailed Procedures  
 
An oven-dried pressure tube equipped with a magnetic stir bar was charged with 
[Ir(cod)Cl]2 (3.4 mg, 0.005 mmol, 2.5 mol%), (S)-Cl-MeO-BIPHEP (6.5 mg, 0.01 mmol, 
5 mol%), 4-CN,3-NO-benzoic acid (3.8 mg, 0.02 mmol, 10 mol%), alcohol 2.1c (51 mg, 
0.2 mmol, 100 mol%) and K2CO3 (13.8 mg, 0.1 mmol, 50 mol%). The vessel was purged 
with argon for 5 minutes. Anhydrous THF (1.0 mL, 0.2 M) and allyl acetate (43 µL, 0.4 
mmol, 200 mol%) were sequentially added via syringe. The reaction vessel was sealed 
and the reaction mixture was allowed to stir at 100 ˚C for 48 h. After reaching ambient 
temperature, the reaction mixture was concentrated in vacuo. The residue was subjected 
to flash column chromatography (SiO2, hexanes: ethyl acetate = 6:1–3:1) to furnish the 
title compound as a colorless oil (48.5 mg, 0.17 mmol, anti:syn = 1:6) in 83% yield. 
 
Spectral data is reported for the major isomer. 
 
TLC (SiO2) Rf  = 0.29 (hexanes/ethyl acetate = 2:1).  
1H NMR (400 MHz, CDCl3): δ = 7.27 (m, 2H), 6.87 (m, 2H), 5.86 (m, 1H), 5.16 (m, 
2H), 4.47 (s, 2H), 3.80 (s, 3H), 3.56 (m, 2H), 3.45 (dd, J = 9.0, 6.5 Hz, 1H), 2.97 (dd, J = 
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7.6, 4.3 Hz, 1H), 2.91 (dd, J = 9.5, 4.3 Hz, 1H), 2.37 (m, 2H), 2.21 (brs, 1H), 1.73 (m, 
1H), 1.03 (d, J = 6.9 Hz, 3H).  
13C NMR (100 MHz, CDCl3): δ = 159.1, 133.3, 130.5, 129.1, 118.2, 113.7, 72.9, 72.9, 
68.7, 60.2, 59.6, 55.2, 39.0, 33.2, 14.0. 
HRMS (ESI) Calculated for C17H24O4 [M+Na
+] = 315.1567, Found 315.1556.  
FTIR (neat) 3423, 2963, 2361, 1612, 1512, 1247, 1088, 1034, 820 cm–1. 
[α]
D



























Detailed Procedures  
 
An oven-dried pressure tube equipped with a magnetic stir bar was charged with 
[Ir(cod)Cl]2 (3.4 mg, 0.005 mmol, 2.5 mol%), (R)-SEGPHOS (6.1 mg, 0.01 mmol, 5 
mol%), 4-CN,3-NO-benzoic acid (3.8 mg, 0.02 mmol, 10 mol%), alcohol 2.1d (35 mg, 
0.2 mmol, 100 mol%) and K2CO3 (13.8 mg, 0.1 mmol, 50 mol%). The vessel was purged 
with argon for 5 minutes. Anhydrous THF (1.0 mL, 0.2 M) and allyl acetate (43 µL, 0.4 
mmol, 200 mol%) were sequentially added via syringe. The reaction vessel was sealed 
and the reaction mixture was allowed to stir at 100 ˚C for 48 h. After reaching ambient 
temperature, the reaction mixture was concentrated in vacuo. The residue was subjected 
to flash column chromatography (SiO2, hexanes: ethyl acetate = 6:1–3:1) to furnish the 
title compound as a colorless oil (32.6 mg, 0.15 mmol, anti:syn = 10:1) in 76% yield. 
 
Spectral data is reported for the major isomer. 
 
TLC (SiO2) Rf  = 0.42 (hexanes/ethyl acetate = 2:1).  
1H NMR (400 MHz, CDCl3): δ = 5.84 (m, 1H), 5.22 (m, 2H), 4.18 (m, 2H), 3.85 (m, 
1H), 3.63 (dt, J = 7.7, 3.9 Hz, 1H), 3.07 (m, 1H), 2.96 (dd, J = 7.3, 4.3 Hz, 1H), 2.55 (m, 
1H), 2.31(m, 1H), 2.11 (d, J = 3.7 Hz, 1H), 1.48 (s, 3H), 1.38 (s, 3H). 
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13C NMR (100 MHz, CDCl3): δ = 133.0, 119.3, 110.1, 74.7, 68.6, 66.5, 57.8, 57.6, 40.1, 
26.5, 25.4. 
HRMS (ESI) Calculated for C11H18O4 [M+Na
+] = 237.1097, Found 237.1095.  
FTIR (neat) 3444, 2986, 1372, 1254, 1211,1154, 1058, 916, 840 cm–1. 
[α]
D






























Detailed Procedures  
 
An oven-dried pressure tube equipped with a magnetic stir bar was charged with 
[Ir(cod)Cl]2 (3.4 mg, 0.005 mmol, 2.5 mol%), (S)-SEGPHOS (6.1 mg, 0.01 mmol, 5 
mol%), 4-CN,3-NO-benzoic acid (3.8 mg, 0.02 mmol, 10 mol%), alcohol 2.1d (35 mg, 
0.2 mmol, 100 mol%) and K2CO3 (13.8 mg, 0.1 mmol, 50 mol%). The vessel was purged 
with argon for 5 minutes. Anhydrous THF (1.0 mL, 0.2 M) and allyl acetate (43 µL, 0.4 
mmol, 200 mol%) were sequentially added via syringe. The reaction vessel was sealed 
and the reaction mixture was allowed to stir at 100 ˚C for 48 h. After reaching ambient 
temperature, the reaction mixture was concentrated in vacuo. The residue was subjected 
to flash column chromatography (SiO2, hexanes: ethyl acetate = 6:1–3:1) to furnish the 








Spectral data is reported for the major isomer. 
 
TLC (SiO2) Rf  = 0.38 (hexanes/ethyl acetate = 2:1).  
1H NMR (400 MHz, CDCl3): δ = 5.82 (m, 1H), 5.17 (m, 2H), 4.11 (dt, J = 11.2, 6.3 Hz, 
2H), 3.79 (dq, J = 7.1, 4.1 Hz, 1H), 3.69 (td, J = 7.0, 5.9 Hz, 1H), 3.11 (dd, J = 7.1, 4.4 
Hz, 1H), 3.03 (dd, J = 6.9, 4.4 Hz, 1H), 2.35 (m, 3H), 1.47 (s, 3H), 1.37 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ = 132.9, 118.7, 110.1, 74.5, 68.4, 66.4, 59.3, 58.5, 39.0, 
26.5, 25.4. 
HRMS (ESI) Calculated for C11H18O4 [M+Na
+] = 237.1097, Found 237.1094.  
FTIR (neat) 3452, 2985, 1372, 1255, 1211,1154, 1057, 915, 843 cm–1. 
[α]
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Detailed Procedures  
 
An oven-dried pressure tube equipped with a magnetic stir bar was charged with 
[Ir(cod)Cl]2 (3.4 mg, 0.005 mmol, 2.5 mol%), (R)-SEGPHOS (6.1 mg, 0.01 mmol, 5 
mol%), 4-CN,3-NO-benzoic acid (3.8 mg, 0.02 mmol, 10 mol%), alcohol 2.1e (35 mg, 
0.2 mmol, 100 mol%) and K2CO3 (13.8 mg, 0.1 mmol, 50 mol%). The vessel was purged 
with argon for 5 minutes. Anhydrous THF (1.0 mL, 0.2 M) and allyl acetate (43 µL, 0.4 
mmol, 200 mol%) were sequentially added via syringe. The reaction vessel was sealed 
and the reaction mixture was allowed to stir at 100 ˚C for 48 h. After reaching ambient 
temperature, the reaction mixture was concentrated in vacuo. The residue was subjected 
to flash column chromatography (SiO2, hexanes: ethyl acetate = 6:1–3:1) to furnish the 
title compound as a colorless oil (33.9 mg, 0.16 mmol, anti:syn = 1:10) in 79% yield. 
 
Spectral data is reported for the major isomer. 
 
TLC (SiO2) Rf  = 0.52 (hexanes/ethyl acetate = 2:1).  
1H NMR (400 MHz, CDCl3): δ = 5.88 (m, 1H), 5.16 (m, 2H), 4.14 (dd, J = 8.5, 6.1 Hz, 
1H), 4.14 (dd, J = 8.5, 5.1 Hz, 1H), 3.92 (m, 1H), 3.65 (m, 1H), 3.04 (m, 2H), 2.47 (m, 
1H), 2.37 (m, 2H), 1.45 (s, 3H), 1.35 (s, 3H). 
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13C NMR (100 MHz, CDCl3): δ = 133.4, 118.4, 109.8, 73.4, 69.0, 68.2, 60.0, 57.4, 38.4, 
26.8, 25.2. 
HRMS (ESI) Calculated for C11H18O4 [M+Na
+] = 237.1097, Found 237.1094.  

































Detailed Procedures  
 
An oven-dried pressure tube equipped with a magnetic stir bar was charged with 
[Ir(cod)Cl]2 (3.4 mg, 0.005 mmol, 2.5 mol%), (S)-SEGPHOS (6.1 mg, 0.01 mmol, 5 
mol%), 4-CN,3-NO-benzoic acid (3.8 mg, 0.02 mmol, 10 mol%), alcohol 2.1e (35 mg, 
0.2 mmol, 100 mol%) and K2CO3 (13.8 mg, 0.1 mmol, 50 mol%). The vessel was purged 
with argon for 5 minutes. Anhydrous THF (1.0 mL, 0.2 M) and allyl acetate (43 µL, 0.4 
mmol, 200 mol%) were sequentially added via syringe. The reaction vessel was sealed 
and the reaction mixture was allowed to stir at 100 ˚C for 48 h. After reaching ambient 
temperature, the reaction mixture was concentrated in vacuo. The residue was subjected 
to flash column chromatography (SiO2, hexanes: ethyl acetate = 6:1–3:1) to furnish the 








Spectral data is reported for the major isomer. 
 
TLC (SiO2) Rf  = 0.48 (hexanes/ethyl acetate = 2:1).  
1H NMR (400 MHz, CDCl3): δ = 5.90 (m, 1H), 5.17 (m, 2H), 4.20 (m, 1H), 4.02 (m, 
1H), 3.57 (m, 1H), 3.00 (m, 2H), 2.77 (dd, J = 2.4, 0.8 Hz, 1H), 2.44 (m, 2H), 1.45 (s, 
3H), 1.34 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ = 133.5, 118.0, 109.8, 74.5, 69.4, 68.4, 58.2, 56.3, 39.2, 
26.7, 25.1.  
HRMS (ESI) Calculated for C11H18O4 [M+Na
+] = 237.1097, Found 237.1095.  


























Detailed Procedures  
 
An oven-dried pressure tube equipped with a magnetic stir bar was charged with 
[Ir(cod)Cl]2 (3.4 mg, 0.005 mmol, 2.5 mol%), (R)-Cl-MeO-BIPHEP (6.5 mg, 0.01 mmol, 
5 mol%), 4-CN,3-NO-benzoic acid (3.8 mg, 0.02 mmol, 10 mol%), alcohol 2.1f (52 mg, 
0.2 mmol, 100 mol%) and K2CO3 (13.8 mg, 0.1 mmol, 50 mol%). The vessel was purged 
with argon for 5 minutes. Anhydrous THF (1.0 mL, 0.2 M) and allyl acetate (43 µL, 0.4 
mmol, 200 mol%) were sequentially added via syringe. The reaction vessel was sealed 
and the reaction mixture was allowed to stir at 100 ˚C for 48 h. After reaching ambient 
temperature, the reaction mixture was concentrated in vacuo. The residue was subjected 
to flash column chromatography (SiO2, hexanes: ethyl acetate = 15:1–12:1) to furnish the 
title compound as a colorless oil (39.1 mg, 0.13 mmol, anti:syn = 17:1) in 65% yield. 
 
Spectral data is reported for the major isomer. 
 
TLC (SiO2) Rf  = 0.58 (hexanes/ethyl acetate = 4:1).  
1H NMR (400 MHz, CDCl3): δ = 5.87 (m, 1H), 5.14 (m, 2H), 3.94 (dd, J  = 11.8, 3.0 Hz, 
1H), 3.89 (m, 1H), 3.77 (dd, J  = 11.8, 4.5 Hz, 1H), 3.20 (m, 1H), 3.02 (dd, J  = 3.3, 2.3 
Hz, 1H), 2.40 (m, 1H), 2.31 (m ,1H), 2.02 (brs, 1H), 1.05 (m, 21H). 
13C NMR (100 MHz, CDCl3): δ = 133.5, 118.1, 67.8, 63.0, 57.5, 55.4, 38.0, 17.9, 11.9.  
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HRMS (ESI) Calculated for C16H32O3Si [M+Na
+] =323.2013, Found 323.2013.  
FTIR (neat) 3438, 2942, 1463, 1114, 1067, 996, 882, 777, 682 cm–1. 
[α]
D






























Detailed Procedures  
 
An oven-dried pressure tube equipped with a magnetic stir bar was charged with 
[Ir(cod)Cl]2 (3.4 mg, 0.005 mmol, 2.5 mol%), (S)-Cl-MeO-BIPHEP (6.5 mg, 0.01 mmol, 
5 mol%), 4-CN,3-NO-benzoic acid (3.8 mg, 0.02 mmol, 10 mol%), alcohol 2.1f (52 mg, 
0.2 mmol, 100 mol%) and K2CO3 (13.8 mg, 0.1 mmol, 50 mol%). The vessel was purged 
with argon for 5 minutes. Anhydrous THF (1.0 mL, 0.2 M) and allyl acetate (43 µL, 0.4 
mmol, 200 mol%) were sequentially added via syringe. The reaction vessel was sealed 
and the reaction mixture was allowed to stir at 100 ˚C for 48 h. After reaching ambient 
temperature, the reaction mixture was concentrated in vacuo. The residue was subjected 
to flash column chromatography (SiO2, hexanes: ethyl acetate = 15:1–12:1) to furnish the 
title compound as a colorless oil (19.2 mg, 0.06 mmol, anti:syn = 1:7) in 32% yield. 
 
Spectral data is reported for the major isomer. 
 
TLC (SiO2) Rf  = 0.54 (hexanes/ethyl acetate = 4:1).  
1H NMR (400 MHz, CDCl3): δ = 5.85 (m, 1H), 5.14 (m, 2H), 3.92 (dd, J  = 11.7, 2.9 Hz, 
1H), 3.77 (dd, J  = 11.8, 4.5 Hz, 1H), 3.60 (m, 1H), 3.11 (ddd, J  = 4.6, 3.1, 2.3 Hz, 1H), 
3.00 (dd, J  = 4.7, 2.3 Hz, 1H), 2.39 (m, 2H), 2.03 (m, 1H), 1.06 (m, 21H).  
13C NMR (100 MHz, CDCl3): δ = 133.4, 118.3, 70.1, 62.9, 58.2, 56.8, 39.2, 17.9, 11.9.  
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HRMS (ESI) Calculated for C16H32O3Si [M+Na
+] =323.2013, Found 323.2014.  
FTIR (neat) 3426, 2942, 1463, 1112, 1067, 996, 882, 781, 682 cm–1. 
[α]
D






















Detailed Procedures  
To a round-bottomed flask with 2.2c (30.0 mg, 0.10 mmol) under an argon atmosphere 
was added 1,2-dichloroethane (3.0 mL, 0.03 M). The reaction vessel was placed in -40 ºC 
bath and n-BuLi (80 µL, 2.5 M in hexanes, 0.25 mmol, 200 mol%) was added. The 
mixture was stirred for 30 minutes, at which point trimethylaluminum (0.16 mL, 2.0 M in 
toluene, 0.31 mmol, 300 mol%) was added dropwise. The mixture was allowed to warm 
to -15 ºC over 4 h. Water (3 mL) was added to the mixture and the mixture was 
transferred to a separatory funnel. The layers were separated and the aqueous layer was 
extracted with CH2Cl2 (10 mL × 3). The combined organic layers were washed with brine 
(10 mL), dried (MgSO4), filtered and concentrated under reduced pressure. The resulting 
oily residue was subjected to flash column chromatography (SiO2, hexanes: ethyl acetate 
= 7:1–4:1) to furnish the title compound as a colorless oil (23.7 mg, 0.08 mmol) in 77% 
yield. 
 
TLC (SiO2) Rf  = 0.40 (hexanes/ethyl acetate = 2:1).  
1H NMR (400 MHz, CDCl3): δ = 7.24 (m, 2H), 6.89 (m, 2H), 5.82 (m, 1H), 5.09 (m, 
2H), 4.46 (s, 2H), 4.36 (brs, 1H), 3.90 (ddd, J = 7.8, 6.3, 1.8 Hz, 1H), 3.81 (s, 3H), 3.75 
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(brs, 1H), 3.70 (m, 1H), 3.58 (dd, J = 9.1, 4.0 Hz, 1H), 3.44 (t, J = 9.2 Hz, 1H), 2.34 (m, 
1H), 2.17 (m, 1H), 2.00 (m, 1H), 1.61 (m, 1H), 0.92 (d, J = 7.0 Hz, 3H), 0.74 (d, J = 6.9 
Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 159.4, 135.6, 129.4, 129.4, 116.8, 113.9, 82.6, 76.5, 
76.0, 73.3, 55.3, 39.5, 37.4, 35.8, 13.0, 4.2. 
HRMS (ESI) Calculated for C18H28O4 [M+K
+] = 347.1619, Found 347.1611. 
FTIR (neat) 3431, 2915, 1612, 1513, 1247, 1079, 1035, 970, 753 cm–1. 
[α]
D




























HPLC: Enantiomeric excess was determined by HPLC analysis of the benzoate 
derivative of the product (Chiralcel OD-H column, hexanes:i-PrOH = 90:10, 1.00 
























Chapter 3:  Nickel-Catalyzed Cross-Coupling of Vinyl Dioxanones to 
Form Enantiomerically Enriched Cyclopropanes* 
 
3.1 Introduction 
Cyclopropanes appear as substructures across diverse secondary metabolites1 and 
are frequently found in commercial medicines, agrochemicals and fragrances.2 Hence, the 
development of methods for cyclopropane formation represents a persistent challenge in 
chemical research.3 Among the most effective methods for the preparation of 
enantiomerically enriched cyclopropanes is the reaction of olefins with metal 
carbenoids.3 Here, we report a strategy for the asymmetric synthesis of cyclopropanes 
under the conditions of metal catalyzed cross-coupling. Specifically, nickel(0) catalysts4,5 
react with enantiomerically enriched 4-aryl-5-vinyl-1,3-dioxanones to form (cyclopropyl-
carbinyl)nickel(II) species, which, in the presence of organoboron reagents or B2(pin)2 
deliver cyclopropanes in a stereospecific manner. Thus, the enantioselective synthesis of 
tetra-substituted cyclopropanes bearing all-carbon quaternary stereocenters is achieved 
(Scheme 3.1). 
 
Scheme 3.1 Synthesis of enantiomerically enriched cyclopropanes from vinyl-
dioxanones by way of transient (cyclopropyl-carbinyl)nickel species. 
 
*This chapter is based on the published work: 




In connection with ongoing investigations into the formation of C-C bonds via 
hydrogenation and transfer hydrogenation,6 we recently reported an iridium catalyzed 
coupling of primary alcohols with isoprene oxide to form products of tert-(hydroxy)-
prenylation – a byproduct-free transformation that occurs with exceptional control of 
anti-diastereo- and enantioselectivity.7 It was posited that cyclic carbonates derived from 
these reaction products should be predisposed toward cyclopropane formation under 
cross-coupling conditions, as geminal substitution of the neopentyl glycol precludes 
competing β-hydride elimination of the σ-benzylmetal intermediate and should 
conformationally bias the system toward olefin insertion8 via Thorpe-Ingold effect.9 
However, the facility of conventional benzylic cross-coupling rendered the feasibility of 







3.2 Reaction Development and Scope 
In an initial experiment, vinyl-dioxanone 3.1a was exposed to the catalyst derived 
from Ni(cod)2 (10 mol%) and PCy3 (20 mol%) in the presence of tri(p-tolyl)boroxine 
3.2a and K3PO4 (200 mol%) in toluene (0.1 M) at 60 
oC. To our delight, cyclopropane 
3.3a was formed in 36% yield as a single diastereomer. Conversion was found to be 
sensitive to concentration and temperature. At 45 oC under otherwise identical conditions, 
a 53% yield of cyclopropane 3.3a was obtained. Using the nickel catalyst modified by 
PCy2Ph (20 mol%), cyclopropane 3.3a was obtained in 77% yield. Finally, at slightly 
higher concentration (toluene, 0.2 M), an 85% yield of cyclopropane 3.3a was achieved 
(eq. 3.1). Stereospecificity was corroborated by chiral stationary phase HPLC analysis of 
cyclopropane 3.3a. Relative stereochemistry of cyclopropane 3.3a was confirmed by 
single crystal X-ray diffraction analysis. p-Tolylboronic acid also delivers cyclopropane 
3.3a (eq. 3.1), but in slightly lower yield. Application of these optimal conditions to 
unsubstituted methyl carbonate model-3.1a did not result in cyclopropane formation; 
rather, the indicated product obtained through β-hydride elimination of the σ-benzyl 
intermediate was formed (eq. 3.2). Cyclic carbonate 3.1a reacted more efficiently than 
related acyclic carbonates, suggesting the internal alkoxide generated upon ionization-
decarboxylation facilitates group transfer from boron to nickel through an internal boron 
ate-complex. 
Optimal conditions utilizing tri(p-tolyl)boroxine 3.2a were applied to a 
structurally diverse set of enantiomerically enriched vinyl-dioxanones 3.1a-3.1i (Table 
3.1). Vinyl dioxanones bearing a variety of substituted aromatic (3.1a-3.1d) and 
heteroaromatic (3.1e-3.1i) rings were converted to cyclopropanes 3.3a-3.3i in good yield 
with complete levels of diastereoselectivity. Relative stereochemistry was assigned in 
analogy to that determined for 3.3a. Although the preexisting non-epimerizable 
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quaternary stereocenter serves as an “internal standard,” stereospecificity was spot-
checked for compounds 3.3a, 3.3b, 3.3d and 3.3h. Notably, unlike prior work involving 
nickel catalyzed benzylic substitution, extended aromatic systems are not required.11 
Standard conditions also were applied to the coupling of vinyl-dioxanones 3.1a and 1h 
with boroxines 3.2b-3.2d, which incorporate p-CF3-phenyl, p-methoxyphenyl and (E)-






























Table 3.1 Stereospecific nickel-catalyzed cross coupling of vinyl-dioxanones 3.1a-
3.1i with tri(p-tolyl)boroxine 3.2a to form cyclopropanes 3.3a-3.3i.a 
 
 
aYields of material isolated by silica gel chromatography. All reactions were conducted using 





Table 3.2 Stereospecific nickel-catalyzed cross coupling of vinyl-dioxanones 3.1a or 




aYields of material isolated by silica gel chromatography. All reactions were conducted using 
enantiomerically enriched starting materials. See Supporting Information for further experimental details. 
 
The resulting cyclopropanes 3.3j-3.3o were formed in good yield in a completely 
stereoselective fashion. The coupling of vinyl-dioxanones 3.1a, 3.1b, 3.1d, 3.1h and 3.1f 
with B2(pin)2 under standard conditions delivers the cyclopropylcarbinyl boronates 3.3p-
3.3t in good yield with complete stereocontrol (Table 3.3).12 To briefly illustrate the 
utility of coupling products, the neopentyl alcohol 3.3a was subjected to Jones oxidation 
to provide the cyclopropyl carboxylic acid 3.4a in good yield (eq. 3.3). Additionally, the 
cyclopropylcarbinyl alcohol 3.3h was exposed to Mitsunobu conditions in the presence of 
phthalimide to furnish 3.4b in excellent yield (eq. 3.4).  
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Table 3.3 Stereospecific nickel-catalyzed cross coupling of vinyl-dioxanones 3.1a, 





aYields of material isolated by silica gel chromatography. All reactions were conducted using 







A general mechanism for stereospecific cyclopropane formation under the 
conditions of nickel catalyzed cross-coupling has been proposed (Scheme 3.2). 
Stereospecific oxidative addition of a nickel(0) species to the benzylic C-O bond occurs 
with inversion to furnish the indicated σ-benzylnickel(II) complex.10 Decarboxylation 
and transmetalation delivers the indicated alkene complex, which upon reversible 
migratory insertion8 provides a (cyclopropylcarbinyl)nickel(II) complex. Regardless of 
the kinetic diastereoselectivity of olefin insertion, reductive elimination occurs 
exclusively from a single stereoisomer of the (cyclopropylcarbinyl)nickel(II) species to 
release the cyclopropane and regenerate the zero-valent nickel catalyst.  
 









In summary, we report a new method for the preparation of enantiomerically 
enriched cyclopropanes via stereospecific nickel catalyzed cross-coupling of vinyl-
dioxanones with boroxines or B2(pin)2. The collective data are consistent with a catalytic 
mechanism involving nickel(0)-mediated benzylic oxidative addition with inversion of 
stereochemistry followed by reversible olefin insertion to form a (cyclopropylcarbinyl) 
nickel complex, which upon reductive elimination delivers the cyclopropane. The novel 
reactivity embodied by this process should serve as the basis for the syntheses of diverse 
enantiomerically enriched cyclopropanes. 
  
3.5 Experimental Details 
 
General Information 
All reactions were run under an atmosphere of argon. Sealed tubes (13x100 mm) 
were purchased from Fischer Scientific (catalog number 14-959-35C) and were oven-
dried followed by cooling in a desiccator. Tetrahydrofuran was distilled from sodium-
benzophenone immediately prior to use. Ethyl Acetate was dried over potassium 
carbonate and distilled immediately prior to use. Anhydrous solvents were transferred by 
oven-dried syringes. Analytical thin-layer chromatography (TLC) was carried out using 
0.25 mm commercial silica gel plates (Dynanmic Absorbents F254). Visualization was 
accomplished with UV light followed by dipping in p-anisaldehyde stain solution then 
heating. Purification of reactions was carried out by flash chromatography using 
Silacycle silica gel (40-63 μm, unless indicated specifically). Potassium phosphate was 
purchased through Acros Organics, flame dried prior to use and stored in a desiccator. 
Ni(cod)2 was purchased from Strem Chemicals. (S)-Ir-Tol-BINAP was synthesized 
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according to literature procedures1. p-Tolyl-boroxine (3.2a)2, 4-(trifluoromethyl)phenyl-
boroxine (3.2b)3, 4-methoxyphenyl-boroxine (3.2c)3 and (E)-styryl-boroxine (3.2d)3 were 
synthesized according to literature procedures.  
 
Spectroscopy, Spectrometry and Data Collection  
Infrared spectra were recorded on a Perkin-Elmer 1600 spectrometer. High-
resolution mass spectra (HRMS) were obtained on a Karatos MS9 and are reported as 
m/z (relative intensity). Accurate masses are reported for the molecular ion (M, M+H, or 
M-H), or a suitable fragment ion. 1H Nuclear magnetic resonance spectra were recorded 
using a 400 MHz or a 500 MHz spectrometer. Coupling constants are reported in Hertz 
(Hz) for CDCl3 solutions, and chemical shifts are reported as parts per million (ppm) 
relative to residual CHCl3 δH (7.26 ppm). 
13C Nuclear magnetic resonance spectra were 
recorded using a 100 MHz or a 125 MHz spectrometer for CDCl3 solutions, and chemical 
shifts are reported as parts per million (ppm) relative to residual CDCl3 δC (77.0 ppm). 
Fluorine-19 nuclear magnetic resonance (19F NMR) spectra were recorded with a Varian 
Gemini 400 (100 MHz) or a Bruker 500 (125 MHz) spectrometer. Melting points were 
taken on a Stuart SMP3 melting point apparatus. 
 
Experimental Details and Spectral Data 





An oven-dried pressure tube equipped with a magnetic stir bar was charged with K3PO4 
(42.4 mg, 0.2 mmol, 5 mol%), (S)-Ir-Tol-BINAP (220 mg, 0.2 mmol, 5 mol%) and p-
tolylmethanol (488 mg, 4.0 mmol, 100 mol%). Under an atmosphere of argon, anhydrous 
THF (8 mL, 0.5 M) and isoprene monoxide (1.18 mL, 12 mmol, 300 mol%) were 
sequentially added via syringe. After sealing the tube with cap, the reaction mixture was 
stirred at 45 ˚C for 24 h. The reaction was cooled to ambient temperature and 
concentrated in vacuo. The residue was subjected to flash column chromatography (SiO2, 
methylene chloride: acetone = 30:1) to furnish the title compound as a yellow oil (626 
mg, 3.0 mmol, anti:syn > 20:1) in 76% yield.  
 
TLC (SiO2) Rf = 0.30 (methylene chloride: acetone = 10:1).  
1H NMR (400 MHz, CDCl3) δ 7.20 – 7.07 (m, 4H), 6.03 (dd, J = 17.7, 11.0 Hz, 1H), 
5.20 (dd, J = 11.0, 1.1 Hz, 1H), 5.01 (dd, J = 17.8, 1.2 Hz, 1H), 4.62 (s, 1H), 3.60 (d, J = 
10.7 Hz, 1H), 3.51 (d, J = 10.7 Hz, 1H), 3.18 (brs, 1H), 2.90 (brs, 1H), 2.33 (s, 3H), 0.90 
(s, 3H). 
13C NMR (100 MHz, CDCl3) δ 139.6, 137.8, 137.2, 128.3, 127.6, 115.9, 79.9, 69.7, 46.2, 
21.0, 17.8. 
HRMS (ESI) Calcd. for C13H18NaO2
+ [M+Na]+: 229.1199, Found: 229.1201. 
FTIR (neat): 3377, 2966, 2919, 2977, 1637, 1515, 1460, 1415, 1378, 1201, 1039, 1018, 
919, 821, 678 cm-1. 
[𝛂]𝐃
𝟑𝟑 : -34.7 (c = 1.0, CHCl3). 
HPLC (two connected chiralcel OJ-H columns, hexanes:i-PrOH = 98:2, 0.80 mL/min, 












An oven-dried vial equipped with a magnetic stir bar was charged with diol SI-1a (50 
mg, 0.24 mmol, 100 mol%). Under argon atmosphere, acetonitrile (2.4 mL, 0.1 M) was 
added via syringe. CDI (77.8 mg, 0.48 mmol, 200 mol%) was added in one portion at 
ambient temperature. The reaction mixture was stirred at 25 ˚C for 16 h. The reaction was 
concentrated in vacuo. The residue was subjected to flash column chromatography (SiO2, 
hexanes: ethyl acetate = 3:1) to furnish the title compound as a white solid (46.3 mg, 0.20 
mmol) in 82 % yield.  
TLC (SiO2) Rf = 0.25 (hexanes/ethyl acetate = 2:1).  
1H NMR (400 MHz, CDCl3) δ 7.20 – 7.12 (m, 4H), 5.65 (ddd, J = 17.6, 11.1, 0.8 Hz, 
1H), 5.30 (d, J = 11.1 Hz, 1H), 5.25 (s, 1H), 5.23 (d, J = 17.6 Hz, 1H), 4.42 (d, J = 11.0 
Hz, 1H), 4.30 (dd, J = 11.0, 0.9 Hz, 1H), 2.36 (s, 3H), 1.04 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ 148.4, 138.8, 134.4, 130.8, 128.7, 127.4, 117.8, 87.0, 
75.1, 38.3, 21.2, 19.5. 
HRMS (ESI) Calcd. for C14H16NaO3
+ [M+Na]+: 255.0992, Found: 255.0994. 
[𝛂]𝐃
𝟑𝟑 : -73.7 (c = 1.0, CHCl3). 
m.p. : 85-86 ˚C 
FTIR (neat): 2977, 1747, 1517, 1478, 1456, 1399, 1378, 1341, 1241, 1200, 1712, 1135, 







An oven-dried vial equipped with a magnetic stir bar was charged with (1R,2R)-1-(4-
fluorophenyl)-2-methyl-2-vinylpropane-1,3-diol4 (100 mg, 0.48 mmol, 100 mol%). 
Under argon atmosphere, acetonitrile (4.8 mL, 0.1 M) was added via syringe. CDI (154 
mg, 0.95 mmol, 200 mol%) was added in one portion at ambient temperature. The 
reaction mixture was stirred at 25 ˚C for 16 h. The reaction was concentrated in vacuo. 
The residue was subjected to flash column chromatography (SiO2, hexanes: ethyl acetate 
= 3:1) to furnish the title compound as a white solid (90.7 mg, 0.38 mmol) in 81 % yield.  
TLC (SiO2) Rf = 0.23 (hexanes/ethyl acetate = 2:1).  
1H NMR (400 MHz, CDCl3) δ 7.28 – 7.23 (m, 2H), 7.10 – 7.03 (m, 2H), 5.64 (ddd, J = 
17.6, 11.0, 0.7 Hz, 1H), 5.32 (d, J = 11.1 Hz, 1H), 5.28 (s, 1H), 5.22 (d, J = 17.6 Hz, 1H), 
4.40 (d, J = 11.0 Hz, 1H), 4.33 (dd, J = 11.0, 0.8 Hz, 1H), 1.02 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ 162.9 (d, J = 248.3 Hz), 148.1, 133.9, 129.6 (d, J = 3.2 
Hz), 129.3 (d, J = 8.3 Hz), 118.2, 115.1 (d, J = 21.7 Hz), 86.3, 75.2, 38.3, 19.2. 
19F NMR (376 MHz, CDCl3) δ -112.4 (tt, J = 8.6, 5.2 Hz). 
HRMS (ESI) Calcd. for C13H13FNaO3
+ [M+Na]+: 259.0741, Found: 259.0744. 
[𝛂]𝐃
𝟑𝟑 : -46.0 (c = 1.0, CHCl3). 
m.p. : 108-109 ˚C 
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FTIR (neat): 2977, 1748, 1608, 1512, 1480, 1456, 1378, 1228, 1203, 1174, 1134, 1098, 



















An oven-dried vial equipped with a magnetic stir bar was charged with (1R,2R)-1-(3,5-
bis(trifluoromethyl)phenyl)-2-methyl-2-vinylpropane-1,3-diol4 (164 mg, 0.5 mmol, 100 
mol%). Under argon atmosphere, acetonitrile (5 mL, 0.1 M) was added via syringe. CDI 
(81 mg, 0.5 mmol, 100 mol%) was added in one portion at ambient temperature. The 
reaction mixture was stirred at 25 ˚C for 16 h. The reaction was concentrated in vacuo. 
The residue was subjected to flash column chromatography (SiO2, hexanes: ethyl acetate 
= 3:1) to furnish the title compound as a white solid (115 mg, 0.32 mmol) in 65% yield.  
TLC (SiO2) Rf = 0.23 (hexanes/ethyl acetate = 2:1). 
1H NMR (500 MHz, CDCl3) δ 7.92 (s, 1H), 7.74 (d, J = 1.5 Hz, 2H), 5.65 (dd, J = 17.5, 
11.0 Hz, 1H), 5.52 – 5.34 (m, 2H), 5.22 (d, J = 17.5 Hz, 1H), 4.55 – 4.18 (m, 2H), 1.07 
(s, 3H). 
13C NMR (125 MHz, CDCl3) δ 147.3, 136.4, 132.6, 131.6 (q, J = 33.8 Hz), 127.6 (d, J = 
4.1 Hz), 124.0, 123.3 – 122.7 (m), 121.8, 119.6, 85.4. 
HRMS (ESI) Calcd. for C15H12F6NaO3
+ [M+Na]+: 377.0583, Found: 377.0590. 
[𝛂]𝐃
𝟑𝟏 : -44.0 (c = 1.0, CHCl3). 
m.p. : 61-62˚C 







 (4R,5R)-4-(benzo[d][1,3]dioxol-5-yl)-5-methyl-5-vinyl-1,3-dioxan-2-one (3.1d) 
 
Detailed Procedures 
An oven-dried vial equipped with a magnetic stir bar was charged with (1R,2R)-1-
(benzo[d][1,3]dioxol-5-yl)-2-methyl-2-vinylpropane-1,3-diol1 (90 mg, 0.38 mmol, 100 
mol%). Under argon atmosphere, acetonitrile (3.8 mL, 0.1 M) was added via syringe. 
CDI (124 mg, 0.76 mmol, 200 mol%) was added in one portion at ambient temperature. 
The reaction mixture was stirred at 25 ˚C for 16 h. The reaction was concentrated in 
vacuo. The residue was subjected to flash column chromatography (SiO2, hexanes: ethyl 
acetate = 2:1) to furnish the title compound as a white solid (99.6 mg, 0.32 mmol) in 84 
% yield.  
TLC (SiO2) Rf = 0.20 (hexanes/ethyl acetate = 2:1).  
1H NMR (400 MHz, CDCl3) δ 6.80 – 6.75 (m, 2H), 6.71 (ddd, J = 8.0, 1.8, 0.5 Hz, 1H), 
5.98 (s, 2H), 5.68 (ddd, J = 17.6, 11.1, 0.9 Hz, 1H), 5.31 (d, J = 11.0 Hz, 1H), 5.24 (d, J = 
17.6 Hz, 1H), 5.19 (s, 1H), 4.39 (d, J = 11.0 Hz, 1H), 4.29 (dd, J = 11.0, 0.9 Hz, 1H), 
1.01 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ 148.2, 148.0, 147.5, 134.3, 127.5, 121.3, 117.9, 108.0, 
107.6, 101.3, 86.8, 75.2, 38.4, 19.4. 
HRMS (ESI) Calcd. for C14H14NaO5
+ [M+Na]+: 285.0733, Found: 285.0741. 
[𝛂]𝐃
𝟑𝟑 : -62.3 (c = 1.0, CHCl3). 
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FTIR (neat): 2970, 2360, 2341, 1748, 1505, 1491, 1447, 1399, 1377, 1253, 1205, 1102, 








An oven-dried pressure tube equipped with a magnetic stir bar was charged with K3PO4 
(10.6 mg, 0.05 mmol, 5 mol%), (S)-Ir-Tol-BINAP (55.0 mg, 0.05 mmol, 5 mol%) and 
benzo[b]thiophen-2-ylmethanol (82.1 mg, 0.5 mmol, 100 mol%). Under an atmosphere 
of argon, anhydrous THF (1.0 mL, 0.5 M) and isoprene monoxide (147 µL, 15 mmol, 
300 mol%) were sequentially added via syringe. After sealing the tube with cap, the 
reaction mixture was stirred at 45 ˚C for 24 h. The reaction was cooled to ambient 
temperature and concentrated in vacuo. The residue was subjected to flash column 
chromatography (SiO2, methylene chloride: acetone = 30:1) to furnish the title compound 
as a yellow oil (102 mg, 0.41 mmol, anti:syn > 20:1) in 82% yield.  
TLC (SiO2) Rf = 0.32 (dichloromethane/acetone = 10:1). 
1H NMR (400 MHz, CDCl3) δ 7.20 – 7.07 (m, 4H), 6.03 (dd, J = 17.7, 11.0 Hz, 1H), 
5.20 (dd, J = 11.0, 1.1 Hz, 1H), 5.01 (dd, J = 17.8, 1.2 Hz, 1H), 4.62 (s, 1H), 3.60 (d, J = 
10.7 Hz, 1H), 3.51 (d, J = 10.7 Hz, 1H), 3.18 (brs, 1H), 2.90 (brs, 1H), 2.33 (s, 3H), 0.90 
(s, 3H). 
13C NMR (100 MHz, CDCl3) δ 145.2, 139.5, 139.1, 139.0, 124.1, 124.1, 123.3, 122.2, 
122.1, 117.0, 69.7, 46.4, 18.0. 
HRMS (ESI) Calcd. for C14H16NaO2S
+ [M+Na]+: 271.0763, Found: 271.0772. 
FTIR (neat): 3345, 2964, 1636, 1457, 1415, 1124, 1014, 921. 832, 745, 725, 709 cm-1. 
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[𝛂]𝐃
𝟑𝟑 : -26.2 (c = 1.0, CHCl3). 
HPLC (one chiralcel OD-H columns, hexanes:i-PrOH = 97:3, 1.0 mL/min, 30 nm), 























An oven-dried vial equipped with a magnetic stir bar was charged with diol SI-3.1e (99.3 
mg, 0.4 mmol, 100 mol%). Under argon atmosphere, acetonitrile (4 mL, 0.1 M) was 
added via syringe. CDI (65 mg, 0.4 mmol, 100 mol%) was added in one portion at 
ambient temperature. The reaction mixture was stirred at 25 ˚C for 16 h. The reaction was 
concentrated in vacuo. The residue was subjected to flash column chromatography (SiO2, 
hexanes: ethyl acetate = 3:1) to furnish the title compound as a white solid (83.3 mg, 0.30 
mmol) in 75% yield.  
TLC (SiO2) Rf = 0.32 (dichloromethane/acetone = 10:1). 
1H NMR (400 MHz, CDCl3) δ 7.86 – 7.80 (m, 1H), 7.79 – 7.76 (m, 1H), 7.40 – 7.35 (m, 
2H), 7.32 (t, J = 0.7 Hz, 1H), 5.92 (ddd, J = 17.6, 11.1, 0.7 Hz, 1H), 5.59 (s, 1H), 5.38 (d, 
J = 11.1 Hz, 1H), 5.34 (d, J = 17.6 Hz, 1H), 4.46 (d, J = 11.1 Hz, 1H), 4.33 (dd, J = 11.0, 
0.8 Hz, 1H), 1.21 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ 147.4, 139.7, 138.5, 136.7, 134.2, 125.0, 124.6, 124.2, 
123.9, 122.2, 118.6, 84.1, 75.3, 38.5, 19.4. 
HRMS (ESI) Calcd. for C15H14NaO3S
+ [M+Na]+: 297.0556, Found: 2970561. 
[𝛂]𝐃
𝟑𝟐 : -37.1 (c = 1.0, CHCl3). 
m.p. : 146-147 ˚C 
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FTIR (neat): 2979, 17332, 1488, 1404, 1332, 1222, 1180, 1127, 1091, 1046, 944, 840, 











To a round-bottomed flask charged with tert-butyl 5-formyl-1H-indole-1-carboxylate5 
(1.70 g, 6.88 mmol, 100 mol%) under an argon atmosphere was added EtOH (26.0 mL, 
0.3 M). The reaction vessel was placed in an ice bath. After 10 minutes, sodium 
borohydride (390 mg, 10.32 mmol, 150 mol%) was added and the mixture was stirred for 
1 h. Water (20 mL) was added to the reaction mixture and the mixture was extracted with 
CH2Cl2 (30 mL × 3). The combined organic layers were washed with brine (100 mL), 
dried (MgSO4), filtered and concentrated under reduced pressure. The resulting oily 
residue was subjected to flash column chromatography (SiO2, hexanes: ethyl acetate = 
10:1–5:1) to furnish the title compound as a colorless oil (1.60 g, 6.5 mmol) in 94% yield. 
TLC (SiO2) Rf = 0.39 (hexanes/ethyl acetate = 2:1).  
1H NMR (500 MHz, CDCl3) δ 8.10 (d, J = 8.6 Hz, 1H), 7.59 (d, J = 3.7 Hz, 1H), 7.51 (d, 
J = 1.6 Hz, 1H), 7.28 (dd, J = 8.5, 1.7 Hz, 1H), 6.53 (d, J = 3.7 Hz, 1H), 4.72 (s, 2H), 
2.35 (s, 1H), 1.67 (s, 9H). 
13C NMR (125 MHz, CDCl3) δ 149.8, 135.4, 134.7, 130.7, 126.3, 123.7, 119.5, 115.2, 
107.3, 83.8, 65.5, 28.2. 
HRMS (ESI) Calcd. for C14H17NO3 [M+Na]
+: 270.1101, Found: 270.1101. 









An oven-dried pressure tube equipped with a magnetic stir bar was charged with K3PO4 
(4.2 mg, 0.02 mmol, 5 mol%), (S)-Ir-Tol-BINAP (22 mg, 0.02 mmol, 5 mol%) and 
alcohol SI-3.4 (100 mg, 0.40 mmol, 100 mol%). Under an atmosphere of argon, 
anhydrous THF (0.8 mL, 0.5 M) and isoprene monoxide (0.12 mL, 1.2 mmol, 300 mol%) 
were sequentially added via syringe. After sealing the tube with cap, the reaction mixture 
was stirred at 45 ˚C for 48 h. The reaction was cooled to ambient temperature and 
concentrated in vacuo. The residue was subjected to flash column chromatography (SiO2, 
hexanes: ethyl acetate = 6:1–4:1) to furnish the title compound as a yellow oil (98 mg, 
0.30 mmol, anti:syn > 20:1) in 74% yield.  
 
 
TLC (SiO2) Rf = 0.28 (hexanes/ethyl acetate = 2:1).  
1H NMR (500 MHz, CDCl3) δ 8.08 (d, J = 8.5 Hz, 1H), 7.61 (d, J = 3.7 Hz, 1H), 7.54 (d, 
J = 1.5 Hz, 1H), 7.31 – 7.27 (m, 1H), 6.57 (d, J = 3.7 Hz, 1H), 6.12 (dd, J = 17.8, 11.0 
Hz, 1H), 5.27 (dd, J = 11.0, 1.2 Hz, 1H), 5.08 (dd, J = 17.8, 1.3 Hz, 1H), 4.85 (d, J = 2.5 
Hz, 1H), 3.68 (dd, J = 10.7, 6.1 Hz, 1H), 3.62 (dd, J = 10.7, 5.1 Hz, 1H), 2.73 (d, J = 2.8 
Hz, 1H), 2.34 (t, J = 5.8 Hz, 1H), 1.69 (s, 9H), 0.98 (s, 3H). 
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13C NMR (125 MHz, CDCl3) δ 149.7, 139.8, 135.2, 134.7, 130.1, 126.2, 124.1, 120.0, 
116.2, 114.2, 107.4, 83.7, 80.1, 69.9, 46.7, 28.2, 17.7. 
HRMS (ESI) Calcd. for C19H25NO4 [M+Na]
+: 354.1676, Found: 354.1680. 
FTIR (neat): 3384, 2978, 1732, 1469, 1352, 1255, 1160, 1022, 754 cm-1. 
[𝛂]𝐃
𝟐𝟗 : –24.0 (c = 1.0, CHCl3). 
HPLC (Chiralcel AS-H columns, hexanes:i-PrOH = 99:1 (100 minutes) – 98:2 (100 






















An oven-dried vial equipped with a magnetic stir bar was charged with diol SI-3.1f (160 
mg, 0.48 mmol, 100 mol%). Under argon atmosphere, acetonitrile (4.8 mL, 0.1 M) was 
added via syringe. CDI (156 mg, 0.97 mmol, 200 mol%) was added in one portion at 
ambient temperature. The reaction mixture was stirred at 25 ˚C for 16 h. The reaction was 
concentrated in vacuo. The residue was subjected to flash column chromatography (SiO2, 
hexanes: ethyl acetate = 2:1) to furnish the title compound as a white solid (147 mg, 0.41 
mmol) in 85% yield.  
TLC (SiO2) Rf = 0.45 (hexanes/ethyl acetate = 1:1).  
1H NMR (500 MHz, CDCl3) δ 8.13 (d, J = 8.8 Hz, 1H), 7.62 (d, J = 3.7 Hz, 1H), 7.49 (d, 
J = 1.7 Hz, 1H), 7.19 (dd, J = 8.6, 1.8 Hz, 1H), 6.57 (d, J = 3.8 Hz, 1H), 5.68 (dd, J = 
17.6, 11.1 Hz, 1H), 5.38 (s, 1H), 5.30 (d, J = 11.1 Hz, 1H), 5.23 (d, J = 17.7 Hz, 1H), 
4.44 (d, J = 11.0 Hz, 1H), 4.33 (d, J = 10.9 Hz, 1H), 1.67 (s, 9H), 1.05 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ 149.5, 148.5, 135.3, 134.5, 130.2, 128.1, 126.7, 123.6, 
120.1, 117.8, 114.5, 107.2, 87.3, 84.0, 75.1, 38.5, 28.1, 19.6. 
HRMS (ESI) Calcd. for C20H23NO5 [M+Na]
+: 380.1468, Found: 380.1468. 
[𝛂]𝐃
𝟐𝟗 : –43.3 (c = 1.0, CHCl3). 
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m.p. : 158–162 ˚C 








An oven-dried pressure tube equipped with a magnetic stir bar was charged with K3PO4 
(4.2 mg, 0.02 mmol, 5 mol%), (S)-Ir-Tol-BINAP (22.0 mg, 0.02 mmol, 5 mol%) and 
(2,3-dimethylquinoxalin-6-yl)methanol6 (75.2 mg, 0.4 mmol, 100 mol%). Under an 
atmosphere of argon, anhydrous THF (0.8 mL, 0.5 M) and isoprene monoxide (0.16 mL, 
1.6 mmol, 400 mol%) were sequentially added via syringe. After sealing the tube with 
cap, the reaction mixture was stirred at 60 ˚C for 24 h. The reaction was cooled to 
ambient temperature and concentrated in vacuo. The residue was subjected to flash 
column chromatography (SiO2, hexanes: ethyl acetate = 1:10) to furnish the title 
compound as a yellow oil (92.0 mg, 0.34 mmol, anti:syn > 20:1) in 85% yield.  
 
TLC (SiO2) Rf = 0.31 (hexanes/ethyl acetate = 1:20). 
1H NMR (500 MHz, CDCl3) δ 7.87 (d, J = 1.3 Hz, 1H), 7.84 (d, J = 8.6 Hz, 1H), 7.64 
(dd, J = 8.6, 1.7 Hz, 1H), 6.12 (dd, J = 17.7, 11.0 Hz, 1H), 5.20 (dd, J = 11.0, 0.8 Hz, 
1H), 4.98 (dd, J = 17.8, 0.9 Hz, 1H), 4.93 (s, 1H), 4.04 (brs, 1H), 3.71 (d, J = 10.6 Hz, 
1H), 3.61 (d, J = 10.6 Hz, 1H), 3.24 (brs, 1H), 2.68 (s, 3H), 2.67 (s, 3H), 0.95 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ 153.5, 153.4, 142.3, 140.4, 140.1, 139.3, 129.0, 127.1, 
126.8, 116.3, 79.5, 69.7, 46.4, 23.0, 18.0. 
HRMS (ESI) Calcd. for C16H21N2O2
+ [M+H]+: 273.1598, Found: 273.1597. 
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FTIR (neat): 3325, 2965, 2877, 1637, 1496, 1450, 1405, 1380, 1334, 1254, 1164, 1148, 
1043, 021, 838, 809, 757, 666 cm-1. 
[𝛂]𝐃
𝟑𝟑 : -23.8 (c = 1.0, CHCl3). 
HPLC (two connected chiralcel AD-H columns, hexanes:i-PrOH = 95:5, 0.80 mL/min, 

























An oven-dried vial equipped with a magnetic stir bar was charged with diol SI-3.1g (65.0 
mg, 0.24 mmol, 100 mol%). Under argon atmosphere, acetonitrile (2.4 mL, 0.1 M) was 
added via syringe. CDI (77.4 mg, 0.48 mmol, 200 mol%) was added in one portion at 
ambient temperature. The reaction mixture was stirred at 25 ˚C for 16 h. The reaction was 
concentrated in vacuo. The residue was subjected to flash column chromatography (SiO2, 
hexanes: ethyl acetate = 1:10) to furnish the title compound as a yellow solid (51.0 mg, 
0.17 mmol) in 72 % yield.  
TLC (SiO2) Rf = 0.37 (hexanes/ethyl acetate = 1:10). 
1H NMR (500 MHz, CDCl3) δ 7.98 (d, J = 8.7 Hz, 1H), 7.88 (d, J = 1.4 Hz, 1H), 7.60 
(dd, J = 8.7, 1.8 Hz, 1H), 5.69 (dd, J = 17.6, 11.1 Hz, 1H), 5.50 (s, 1H), 5.32 (d, J = 11.1 
Hz, 1H), 5.22 (d, J = 17.6 Hz, 1H), 4.45 (d, J = 11.0 Hz, 1H), 4.39 (d, J = 11.1 Hz, 1H), 
2.74 (s, 3H), 2.74 (s, 3H), 1.10 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ 154.5, 154.4, 147.9, 141.0, 140.2, 134.6, 133.9, 128.2, 
127.7, 127.4, 118.4, 86.6, 75.2, 38.5, 23.2, 23.2, 19.4. 
HRMS (ESI) Calcd. for C17H19N2O3
+ [M+Na]+: 299.1390, Found: 299.1392. 
[𝛂]𝐃
𝟑𝟑 : -70.8 (c = 1.0, CHCl3). 
m.p. : 218-220 ˚C (decomposed) 
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FTIR (neat): 2970, 1747, 1456, 1401, 1335, 1240, 1210, 1166, 1134, 1103, 999, 974, 

















An oven-dried vial equipped with a magnetic stir bar was charged with (1R,2R)-1-(6-
methoxypyridin-3-yl)-2-methyl-2-vinylpropane-1,3-diol4 (558 mg, 2.5 mmol, 100 
mol%). Under argon atmosphere, acetonitrile (25 mL, 0.1 M) was added via syringe. CDI 
(810 mg, 5.0 mmol, 200 mol%) was added in one portion at ambient temperature. The 
mixture was stirred at 25 ˚C for 16 h. The reaction was concentrated in vacuo. The 
residue was subjected to flash column chromatography (SiO2, hexanes: ethyl acetate = 
1:1) to furnish the title compounds as a white solid (418 mg, 1.68 mmol) in 82% yield. 
TLC (SiO2) Rf = 0.31 (hexanes/ethyl acetate = 1:1). 
1H NMR (500 MHz, CDCl3) δ 8.07 (d, J = 2.6 Hz, 1H), 7.56 (dd, J = 8.7, 2.5 Hz, 1H), 
6.78 (d, J = 8.7 Hz, 1H), 5.74 (dd, J = 17.6, 11.1 Hz, 1H), 5.38 (d, J = 11.1 Hz, 1H), 5.28 
(s, 1H), 5.25 (d, J = 15.0 Hz, 1H), 4.42 (d, J = 11.0 Hz, 1H), 4.36 (d, J = 11.0 Hz, 1H), 
3.97 (s, 3H), 1.04 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ 164.7, 148.1, 146.0, 137.9, 133.7, 122.5, 118.7, 110.6, 
85.0, 75.5, 53.6, 38.4, 19.0. 
HRMS (ESI) Calcd. for C13H15NNaO4
+ [M+Na]+: 272.0894, Found: 272.0892 
[𝛂]𝐃
𝟑𝟎 : +110.9 (c = 0.61, CHCl3) 
m.p.: 102 – 104 ˚C 










An oven-dried vial equipped with a magnetic stir bar was charged with (1R,2R)-2-
methyl-1-(2-phenylpyrimidin-5-yl)-2-vinylpropane-1,3-diol4 (162 mg, 0.6 mmol, 100 
mol%). Under argon atmosphere, acetonitrile (6 mL, 0.1 M) was added via syringe. CDI 
(194 mg, 1.2 mmol, 200 mol%) was added in one portion at ambient temperature. The 
mixture was stirred at 25 ˚C for 16 h. The reaction was concentrated in vacuo. The 
residue was subjected to flash column chromatography (SiO2, hexanes: ethyl acetate = 
1:1) to furnish the title compounds as a white solid (128 mg, 0.43 mmol) in 72% yield. 
TLC (SiO2) Rf = 0.25 (hexanes/ethyl acetate = 1:1).  
1H NMR (500 MHz, CDCl3) δ 8.75 (s, 2H), 8.52 – 8.40 (m, 2H), 7.57 – 7.48 (m, 3H), 
5.82 (dd, J = 17.5, 11.0 Hz, 1H), 5.47 (d, J = 11.0 Hz, 1H), 5.39 (s, 1H), 5.29 (d, J = 17.5 
Hz, 1H), 4.46 (d, J = 11.0 Hz, 1H), 4.43 (d, J = 11.1 Hz, 1H), 1.11 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ 165.2, 156.1, 147.4, 136.7, 132.8, 131.3, 128.7, 128.4, 
125.1, 119.9, 83.50, 75.7, 38.3, 18.6. 
HRMS (ESI) Calcd. for C17H16N2NaO3
+ [M+Na]+: 319.1054, Found: 319.1059 
[𝛂]𝐃
𝟑𝟎 : +139.9 (c = 0.56, CHCl3) 
m.p.: 153 – 154 ˚C 






Procedures and Spectral Data for the Model study of Cyclopropane Formation: 
methyl (1-(p-tolyl)but-3-en-1-yl) carbonate (model-3.1a) 
 
Detailed Procedures 
An oven-dried vial equipped with a magnetic stir bar was charged with 1-(p-tolyl)but-3-
en-1-ol (324 mg, 2.0 mmol, 100 mol%) and 4-dimethylaminopyridine (439 mg, 3.6 
mmol, 180 mol%). Under argon atmosphere, DCM (5 mL, 0.4 M) was added via syringe. 
Then, methyl chloroformate (0.23 mL, 3.0 mmol, 150 mol%) was added dropwise at 0 
˚C. The reaction mixture was stirred at ambient temperature for 16 h. Saturated aqueous 
ammonium chloride (15 mL) was added. The aqueous layer was extracted with ethyl 
acetate (30 mL x 2). The combined organic layers were washed with brine (20 mL), dried 
(Na2SO4), filtered and concentrated in vacuo. The residue was subjected to flash column 
chromatography (SiO2, hexanes: ethyl acetate = 30:1) to furnish the title compound as a 
colorless oil (356 mg, 1.7 mmol) in 86% yield.  
TLC (SiO2) Rf = 0.35 (hexanes/ethyl acetate = 10:1).  
1H NMR (400 MHz, CDCl3) δ 7.25 (d, J = 8.0 Hz, 2H), 7.17 (d, J = 7.9 Hz, 2H), 5.72 
(ddt, J = 17.2, 10.2, 7.0 Hz, 1H), 5.61 – 5.55 (m, 1H), 5.15 – 5.04 (m, 2H), 3.74 (s, 3H), 
2.77 – 2.65 (m, 1H), 2.62 – 2.51 (m, 1H), 2.34 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ 155.2, 138.0, 136.5, 133.0, 129.2, 126.5, 118.2, 79.4, 
54.7, 40.6, 21.2. 
HRMS (ESI) Calcd. for C11H13
+ [M-OCO2Me]
+: 145.1012, Found: 145.1011. 








An oven-dried sealed tube equipped with a magnetic stir bar was charged with carbonate 
model-3.1a (22.0 mg, 0.1 mmol, 100 mol%), tri(p-tolyl)boroxine (30.1 mg, 0.085 mmol, 
85 mol%) 3.2a, dicyclohexylphenylphosphine (5.8 mg, 0.02 mmol, 20 mol%, 95%wt) 
and potassium phosphate (42.4 mg, 0.2 mmol, 200 mol%). This tube was transferred into 
an argon-atmosphere glovebox. Ni(cod)2 (2.8 mg, 0.01 mmol, 10 mol%) and toluene (0.5 
mL, 0.2 M) were added. After sealing the tube with cap, the tube was removed from the 
glovebox and the reaction mixture was stirred at 45 ˚C for 48 h. The reaction was cooled 
to ambient temperature, diluted with Et2O (1 mL) and filtered through a plug of silica gel, 
which was rinsed with Et2O (2 mL). The combined organic solution was concentrated in 
vacuo. The residue was subjected to flash column chromatography (SiO2, hexanes) to 
furnish the known title compound7 as a colorless oil (7.3 mg, 0.03 mmol) in 31% yield.  
 
TLC (SiO2) Rf = 0.28 (hexanes).  
1H NMR (400 MHz, CDCl3) δ 7.24 – 7.07 (m, 8H), 6.38 (d, J = 16.0 Hz, 1H), 6.31 (dd, J 
= 15.9, 6.2 Hz, 1H), 3.64 – 3.56 (m, 1H), 2.33 (s, 3H), 2.32 (s, 3H), 1.44 (d, J = 6.8 Hz, 
3H). 
 149 
13C NMR (125 MHz, CDCl3) δ 142.8, 136.7, 135.6, 134.8, 134.4, 129.1, 129.1, 128.1, 
127.2, 126.0, 42.1, 21.3, 21.1, 21.0. 
HRMS (CI) Calcd. for C18H20
+ [M]+: 236.1560, Found: 236.1570. 











An oven-dried sealed tube equipped with a magnetic stir bar was charged with vinyl-
dioxanone 3.1a (23.2 mg, 0.1 mmol, 100 mol%), tri(p-tolyl)boroxine (30.1 mg, 0.085 
mmol, 85 mol%) 3.2a, dicyclohexylphenylphosphine (5.8 mg, 0.02 mmol, 20 mol%, 
95%wt) and potassium phosphate (42.4 mg, 0.2 mmol, 200 mol%). This tube was 
transferred into an argon-atmosphere glovebox. Ni(cod)2 (2.8 mg, 0.01 mmol, 10 mol%) 
and toluene (0.5 mL, 0.2 M) were added. After sealing the tube with cap, the tube was 
removed from the glovebox and the reaction mixture was stirred at 45 ˚C for 48 h. The 
reaction was cooled to ambient temperature, diluted with Et2O (1 mL) and filtered 
through a plug of silica gel, which was rinsed with Et2O (2 mL). The combined organic 
solution was concentrated in vacuo. The residue was subjected to flash column 
chromatography (SiO2, hexanes: ethyl acetate = 10:1) to furnish the title compound as a 






TLC (SiO2) Rf = 0.45 (hexanes/ethyl acetate = 3:1).  
1H NMR (400 MHz, CDCl3) δ 7.20 – 7.05 (m, 8H), 3.39 (dd, J = 11.6, 7.6 Hz, 1H), 3.24 
(dd, J = 11.6, 4.4 Hz, 1H), 2.89 – 2.74 (m, 2H), 2.33 (s, 3H), 2.31 (s, 3H), 1.89 (d, J = 5.9 
Hz, 1H), 1.52 (dd, J = 13.0, 7.1 Hz, 1H), 1.41 (s, 3H), 0.93 – 0.87 (m, 1H). 
13C NMR (100 MHz, CDCl3) δ 138.7, 135.7, 135.7, 135.3, 129.1, 129.1, 128.3, 128.0, 
68.2, 35.1, 34.2, 29.6, 27.4, 21.0, 21.0, 17.2. 
HRMS (ESI) Calcd. for C20H24NaO
+ [M+Na]+: 303.1719, Found: 303.1720. 
[𝛂]𝐃
𝟑𝟑 : +24.0 (c = 1.0, CHCl3). 
m.p. : 59-60 ˚C 
FTIR (neat): 3394, 2920, 2361, 2342, 1514, 1460, 1113, 1020, 825, 807, 759, 669 cm-1 
HPLC (two connected chiralcel OJ-H columns, hexanes:i-PrOH = 98:2, 1.0 mL/min, 230 
















An oven-dried sealed tube equipped with a magnetic stir bar was charged with vinyl-
dioxanone 3.1a (23.6 mg, 0.1 mmol, 100 mol%), tri(p-tolyl)boroxine (30.1 mg, 0.085 
mmol, 85 mol%) 3.2a, dicyclohexylphenylphosphine (5.8 mg, 0.02 mmol, 20 mol%, 
95%wt) and potassium phosphate (42.4 mg, 0.2 mmol, 200 mol%). This tube was 
transferred into an argon-atmosphere glovebox. Ni(cod)2 (2.8 mg, 0.01 mmol, 10 mol%) 
and toluene (0.5 mL, 0.2 M) were added. After sealing the tube with cap, the tube was 
removed from the glovebox and the reaction mixture was stirred at 45 ˚C for 48 h. The 
reaction was cooled to ambient temperature, diluted with Et2O (1 mL) and filtered 
through a plug of silica gel, which was rinsed with Et2O (2 mL). The combined organic 
solution was concentrated in vacuo. The residue was subjected to flash column 
chromatography (SiO2, hexanes: ethyl acetate = 10:1) to furnish the title compound as a 
white solid (21.9 mg, 0.08 mmol) in 77% yield.  
 
TLC (SiO2) Rf = 0.31 (hexanes/ethyl acetate = 3:1).  
1H NMR (400 MHz, CDCl3) δ 7.20 – 7.10 (m, 6H), 6.98 – 6.91 (m, 2H), 3.35 (d, J = 
11.5 Hz, 1H), 3.22 (d, J = 11.5 Hz, 1H), 2.88 – 2.73 (m, 2H), 2.34 (s, 3H), 1.89 (d, J = 
5.9 Hz, 1H), 1.50 – 1.44 (m, 1H), 1.41 (s, 3H). 
 157 
13C NMR (100 MHz, CDCl3) δ 161.4 (d, J = 244.5 Hz), 138.5, 135.4, 134.5 (d, J = 3.1 
Hz), 130.0 (d, J = 7.8 Hz), 129.2, 128.0, 115.1 (d, J = 21.2 Hz), 68.1, 34.7, 34.1, 29.5, 
27.9, 21.0, 17.1. 
19F NMR (376 MHz, CDCl3) δ -116.8 – -116.9 (m). 
HRMS (CI) Calcd. for C19H20FO
+ [M-H]+: 283.1493, Found: 283.1492. 
[𝛂]𝐃
𝟑𝟑 : +26.7 (c = 1.0, CHCl3). 
FTIR (neat): 3360, 2921, 1604, 1510, 1456, 1222, 1157, 1103, 1069, 1015, 838, 769 cm-
1 





























An oven-dried sealed tube equipped with a magnetic stir bar was charged with vinyl-
dioxanone 3.1a (35.4 mg, 0.1 mmol, 100 mol%), tri(p-tolyl)boroxine (30.1 mg, 0.085 
mmol, 85 mol%) 3.2a, dicyclohexylphenylphosphine (5.8 mg, 0.02 mmol, 20 mol%, 
95%wt) and potassium phosphate (42.4 mg, 0.2 mmol, 200 mol%). This tube was 
transferred into an argon-atmosphere glovebox. Ni(cod)2 (2.8 mg, 0.01 mmol, 10 mol%) 
and toluene (0.5 mL, 0.2 M) were added. After sealing the tube with cap, the tube was 
removed from the glovebox and the reaction mixture was stirred at 55 ˚C for 48 h. The 
reaction was cooled to ambient temperature, diluted with Et2O (1 mL) and filtered 
through a plug of silica gel, which was rinsed with Et2O (2 mL). The combined organic 
solution was concentrated in vacuo. The residue was subjected to flash column 
chromatography (SiO2, hexanes: ethyl acetate = 20:1) to furnish the title compound as a 
colorless oil (22.7 mg, 0.07 mmol) in 73% yield.  
TLC (SiO2) Rf = 0.41 (hexanes/ethyl acetate = 5:1). 
1H NMR (500 MHz, CDCl3) δ 7.68 (s, 1H), 7.59 (s, 2H), 7.23 – 7.04 (m, 4H), 3.36 (dd, 
J = 11.3, 4.9 Hz, 1H), 3.21 (dd, J = 11.3, 5.0 Hz, 1H), 2.84-2.86 (m, J = 7.2, 3.5 Hz, 2H), 
2.33 (s, 3H), 1.97 (d, J = 6.0 Hz, 1H), 1.64 – 1.48 (m, 1H), 1.44 (s, 3H), 1.04 (t, J = 5.4 
Hz, 1H). 
 163 
13C NMR (125 MHz, CDCl3) δ 141.8, 137.9, 135.8, 131.3 (q, J = 33.1 Hz), 129.3, 128.9 
(d, J = 3.7 Hz), 127.9, 124.4, 122.2, 120.8 – 119.6 (m), 67.5, 34.9, 33.8, 30.5, 28.69, 
20.9, 17.0. 
HRMS (ESI) Calcd. for C21H20F6NaO
+ [M+Na]+: 425.1311, Found: 425.1315. 
[𝛂]𝐃
𝟑𝟐 : +23.0 (c = 1.0, CHCl3). 












An oven-dried sealed tube equipped with a magnetic stir bar was charged with vinyl-
dioxanone 3.1a (26.2 mg, 0.1 mmol, 100 mol%), tri(p-tolyl)boroxine (30.1 mg, 0.085 
mmol, 85 mol%) 3.2a, dicyclohexylphenylphosphine (5.8 mg, 0.02 mmol, 20 mol%, 
95%wt) and potassium phosphate (42.4 mg, 0.2 mmol, 200 mol%). This tube was 
transferred into an argon-atmosphere glovebox. Ni(cod)2 (2.8 mg, 0.01 mmol, 10 mol%) 
and toluene (0.5 mL, 0.2 M) were added. After sealing the tube with cap, the tube was 
removed from the glovebox and the reaction mixture was stirred at 55 ˚C for 48 h. The 
reaction was cooled to ambient temperature, diluted with Et2O (1 mL) and filtered 
through a plug of silica gel, which was rinsed with Et2O (2 mL). The combined organic 
solution was concentrated in vacuo. The residue was subjected to flash column 
chromatography (SiO2, hexanes: ethyl acetate = 5:1) to furnish the title compound as a 
white solid (21.6 mg, 0.07 mmol) in 70% yield.  
 
TLC (SiO2) Rf = 0.25 (hexanes/ethyl acetate = 3:1).  
1H NMR (400 MHz, CDCl3) δ 7.21 – 7.07 (m, 4H), 6.74 – 6.62 (m, 3H), 5.92 (s, 2H), 
3.38 (dd, J = 11.5, 4.4 Hz, 1H), 3.25 (d, J = 11.5 Hz, 1H), 2.88 – 2.70 (m, 2H), 2.33 (s, 
3H), 1.86 (d, J = 5.9 Hz, 1H), 1.46 – 1.40 (m, 1H), 1.39 (s, 3H), 0.98 (brs, 1H). 
 167 
13C NMR (100 MHz, CDCl3) δ 147.6, 145.9, 138.6, 135.4, 132.7, 129.2, 128.0, 121.4, 
109.0, 108.1, 100.9, 68.2, 35.2, 34.1, 29.5, 27.8, 21.0, 17.1. 
HRMS (CI) Calcd. for C20H22O3
+ [M]+: 310.1563, Found: 310.1567. 
[𝛂]𝐃
𝟑𝟑 : +25.7 (c = 1.0, CHCl3). 
FTIR (neat): 3430, 2919, 1608 1503, 1490, 1441, 1234, 1189, 1039, 935, 808 cm-1 


















An oven-dried sealed tube equipped with a magnetic stir bar was charged with vinyl-
dioxanone 3.1a (27.4 mg, 0.1 mmol, 100 mol%), tri(p-tolyl)boroxine (30.1 mg, 0.085 
mmol, 85 mol%) 3.2a, dicyclohexylphenylphosphine (5.8 mg, 0.02 mmol, 20 mol%, 
95%wt) and potassium phosphate (42.4 mg, 0.2 mmol, 200 mol%). This tube was 
transferred into an argon-atmosphere glovebox. Ni(cod)2 (2.8 mg, 0.01 mmol, 10 mol%) 
and toluene (0.5 mL, 0.2 M) were added. After sealing the tube with cap, the tube was 
removed from the glovebox and the reaction mixture was stirred at 45 ˚C for 48 h. The 
reaction was cooled to ambient temperature, diluted with Et2O (1 mL) and filtered 
through a plug of silica gel, which was rinsed with Et2O (2 mL). The combined organic 
solution was concentrated in vacuo. The residue was subjected to flash column 
chromatography (SiO2, hexanes: ethyl acetate = 20:1) to furnish the title compound as a 
colorless oil (15.7 mg, 0.068 mmol) in 68% yield.  
 
TLC (SiO2) Rf = 0.26 (hexanes/ethyl acetate = 5:1). 
1H NMR (400 MHz, CDCl3) δ 7.75 – 7.69 (m, 1H), 7.66 – 7.60 (m, 1H), 7.36 – 7.27 (m, 
2H), 7.20 (d, J = 8.0 Hz, 2H), 7.13 (d, J = 8.0 Hz, 2H), 6.96 (t, J = 1.0 Hz, 1H), 3.56 (d, J 
= 11.8 Hz, 1H), 3.40 (d, J = 11.8 Hz, 1H), 2.91 – 2.80 (m, 2H), 2.34 (s, 3H), 2.03 (d, J = 
5.7 Hz, 1H), 1.61 (td, J = 7.1, 5.7 Hz, 1H), 1.44 (s, 3H). 
 172 
13C NMR (125 MHz, CDCl3) δ 143.9, 140.0, 139.2, 138.0, 135.6, 129.2, 128.0, 124.3, 
123.8, 122.9, 122.0, 121.5, 67.9, 33.8, 31.3, 30.4 (d, J = 7.9 Hz), 21.0, 16.6. 
HRMS (ESI) Calcd. for C21H22NaOS
+ [M+Na]+: 345.1284, Found: 345.1295. 
[𝛂]𝐃
𝟑𝟑 : +17.0 (c = 1.0, CHCl3). 













An oven-dried sealed tube equipped with a magnetic stir bar was charged with vinyl-
dioxanone 3.1e (35.7 mg, 0.1 mmol, 100 mol%), tri(p-tolyl)boroxizne (30.1 mg, 0.085 
mmol, 85 mol%) 3.2a, dicyclohexylphenylphosphine (5.8 mg, 0.02 mmol, 20 mol%, 
95%wt) and potassium phosphate (42.4 mg, 0.2 mmol, 200 mol%). This tube was 
transferred into an argon-atmosphere glovebox. Ni(cod)2 (2.8 mg, 0.01 mmol, 10 mol%) 
and toluene (0.5 mL, 0.2 M) were added. After sealing the tube with cap, the tube was 
removed from the glovebox and the reaction mixture was stirred at 70 ˚C for 48 h. The 
reaction was cooled to ambient temperature, diluted with Et2O (1 mL) and filtered 
through a plug of silica gel, which was rinsed with Et2O (2 mL). The combined organic 
solution was concentrated in vacuo. The residue was subjected to flash column 
chromatography (SiO2, hexanes: ethyl acetate = 12:1) to furnish the title compound as a 







TLC (SiO2) Rf = 0.43 (hexanes/ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3) δ 8.02 (d, J = 8.5 Hz, 1H), 7.56 (d, J = 3.7 Hz, 1H), 7.38 – 
7.34 (m, 1H), 7.23 – 7.16 (m, 3H), 7.12 (d, J = 7.7 Hz, 2H), 6.48 (d, J = 3.7 Hz, 1H), 3.39 
(dd, J = 11.6, 7.5 Hz, 1H), 3.24 (dd, J = 11.6, 4.2 Hz, 1H), 2.85 (d, J = 7.0 Hz, 2H), 2.33 
(s, 3H), 2.03 (d, J = 5.8 Hz, 1H),tbs 1.66 (s, 9H), 1.60 (td, J = 7.1, 5.8 Hz, 1H), 1.43 (s, 
3H), 0.87 (dd, J = 7.8, 5.0 Hz, 1H). 
13C NMR (125 MHz, CDCl3) δ 149.7, 138.8, 135.4, 133.8, 133.1, 130.8, 129.2, 128.0, 
126.2, 125.1, 120.2, 115.0, 107.1, 83.6, 68.3, 35.5, 34.2, 29.6, 28.2, 27.5, 21.0, 17.2. 
HRMS (ESI) Calcd. for C26H31NO3
+ [M+Na]+: 428.2196, Found: 428.2200. 
[𝛂]𝐃
𝟐𝟓 : +33.2 (c = 1.0, CHCl3). 
























An oven-dried sealed tube equipped with a magnetic stir bar was charged with vinyl-
dioxanone 3.1g (29.8 mg, 0.1 mmol, 100 mol%), tri(p-tolyl)boroxine (30.1 mg, 0.085 
mmol, 85 mol%) 3.2a, dicyclohexylphenylphosphine (5.8 mg, 0.02 mmol, 20 mol%, 
95%wt) and potassium phosphate (42.4 mg, 0.2 mmol, 200 mol%). This tube was 
transferred into an argon-atmosphere glovebox. Ni(cod)2 (2.8 mg, 0.01 mmol, 10 mol%) 
and toluene (0.5 mL, 0.2 M) were added. After sealing the tube with cap, the tube was 
removed from the glovebox and the reaction mixture was stirred at 55 ˚C for 48 h. The 
reaction was cooled to ambient temperature, diluted with Et2O (1 mL) and filtered 
through a plug of silica gel, which was rinsed with Et2O (2 mL). The combined organic 
solution was concentrated in vacuo. The residue was subjected to flash column 
chromatography (SiO2, hexanes: ethyl acetate = 1:1) to furnish the title compound as a 
yellow solid (21.4 mg, 0.06 mmol) in 62% yield.  
 
TLC (SiO2) Rf = 0.29 (hexanes/ethyl acetate = 1:1).  
1H NMR (500 MHz, CDCl3) δ 7.84 (d, J = 8.6 Hz, 1H), 7.69 (s, 1H), 7.56 (dd, J = 8.5, 
1.3 Hz, 1H), 7.20 – 7.07 (m, 4H), 3.40 (d, J = 11.3 Hz, 1H), 3.29 (d, J = 11.5 Hz, 1H), 
 180 
2.92 – 2.81 (m, 2H), 2.69 (s, 3H), 2.69 (s, 3H), 2.32 (s, 3H), 2.09 (d, J = 5.9 Hz, 1H), 
1.75 – 1.71 (m, 1H), 1.47 (s, 3H), 1.13 (brs, 1H). 
13C NMR (125 MHz, CDCl3) δ 153.5, 152.8, 140.9, 140.4, 139.8, 138.3, 135.5, 130.7, 
129.2, 128.0, 127.9, 126.1, 67.6, 35.7, 34.1, 31.0, 28.1, 23.1, 23.0, 21.0, 17.2. 
HRMS (ESI) Calcd. for C23H27N2O
+ [M+H]+: 347.2118, Found: 347.2120. 
[𝛂]𝐃
𝟑𝟑 : +25.0 (c = 1.0, CHCl3). 
m.p. : 152-153 ˚C 
FTIR (neat): 3350, 2920, 2866, 2360, 2343, 1619, 1556, 1514, 1498, 1449, 1379, 1334, 












An oven-dried sealed tube equipped with a magnetic stir bar was charged with vinyl-
dioxanone 3.1h (24.9 mg, 0.1 mmol, 100 mol%), tri(p-tolyl)boroxine (30.1 mg, 0.085 
mmol, 85 mol%) 3.2a, dicyclohexylphenylphosphine (5.8 mg, 0.02 mmol, 20 mol%, 
95%wt) and potassium phosphate (42.4 mg, 0.2 mmol, 200 mol%). This tube was 
transferred into an argon-atmosphere glovebox. Ni(cod)2 (2.8 mg, 0.01 mmol, 10 mol%) 
and toluene (0.5 mL, 0.2 M) were added. After sealing the tube with cap, the tube was 
removed from the glovebox and the reaction mixture was stirred at 45 ˚C for 48 h. The 
reaction was cooled to ambient temperature, diluted with Et2O (1 mL) and filtered 
through a plug of silica gel, which was rinsed with Et2O (2 mL). The combined organic 
solution was concentrated in vacuo. The residue was subjected to flash column 
chromatography (SiO2, hexanes: ethyl acetate = 4:1) to furnish the title compound as oil 
(27.2 mg, 0.92 mmol) in 92% yield. 
TLC (SiO2) Rf = 0.10 (hexanes/ethyl acetate = 4:1).  
1H NMR (400 MHz, CDCl3) δ 7.95 (d, J = 2.5 Hz, 1H), 7.38 (ddd, J = 8.5, 2.5, 0.7 Hz, 
1H), 7.17 (d, J = 8.0 Hz, 2H), 7.11 (d, J = 8.0 Hz, 2H), 6.63 (dd, J = 8.5, 0.7 Hz, 1H), 
3.89 (s, 3H), 3.35 (dd, J = 11.6, 4.7 Hz, 1H), 3.22 (dd, J = 11.5, 3.8 Hz, 1H), 2.87 (dd, J = 
15.0, 6.6 Hz, 1H), 2.73 (dd, J = 15.0, 7.6 Hz, 1H), 2.33 (s, 3H), 1.79 (d, J = 5.9 Hz, 1H), 
1.46 – 1.41 (m, 1H), 1.40 (s, 3H), 1.13 (t, J = 5.4 Hz, 1H). 
 184 
13C NMR (100 MHz, CDCl3) δ 162.8, 146.6, 139.4, 138.4, 135.5, 129.2, 128.0, 127.1, 
110.2, 68.0, 53.3, 34.2, 32.0, 29.0, 27.8, 21.0, 17.0. 
HRMS (ESI) Calcd. for C19H23NNaO2
+ [M+Na]+: 320.1621, Found: 320.1625 
[𝛂]𝐃
𝟑𝟏: +100.6 (c = 1.3, CHCl3) 
FTIR (neat): 1607, 1494, 1408, 1373, 1316, 1283, 1258, 1109, 1022, 814, 726 cm-1. 



























An oven-dried sealed tube equipped with a magnetic stir bar was charged with vinyl-
dioxanone 3.1i (29.6 mg, 0.1 mmol, 100 mol%), tri(p-tolyl)boroxine (30.1 mg, 0.085 
mmol, 85 mol%) 3.2a, dicyclohexylphenylphosphine (5.8 mg, 0.02 mmol, 20 mol%, 
95%wt) and potassium phosphate (42.4 mg, 0.2 mmol, 200 mol%). This tube was 
transferred into an argon-atmosphere glovebox. Ni(cod)2 (2.8 mg, 0.01 mmol, 10 mol%) 
and toluene (0.5 mL, 0.2 M) were added. After sealing the tube with cap, the tube was 
removed from the glovebox and the reaction mixture was stirred at 45 ˚C for 48 h. The 
reaction was cooled to ambient temperature, diluted with Et2O (1 mL) and filtered 
through a plug of silica gel, which was rinsed with Et2O (2 mL). The combined organic 
solution was concentrated in vacuo. The residue was subjected to flash column 
chromatography (SiO2, hexanes: ethyl acetate = 4:1) to furnish the title compound (29.2 
mg, 0.85 mmol) in 85% yield. 
 
TLC (SiO2) Rf = 0.10 (hexanes/ethyl acetate = 4:1).  
1H NMR (400 MHz, CDCl3) δ 8.58 (s, 2H), 8.41 – 8.33 (m, 2H), 7.47 (s, 3H), 7.15 (s, 
4H), 3.45 (d, J = 11.3 Hz, 1H), 3.22 (d, J = 11.3 Hz, 1H), 2.93 (dd, J = 14.9, 6.5 Hz, 1H), 
2.75 (dd, J = 14.9, 7.8 Hz, 1H), 2.34 (s, 3H), 1.81 (d, J = 5.9 Hz, 1H), 1.54 (dt, J = 7.9, 
6.3 Hz, 1H), 1.45 (s, 3H), 1.42 (s, 1H). 
 189 
13C NMR (100 MHz, CDCl3) δ 162.5, 157.6, 138.0, 137.4, 135.7, 130.5, 130.2, 129.4, 
128.6, 127.9, 127.9, 67.4, 34.0, 30.0, 29.8, 28.1, 21.0, 17.0. 
HRMS (ESI) Calcd. for C23H24N2NaO
+ [M+Na]+: 367.1781, Found: 367.1784 
[𝛂]𝐃
𝟑𝟏: +120.3 (c = 1.1, CHCl3) 



















An oven-dried sealed tube equipped with a magnetic stir bar was charged with vinyl-
dioxanone 3.1a (23.3 mg, 0.1 mmol, 100 mol%), tri(p-tolyl)boroxine (43.9 mg, 0.085 
mmol, 85 mol%) 3.2b, dicyclohexylphenylphosphine (5.8 mg, 0.02 mmol, 20 mol%, 
95%wt) and potassium phosphate (42.4 mg, 0.2 mmol, 200 mol%). This tube was 
transferred into an argon-atmosphere glovebox. Ni(cod)2 (2.8 mg, 0.01 mmol, 10 mol%) 
and toluene (0.5 mL, 0.2 M) were added. After sealing the tube with cap, the tube was 
removed from the glovebox and the reaction mixture was stirred at 45 ˚C for 48 h. The 
reaction was cooled to ambient temperature, diluted with Et2O (1 mL) and filtered 
through a plug of silica gel, which was rinsed with Et2O (2 mL). The combined organic 
solution was concentrated in vacuo. The residue was subjected to flash column 
chromatography (SiO2, hexanes: ethyl acetate = 4:1) to furnish the title compound as oil 








TLC (SiO2) Rf = 0.30 (hexanes/ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3) δ 7.55 (d, J = 7.9 Hz, 2H), 7.41 (d, J = 7.9 Hz, 2H), 7.11 – 
7.03 (m, 4H), 3.39 (dd, J = 11.9, 5.6 Hz, 1H), 3.26 (d, J = 11.4 Hz, 1H), 2.95 (dd, J = 
15.4, 6.8 Hz, 1H), 2.87 (dd, J = 15.4, 7.5 Hz, 1H), 2.31 (s, 3H), 1.92 (d, J = 5.8 Hz, 1H), 
1.55 (q, J = 6.8 Hz, 1H), 1.41 (s, 3H), 0.95 (s, 1H). 
13C NMR (125 MHz, CDCl3) δ 145.9, 136.0, 135.2, 129.2, 128.5, 128.5, 128.2, 125.5, 
125.4, 125.4, 125.4, 123.3, 68.0, 35.1, 34.5, 29.6, 26.7, 21.0, 17.2. 
HRMS (ESI) Calcd. for C20H21F3NaO
+ [M+Na]+: 357.1437, Found: 357.1442 
[𝛂]𝐃
𝟐𝟗: +19.7 (c = 0.76, CHCl3) 




















An oven-dried sealed tube equipped with a magnetic stir bar was charged with vinyl-
dioxanone 3.1a (29.8 mg, 0.1 mmol, 100 mol%), tri(p-methoxyphenyl)boroxine (34.2 
mg, 0.085 mmol, 85 mol%) 3.2c, dicyclohexylphenylphosphine (5.8 mg, 0.02 mmol, 20 
mol%, 95%wt) and potassium phosphate (42.4 mg, 0.2 mmol, 200 mol%). This tube was 
transferred into an argon-atmosphere glovebox. Ni(cod)2 (2.8 mg, 0.01 mmol, 10 mol%) 
and toluene (0.5 mL, 0.2 M) were added. After sealing the tube with cap, the tube was 
removed from the glovebox and the reaction mixture was stirred at 55 ˚C for 48 h. The 
reaction was cooled to ambient temperature, diluted with Et2O (1 mL) and filtered 
through a plug of silica gel, which was rinsed with Et2O (2 mL). The combined organic 
solution was concentrated in vacuo. The residue was subjected to flash column 
chromatography (SiO2, hexanes: ethyl acetate = 8:1) to furnish the title compound as a 
yellow solid (22.5 mg, 0.08 mmol) in 76% yield.  
 
TLC (SiO2) Rf = 0.30 (hexanes/ethyl acetate = 4:1).  
1H NMR (400 MHz, CDCl3) δ 7.23 – 7.18 (m, 2H), 7.10 – 7.04 (m, 4H), 6.87 – 6.82 (m, 
2H), 3.79 (s, 3H), 3.38 (d, J = 11.6 Hz, 1H), 3.24 (d, J = 11.6 Hz, 1H), 2.82 (dd, J = 15.1, 
6.9 Hz, 1H), 2.76 (dd, J = 15.1, 7.3 Hz, 1H), 2.31 (s, 3H), 1.89 (d, J = 5.9 Hz, 1H), 1.51 
(dd, J = 13.1, 7.1 Hz, 1H), 1.40 (s, 3H), 0.93 (brs, 1H). 
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13C NMR (100 MHz, CDCl3) δ 157.8, 135.7, 135.7, 133.9, 129.1, 129.0, 128.3, 113.9, 
68.2, 55.2, 35.1, 33.7, 29.6, 27.5, 21.0, 17.2. 
HRMS (CI) Calcd. for C20H24O2
+ [M]+: 296.1771, Found: 296.1771. 
[𝛂]𝐃
𝟑𝟑 : +29.0 (c = 1.0, CHCl3). 










An oven-dried sealed tube equipped with a magnetic stir bar was charged with vinyl-
dioxanone 3.1a (23.2 mg, 0.1 mmol, 100 mol%), tri(phenylvinyl)boroxine 3.2d (33.2 mg, 
0.085 mmol, 85 mol%), dicyclohexylphenylphosphine (5.8 mg, 0.02 mmol, 20 mol%, 
95%wt) and potassium phosphate (42.4 mg, 0.2 mmol, 200 mol%). This tube was 
transferred into an argon-atmosphere glovebox. Ni(cod)2 (2.8 mg, 0.01 mmol, 10 mol%) 
and toluene (0.5 mL, 0.2 M) were added. After sealing the tube with cap, the tube was 
removed from the glovebox and the reaction mixture was stirred at 65 ˚C for 48 h. The 
reaction was cooled to ambient temperature, diluted with Et2O (1 mL) and filtered 
through a plug of silica gel, which was rinsed with Et2O (2 mL). The combined organic 
solution was concentrated in vacuo. The residue was subjected to flash column 
chromatography (SiO2, hexanes: ethyl acetate = 20:1) to furnish the title compound as a 
colorless oil (18.7 mg, 0.064 mmol) in 64% yield.  
TLC (SiO2) Rf = 0.35 (hexanes/ethyl acetate = 4:1). 
1H NMR (400 MHz, CDCl3) δ 7.37 – 7.26 (m, 4H), 7.22 – 7.05 (m, 5H), 6.54 – 6.43 (m, 
1H), 6.32 (dt, J = 15.8, 6.5 Hz, 1H), 3.40 (d, J = 11.6 Hz, 1H), 3.24 (d, J = 11.6 Hz, 1H), 
2.41-2.39 (m, 2H), 2.31 (s, 3H), 1.80 (d, J = 5.9 Hz, 1H), 1.41-1.36(m, 1H), 1.37 (s, 3H) 
13C NMR (100 MHz, CDCl3) δ 137.6, 135.7 (d, J = 2.3 Hz), 130.1, 129.6, 129.1, 128.4, 
128.2, 126.9, 126.0, 68.1, 34.7, 32.0, 29.6, 25.6, 20.9, 16.9. 
HRMS (ESI) Calcd. for C21H24NaO
+ [M+Na]+: 315.1719, Found: 315.1729. 
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[𝛂]𝐃
𝟑𝟑 : +9.7 (c = 1.0, CHCl3). 



























An oven-dried sealed tube equipped with a magnetic stir bar was charged with vinyl-
dioxanone 3.1h (24.9 mg, 0.1 mmol, 100 mol%), tri(p-tolyl)boroxine (43.9 mg, 0.085 
mmol, 85 mol%) 3.2b, dicyclohexylphenylphosphine (5.8 mg, 0.02 mmol, 20 mol%, 
95%wt) and potassium phosphate (42.4 mg, 0.2 mmol, 200 mol%). This tube was 
transferred into an argon-atmosphere glovebox. Ni(cod)2 (2.8 mg, 0.01 mmol, 10 mol%) 
and toluene (0.5 mL, 0.2 M) were added. After sealing the tube with cap, the tube was 
removed from the glovebox and the reaction mixture was stirred at 55 ˚C for 48 h. The 
reaction was cooled to ambient temperature, diluted with Et2O (1 mL) and filtered 
through a plug of silica gel, which was rinsed with Et2O (2 mL). The combined organic 
solution was concentrated in vacuo. The residue was subjected to flash column 
chromatography (SiO2, hexanes: ethyl acetate = 3:1,) to furnish the title compound as oil 
(25.2 mg, 0.72 mmol) in 72% yield. 
 
TLC (SiO2) Rf = 0.10 (hexanes/ethyl acetate = 3:1). 
1H NMR 1H NMR (500 MHz, CDCl3) δ 7.94 (d, J = 2.4 Hz, 1H), 7.56 (d, J = 8.0 Hz, 
2H), 7.40 (d, J = 8.6 Hz, 2H), 7.38 (dd, J = 6.4, 2.3 Hz, 1H), 6.64 (d, J = 8.4 Hz, 1H), 
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3.89 (s, 3H), 3.36 (d, J = 11.4 Hz, 1H), 3.25 (d, J = 11.4 Hz, 1H), 2.97 (dd, J = 15.2, 6.6 
Hz, 1H), 2.84 (dd, J = 15.2, 7.7 Hz, 1H), 1.82 (d, J = 5.8 Hz, 1H), 1.46 (q, J = 6.5 Hz, 
1H), 1.40 (s, 3H), 1.10 (s, 1H). 
13C NMR (125 MHz, CDCl3) δ 163.1, 146.7, 145.8, 139.4, 128.6 (q, J
3
CF = 32.5 Hz), 
128.6, 126.7, 125.6 (q, J1CF = 3.8 Hz), 124.4 (q, J
2
CF = 271 Hz, 110.5, 67.9, 53.5, 34.7, 
32.2, 29.1, 27.2, 17.1. 
19F NMR (470 MHz, CDCl3) δ -62.3. 
HRMS (ESI) Calcd. for C19H20F3NNaO2
+ [M+Na]+: 374.1339, Found: 374.1343 
[α]D29: +5.7 (c = 0.82, CHCl3) 
















An oven-dried sealed tube equipped with a magnetic stir bar was charged with vinyl-
dioxanone 3.1h (29.8 mg, 0.1 mmol, 100 mol%), tri(p-tolyl)boroxine 3.2d (34.2 mg, 
0.085 mmol, 85 mol%), dicyclohexylphenylphosphine (5.8 mg, 0.02 mmol, 20 mol%, 
95%wt) and potassium phosphate (42.4 mg, 0.2 mmol, 200 mol%). This tube was 
transferred into an argon-atmosphere glovebox. Ni(cod)2 (2.8 mg, 0.01 mmol, 10 mol%) 
and toluene (0.5 mL, 0.2 M) were added. After sealing the tube with cap, the tube was 
removed from the glovebox and the reaction mixture was stirred at 55 ˚C for 48 h. The 
reaction was cooled to ambient temperature, diluted with Et2O (1 mL) and filtered 
through a plug of silica gel, which was rinsed with Et2O (2 mL). The combined organic 
solution was concentrated in vacuo. The residue was subjected to flash column 
chromatography (SiO2, hexanes: ethyl acetate = 3:1) to furnish the title compound as a 
yellow solid (23.2 mg, 0.07 mmol) in 74% yield.  
 
TLC (SiO2) Rf = 0.24 (hexanes/ethyl acetate = 2:1).  
1H NMR (400 MHz, CDCl3) δ 7.95 (d, J = 2.5 Hz, 1H), 7.38 (dd, J = 8.4, 2.3 Hz, 1H), 
7.22 – 7.15 (m, 2H), 6.90 – 6.80 (m, 2H), 6.63 (d, J = 8.5 Hz, 1H), 3.89 (s, 3H), 3.79 (s, 
3H), 3.34 (d, J = 11.4 Hz, 1H), 3.22 (d, J = 11.4 Hz, 1H), 2.85 (dd, J = 14.9, 6.6 Hz, 1H), 
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2.71 (dd, J = 15.0, 7.7 Hz, 1H), 1.78 (d, J = 5.8 Hz, 1H), 1.44 – 1.37 (m, 1H), 1.40 (s, 
3H), 1.10 (brs, 1H). 
13C NMR (125 MHz, CDCl3) δ 162.8, 157.9, 146.6, 139.4, 133.6, 129.0, 127.0, 114.0, 
110.2, 68.0, 55.2, 53.3, 33.7, 32.0, 29.0, 28.0, 16.9. 
HRMS (ESI) Calcd. for C19H24NO3
+ [M+H]+: 314.1751, Found: 314.1754. 
[𝛂]𝐃
𝟑𝟑 : +9.0 (c = 1.0, CHCl3). 



















An oven-dried sealed tube equipped with a magnetic stir bar was charged with vinyl-
dioxanone 3.1h (23.2 mg, 0.1 mmol, 100 mol%), tri(phenylvinyl)boroxine 3.2d (33.2 mg, 
0.085 mmol, 85 mol%), dicyclohexylphenylphosphine (5.8 mg, 0.02 mmol, 20 mol%, 
95%wt) and potassium phosphate (42.4 mg, 0.2 mmol, 200 mol%). This tube was 
transferred into an argon-atmosphere glovebox. Ni(cod)2 (2.8 mg, 0.01 mmol, 10 mol%) 
and toluene (0.5 mL, 0.2 M) were added. After sealing the tube with cap, the tube was 
removed from the glovebox and the reaction mixture was stirred at 60 ˚C for 48 h. The 
reaction was cooled to ambient temperature, diluted with Et2O (1 mL) and filtered 
through a plug of silica gel, which was rinsed with Et2O (2 mL). The combined organic 
solution was concentrated in vacuo. The residue was subjected to flash column 
chromatography (SiO2, hexanes: ethyl acetate = 10:1) to furnish the title compound as a 
colorless oil (18.9 mg, 0.061 mmol) in 61% yield.  
TLC (SiO2) Rf = 0.40 (hexanes/ethyl acetate = 3:1). 
1H NMR (500 MHz, CDCl3) δ 8.05 (d, J = 2.4 Hz, 1H), 7.45 (dd, J = 8.6, 2.5 Hz, 1H), 
7.39 – 7.27 (m, 4H), 7.24 – 7.19 (m, 1H), 6.66 (d, J = 8.4 Hz, 1H), 6.52 – 6.46 (m, 1H), 
6.32 (dt, J = 15.8, 6.5 Hz, 1H), 3.38 (d, J = 11.4 Hz, 3H), 3.24 (d, J = 11.5 Hz, 1H), 2.43-
2.42 (m, 2H), 1.71 (d, J = 5.8 Hz, 1H), 1.37 (s, 3H), 1.31 (td, J = 7.2, 5.9 Hz, 1H). 
 213 
13C NMR (125 MHz, CDCl3) δ 162.8, 146.6, 139.2, 137.5, 130.4, 129.2, 128.5, 127.0, 
126.0, 110.2, 67.9, 53.3, 32.0, 31.7, 28.9, 25.8, 16.7. 
HRMS (ESI) Calcd. for C20H23NaNO2
+ [M+Na]+: 310.1802, Found: 310.1800. 
[𝛂]𝐃
𝟑𝟑 : +5.5 (c = 1.0, CHCl3). 













An oven-dried sealed tube equipped with a magnetic stir bar was charged with vinyl-
dioxanone 3.1a (29.8 mg, 0.1 mmol, 100 mol%), B2pin2 (50.8 mg, 0.2 mmol, 200 mol%) 
3.2a, dicyclohexylphenylphosphine (5.8 mg, 0.02 mmol, 20 mol%, 95%wt) and 
potassium phosphate (42.4 mg, 0.2 mmol, 200 mol%). This tube was transferred into an 
argon-atmosphere glovebox. Ni(cod)2 (2.8 mg, 0.01 mmol, 10 mol%) and toluene (0.5 
mL, 0.2 M) were added. After sealing the tube with cap, the tube was removed from the 
glovebox and the reaction mixture was stirred at 55 ˚C for 48 h. The reaction was cooled 
to ambient temperature, diluted with Et2O (1 mL) and filtered through a plug of silica gel, 
which was rinsed with Et2O (2 mL). The combined organic solution was concentrated in 
vacuo. The residue was subjected to flash column chromatography (SiO2, hexanes: ethyl 
acetate = 4:1) to furnish the title compound as a yellow solid (26.8 mg, 0.08 mmol) in 
85% yield.  
 
TLC (SiO2) Rf = 0.30 (hexanes/ethyl acetate = 4:1).  
1H NMR (400 MHz, CDCl3) δ 7.10 – 7.02 (m, 4H), 3.37 (dd, J = 10.9, 7.2 Hz, 1H), 3.01 
(d, J = 10.9 Hz, 1H), 2.30 (s, 3H), 2.06 (brs, 1H), 1.35 – 1.31 (m, 1H), 1.29 – 1.25 (m, 
16H), 0.78 – 0.71 (m, 1H). 
13C NMR (100 MHz, CDCl3) δ 136.1, 135.3, 128.8, 128.4, 83.5, 69.0, 36.6, 28.5, 25.0, 
24.8, 24.8, 22.6, 21.0, 17.1. 
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HRMS (CI) Calcd. for C19H29BO3
+ [M]+: 316.2204, Found: 316.2204. 
[𝛂]𝐃
𝟑𝟑 : +38.7 (c = 1.0, CHCl3). 













An oven-dried sealed tube equipped with a magnetic stir bar was charged with vinyl-
dioxanone 3.1h (24.9 mg, 0.1 mmol, 100 mol%), bis(pinacolato)diboron (50.8 mg, 0.2 
mmol, 200 mol%),  dicyclohexylphenylphosphine (5.8 mg, 0.02 mmol, 20 mol%, 
95%wt) and potassium phosphate (42.4 mg, 0.2 mmol, 200 mol%). This tube was 
transferred into an argon-atmosphere glovebox. Ni(cod)2 (2.8 mg, 0.01 mmol, 10 mol%) 
and toluene (0.5 mL, 0.2 M) were added. After sealing the tube with cap, the tube was 
removed from the glovebox and the reaction mixture was stirred at 45 ˚C for 48 h. The 
reaction was cooled to ambient temperature, diluted with Et2O (1 mL) and filtered 
through a plug of silica gel, which was rinsed with Et2O (2 mL). The combined organic 
solution was concentrated in vacuo. The residue was subjected to flash column 
chromatography (SiO2, CH2Cl2: acetone = 20:1–10:1) to furnish the title compound as a 
colorless oil (24.0 mg, 0.07 mmol) in 72% yield.  
 
TLC (SiO2) Rf = 0.41 (hexanes/ethyl acetate = 1:1).  
1H NMR (500 MHz, CDCl3) δ 8.00 (d, J = 2.4 Hz, 1H), 7.39 (dd, J = 8.5, 2.5 Hz, 1H), 
6.62 (d, J = 8.5 Hz, 1H), 3.90 (s, 3H), 3.39 (dd, J = 10.9, 8.0 Hz, 1H), 2.97 (dd, J = 10.9, 
2.9 Hz, 1H), 2.09 (dd, J = 8.2, 3.1 Hz, 1H), 1.60 (d, J = 5.4 Hz, 1H), 1.34 – 1.29 (m, J = 
5.9 Hz, 1H), 1.27 (d, J = 3.2 Hz, 12H), 1.23 (s, 3H), 0.81 – 0.70 (m, 1H). 
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13C NMR (125 MHz, CDCl3) δ 162.7, 146.7, 139.2, 127.5, 110.0, 83.6, 68.9, 53.3, 33.5, 
28.0, 24.8, 24.8, 22.9, 16.9. 
HRMS (ESI) Calcd. for C18H28BNO4 [M+H]
+: 334.2187, Found: 334.2192. 
[𝛂]𝐃
𝟐𝟓 : +33.7 (c = 1.0, CHCl3). 




















An oven-dried sealed tube equipped with a magnetic stir bar was charged with vinyl-
dioxanone 3.1e (35.7 mg, 0.1 mmol, 100 mol%), bis(pinacolato)diboron (50.8 mg, 0.2 
mmol, 200 mol%),  dicyclohexylphenylphosphine (5.8 mg, 0.02 mmol, 20 mol%, 
95%wt) and potassium phosphate (42.4 mg, 0.2 mmol, 200 mol%). This tube was 
transferred into an argon-atmosphere glovebox. Ni(cod)2 (2.8 mg, 0.01 mmol, 10 mol%) 
and toluene (0.5 mL, 0.2 M) were added. After sealing the tube with cap, the tube was 
removed from the glovebox and the reaction mixture was stirred at 75 ˚C for 48 h. The 
reaction was cooled to ambient temperature, diluted with Et2O (1 mL) and filtered 
through a plug of silica gel, which was rinsed with Et2O (2 mL). The combined organic 
solution was concentrated in vacuo. The residue was subjected to flash column 
chromatography (SiO2, hexanes: ethyl acetate = 15:1–10:1) to furnish the title compound 
as a colorless oil (33.1 mg, 0.08 mmol) in 75% yield.  
 
TLC (SiO2) Rf = 0.43 (hexanes/ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3) δ 7.99 (d, J = 8.5 Hz, 1H), 7.55 (d, J = 3.7 Hz, 1H), 7.38 (s, 
1H), 7.17 (dd, J = 8.5, 1.6 Hz, 1H), 6.48 (d, J = 3.7 Hz, 1H), 3.43 – 3.32 (m, 1H), 3.00 (d, 
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J = 11.0 Hz, 1H), 2.04 (d, J = 5.3 Hz, 1H), 1.83 (d, J = 6.0 Hz, 1H), 1.66 (s, 9H), 1.45 – 
1.33 (m, 2H), 1.30 (s, 3H), 1.28 (s, 12H), 1.24 (s, 1H), 0.79 (dd, J = 16.9, 9.8 Hz, 1H). 
13C NMR (125 MHz, CDCl3) δ 149.7, 133.6, 130.6, 126.0, 125.3, 120.4, 114.6, 107.1, 
83.5, 69.1, 36.9, 29.7, 28.5, 28.2, 24.8, 24.8, 22.8, 17.1. 
HRMS (ESI) Calcd. for C25H36BNO5 [M+K]
+: 480.2323, Found: 480.2339. 
[𝛂]𝐃
𝟐𝟒 : +31.7 (c = 1.0, CHCl3). 



















An oven-dried sealed tube equipped with a magnetic stir bar was charged with vinyl-
dioxanone 3.1b (23.6 mg, 0.1 mmol, 100 mol%), bis(pinacolato)diboron (50.8 mg, 0.2 
mmol, 200 mol%),  dicyclohexylphenylphosphine (5.8 mg, 0.02 mmol, 20 mol%, 
95%wt) and potassium phosphate (42.4 mg, 0.2 mmol, 200 mol%). This tube was 
transferred into an argon-atmosphere glovebox. Ni(cod)2 (2.8 mg, 0.01 mmol, 10 mol%) 
and toluene (0.5 mL, 0.2 M) were added. After sealing the tube with cap, the tube was 
removed from the glovebox and the reaction mixture was stirred at 55 ˚C for 48 h. The 
reaction was cooled to ambient temperature, diluted with Et2O (1 mL) and filtered 
through a plug of silica gel, which was rinsed with Et2O (2 mL). The combined organic 
solution was concentrated in vacuo. The residue was subjected to flash column 
chromatography (SiO2, hexanes: ethyl acetate = 6:1) to furnish the title compound as a 
colorless oil (24.3 mg, 0.076 mmol) in 76% yield.  
 
TLC (SiO2) Rf = 0.7 (hexanes/ethyl acetate = 1:1).  
1H NMR (500 MHz, CDCl3) δ 7.15 (dd, J = 8.4, 5.5 Hz, 2H), 6.92 (t, J = 8.7 Hz, 2H), 
3.37 (dd, J = 11.0, 7.7 Hz, 1H), 2.96 (dd, J = 11.0, 2.7 Hz, 1H), 2.06 (dd, J = 8.0, 3.2 Hz, 
1H), 1.68 (d, J = 5.8 Hz, 1H), 1.32 – 1.29 (m, 1H), 1.28 – 1.25 (m, 16H), 0.75 (dd, J = 
18.2, 11.2 Hz, 1H). 
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13C NMR (125 MHz, CDCl3) δ 161.4 (d, J
1
CF = 243.9 Hz), 135.1 (d, J
4
CF = 3.1 Hz), 
130.2 (d, J3CF = 7.8 Hz), 115.0 (d, J
2
CF = 21.1 Hz), 83.7, 69.1, 36.4, 28.5, 25.2, 25.0, 24.9, 
23.2, 17.1. 
HRMS (ESI) Calcd. for C18H26BFNaO3 [M+Na]
+: 343.1851, Found: 343.1857. 
[𝛂]𝐃
𝟐𝟒 : +25.6 (c = 1.2, CHCl3). 












An oven-dried sealed tube equipped with a magnetic stir bar was charged with vinyl-
dioxanone 3.1d (26.2 mg, 0.1 mmol, 100 mol%), bis(pinacolato)diboron (50.8 mg, 0.2 
mmol, 200 mol%),  dicyclohexylphenylphosphine (5.8 mg, 0.02 mmol, 20 mol%, 
95%wt) and potassium phosphate (42.4 mg, 0.2 mmol, 200 mol%). This tube was 
transferred into an argon-atmosphere glovebox. Ni(cod)2 (2.8 mg, 0.01 mmol, 10 mol%) 
and toluene (0.5 mL, 0.2 M) were added. After sealing the tube with cap, the tube was 
removed from the glovebox and the reaction mixture was stirred at 55 ˚C for 48 h. The 
reaction was cooled to ambient temperature, diluted with Et2O (1 mL) and filtered 
through a plug of silica gel, which was rinsed with Et2O (2 mL). The combined organic 
solution was concentrated in vacuo. The residue was subjected to flash column 
chromatography (SiO2, hexanes: ethyl acetate = 5:1) to furnish the title compound as a 
colorless oil (27.3 mg, 0.079 mmol) in 79% yield. 
 
TLC (SiO2) Rf = 0.25 (hexanes/ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3) δ 6.70 – 6.63 (m, 3H), 5.90 (s, 2H), 3.38 (dd, J = 10.9, 7.5 
Hz, 1H), 3.00 (dd, J = 11.1, 2.8 Hz, 1H), 2.05 (t, J = 7.5, 3.0 Hz, 1H), 1.65 (d, J = 5.5 Hz, 
1H), 1.28 – 1.23 (m, 17H), 0.73 (dd, J = 18.5, 11.2 Hz, 1H). 
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13C NMR (125 MHz, CDCl3) δ 147.5, 145.9, 133.4, 121.6, 109.4, 108.0, 100.9, 83.7, 
69.2, 36.9, 28.5, 25.2, 25.0, 24.9, 23.2, 17.1. 
HRMS (ESI) Calcd. for C19H27BNaO5 [M+Na]
+: 369.1844, Found: 369.1838. 
[𝛂]𝐃
𝟐𝟒 : +57.3 (c = 1.1, CHCl3). 















A vial equipped with a magnetic stir bar was charged with 3.3a (22.4 mg, 0.08 mmol, 
100 mol%). Under argon atmosphere, acetone (0.8 mL, 0.1 M) was added via syringe. 
The mixture was cooled to 0 °C and freshly prepared H2CrO4 (0.16 mL, 2.5 M, 500 
mol%) was added dropwise. The reaction mixture was stirred at ambient temperature for 
4 h. 2-propanol (0.5 mL) was slowly added. The mixture was filtered through a plug of 
sodium sulfate, which was rinsed with ethyl acetate (2 mL). The filtrate was concentrated 
in vacuo. The residue was subjected to flash column chromatography (SiO2, hexanes: 
ethyl acetate = 3:1) to furnish the title compound as a colorless oil (17.8 mg, 0.06 mmol) 
in 76% yield. 
TLC (SiO2) Rf = 0.23 (hexanes/ethyl acetate = 3:1). 
1H NMR (500 MHz, CDCl3) δ 7.18 – 7.08 (m, 4H), 7.00 (s, 4H), 2.87 (dd, J = 15.1, 6.8 
Hz, 1H), 2.79 (dd, J = 15.1, 7.7 Hz, 1H), 2.47 – 2.40 (m, 1H), 2.33 (s, 3H), 2.29 (s, 3H), 
2.24 (d, J = 7.5 Hz, 1H), 1.49 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ 177.4, 137.4, 136.0, 135.6, 133.6, 129.2, 128.8, 128.6, 
128.1, 41.0, 34.2, 31.4, 30.8, 21.1, 21.0, 15.6. 
HRMS (ESI) Calcd. for C20H22NaO2
+ [M+Na]+: 317.1512, Found: 317.1512. 
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[𝛂]𝐃
𝟑𝟒 : -10.0 (c = 0.88, CHCl3). 























An oven-dried vial equipped with a magnetic stir bar was charged with 3.3h (29.7 mg, 
0.1 mmol, 100 mol%), triphenylphosphine (39.3 mg, 0.15 mmol, 150 mol%), phthalimide 
(22.1 mg, 0.15 mmol, 150 mol%). Under argon atmosphere, THF (1 mL, 0.1 M) was 
added via syringe. DEAD (65.3 mg, 0.15 mmol, 150 mol%, 40% w/w in toluene) was 
added slowly at ambient temperature. The mixture was stirred at 25 ˚C for 2 h. Saturated 
NaHCO3 was added and the mixture was extracted by EA (20 mL x 2), dried (Na2SO4), 
filtered and concentrated in vacuo. The residue was subjected to flash column 
chromatography (SiO2, hexanes: ethyl acetate = 4:1) to furnish the title compounds as oil 
(37.4 mg, 0.88 mmol) in 88% yield. 
 
TLC (SiO2) Rf = 0.20 (hexanes/ethyl acetate = 4:1). 
1H NMR (500 MHz, CDCl3) δ 8.08 (d, J = 2.5 Hz, 1H), 7.77 (s, 2H), 7.71 (s, 2H), 7.50 
(dd, J = 8.5, 2.4 Hz, 1H), 7.05 (d, J = 7.7 Hz, 2H), 6.86 (d, J = 7.7 Hz, 2H), 6.69 (d, J = 
8.5 Hz, 1H), 3.91 (s, 3H), 3.70 (d, J = 14.2 Hz, 1H), 2.92 (d, J = 14.2 Hz, 1H), 2.70 (d, J 
= 7.3 Hz, 1H), 2.17 – 2.14 (m, 4H), 2.00 (q, J = 7.1 Hz, 1H), 1.82 (d, J = 6.3 Hz, 1H), 
1.32 (s, 3H). 
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13C NMR (125 MHz, CDCl3) δ 168.7, 163.0, 147.3, 139.4, 138.5, 135.2, 133.8, 132.2, 
129.0, 128.2, 126.8, 123.2, 110.4, 53.5, 44.4, 34.5, 33.1, 29.8, 27.2, 21.1, 19.0. 
HRMS (ESI) Calcd. for C27H26N2NaO3
+ [M+Na]+: 449.1836, Found: 449.1840 
[𝛂]𝐃
𝟑𝟎 : +97.0 (c = 1.0, CHCl3) 













Crystallographic Material for 3.3a: 
 
Table 1.  Crystal data and structure refinement for 1. 
Empirical formula  C20 H24 O 
Formula weight  280.39 
Temperature  100(2) K 
Wavelength  1.54184 Å 
Crystal system  monoclinic 
Space group  I 2 
  Unit cell dimensions a = 34.187(2) Å = 90°. 
 b = 5.8361(4) Å = 91.395(7)°. 
 c = 33.294(3) Å  = 90°. 
Volume 6640.8(8) Å3 
Z 16 
Density (calculated) 1.122 Mg/m3 
Absorption coefficient 0.510 mm-1 
F(000) 2432 
Crystal size 0.350 x 0.038 x 0.032 mm3 
Theta range for data collection 2.586 to 75.298°. 
Index ranges -42<=h<=41, -3<=k<=7, -41<=l<=41 
Reflections collected 11258 
Independent reflections 8398 [R(int) = 0.0792] 
Completeness to theta = 67.684° 98.6 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00 and 0.408 
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Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8398 / 505 / 773 
Goodness-of-fit on F2 1.122 
Final R indices [I>2sigma(I)] R1 = 0.0897, wR2 = 0.2422 
R indices (all data) R1 = 0.1131, wR2 = 0.2616 
Absolute structure parameter -0.3(6) 
Extinction coefficient n/a 







Chapter 4:  Amphiphilic π‑Allyliridium C,O‑Benzoates Enable Regio- 
and Enantioselective Amination of Branched Allylic Acetates Bearing 
Linear Alkyl Groups* 
 
4.1 Introduction 
Since the discovery of the Tsuji-Trost reaction,1 diverse catalytic systems for 
metal catalyzed allylic substitution have emerged.2 Among the many useful 
transformations based on this pattern of reactivity, enantioselective iridium catalyzed 
aminations figure prominently.3-11 Largely due to the pioneering work of Takeuchi,3,4 
Helmchen,5,6 Hartwig,7,8 Carreira9 and You,10,11 a broad range of amine nucleophiles can 
now be accommodated in highly regio- and enantioselective reactions of linear or 
branched allylic acetates (and in certain cases allylic alcohols).3-11 Two classes of iridium 
catalysts may be distinguished on the basis of their ability to promote regio- and 
enantioselective reactions of either linear or branched allylic acetates (Figure 1). For type 
I catalysts, linear allyl proelectrophiles are used under basic conditions. For type II 
catalysts, branched allyl proelectrophiles are used under acidic conditions. While type I 
catalysts are modified by one phosphoramidite and one external diene ligand, type II 
catalysts incorporate an internal mono-olefin ligand and two phosphoramidites, which 
may account for their exceptional electrophilicity. The internal olefin of type II catalysts 
may enhance enantioselectivity in reactions of branched allyl proelectrophiles by 
displacing the π-bond of (σ+π)-allyl (enyl) iridium intermediates,12 thus enabling rapid π-
facial interconversion in otherwise stereospecific substitutions.13 
 
 
*This chapter is based on the published work: 
Meza, A. T.; Wurm, T.; Smith, L.; Kim, S. W.; Zbieg, J. R.; Stivala, C. E.; Krische, M. J. J. Am. Chem. 




Figure 4.1 Phosphoramidite modified iridium complexes and amphiphilic π-
allyliridium C,O-benzoates for regio- and enantioselective allylic 
amination. 
 
Both type I and II catalysts bear π-acidic ligands and a formal positive charge at 
the metal center. These features enforce electrophilic properties of the allyliridium 
intermediate. In contrast, we have developed π-allyliridium C,O-benzoates, which are 
neutral and incorporate relatively strong σ-donor ligands (Figure 4.1).14,15  As 
demonstrated by their ability to promote diverse allylative carbonyl additions, the 
supporting  ligands of this catalyst confer nucleophilic character onto the allyl moiety.16 
However, as observed in our initial studies,14b carbonyl allylation is often accompanied 
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by small quantities of O-allylation, suggesting amphiphilic character of these π-allyl 
complexes. Pursuant to an accumulation of similar observations by coauthors at 
Genentech, a systematic attempt to evoke electrophilic behavior was undertaken in the 
context of allylic amination. Here, we show that the commercially available π-
allyliridium C,O-benzoate modified by SEGPHOS catalyzes asymmetric allylic 
amination. This catalyst overcomes a significant limitation in scope across all known 
catalytic systems – the ability to engage branched allylic acetates bearing linear alkyl 
groups with uniformly high levels of regio- and enantioselectivity.3-11,17,18 
 
4.2 Reaction Development and Scope 
In an initial set of experiments, α-methyl allyl acetate 4.1a (100 mol%) was 
exposed to benzyl amine 4.2a (200 mol%) in the presence of the SEGPHOS modified π-
allyliridium C,O-benzoate (5 mol%) in THF (1 M) at 40 oC (Table 4.1). In the absence of 
base, products of amination were not observed. However, after screening various 
heterogeneous bases, it was found that reactions conducted in the presence of Cs2CO3 
(120 mol%) provided the desired product of allylic amination 4.3a exclusively as the 
branched regioisomer with high levels of enantiomeric enrichment. After further 
optimization, the allylic amine 4.3a could be obtained in 90% isolated yield as a single 
regioisomer in 90% enantiomeric excess. Wet THF solvent is required, perhaps to 
partially solubilize Cs2CO3. Using distilled THF under otherwise optimal conditions, 4.3a 
was obtained in only 61% yield. Optimal yields were re-stored using distilled THF in 
combination with water (250 mol%). The absolute stereochemistry of 4.3a was 
determined by comparison of its optical rotation to that of an authentic sample reported in 




Table 4.1 Influence of Base in the Amination of α-Methyl Allyl Acetate 4.1a to 
Form Allylic Amine 4.3a.a 
 
 
aAll reactions were performed on a 0.44 mmol scale. Enantioselectivities were determined by chiral 
stationary phase HPLC analysis. See Supporting Information for further experimental details. bConversion 
was determined by 1H NMR. cCs2CO3 (200 mol%). dYield of material isolated by silica gel 
chromatography. 
 
Under these optimized conditions, primary benzylic, allylic and aliphatic amines 
serve as nucleophilic partners in aminations of diverse branched allylic acetates (Table 
4.2). Complete branched-regioselectivity was accompanied by high levels of 
enantioselectively (1H NMR & HPLC). Additionally, the levels of chemoselectivity in 
favor of primary amine allylation were sufficiently high that N-benzyl ethylene diamine 
and tryptamine could be converted to the respective amination products 4.3l and 4.3a′ 
without competing allylation of the secondary amine. As demonstrated by the formation 
of 4.3z, 4.3g′, 4.3h′, 4.3i′, primary amines that are branched at the α-position are 
effective nucleophilic partners. Further, as illustrated by the formation of 4.3b vs 4.3c, 
4.3e vs 4.3f and 4.3h vs 4.3i, excellent levels of catalyst-directed stereoinduction are 
observed. Perhaps the notable feature of this catalytic system, however, resides in the 
ability to engage branched allylic acetates bearing linear alkyl groups in highly regio- and 
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enantioselective aminations – a capability that complements the scope of previously 
reported iridium catalysts for allylic amination.3-11,17,18 
 




aYields of material isolated by silica gel chromatography. Standard conditions: (R)-IrLn (5 mol%), amine 
(200 mol%), Cs2CO3 (200 mol%), “wet” THF (1 M), 50 oC. Enantioselectivities were determined by chiral 
stationary phase HPLC analysis. See Supporting Information for further experimental details. 
bH2NCH2CH2NHBn (400 mol%), ee% determined at the stage of 4.4l (eq. 4.1). cThe cyclometallated 
iridium catalyst modified by the Roche ligand was used.18 
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To illustrate the utility of the reaction products a series of transformations were 
performed. The N-benzyl ethylene diamine adduct 4.3l was subjected to reductive 
amination with glyoxal to form the piperazine 4.4l (eq. 4.1).20 Adducts 4.3x and 4.3j′ 
were converted to 1-(N-benzyl-amino)-2-cyclohexene 4.4x (eq. 4.2)21 and the 











Scheme 4.1 Identical π-allyliridium C,O-benzoate complexes promote both 
nucleophilic and electrophilic allylation.a 
 
 
aSee Supporting Information for further experimental details. 
 
While numerous reports of “umpoled allylations” exist,22 the amphiphilic 
properties displayed by π-allyliridium C,O-benzoates appear quite unique.23 The same 
catalyst, (R)-IrLn (5 mol%), will promote both nucleophilic and electrophilic allylation 
under very similar conditions. For example, under standard amination conditions, 4-
aminomethyl-benzyl alcohol and α-methyl allyl acetate are directly converted to 
compound 4.7 in 36% yield. Alternatively, compound 4.5 can be converted to compound 
4.7 in a step-wise manner with higher levels of stereoselectivity using the same iridium 
catalyst (Scheme 4.1). 
 
4.3 Discussion 
The nature of the C-N bond forming event merits discussion. For related 
enantioselective iridium catalyzed allylic aminations, an outer-sphere mechanism is 
postulated.3-11 While it is likely such pathways are also operative in aminations catalyzed 
by π-allyliridium C,O-benzoates, an inner-sphere mechanism cannot be excluded. The 
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more stringent steric constraints of an inner-sphere mechanism may account for the fact 
that primary amines engage in allylation while secondary amines do not. Furthermore, 
enantiofacial selectivity for amination through an inner sphere mechanism matches that 
observed in nucleophilic allylations of α-substituted allylic acetates (Figure 4.2). 
Computational studies are underway to evaluate outer vs inner sphere pathways.  
 
Figure 4.2 Stereochemical models accounting for equivalent π-facial selectivity in 





In summary, highly tractable and commercially available π-allyliridium C,O-
benzoates, which are well known to catalyze nucleophilic carbonyl allylation, are now 
shown to catalyze chemo-, regio- and enantioselective electrophilic aminations of 
branched allylic acetates bearing linear alkyl groups. These processes broaden access to 
chiral N-containing building blocks24 and establish unique amphiphilic properties of π-
allyliridium C,O-benzoates, which should inform the design of new catalytic process. 
More broadly, this work demonstrates how academic-industrial collaboration accelerates 
the discovery of robust, innovative methods for chemical synthesis. 
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4.5 Experimental Details 
 
General Information 
All reactions were carried out under inert gas atmosphere (nitrogen or argon) 
unless otherwise indicated. Resealable pressure tubes (13x100 mm) were purchased from 
Fischer Scientific (catalog number 14-959-35C) and were flame dried followed by 
cooling in a desiccator or under a stream of inter gas prior to use. All commercial 
reagents and anhydrous solvents were used as received from vendors (Fischer Scientific, 
Sigma Aldrich and Combi Blocks) without further purification. The used Iridium catalyst 
[(R)-(+)-5,5'-bis(diphenylphosphino)-4,4'-bi-1,3-benzodioxole][4-cyano-3-
nitrobenzenecarboxylato][1,2,3-eta-2-propenyl Ir(III)]  and its enantiomer were either 
obtained from Strem Chemicals (catalog numbers: 77-5074 (R-catalyst) 77-5075 (S-
catalyst)) or prepared according to literature known procedures.1 The compounds (4-
(pentafluoro-λ6-sulfaneyl)phenyl)methanamine,2 (E)-3-phenylprop-2-en-1-amine,3 
geranylamine,4 5-phenylpenten-3-yl acetate,5 α-cyclopropyl  allyl  acetate,6 and 1,7-
octadien-3-yl acetate7 were also prepared according to literature procedures. Preparative 
column chromatography employing Silicycle silica gel (40-63 μm) was performed 
according to the method of Still8 or on a Teledyne Isco Combiflash Rf utilizing Silicycle 
HP columns using a mobile phase composed of either heptane/isopropyl acetate, 
hexane/ethyl acetate or dichloromethane/methanol. Reactions were monitored by a 
Shimadzu LCMS/UV system with LC-30AD solvent pump, 2020 MS, Sil-30AC 
autosampler, SPD-M30A UV detector, CTO-20A column oven, using a 2-98% 
acetonitrile/0.1% formic acid (or 0.001% ammonia) gradient over 2.5 minutes. Analytical 
thin-layer chromatography (TLC) was carried out using 0.25 mm commercial silica gel 
plates (Dynamic Absorbents F). Visualization was accomplished with UV light followed 
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by dipping in CAM, p-Anisaldehyde (PAA), or KMnO4 stain solution followed by 
heating. Specific optical rotations were recorded on an Atago AP-300 automatic 
polarimeter at the sodium line (589.3 nm) in CHCl3 Solution concentrations are given in 
the units of 10-2 g ml-1. 
 
Spectroscopy, Spectrometry and Data Collection  
Infrared spectra were recorded on a Perkin-Elmer 1600 spectrometer. High-
resolution mass spectra (HRMS) were obtained on a Karatos MS9 and are reported as 
m/z (relative intensity). Accurate masses are reported for the molecular ion (M+H, 
M+Na), or a suitable fragment ion. Proton nuclear magnetic resonance (1H NMR) spectra 
were recorded with a Bruker BioSpin GmbG, Varian Gemini (400 MHz) or Varian 
INOVA (500 MHz) spectrometer equipped with a Bruker cryoprobe. Chemical shifts are 
reported in delta (δ) units, parts per million (ppm) downfield from tetramethylsilane or 
ppm relative to the center of the singlet at 7.26 ppm for deuteriochloroform. Data 
reported as multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet). 
Integration and coupling constants were reported in Hertz (Hz). Carbon-13 nuclear 
magnetic resonance (13C NMR) spectra were recorded with a Bruker BioSpin GmbG, 
Varian Gemini (100 MHz) or Varian INOVA (125 MHz) spectrometer and were 
routinely run with broadband decoupling. Chemical shifts are reported in delta (δ) units, 
ppm relative to the center of the triplet at 77.16 ppm for deuteriochloroform. Fluorine-19 






Experimental Details and Spectral Data 
 





An oven-dried pressure tube equipped with a magnetic stir bar was charged with cesium 
carbonate (200 mol%), (R)-Ir-SEGPHOS (5 mol%). The tube was purged with argon for 
5 minutes. THF (1.0 M) was added followed by the allylic acetate (100 mol%) and the 
amine (200 mol%). The tube was sealed with a PTFE lined cap and was placed in an oil 
bath at the indicated temperature and stirred for the indicated period of time. After 














The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (94.3 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (50 oC, 18 hr). The 
title compound was obtained in 90% yield (63.2 mg, 0.39 mmol) as a light yellow oil 
after purification by flash column chromatography (SiO2, heptane: isopropyl acetate = 
1:0–0:1). 
 
TLC (SiO2) Rf  = 0.20 (hexanes:ethyl acetate 1:1).  
1H NMR (400 MHz, CDCl3): δ = 7.38 - 7.26 (m, 4H), 7.26 – 7.17 (m, 1H), 5.72 (ddd, J = 
17.6, 10.2, 7.7 Hz, 1H), 5.18 – 5.09 (m, 1H), 5.09 - 5.05 (m, 1H), 3.81 (d, J = 13.2 Hz, 
1H), 3.69 (d, J = 13.3 Hz, 1H), 3.28 – 3.16 (m, 1H), 1.18 (d, J = 6.5 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 142.6, 140.7, 128.4, 128.1, 126.8, 114.7, 56.0, 51.4, 
21.8. 
HRMS (ESI): Calculated for C11H16N [M+H
+] = 162.1283, found 162.1274. 
FTIR (neat): 3063, 3027, 2971, 1640, 1495, 1452, 1415, 1369, 1312, 1166, 1114, 1073, 
1028, 993, 916, 731, 696 cm–1. 
[α]
D
𝟐𝟒 = –5.6 (c 0.35, CHCl3). 





























































































































1 Data File Name: Z:/stivalac/nmr/79939-86-1/10/fid
2 Sample ID 79939-86-1
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl3
6 Pulse Sequence: zg30
7 Acquisition Date: 2017-05-26T18:01:55
8 Temperature: 300



















































1 Data File Name: Z:/stivalac/nmr/79939-86-c13/10/fid
2 Sample ID 79939-86-c13
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl3
6 Pulse Sequence: zgpg30
7 Acquisition Date: 2017-05-30T17:53:40
8 Temperature: 300















The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (107 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (50 oC, 18 hr). The 
title compound was obtained in 93% yield, >20:1 dr (71.4 mg, 0.41 mmol) as a light 
yellow oil after purification by flash column chromatography (SiO2, heptane: isopropyl 
acetate = 1:0–0:1). 
 
TLC (SiO2) Rf  = 0.32 (hexanes:ethyl acetate 1:1).  
1H NMR (400 MHz, CDCl3): δ = 7.37 – 7.18 (m, 5H), 5.63 (ddd, J = 17.1, 10.1, 8.0 Hz, 
1H), 5.03 (dd, J = 10.2, 1.8 Hz, 1H), 4.92 (ddd, J = 17.1, 2.0, 0.9 Hz, 1H), 3.82 (q, J = 
6.7 Hz, 1H), 2.98 – 2.86 (m, 1H), 1.32 (d, J = 6.7 Hz, 3H), 1.08 (d, J = 6.6 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 145.9, 142.5, 128.4, 126.7, 126.6, 114.5, 54.9, 53.7, 
25.0, 22.5. 
HRMS (ESI): Calculated for C12H18N [M+H
+] = 176.1439, found 176.1430 
FTIR (neat): 2959, 2924, 1672, 1602, 1492, 1450, 1415, 1368, 1306, 1120, 1081, 1027, 
993, 956, 916, 845, 761, 699 cm–1. 
[α]
D


































































































































1 Data File Name: Z:/stivalac/nmr/79939-87/10/fid
2 Sample ID 79939-87
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl3
6 Pulse Sequence: zg30
7 Acquisition Date: 2017-05-30T08:51:31
8 Temperature: 300






















































1 Data File Name: Z:/stivalac/nmr/79939-87-c13/10/fid
2 Sample ID 79939-87-c13
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl3
6 Pulse Sequence: zgpg30
7 Acquisition Date: 2017-05-30T10:32:30
8 Temperature: 300













The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (107 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (50 oC, 18 hr). The 
title compound was obtained in 92% yield, 14:1 dr (70.6 mg, 0.40 mmol) as a light 
yellow oil after purification by flash column chromatography (SiO2, heptane: isopropyl 
acetate = 1:0–0:1). 
 
 
TLC (SiO2) Rf  = 0.32 (hexanes:ethyl acetate 1:1).  
1H NMR (400 MHz, CDCl3): δ = 7.35 - 7.70 (m, 5H), 5.69 (ddd, J = 17.3, 10.2, 7.2 Hz, 
1H), 5.09 - 5.02 (m, 1H), 5.01 - 4.96 (m, 1H), 3.88 (q, J = 6.6 Hz, 1H), 3.21 – 3.09 (m, 
1H), 1.33 (d, J = 6.6 Hz, 3H), 1.13 (d, J = 6.4 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 146.0, 143.0, 128.4, 126.8, 126.5, 113.7, 54.7, 53.3, 
23.8, 20.9. 
HRMS (ESI): Calculated for C12H18N [M+H
+] = 176.1439, found 176.1430 
FTIR (neat): 2966, 2926, 1638, 1492, 1451, 1416, 1368, 1326, 1209, 1127, 993, 915, 
844, 760, 698 cm–1. 
[α]
D
















































































































































1 Data File Name: Z:/tenameza/nmr/79964-1/10/fid
2 Sample ID 79964-1
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl3
6 Pulse Sequence: zg30
7 Acquisition Date: 2017-05-31T17:31:14
8 Temperature: 300





















































1 Data File Name: Z:/tenameza/nmr/79964-1-1H/11/fid
2 Sample ID 79964-1-1H
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl3
6 Pulse Sequence: zgpg30
7 Acquisition Date: 2017-05-31T17:29:18
8 Temperature: 300













The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (138 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (50 oC, 18 hr). The 
title compound was obtained in 99% yield (92.0 mg, 0.44 mmol) as a light yellow oil 
after purification by flash column chromatography (SiO2, heptane: isopropyl acetate = 
1:0–0:1). 
 
TLC (SiO2) Rf  = 0.20 (hexanes:ethyl acetate 1:1).  
1H NMR (400 MHz, CDCl3): δ = 7.86 – 7.72 (m, 4H), 7.51 – 7.39 (m, 3H), 5.76 (ddd, J 
= 17.5, 10.2, 7.6 Hz, 1H), 5.19 – 5.06 (m, 2H), 3.98 (d, J = 13.2 Hz, 1H), 3.86 (d, J = 
13.3 Hz, 1H), 3.34 – 3.21 (m, 1H), 1.21 (d, J = 6.4 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 142.6, 138.2, 133.5, 132.6, 128.0, 127.7, 127.6, 126.7, 
126.4, 126.0, 125.5, 114.8, 56.0, 51.5, 21.8. 
HRMS (ESI): Calculated for C15H18N [M+H
+] = 212.1439, found 212.1429. 
FTIR (neat): 3053, 2968, 2817, 2362, 1636, 1600, 1508, 1438, 1414, 1367, 1311, 1270, 
1170, 1124, 993, 916, 854, 814, 746, 682 cm–1. 
[α]
D
𝟐𝟒= –8.1 (c 0.41, CHCl3). 



























































































































1 Data File Name: Z:/tenameza/nmr/79964-51-4NC-Pure/10/fid
2 Sample ID 79964-51-4NC-Pure
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl3
6 Pulse Sequence: zg30
7 Acquisition Date: 2017-06-28T14:35:46
8 Temperature: 300



























































1 Data File Name: A:/tenameza/nmr/79964-51-4NC-
Pure-13Carbon/10/fid
2 Sample ID 79964-51-4NC-Pure-13Carbon
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl3
6 Pulse Sequence: zgpg30
7 Acquisition Date: 2017-07-03T14:24:26
8 Temperature: 300


















The allylic acetate (22.8 mg, 0.20 mmol, 100 mol%) and the primary amine (68.5 mg, 
0.40 mmol, 200 mol%) were subject to standard reaction conditions (60 oC, 60 hr). The 
title compound was obtained in 95% yield, >20:1 dr (43.0 mg, 0.19 mmol) as a light 
yellow oil after purification by flash column chromatography (SiO2, hexanes: ethyl 
acetate = 10:1–3:1). 
 
TLC (SiO2) Rf  = 0.34 (hexanes/ethyl acetate = 1:1).  
1H NMR (400 MHz, CDCl3): δ = 7.82 (ddt, J = 7.1, 5.4, 0.7 Hz, 3H), 7.68 (dd, J = 1.5, 
0.9 Hz, 1H), 7.50 – 7.41 (m, 3H), 5.64 (ddd, J = 17.1, 10.2, 8.1 Hz, 1H), 5.06 (ddd, J = 
10.1, 1.8, 0.6 Hz, 1H), 4.92 (ddd, J = 17.1, 1.8, 0.8 Hz, 1H), 4.00 (q, J = 6.7 Hz, 1H), 
2.94 (ddt, J = 8.0, 7.2, 6.1 Hz, 1H), 1.40 (d, J = 6.7 Hz, 3H), 1.09 (d, J = 6.6 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 143.2, 142.4, 133.4, 132.7, 128.2, 127.6, 127.6, 125.9, 
125.3, 125.2, 124.8, 114.6, 55.0, 53.7, 24.9, 22.5. 
HRMS (ESI): Calculated for C16H19N [M+H
+] = 226.1590, Found 226.1584. 
FTIR (neat): 2960, 1449, 1368, 1126, 917, 856, 819, 746 cm–1. 
[α]
D











The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (151 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (50 oC, 18 hr). The 
title compound was obtained in 97% yield, 16:1 dr (96.0 mg, 0.43 mmol) as a light 
yellow oil after purification by flash column chromatography (SiO2, heptane: isopropyl 
acetate = 1:0–0:1). 
 
 
TLC (SiO2) Rf  = 0.30 (hexanes:ethyl acetate 1:1).  
1H NMR (400 MHz, CDCl3): δ = 7.87 – 7.76 (m, 3H), 7.74 - 7.71 (m, 1H), 7.50 - 7.40 
(m, 3H), 5.71 (ddd, J = 17.3, 10.2, 7.1 Hz, 1H), 5.07 (dt, J = 17.3, 1.4 Hz, 1H), 4.98 (dt, J 
= 10.2, 1.3 Hz, 1H), 4.06 (q, J = 6.5 Hz, 1H), 3.28 – 3.08 (m, 1H), 1.41 (d, J = 6.5 Hz, 
4H), 1.16 (d, J = 6.3 Hz, 3H).  
13C NMR (100 MHz, CDCl3): δ = 143.5, 143.0, 133.5, 132.7, 128.2, 127.7, 127.6, 125.9, 
125.4, 125.1, 125.0, 113.8, 54.8, 53.4, 23.8, 20.9. 
HRMS (ESI): Calculated for C16H20N [M+H
+] = 226.1596, found 226.1586 
FTIR (neat): 3055, 2965, 2923, 1637, 1600, 1506, 1451, 1415, 1367, 1315, 1269, 1128, 
1019, 993, 947, 915, 891, 855, 817, 744, 659 cm–1. 
[α]
D





















































































































































1 Data File Name: Z:/tenameza/nmr/79964-93-4NC-Pure/10/fid
2 Sample ID 79964-93-4NC-Pure
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl3
6 Pulse Sequence: zg30
7 Acquisition Date: 2017-07-21T15:39:57
8 Temperature: 300

































































1 Data File Name: Z:/tenameza/nmr/79964-93-4NC-Pure-13C/10/fid
2 Sample ID 79964-93-4NC-Pure-13C
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl3
6 Pulse Sequence: zgpg30
7 Acquisition Date: 2017-07-21T16:28:26
8 Temperature: 300












The allylic acetate (22.8 mg, 0.20 mmol, 100 mol%) and the primary amine (62.9 mg, 
0.40 mmol, 200 mol%) were subject to standard reaction conditions (60 oC, 60 hr). The 
title compound was obtained in 88% yield (37.2 mg, 0.18 mmol) as a light yellow oil 
after purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 1:1). 
 
TLC (SiO2) Rf  = 0.52 (hexanes/ethyl acetate = 1:1).  
1H NMR (500 MHz, CDCl3): δ = 8.08 (d, J = 8.6 Hz, 1H), 7.84 (d, J = 8.6 Hz, 1H), 7.75 
(d, J = 8.6 Hz, 1H), 7.54-7.44 (m, 3H), 7.43-7.38 (m, 1H), 5.79 (ddd, J = 17.2, 10.2, 7.8 
Hz, 1H), 5.2 (d, J = 17.2 Hz, 1H), 5.13 (d, J = 10.2 Hz, 1H), 4.26 (d, J = 13.0 Hz, 1H), 
4.26 (d, J = 13.0 Hz, 1H), 4.08 (d, J = 13.0 Hz, 1H), 3.36-3.28 (m, 1H), 1.62 (bs, 1H), 
1.21 (d, J = 6.5 Hz, 3H). 
13C NMR (125 MHz, CDCl3): δ = 142.7, 136.3, 134.1, 132.0, 128.9, 127.9, 126.3(x2), 
125.8, 125.6, 123.9, 115.3, 57.1, 49.3, 22.1. 
HRMS (ESI): Calculated for C15H17N [M+H
+] = 212.1434, Found 212.1429. 
FTIR (neat): 3063, 3027, 2970, 2923, 1640, 1495, 1452, 1415, 1369, 1312, 1113, 1073, 
1028, 993, 916, 713, 696 cm–1. 
[α]
D
𝟐𝟒= –42.5 (c 2.1, CHCl3). 
















The allylic acetate (60.5 mg, 0.53 mmol, 100 mol%) and the primary amine (182 mg, 
1.06 mmol, 200 mol%) were subject to standard reaction conditions (50 oC, 18 hr). The 
title compound was obtained in 91% yield, 17:1 dr (108 mg, 0.48 mmol) as a light yellow 
oil after purification by flash column chromatography (SiO2, heptane: isopropyl acetate = 
1:0–0:1). 
 
TLC (SiO2) Rf  = 0.43 (hexanes:ethyl acetate 1:1).  
1H NMR (400 MHz, CDCl3): δ = 8.22 – 8.14 (m, 1H), 7.90 – 7.84 (m, 1H), 7.76 - 7.71 
(m, 1H), 7.67 - 7.62 (m, 1H), 7.55 – 7.41 (m, 3H), 5.69 (ddd, J = 17.1, 10.1, 7.9 Hz, 1H), 
5.04 – 4.84 (m, 1H), 4.81 (ddd, J = 17.2, 1.9, 0.9 Hz, 1H), 4.71 (q, J = 6.7 Hz, 1H), 3.06 
– 2.94 (m, 1H), 1.44 (d, J = 6.7 Hz, 3H), 1.14 (d, J = 6.5 Hz, 3H).  
13C NMR (100 MHz, CDCl3): δ = 142.7, 141.7, 134.0, 131.4, 128.9, 127.0, 125.7, 125.6, 
125.2, 123.0, 122.6, 114.6, 54.0, 50.4, 24.6, 22.4. 
HRMS (ESI): Calculated for C16H20N [M+H
+] = 226.1596, found 226.1585. 
FTIR (neat): 3064, 2969, 2923, 1595, 1509, 1448, 1417, 1393, 1367, 1323, 1230, 1171, 
1125, 1087, 992, 918, 859, 798, 777, 735, 681 cm–1. 
[α]
D


































































































































1 Data File Name: Z:/tenameza/nmr/79964-93-4NC/10/fid
2 Sample ID 79964-93-4NC
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl3
6 Pulse Sequence: zg30
7 Acquisition Date: 2017-06-13T09:39:09
8 Temperature: 300




































































1 Data File Name: Z:/tenameza/nmr/79964-93-4NC/20/fid
2 Sample ID 79964-93-4NC
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl3
6 Pulse Sequence: zgpg30
7 Acquisition Date: 2017-06-13T09:46:35
8 Temperature: 300













The allylic acetate (60.5 mg, 0.53 mmol, 100 mol%) and the primary amine (182 mg, 
1.06 mmol, 200 mol%) were subject to standard reaction conditions (50 oC, 18 hr). The 
title compound was obtained in 95% yield, > 20:1 dr (113 mg, 0.50 mmol) as a light 
yellow oil after purification by flash column chromatography (SiO2, heptane: isopropyl 
acetate = 1:0–0:1). 
 
 
TLC (SiO2) Rf  = 0.43 (hexanes:ethyl acetate 1:1).  
1H NMR (400 MHz, CDCl3): δ = 8.20-8.16 (m, 1H), 7.88-7.84 (m, 1H), 7.77 - 7.72 (m, 
1H), 7.66 - 7.60 (m, 1H), 7.55 – 7.38 (m, 3H), 5.75 (ddd, J = 17.4, 10.2, 7.4 Hz, 1H), 
5.20 - 5.10 (m, 1H), 5.08 - 5.02 (m, 1H), 4.74 (q, J = 6.5 Hz, 1H), 3.37 – 3.25 (m, 1H), 
1.48 (d, J = 6.5 Hz, 3H), 1.16 (d, J = 6.4 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 142.9, 141.8, 134.0, 131.1, 128.9, 127.1, 125.8, 125.7, 
125.3, 123.0, 122.9, 114.0, 53.6, 49.7, 22.9, 21.4. 
HRMS (ESI): Calculated for C16H20N [M+H
+] = 226.1596, found 226.1586. 
FTIR (neat): 3049, 2967, 1638, 1595, 1509, 1450, 1416, 1394, 1367, 1317, 1230, 1169, 
1128, 995, 916, 859, 798, 776, 754, 684 cm–1. 
[α]
D






























































































































1 Data File Name: Z:/tenameza/nmr/79964-95-4NC-Purified/10/fid
2 Sample ID 79964-95-4NC-Purified
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl3
6 Pulse Sequence: zg30
7 Acquisition Date: 2017-06-13T13:23:22
8 Temperature: 300




































































1 Data File Name: Z:/tenameza/nmr/79964-95-4NC-purified-
Carbon/10/fid
2 Sample ID 79964-95-4NC-purified-Carbon
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl3
6 Pulse Sequence: zgpg30
7 Acquisition Date: 2017-06-13T16:44:32
8 Temperature: 300













The allylic acetate (22.8 mg, 0.20 mmol, 100 mol%) and the primary amine (53.3 mg, 
0.40 mmol, 200 mol%) were subject to standard reaction conditions (50 oC, 18 hr). The 
title compound was obtained in 85% yield (32.0 mg, 0.17 mmol) as a light yellow oil 
after purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 10:1–
1:1). 
TLC (SiO2) Rf  = 0.20 (hexanes/ethyl acetate = 1:1).  
1H NMR (400 MHz, CDCl3): δ = 7.39 – 7.34 (m, 2H), 7.33 – 7.27 (m, 2H), 7.24 – 7.19 
(m, 1H), 6.51 (dt, J = 15.9, 1.5 Hz, 1H), 6.30 (ddd, J = 15.9, 6.6, 6.1 Hz, 1H), 5.70 (ddd, 
J = 17.2, 10.2, 7.7 Hz, 1H), 5.18 – 5.04 (m, 2H), 3.43 (ddd, J = 13.9, 6.1, 1.5 Hz, 1H), 
3.33 (ddd, J = 13.9, 6.6, 1.3 Hz, 1H), 3.29 – 3.22 (m, 1H), 1.47 (br, 1H), 1.19 (d, J = 6.5 
Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 142.2, 137.1, 131.2, 128.5, 128.4, 127.3, 126.2, 114.8, 
56.1, 49.3, 21.7. 
HRMS (ESI): Calculated for C13H17N [M+H
+] = 188.1434, Found 188.1427. 
FTIR (neat): 2970, 1738, 1448, 1368, 1216, 1116, 966, 918, 747, 691 cm–1. 
[α]
D
𝟑𝟎= –8.00 (c 1.0, CHCl3). 















The allylic acetate (22.8 mg, 0.20 mmol, 100 mol%) and the primary amine (61.3 mg, 
0.40 mmol, 200 mol%) were subject to standard reaction conditions (50 oC, 18 hr). The 
title compound was obtained in 90% yield (37.3 mg, 0.18 mmol) as a light yellow oil 




TLC (SiO2) Rf  = 0.16 (methanol/ethyl acetate = 1:9).  
1H NMR (400 MHz, CDCl3): δ = 5.69 (ddd, J = 17.1, 10.2, 7.9 Hz, 1H), 5.28 – 5.20 (m, 
1H), 5.13 – 5.02 (m, 3H), 3.19 (dtd, J = 25.9, 12.8, 6.8 Hz, 3H), 3.03 (br, 1H), 2.09 – 
1.95 (m, 4H), 1.66 (d, J = 1.3 Hz, 3H), 1.60 (s, 3H), 1.58 (s, 3H), 1.17 (d, J = 6.5 Hz, 
3H). 
13C NMR (100 MHz, CDCl3): δ = 141.7, 138.2, 131.5, 124.0, 121.9, 115.1, 56.0, 44.4, 
39.6, 26.4, 25.7, 21.4, 17.6, 16.3. 
HRMS (ESI): Calculated for C14H25N [M+H
+] = 208.2060, Found 208.2054. 
FTIR (neat): 2924, 2359, 1629,1439, 1376, 1108, 993, 916, 753 cm–1. 
[α]
D
𝟐𝟖= –6.38 (c 1.0, CHCl3). 
 280 
HPLC Enantiomeric excess was determined by HPLC analysis of the p-tosyl derivative 
of the product (Chiralcel OJ-H column, hexanes:i-PrOH = 98:2, 1.00 mL/min, 210 nm), 















The allylic acetate (22.8 mg, 0.20 mmol, 100 mol%) and the amine (120 mg, 0.80 mmol, 
400 mol%) were subject to standard reaction conditions (60 oC, 60 hr). The title 
compound was obtained in 710% yield (28.9 mg, 0.14 mmol) as a pale red oil after 
purification by flash column chromatography (SiO2, ethyl acetate : MeOH = 10:1–3:1). 
 
 
TLC (SiO2) Rf  = 0.10 (ethyl acetate).  
1H NMR (500 MHz, CDCl3): δ = 7.34-7.30 (m, 4H), 7.27-7.22 (m, 1H), 5.66 (ddd, J = 
17.0, 10.2, 7.6 Hz, 1H),  5.08 (d, J = 17.0 Hz, 1H), 5.02 (d, J = 10.2 Hz, 1H), 3.79 (s, 
2H), 3.16-3.09 (m, 1H), 2.78-2.69 (m, 3H), 2.68-2.61 (m, 1H), 1.56 (bs, 1H), 1.15 (d, J = 
6.5 Hz, 3H) 
13C NMR (125 MHz, CDCl3): δ = 142.9, 140.7, 128.6 (2C), 128.3 (2C), 127.1, 114.6, 
57.0, 54.1, 49.2, 47.1, 22.0. 
HRMS (ESI): Calculated for C13H20N2 [M+H
+] = 205.1699, Found 205.1693. 
FTIR (neat): 3315, 3063, 3027, 2971, 2925, 2819, 2187, 1639, 1602, 1494, 1452, 1415, 
1369, 1312, 1114 1073, 1027, 993, 911, 729, 697 cm–1. 
[α]
D









The allylic acetate (22.8 mg, 0.20 mmol, 100 mol%) and the primary amine (43.2 mg, 
0.40 mmol, 200 mol%) were subject to standard reaction conditions (50 oC, 18 hr). The 
title compound was obtained in 90% yield (29.0 mg, 0.18 mmol) as a light yellow oil 
after purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 2:1–
1:2). 
 
TLC (SiO2) Rf  = 0.13 (ethyl acetate).  
1H NMR (400 MHz, CDCl3): δ = 8.55 (ddd, J = 4.9, 1.9, 0.9 Hz, 1H), 7.62 (td, J = 7.7, 
1.8 Hz, 1H), 7.28 (m, 1H), 7.15 (ddd, J = 7.6, 4.9, 1.2 Hz, 1H), 5.73 (ddd, J = 17.2, 10.2, 
7.8 Hz, 1H), 5.16 – 5.05 (m, 2H), 3.91 (d, J = 14.0 Hz, 1H), 3.81 (d, J = 14.0 Hz, 1H), 
3.27 – 3.18 (m, 1H), 1.87 (br, 1H), 1.21 (d, J = 6.5 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 159.7, 149.2, 142.3, 136.3, 122.4, 121.8, 114.9, 56. 5, 
52.6, 21.8. 
HRMS (ESI): Calculated for C10H14N2 [M+H
+] = 163.1230, Found 163.1226. 
FTIR (neat): 2962, 1592, 1434, 1216, 1118, 995, 921, 751 cm–1. 
[α]
D
𝟑𝟎= –19.50 (c 1.0, CHCl3). 
HPLC Enantiomeric excess was determined by HPLC analysis of the product with (S)-Ir-















The allylic acetate (22.8 mg, 0.20 mmol, 100 mol%) and the primary amine (74.4 mg, 
0.40 mmol, 200 mol%) were subject to standard reaction conditions (60 oC, 60 hr). The 
title compound was obtained in 86% yield (41.3 mg, 0.17 mmol) as a pale yellow oil after 
purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 1:1). 
 
TLC (SiO2) Rf  = 0.64 (hexanes/ethyl acetate = 1:1).  
1H NMR (500 MHz, CDCl3): δ = 7.49 (s, 1H), 7.37 (d, J = 7.8 Hz, 1H), 7.24 (d, J = 7.8 
Hz, 1H), 7.18 (t, J = 7.8 Hz, 1H), 5.69 (ddd, J = 17.2, 10.2, 7.7 Hz, 1H), 5.16-5.06 (m, 
2H), 3.77 (d, J = 13.4 Hz, 1H), 3.65 (d, J = 13.4 Hz, 1H), 3.23-3.16 (m, 1H), 1.36 (bs, 
1H), 1.18 (d, J = 6.5 Hz, 3H).  
13C NMR (125 MHz, CDCl3): δ = 143.3, 142.5, 131.3, 130.1(x2), 126.9, 122.7, 115.2, 
56.3, 50.9, 22.0. 
HRMS (ESI): Calculated for C11H14BrN [M+H
+] = 240.0382, Found 240.0375. 
FTIR (neat): 3311, 3073, 2971, 2923, 2818, 1775, 1640, 1594, 1568, 1470, 145, 1370, 
1312, 1195, 1165, 1114, 1068, 1038, 994, 918, 883, 859, 829, 775, 683, 667 cm–1. 
[α]
D
𝟐𝟒= –8.3 (c 3.1, CHCl3). 
















The allylic acetate (22.8 mg, 0.20 mmol, 100 mol%) and the primary amine (60.5 mg, 
0.40 mmol, 200 mol%) were subject to standard reaction conditions (50 oC, 18 hr). The 
title compound was obtained in 92% yield (37.7 mg, 0.18 mmol) as a light yellow oil 




TLC (SiO2) Rf  = 0.22 (hexanes/ethyl acetate = 1:1).  
1H NMR (400 MHz, CDCl3): δ = 6.83 (s, 1H), 6.75 (d, J = 1.1 Hz, 2H), 5.93 (s, 2H), 
5.69 (ddd, J = 17.2, 10.2, 7.7 Hz, 1H), 5.16 – 5.03 (m, 2H), 3.70 (d, J = 13.1 Hz, 1H), 
3.58 (d, J = 13.0 Hz, 1H), 3.24 – 3.15 (m, 1H), 1.16 (d, J = 6.5 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 147.6, 146.3, 142.4, 134.6, 121.1, 114.7, 108.7, 108.0, 
100.8, 55.8, 51.1, 21.8. 
HRMS (ESI): Calculated for C12H15NO2 [M+H
+] = 206.1176, Found 206.1169. 
FTIR (neat): 2971, 1488, 1441, 1249, 1040, 923, 808, 754 cm–1. 
[α]
D
𝟐𝟖= –6.25 (c 1.0, CHCl3). 















The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (85.5 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (50 oC, 18 hr). The 
title compound was obtained in 74% yield (48.9 mg, 0.32 mmol) as a light yellow oil 
after purification by flash column chromatography (SiO2, heptane: isopropyl acetate = 
1:0–0:1). 
 
TLC (SiO2) Rf  = 0.23 (hexanes:ethyl acetate 1:1).  
1H NMR (400 MHz, CDCl3): δ = 7.37-7.34 (m, 1H), 6.32-6.28 (m, 1H), 6.17-6.12 (m, 
1H), 5.68 (ddd, J = 17.5, 10.2, 7.8 Hz, 1H), 5.17 – 5.04 (m, 2H), 3.79 (d, J = 14.3 Hz, 
1H), 3.69 (d, J = 14.4 Hz, 1H), 3.24 - 3.15 (m, 1H), 1..17 (d, J = 6.5 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 154.1, 142.1, 141.7, 115.1, 110.0, 106.7, 55.7, 43.7, 
21.7. 
HRMS (ESI): Calculated for C9H14NO [M+H
+] = 152.1075, found 152.1067. 
FTIR (neat): 2973, 1672, 1600, 1505, 1439, 1416, 1370, 1315, 1251, 1147, 1110, 1074, 
1011, 995, 918, 884, 804, 730 cm–1. 
[α]
D
𝟐𝟒= +18.5 (c 0.63, CHCl3). 
















































































1 Data File Name: A:/tenameza/nmr/79964-48-4NC-Pure/10/fid
2 Sample ID 79964-48-4NC-Pure
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl3
6 Pulse Sequence: zg30
7 Acquisition Date: 2017-06-22T16:55:50
8 Temperature: 300




















































1 Data File Name: Z:/tenameza/nmr/79964-48-4NC-Carbon(2)/10/fid
2 Sample ID 79964-48-4NC-Carbon(2)
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl3
6 Pulse Sequence: zgpg30
7 Acquisition Date: 2017-06-22T18:50:22
8 Temperature: 300


















The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (99.6 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (50 oC, 18 hr). The 
title compound was obtained in 98% yield (71.5 mg, 0.43 mmol) as a light yellow oil 
after purification by flash column chromatography (SiO2, heptane: isopropyl acetate = 
1:0–0:1). 
 
TLC (SiO2) Rf  = 0.40 (hexanes:ethyl acetate 1:1).  
1H NMR (400 MHz, CDCl3): δ = 7.22 - 7.17 (m, 1H), 6.96 – 6.92 (m, 1H), 6.92 - 6.89 
(m, 1H), 5.69 (ddd, J = 17.6, 10.2, 7.7 Hz, 1H), 5.18 – 5.05 (m, 2H), 3.99 (dd, J = 14.1, 
0.9 Hz, 1H), 3.90 (dd, J = 14.1, 0.8 Hz, 1H), 3.31 - 3.21 (m, 1H), 1.17 (d, J = 6.5 Hz, 
3H). 
13C NMR (100 MHz, CDCl3): δ = 144.4, 142.2, 126.6, 124.7, 124.2, 115.0, 55.6, 45.7, 
21.7. 
HRMS (ESI): Calculated for C9H14NS [M+H
+] = 168.0847, found 168.0838. 
FTIR (neat): 3072, 2971, 1636, 1439, 1416, 1369, 1311, 1218, 1171, 1111, 1038, 993, 
918, 852, 824, 693 cm–1. 
[α]
D
𝟐𝟒= +18.5 (c 0.63, CHCl3). 





























































































































1 Data File Name: Z:/tenameza/nmr/79964-58-4NC-Pure(3rd)/10/fid
2 Sample ID 79964-58-4NC-Pure(3rd)
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl3
6 Pulse Sequence: zg30
7 Acquisition Date: 2017-07-03T15:10:21
8 Temperature: 300




















































1 Data File Name: A:/tenameza/nmr/79964-58-4NC-Pure(3rd)/11/fid
2 Sample ID 79964-58-4NC-Pure(3rd)
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl3
6 Pulse Sequence: zgpg30
7 Acquisition Date: 2017-07-03T15:15:28
8 Temperature: 300



















The allylic acetate (22.8 mg, 0.20 mmol, 100 mol%) and the primary amine (45.6 mg, 
0.40 mmol, 200 mol%) were subject to standard reaction conditions (50 oC, 18 hr). The 
title compound was obtained in 80% yield (26.8 mg, 0.16 mmol) as a light yellow oil 




TLC (SiO2) Rf  = 0.21 (hexanes/ethyl acetate = 1:1).  
1H NMR (400 MHz, CDCl3): δ = 7.71 (d, J = 3.3 Hz, 1H), 7.25 (d, J = 3.3 Hz, 1H), 5.69 
(ddd, J = 17.2, 10.2, 7.6 Hz, 1H), 5.17 – 5.07 (m, 2H), 4.12 (d, J = 15.4 Hz, 1H), 4.06 (d, 
J = 15.4 Hz, 1H), 3.28 (ddt, J = 7.4, 6.5, 0.9 Hz, 1H), 1.94 (br, 1H), 1.21 (d, J = 6.5 Hz, 
3H). 
13C NMR (100 MHz, CDCl3): δ = 172.0, 142.4, 141.6, 118.6, 115.3, 56.1, 48.2, 21.6. 
HRMS (ESI): Calculated for C8H12N2S [M+H
+] = 169.0794, Found 169.0789. 
FTIR (neat): 2972, 1505, 1214, 1185, 1137, 993, 922, 750 cm–1. 
[α]
D
𝟐𝟖= –8.25 (c 1.0, CHCl3). 














The allylic acetate (103 mg, 0.44 mmol, 100 mol%) and the primary amine (94.3 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (60 oC, 60 hr). The 
title compound was obtained in 84% yield (103 mg, 0.37 mmol) as a light yellow oil after 
purification by flash column chromatography (SiO2, heptane: isopropyl acetate = 1:0–
0:1). 
 
TLC (SiO2) Rf  = 0.26 (hexanes/ethyl acetate = 1:1).  
1H NMR (400 MHz, CDCl3): δ = 7.45 – 7.19 (m, 10H), 5.65 (ddd, J = 16.8, 10.5, 8.1 Hz, 
1H), 5.18 – 5.07 (m, 2H), 4.48 (d, J = 11.8 Hz, 1H), 4.45 (d, J = 11.8 Hz, 1H) 3.82 (d, J = 
13.3 Hz, 1H), 3.63 (d, J = 13.1 Hz, 1H), 3.62 – 3.46 (m, 2H), 3.27 – 3.19 (m, 1H), 1.90 - 
1.80 (m, 1H), 1.78 - 1.67 (m, 1H). 
13C NMR (100 MHz, CDCl3): δ = 140.5, 140.7, 138.5, 128.3, 128.2, 127.7, 127.5, 126.8, 
116.1, 100.0, 73.0, 67.8, 59.0, 51.3, 35.7. 
HRMS (ESI): calcd for C19H24NO [M+H]
+: 282.1858, found: 282.1846 
FTIR (neat): 3028, 2856, 1639, 1494, 1453, 1362, 1203, 1098, 1027, 994, 918, 733, 695 
cm–1. 
 [𝛼]𝐷
24 = –3.4 (c 0.84, CHCl3,). 














































































































































































1 Data File Name: Z:/tenameza/nmr/79964-83-4NC0-Pure(2)/10/fid
2 Sample ID 79964-83-4NC0-Pure(2)
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl3
6 Pulse Sequence: zg30
7 Acquisition Date: 2017-07-13T17:03:19
8 Temperature: 300

































































1 Data File Name: A:/tenameza/nmr/79964-83-4NC-13Carbon/10/fid
2 Sample ID 79964-83-4NC-13Carbon
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl3
6 Pulse Sequence: zgpg30
7 Acquisition Date: 2017-07-17T12:44:04
8 Temperature: 300


















The allylic acetate (103 mg, 0.44 mmol, 100 mol%) and the primary amine (99.6 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (60 oC, 60 hr). The 
title compound was obtained in 85% yield (107 mg, 0.37 mmol) as a light yellow oil after 
purification by flash column chromatography (SiO2, heptane: isopropyl acetate = 1:0–
0:1). 
 
TLC (SiO2) Rf  = 0.17 (hexanes/ethyl acetate = 1:1).  
1H NMR (400 MHz, CDCl3): δ = 7.38 - 7.22 (m, 5H), 5.59 (ddd, J = 17.0, 10.3, 8.1 Hz, 
1H), 5.13 – 5.02 (m, 2H), 4.51 (d, J = 11.9 Hz, 1H) ,4.47 (d, J = 12.0 Hz, 1H), 3.62 – 
3.46 (m, 2H), 3.18 - 3.09 (m, 1H), 2.43 (dd, J = 11.5, 6.8 Hz, 1H), 2.29 (dd, J = 11.6, 6.6 
Hz, 1H), 1.88 - 1.77 (m, 1H), 1.76 – 1.60 (m, 6H), 1.45 - 1.32 (m, 1H), 1.29 – 1.07 (m, 
3H), 0.95 - 0.80 (m, 2H). 
13C NMR (100 MHz, CDCl3): δ = 141.4, 128.3, 127.7, 127.5, 115.6, 100.0, 73.0, 67.8, 
59.7, 54.2, 38.1, 35.7, 31.6, 31.5, 26.7, 26.1(x2). 
HRMS (ESI): calcd for C19H30NO [M+H]
+: 288.2327, found: 288.2316 
FTIR (neat): 2920, 2850, 1639, 1495, 1450, 1415, 1363, 1261, 1206, 1100, 1027, 993, 
916, 733, 696 cm–1. 
 [𝛼]𝐷
24 = –10.7 (c 0.30, CHCl3,). 










































































































































































1 Data File Name: Z:/tenameza/nmr/79964-86-4NC-Pure(2)/10/fid
2 Sample ID 79964-86-4NC-Pure(2)
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl
6 Pulse Sequence: zg30
7 Acquisition Date: 2017-07-17T10:15:43
8 Temperature: 300
































































1 Data File Name: A:/tenameza/nmr/79964-86-4NC-13Carbon/10/fid
2 Sample ID 79964-86-4NC-13Carbon
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl3
6 Pulse Sequence: zgpg30
7 Acquisition Date: 2017-07-17T12:58:15
8 Temperature: 300


















The allylic acetate (103 mg, 0.44 mmol, 100 mol%) and the primary amine (64.4 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (60 oC, 60 hr). The 
title compound was obtained in 78% yield (84.4 mg, 0.34 mmol) as a light yellow oil 
after purification by flash column chromatography (SiO2, heptane: isopropyl acetate = 
1:0–0:1). 
 
TLC (SiO2) Rf  = 0.19 (hexanes/ethyl acetate = 1:1). 
1H NMR (400 MHz, CDCl3): δ = 7.41 – 7.22 (m, 5H), 5.60 (ddd, J = 17.0, 10.3, 8.1 Hz, 
1H), 5.13 – 5.03 (m, 2H), 4.50 (d, J = 12.0 Hz, 1H), 4.47 (d, J = 11.9 Hz, 1H), 3.62 – 
3.46 (m, 2H), 3.19 - 3.10 (m, 1H), 2.41 (dd, J = 11.5, 6.9 Hz, 1H), 2.28 (dd, J = 11.5, 6.6 
Hz, 1H), 1.88 - 1.77 (m, 1H), 1.75 – 1.60 (m, 2H), 0.88 (d, J = 6.7, 3H), 0.87 (d, J = 6.7, 
3H). 
13C NMR (100 MHz, CDCl3): δ = 141.4, 138.5, 128.3, 127.7, 127.5, 115.6, 73.0, 67.8, 
59.6, 55.5, 35.7, 28.4, 20.8, 20.7. 
HRMS (ESI): calcd for C16H26NO [M+H]
+: 248.2014, found: 248.2004 
FTIR (neat): 3031, 2952, 2867, 1639, 1495, 1453, 1415, 1385, 1363, 1246, 1203, 1101, 
1027, 994, 916, 733, 696 cm–1. 
 [𝛼]𝐷
24 = –13.8 (c 0.72, CHCl3,). 












































































































































1 Data File Name: Z:/tenameza/nmr/79964-84-4NC-Pure/10/fid
2 Sample ID 79964-84-4NC-Pure
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl3
6 Pulse Sequence: zg30
7 Acquisition Date: 2017-07-14T16:13:02
8 Temperature: 300




























































1 Data File Name: A:/tenameza/nmr/79964-84-4NC-13Carbon/10/fid
2 Sample ID 79964-84-4NC-13Carbon
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl3
6 Pulse Sequence: zgpg30
7 Acquisition Date: 2017-07-17T12:51:03
8 Temperature: 300



















The allylic acetate (114 mg, 0.44 mmol, 100 mol%) and the primary amine (94.3 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (60 oC, 60 hr). The 
title compound was obtained in 80% yield (107 mg, 0.35 mmol) as a light yellow oil after 
purification by flash column chromatography (SiO2, heptane: isopropyl acetate = 1:0–
0:1). 
TLC (SiO2) Rf  = 0.51 (hexanes/ethyl acetate = 1:1). 
1H NMR (400 MHz, CDCl3): δ = 7.40 – 7.18 (m, 5H), 5.66 (ddd, J = 16.4, 11.0, 8.2 Hz, 
1H), 5.17 – 5.08 (m, 2H), 3.83 (d, J = 13.2 Hz, 1H), 3.75 - 3.61 (m, 2H), 3.63 (d, J = 13.2 
Hz, 1H), 3.22 (q, J = 6.7 Hz, 1H), 1.82 – 1.68 (m, 1H), 1.68 - 1.58 (m, 1H), 0.86 (s, 9H), 
0.03 (s, 6H). 
13C NMR (100 MHz, CDCl3): δ = 141.1, 140.8, 128.3, 128.2, 126.7, 115.9, 60.7, 58.9, 
51.3, 38.6, 25.9, 18.2, -5.4. 
HRMS (ESI): calcd for C18H32NOSi [M+H]
+: 306.2253 found: 306.2244 
FTIR (neat): 2952, 2927, 2856, 1494, 1471, 1462, 1415, 1387, 1360, 1254, 1091, 1028, 
1004, 918, 833, 773, 730, 696, 662 cm–1. 
 [𝛼]𝐷
24  = –3.5 (c 0.51, CHCl3,). 
HPLC (Chiralpak AD-H, heptane/isopropanol 60:40, 1.0 mL/min, 254 nm) ee = 95% 
































































































































































1 Data File Name: Z:/tenameza/nmr/79964-115-4NC-Si-Pure(2)/10/fid
2 Sample ID 79964-115-4NC-Si-Pure(2)
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl3
6 Pulse Sequence: zg30
7 Acquisition Date: 2017-08-14T16:04:49
8 Temperature: 300
































































1 Data File Name: Z:/tenameza/nmr/79964-115-4NC-Pure-
Carbon/10/fid
2 Sample ID 79964-115-4NC-Pure-Carbon
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl3
6 Pulse Sequence: zgpg30
7 Acquisition Date: 2017-08-14T18:27:30
8 Temperature: 300























The allylic acetate (74.9 mg, 0.44 mmol, 100 mol%) and the primary amine (94.3 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (60 oC, 60 hr). The 
title compound was obtained in 82% yield (79.0 mg, 0.36 mmol) as a light yellow oil 
after purification by flash column chromatography (SiO2, heptane: isopropyl acetate = 
1:0–0:1). 
 
TLC (SiO2) Rf  = 0.54 (hexanes/ethyl acetate = 1:1). 
1H NMR (400 MHz, CDCl3): δ = 7.36 - 7.28 (m, 4H), 7.28 – 7.18 (m, 1H), 5.62 (ddd, J = 
17.1, 10.3, 8.2 Hz, 1H), 5.18 – 5.05 (m, 2H), 3.83 (d, J = 13.1 Hz, 1H), 3.64 (d, J = 13.2 
Hz, 1H), 3.05 - 2.97 (m, 1H), 1.70 – 1.15 (m, 8H), 0.87 (t, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 141.5, 140.8, 128.3, 128.2, 126.8, 115.9, 61.3, 51.3, 
35.8, 31.9, 25.6, 22.6, 14.0. 
HRMS (ESI): calcd for C15H24N [M+H]
+: 218.1909, found: 218.1899 
FTIR (neat): 3063, 3027, 2955, 2927, 2856, 1639, 1494, 1453, 1414, 1377, 1200, 1111, 
1028, 993, 916, 729, 697 cm–1. 
 [𝛼]𝐷
24 = +1.6 (c 0.77, CHCl3,). 
























































































































1 Data File Name: Z:/tenameza/nmr/79964-65-4NC-Pure(1)/10/fid
2 Sample ID 79964-65-4NC-Pure(1)
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl3
6 Pulse Sequence: zg30
7 Acquisition Date: 2017-07-06T15:46:29
8 Temperature: 300



























































1 Data File Name: A:/tenameza/nmr/79964-65-4NC-13C-Pure/10/fid
2 Sample ID 79964-65-4NC-13C-Pure
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl3
6 Pulse Sequence: zgpg30
7 Acquisition Date: 2017-07-06T17:48:01
8 Temperature: 300


















The allylic acetate (33.6 mg, 0.20 mmol, 100 mol%) and the primary amine (42.9 mg, 
0.40 mmol, 200 mol%) were subject to standard reaction conditions (60 oC, 60 hr). The 
title compound was obtained in 85% yield (36.5 mg, 0.17 mmol) as a light yellow oil 
after purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 10:1–
2:1). 
 
TLC (SiO2) Rf  = 0.55 (hexanes/ethyl acetate = 1:1).  
1H NMR (400 MHz, CDCl3): δ = 7.40 – 7.17 (m, 5H), 5.78 (ddt, J = 16.9, 10.2, 6.7 Hz, 
1H), 5.62 (ddd, J = 17.1, 10.3, 8.3 Hz, 1H), 5.28 – 5.06 (m, 2H), 5.03 – 4.85 (m, 2H), 
3.83 (d, J = 13.2 Hz, 1H), 3.64 (d, J = 13.2 Hz, 1H), 3.02 (td, J = 7.7, 5.4 Hz, 1H), 2.03 
(tdt, J = 7.1, 5.4, 1.4 Hz, 2H), 1.61 – 1.36 (m, 4H), 1.31 (br, 1H). 
13C NMR (100 MHz, CDCl3): δ = 141.2, 140.7, 138.7, 128.3, 128.1, 126.8, 116.1, 114.5, 
61.1, 51.2, 35.1, 33.7, 25.2. 
HRMS (ESI): Calculated for C15H21N [M+H
+] = 216.1747, Found 216.1743. 
FTIR (neat): 2928, 1640, 1454, 1216, 993, 913, 752, 698  cm–1. 
[α]
D
𝟑𝟏= –51.0 (c 1.0, CHCl3). 














The allylic acetate (33.6 mg, 0.20 mmol, 100 mol%) and the primary amine (93.3 mg, 
0.40 mmol, 200 mol%) were subject to standard reaction conditions (60 oC, 60 hr). The 
title compound was obtained in 73% yield (49.8 mg, 0.15 mmol) as a pale yellow oil after 
purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 5:1). 
 
TLC (SiO2) Rf  = 0.72 (hexanes/ethyl acetate = 1:1).  
1H NMR (500 MHz, CDCl3): δ = 7.67 (d, J = 8.6 Hz, 2H), 7.39 (d, J = 8.6 Hz, 2H), 5.81-
5.70 (m, 1H), 5.60-5.51 (m, 1H), 5.17-5.04 (m, 2H), 4.99-4.89 (m, 2H), 3.84 (d, J = 14.1 
Hz, 1H),  3.68  (d, J = 14.1 Hz, 1H),  3.00-2.92 (m, 1H), 2.05-1.98 (m, 2H), 1.5z9-1.35 
(m, 5H). 
13C NMR (125 MHz, CDCl3): δ = 152.7 (m, JCF = 15.7 Hz), 145.1, 141.0, 138.8, 128.4, 
126.2 (2C), (m, JCF = 4.6 Hz, 2C), 116.7, 114.8, 61.3, 50.4, 35.4, 33.9, 25.4. 
19F NMR (376 MHz, CDCl3): δ = 87.2 – 83.4 (m, 1F), 63.0 (d, J = 149.8 Hz, 4F). 
HRMS (ESI): Calculated for C15H20F5NS [M+H
+] = 342.1309, Found 342.1302. 
FTIR (neat): 2926, 1641, 1459, 1414, 1095, 993, 915, 830, 669 cm–1. 
[α]
D
𝟐𝟑= –37.2 (c 1.3, CHCl3). 






















The allylic acetate (33.6 mg, 0.20 mmol, 100 mol%) and the primary amine (93.7 mg, 
0.40 mmol, 200 mol%) were subject to standard reaction conditions (60 oC, 60 hr). The 
title compound was obtained in 70% yield (48.0 mg, 0.14 mmol) as a light yellow oil 
after purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 10:1–
2:1). 
 
TLC (SiO2) Rf  = 0.28 (ethyl acetate).  
1H NMR (400 MHz, CDCl3): δ = 7.36 – 7.25 (m, 5H), 5.76 (ddt, J = 16.9, 10.2, 6.7 Hz, 
1H), 5.51 (ddd, J = 17.0, 10.3, 8.3 Hz, 1H), 5.09 (s, 2H), 5.08 – 4.89 (m, 4H), 4.08 (br, 
2H), 3.16 – 3.05 (m, 1H), 2.95 – 2.75  (m, 2H), 2.66 (tt, J = 10.2, 3.9 Hz, 1H), 2.09 – 
1.96 (m, 2H), 1.87 (br, 1H), 1.79 – 1.66 (m, 1H), 1.47 – 1.01 (m, 8H). 
13C NMR (100 MHz, CDCl3): δ = 155.2, 141.6, 138.6, 136.8, 128.4, 127.9, 127.7, 115.5, 114.5, 
66.9, 58.2, 51.3, 42.9, 42.6, 35.5, 33.6, 25.2. 
HRMS (ESI): Calculated for C21H30N2O2 [M+H
+] = 343.2380, Found 343.2376. 
FTIR (neat): 2930, 1691, 1433, 1364, 1228, 996, 914, 752, 697cm–1. 
[α]
D
𝟐𝟓= +51.0 (c 1.0, CHCl3). 
HPLC (two connected chiralcel OD-H column, hexanes:i-PrOH = 98:2, 1.00 mL/min, 














The allylic acetate (33.6 mg, 0.20 mmol, 100 mol%) and the primary amine (64.1 mg, 
0.40 mmol, 200 mol%) were subject to standard reaction conditions (60 oC, 60 hr). The 
title compound was obtained in 69% yield (37.0 mg, 0.14 mmol) as a light yellow oil 
after purification by flash column chromatography (SiO2, ethyl acetate). 
 
TLC (SiO2) Rf  = 0.15 (hexanes/ethyl acetate = 1:1).  
1H NMR (500 MHz, CDCl3): δ = 8.10 (s, 1H), 7.62 (d, J = 7.9 Hz, 1H), 7.36 (d, J = 7.9 
Hz, 1H), 7.16 (t, J = 7.6 Hz, 1H), 7.12 (t, J = 7.6 Hz, 1H), 7.03 (s, 1H), 5.80 - 5.70 (m, 
1H), 5.55 (ddd, J = 16.7, 10.8, 8.4 Hz, 1H), 5.13-5.04 (m, 2H), 5.00-4.98 (m, 2H), 3.03-
2.92 (m, 4H), 2.87-2.81 (m, 1H), 2.07-1.95 (m, 2H), 1.59-1.22 (m, 5H). 
13C NMR (125 MHz, CDCl3): δ = 141.5, 138.9, 136.6, 127.6, 122.2, 122.1, 119.4, 119.1, 
116.2, 114.7, 114.3, 111.3, 62.2, 47.5, 35.3, 33.9, 26.0, 25.4. 
HRMS (ESI): Calculated for C18H24N2 [M+H
+] = 269.2012, Found 269.2017. 
FTIR (neat): 3296, 2969, 2928, 1457, 1414, 1378, 1339, 1306, 1231, 1160, 1127, 1104, 
994, 951, 916, 816, 739 cm–1. 
[α]
D
𝟐𝟒= +48.5 (c 1.5, CHCl3). 














The allylic acetate (89.9 mg, 0.44 mmol, 100 mol%) and the primary amine (94.3 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (60 oC, 60 hr). The 
title compound was obtained in 78% yield (85.3 mg, 0.34 mmol) as a light yellow oil 




TLC (SiO2) Rf  = 0.45 (hexanes/ethyl acetate = 1:1). 
1H NMR (400 MHz, CDCl3): δ = 7.30 – 7.12 (m, 10H), 5.68 (ddd, J = 17.3, 10.3, 8.2 Hz, 
1H), 5.24 – 5.10 (m, 2H), 3.83 (d, J = 13.1 Hz, 1H), 3.64 (d, J = 13.1 Hz, 1H), 3.12 - 3.03 
(m, 1H), 2.74 – 2.56 (m, 2H), 1.91 – 1.68 (m, 2H). 
13C NMR (100 MHz, CDCl3): δ = 142.2, 141.0, 140.7, 128.4, 128.4, 128.3, 128.2, 126.8, 
125.7, 116.4, 60.8, 51.2, 37.4, 32.2. 
HRMS (ESI): calcd for C18H22N [M+H]
+: 252.1752, found: 252.1743 
FTIR (neat): 3061, 3025, 2920, 1639, 1602, 1495, 1452, 1108, 1072, 1028, 993, 918, 
742, 696 cm–1. 
 [𝛼]𝐷
24 = +7.4 (c 0.48, CHCl3,). 




















































































































































1 Data File Name: Z:/tenameza/nmr/79964-95-4NC-Pure-a(1)/10/fid
2 Sample ID 79964-95-4NC-Pure-a(1)
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl3
6 Pulse Sequence: zg30
7 Acquisition Date: 2017-07-24T12:46:40
8 Temperature: 300
































































1 Data File Name: A:/tenameza/nmr/79964-95-4NC-a(13C) Pure/10/fid
2 Sample ID 79964-95-4NC-a(13C) Pure
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl3
6 Pulse Sequence: zgpg30
7 Acquisition Date: 2017-07-25T09:06:57
8 Temperature: 300

















The allylic acetate (89.9 mg, 0.44 mmol, 100 mol%) and the primary amine (62.6 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (60 oC, 60 hr). The 
title compound was obtained in 75% yield (70.3 mg, 0.33 mmol) as a light yellow oil 
after purification by flash column chromatography (SiO2, dichloromethane : methanol = 
1:0 – 20:1). 
 
 
TLC (SiO2) Rf  = 0.45 (hexanes/ethyl acetate = 1:1). 
1H NMR (400 MHz, CDCl3): δ = 7.32 - 7.12 (m, 5H), 5.63 (ddd, J = 17.0, 10.3, 8.3 Hz, 
1H), 5.19 – 5.06 (m, 2H), 3.09 - 2.99 (m, 1H), 2.74 - 2.54 (m, 2H), 2.46 (dd, J = 12.0, 7.0 
Hz, 1H), 2.35 (dd, J = 12.0, 6.8 Hz, 1H), 1.92 - 1.80 (m, 1H), 1.80 - 1.67 (m, 1H), 1.00 – 
0.85 (m, 1H), 0.52 – 0.39 (m, 2H), 0.16 – 0.03 (m, 2H). 
13C NMR (100 MHz, CDCl3): δ = 142.1, 141.0, 128.4, 128.3, 125.7, 116.4, 61.4, 52.4, 
37.1, 32.2, 11.3, 3.5, 3.3. 
HRMS (ESI): calcd for C15H22N [M+H]
+: 216.1752, found: 216.1742 
FTIR (neat): 3077, 3002, 2921, 1603, 1496, 1453, 1318, 1113, 1045, 1016, 994, 917, 
825, 748, 697 cm–1. 
 [𝛼]𝐷
24 = +4.2 (c 0.42, CHCl3,). 


























































































































































1 Data File Name: Y:/tenameza/nmr/79964-103-4NC-Pure/10/fid
2 Sample ID 79964-103-4NC-Pure
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl3
6 Pulse Sequence: zg30
7 Acquisition Date: 2017-07-31T17:29:44
8 Temperature: 299.9996


























































1 Data File Name: Z:/tenameza/nmr/79964-103-4NC-
Carbon/100010/fid
2 Sample ID 
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl3
6 Pulse Sequence: zgpg30
7 Acquisition Date: 2017-08-03T18:47:56
8 Temperature: 300.002

















The allylic acetate (89.9 mg, 0.44 mmol, 100 mol%) and the primary amine (99.5 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (60 oC, 60 hr). The 
title compound was obtained in 80% yield (89.9 mg, 0.35 mmol) as a light yellow oil 




TLC (SiO2) Rf  = 0.61 (hexanes/ethyl acetate = 1:1). 
1H NMR (400 MHz, CDCl3): δ = 7.33 – 7.14 (m, 5H), 5.59 (ddd, J = 17.1, 10.2, 8.2 Hz, 
1H), 5.22 – 5.09 (m, 2H), 3.04 - 2.96 (m, 1H), 2.88 (dt, J = 12.3, 7.3 Hz, 1H), 2.78 – 2.55 
(m, 3H), 2.33 - 2.16 (m, 2H), 1.87 – 1.65 (m, 2H). 
13C NMR (100 MHz, CDCl3): δ = 141.9, 140.5, 128.4(x2), 125.8, 116.8, 61.3, 40.0 (q, J 
= 3.7 Hz), 37.2, 34.5 (d, J = 27.4 Hz), 32.1. 
19F NMR (376 MHz, CDCl3): δ = –65.1 (t, J = 10.9 Hz, 3F). 
HRMS (ESI): calcd for C14H19F3N [M+H]
+: 258.1470, found: 258.1460 
FTIR (neat): 3028, 2926, 2859, 1641, 1603, 1496, 1454, 1440, 1384, 1339, 1252, 1139, 
1030, 996, 921, 845, 748, 698, 654 cm–1. 
 [𝛼]𝐷
24 = +5.9 (c 0.47, CHCl3,). 









































































































































1 Data File Name: Y:/tenameza/nmr/79964-105-4NC-Pure/10/fid
2 Sample ID 79964-105-4NC-Pure
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl3
6 Pulse Sequence: zg30
7 Acquisition Date: 2017-07-31T18:56:14
8 Temperature: 299.9992

























































1 Data File Name: Z:/tenameza/nmr/79964-105-4NC-
Carbon/100010/fid
2 Sample ID 
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl3
6 Pulse Sequence: zgpg30
7 Acquisition Date: 2017-08-03T18:55:18
8 Temperature: 299.9992



























The allylic acetate (89.9 mg, 0.44 mmol, 100 mol%) and the primary amine (103 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (60 oC, 60 hr). The 
title compound was obtained in 83% yield (94.7 mg, 0.36 mmol) as a light yellow oil 
after purification by flash column chromatography (SiO2, heptane: isopropyl acetate = 
1:0–0:1). 
TLC (SiO2) Rf  = 0.39 (hexanes/ethyl acetate = 1:1). 
1H NMR (400 MHz, CDCl3): δ = 7.31 – 7.22 (m, 2H), 7.21 – 7.12 (m, 3H), 5.62 (ddd, J 
= 17.1, 10.3, 8.1 Hz, 1H), 5.18 – 5.06 (m, 2H), 4.01 – 3.87 (m, 4H), 3.06 - 2.97 (m, 1H), 
2.76 (d, J = 12.3 Hz, 1H), 2.73 – 2.59 (m, 2H), 2.56 (d, J = 12.2 Hz, 1H), 1.89 – 1.65 (m, 
2H), 1.37 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ = 142.3, 141.2, 128.4, 128.3, 125.7, 116.1, 109.5, 64.9, 
64.9, 61.5, 53.6, 37.3, 32.2, 22.9. 
HRMS (ESI): calcd for C16H24NO2 [M+H]
+: 262.1807, found: 262.1795 
FTIR (neat): 2980, 2879, 1603, 1496, 1454, 1376, 122, 1162, 1118, 1051, 994, 945, 918, 
859, 749, 698 cm–1. 
 [𝛼]𝐷
24 = +1.7 (c 0.47, CHCl3,). 











































































































































1 Data File Name: Z:/tenameza/nmr/79964-101-4NC-Pure/10/fid
2 Sample ID 79964-101-4NC-Pure
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl3
6 Pulse Sequence: zg30
7 Acquisition Date: 2017-07-28T11:47:37
8 Temperature: 300































































1 Data File Name: Z:/tenameza/nmr/79964-101-4nc-13C/100010/fid
2 Sample ID 
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl3
6 Pulse Sequence: zgpg30
7 Acquisition Date: 2017-07-28T17:06:38
8 Temperature: 300.0021




















The allylic acetate (89.9 mg, 0.44 mmol, 100 mol%) and the primary amine (189 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (60 oC, 60 hr). The 
title compound was obtained in 83% yield, 17:1 dr (130 mg, 0.36 mmol) as a light yellow 
oil after purification by flash column chromatography (SiO2, dichloromethane: methanol 
= 1:0–20:1). 
 
TLC (SiO2) Rf  = 0.39 (hexanes/ethyl acetate = 1:1). 
1H NMR (400 MHz, DMSO-d6): δ = 7.31 – 7.11 (m, 5H), 5.59 (ddd, J = 17.0, 10.4, 7.9 
Hz, 1H), 5.12 – 5.00 (m, 2H), 4.07 – 3.85 (m, 1H), 3.80 - 3.67 (m, 1H), 2.86 (q, J = 7.0 
Hz, 1H), 2.77 (ddd, J = 13.6, 11.0, 3.1 Hz, 1H), 2.60 (t, J = 8.0 Hz, 2H), 2.56 – 2.43 (m, 
1H), 2.33 (dd, J = 11.8, 8.1 Hz, 1H), 2.25 (dd, J = 11.9, 5.5 Hz, 1H), 1.78 – 1.20 (m, 
15H), 1.14 - 1.00 (m, 1H). 
13C NMR (125 MHz, CDCl3): δ = 154.9, 142.2, 141.1, 128.4, 128.3, 125.7, 116.2, 79.3, 
61.4, 50.0, 37.2, 36.1(x2), 32.2, 29.1, 28.4(x2), 24.4. 
HRMS (ESI): calcd for C22H35N2O2 [M+H]
+: 359.2699, found: 359.2686 
FTIR (neat): 2975, 2928, 2853, 1685, 1496, 1420, 1390, 1364, 1265, 1240, 1174, 1147, 
1030, 994, 967, 917, 881, 750, 698, 665 cm–1. 
 [𝛼]𝐷












































































































































































1 Data File Name: Y:/tenameza/nmr/79964-109-4NC-
Pure(DMSO)/10/fid
2 Sample ID 79964-109-4NC-Pure(DMSO)
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: DMSO
6 Pulse Sequence: zg30
7 Acquisition Date: 2017-08-02T21:05:17
8 Temperature: 299.9984















The allylic acetate (40.9 mg, 0.20 mmol, 100 mol%) and the primary amine (22.8 mg, 
0.40 mmol, 200 mol%) were subject to standard reaction conditions (60 oC, 60 hr). The 
title compound was obtained in 79% yield (31.8 mg, 0.16 mmol) as a light yellow oil 
after purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 1:1). 
TLC (SiO2) Rf  = 0.54 (hexanes/ethyl acetate = 1:1).  
1H NMR (400 MHz, CDCl3): δ = 7.24-7.17 (m, 2H), 7.14-7.07 (m, 3H), 5.67-5.56 (m, 
1H), 5.11-5.08 (m, 1H), 5.07-5.04 (m, 1H), 3.10-3.02 (m, 1H), 2.63-2.47 (m, 2H), 2.07-
2.00 (m, 1H), 1.83-1.72 (m, 1H), 1.68-1.56 (m, 1H), 0.42-0.26 (m, 3H), 0.24-0.16 (m, 
1H). 
13C NMR (125 MHz, CDCl3): δ = 142.5, 141.5, 128.6 (2C), 128.5 (2C), 125.9, 116.0, 
61.9, 37.1, 32.4, 28.6, 7.0, 6.5. 
HRMS (ESI): Calculated for C14H19N [M+H
+] = 202.1590, Found 202.1586. 
FTIR (neat): 3084, 3026, 2924, 1738, 1639, 1603, 1496, 1453, 1369, 1237, 1014, 993, 
916, 827, 746, 697 cm–1. 
 [𝛼]𝐷
24 = –11.3 (c 1.1, CHCl3,). 
















The allylic acetate (89.9 mg, 0.44 mmol, 100 mol%) and the primary amine (152 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (60 oC, 60 hr). The 
title compound was obtained in 74% yield (102 mg, 0.32 mmol) as a light yellow oil after 




TLC (SiO2) Rf  = 0.32 (hexanes/ethyl acetate = 1:1). 
1H NMR (400 MHz, CDCl3): δ = 7.32 – 7.22 (m, 2H), 7.23 – 7.13 (m, 3H), 5.60 (ddd, J 
= 17.0, 10.2, 8.5 Hz, 1H), 5.18 – 5.06 (m, 2H), 4.09 – 3.97 (m, 2H), 3.64 – 3.52 (m, 3H), 
3.04 - 2.94 (m, 1H), 2.73 – 2.53 (m, 2H), 1.87 – 1.65 (m, 2H), 1.43 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ = 156.1, 141.7, 140.6, 128.4, 128.3, 125.9, 116.9, 79.0, 
60.1, 45.9, 37.2, 32.1, 28.4, 25.4. 
HRMS (ESI): calcd for C19H29N2O2 [M+H]
+: 317.2229, found: 317.2215 
FTIR (neat): 2973, 2876, 1692, 1603, 1496, 1476, 1454, 1401, 1365, 1290, 1251, 1158, 
1118, 1030, 995, 919, 861, 750, 698 cm–1. 
 [𝛼]𝐷
24 = +4.5 (c 0.40, CHCl3,). 



































































































































1 Data File Name: Z:/tenameza/nmr/79964-107-4NC-Pure(3)/10/fid
2 Sample ID 79964-107-4NC-Pure(3)
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl3
6 Pulse Sequence: zg30
7 Acquisition Date: 2017-08-03T14:18:57
8 Temperature: 300

































































1 Data File Name: Z:/tenameza/nmr/79964-107-4NC-
Carbon/100010/fid
2 Sample ID 
3 Origin: Bruker BioSpin GmbH
4 Owner: chemnmr
5 Solvent: CDCl3
6 Pulse Sequence: zgpg30
7 Acquisition Date: 2017-08-03T19:03:03
8 Temperature: 300.0003




















The allylic acetate (40.9 mg, 0.20 mmol, 100 mol%) and the primary amine (46.9 mg, 
0.40 mmol, 200 mol%) were subject to standard reaction conditions (60 oC, 60 hr). The 
title compound was obtained in 79% yield (41.8 mg, 0.16 mmol) as a light yellow oil 
after purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 1:1). 
TLC (SiO2) Rf  = 0.50 (hexanes/ethyl acetate = 1:1).  
1H NMR (500 MHz, CDCl3): δ = 7.30 – 7.25 (m, 2H), 7.20 - 7.15 (m, 3H), 5.58 (ddd, J = 
17.2, 10.2, 8.3 Hz, 1H), 5.13 (d, J = 10.2 Hz, 1H), 5.08 (d, J = 17.2 Hz, 1H), 3.2-3.12 (m, 
1H), 2.72-2.46 (m, 7H), 2.17-2.11 (m, 1H), 2.07-2.01 (m,1H), 1.83-1.65 (m, 2H), 1.57-
1.48 (m, 1H), 1.44-1.34 (m, 1H), 1.09 (bs, 1H).  
13C NMR (125 MHz, CDCl3): δ = 142.3, 141.7, 128.6 (2C), 128.5 (2C), 126.0, 116.1, 
57.9, 52.6, 37.8, 35.9, 34.3, 32.4, 28.0, 27.7. 
HRMS (ESI): Calculated for C16H23NS [M+H
+] = 262.1624, Found 262.1620. 
FTIR (neat): 3024, 2922, 2841, 1775, 1697, 1638, 1602, 1495, 1453, 1427, 1365, 1268, 
1235, 1118, 1030, 994, 916, 747, 698, 659 cm–1. 
 [𝛼]𝐷
24 = –15.6 (c 1.4, CHCl3,). 















The allylic acetate (28.0 mg, 0.20 mmol, 100 mol%) and the primary amine (42.9 mg, 
0.40 mmol, 200 mol%) were subject to standard reaction conditions (60 oC, 60 hr). The 
title compound was obtained in 76% yield (28.5 mg, 0.15 mmol) as a light yellow oil 
after purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 1:1). 
 
 
TLC (SiO2) Rf  = 0.4 (hexanes/ethyl acetate = 1:1).  
1H NMR (400 MHz, CDCl3): δ = 7.29-7.21 (m, 4H), 7.21-7.15 (m, 1H), 5.74 (m, 1H), 
5.09-5.02 (m, 2H), 3.78, (d, J = 13.3 Hz, 1H), 3.62, (d, J = 13.3 Hz, 1H), 2.24 (dd, J = 
8.6, 7.8 Hz, 1H), 1.58 (s, 1H), 0.89 – 0.80 (m, 1H), 0.5-0.35 (m, 2H), 0.15-0.05.  
13C NMR (125 MHz, CDCl3): δ = 140.8, 140.5, 128.6 (2C), 128.3 (2C), 127.0, 115.8, 
66.3, 51.6, 16.8, 4.3, 2.5. 
HRMS (ESI): Calculated for C13H17N [M+H
+] = 188.1434, Found 188.1433. 
FTIR (neat): 3339, 3076, 3025, 3002, 2815, 1640, 1603, 1494, 1453, 1428, 1413, 1358, 
1302, 1172, 1101, 1074, 1046, 1018, 993, 917, 859, 822, 733, 697, 672 cm–1. 
 [𝛼]𝐷
24 = –14.6 (c 1.4, CHCl3,). 

















To a round bottomed flask equipped with a magnetic stir bar charged with 4.3l (60 mg, 
0.3 mmol, 100 mol%) dissolved in methanol (30 ml, 0.01M) was added glyoxal (4.5 µl, 
0.33 mmol, 110 mol%, of a 40 wt% aqueous solution). This mixture was cooled to 0 °C 
with an icewater bath, before sodium cyanoborohydride (37.0 mg, 0.63 mmol, 210 
mol%) was added. The resulting reaction mixture was stirred for 17 hours. During this 
time the cooling bath was allowed to warm to room temperature. The reaction was 
quenched with NaHCO3 (20 ml of a saturated aqueous solution) and further diluted with 
water (20 ml). The obtained aqueous solution was extracted with CH2Cl2 (3 x 30 ml). The 
combined organic extracts were dried over MgSO4, filtered and the solvent was removed 
in vacuo. The resulting residue was subjected to flash column chromatography (SiO2, 
hexanes, ethyl acetate 1:1) to furnish the title compound as a pale yellow oil in 69 % 
yield (47.5 mg, 0.21 mmol). 
 
TLC (SiO2) Rf  = 0.20 (hexanes/ethyl acetate = 1:1).  
1H NMR (500 MHz, CDCl3): δ = 7.30-7.26 (m, 4H), 7.25-7.20 (m, 1H), 5.76 (ddd, J = 
17.1, 10.4, 7.9 Hz, 1H), 5.10-5.02 (m, 2H), 3.49 (s, 2H), 2.91-2.83 (m, 1H), 2.49 (bs, 
8H), 1.14 (d, J = 6.6 Hz, 3H).  
13C NMR (125 MHz, CDCl3): δ = 140.8, 138.2, 129.5 (2C), 128.4 (2C), 127.2, 115.9, 
63.4, 63.3, 53.5 (2C), 50.0 (2C), 17.7. 
 359 
HRMS (ESI): Calculated for C15H22N2 [M+H
+] =231.1856, Found 231.1851. 
FTIR (neat): 2932, 2807, 2764, 1494, 1453, 1372, 1318, 1265, 1139, 1073, 1048, 1028, 
1011, 953, 916, 815, 736, 697 cm–1. 
 [𝛼]𝐷
24 = –18.3 (c 1.5, CHCl3,). 
























Detailed Procedures  
To a round-bottomed flask with a magnetic stir bar was charged with 4.3x (32.3 mg, 0.15 
mmol, 100 mol%). Under argon atmosphere, toluene (6.5 mL, 0.02 M) was added via 
syringe, followed by the addition of a solution of Grubbs Catalyst II (19.1 mg, 0.023 
mmol, 15 mol%) in toluene (1.0 mL). The reaction mixture was heated to 70 °C. After 
this mixture was cooled to ambient temperature, it was concentrated in vacuo. The 
residue was subjected to flash column chromatography (SiO2, hexanes: ethyl acetate = 
5:1–2:1) to give 19.1 mg, 0.10 mmol (68%) as a light dark oil. 
 
TLC (SiO2) Rf  = 0.21 (hexanes/ethyl acetate = 1:1).  
1H NMR (400 MHz, CDCl3): δ = 7.39 – 7.22 (m, 5H), 5.87 – 5.64 (m, 2H), 3.88 (d, J = 
13.0 Hz, 1H), 3.83 (d, J = 13.0 Hz, 1H), 3.22 (dp, J = 7.0, 2.3 Hz, 1H), 2.04 – 1.86 (m, 
3H), 1.81 – 1.71 (m, 1H), 1.62 – 1.42 (m, 2H), 1.31 (br, 1H). 
13C NMR (100 MHz, CDCl3): δ = 140.7, 129.9, 128.9, 128.3, 128.1, 126.8, 52.3, 51.0, 29.4, 25.3, 
20.2. 
HRMS (ESI): Calculated for C13H17N [M+H
+] = 188.1434, Found 188.1430. 
FTIR (neat): 2929, 1452, 1215, 1103, 748, 689, 667  cm–1. 
[α]
D
𝟐𝟔= +67.5 (c 1.0, CHCl3). 













To a round bottomed flask equipped with a magnetic stir bar charged with 3j’ (90 mg, 
0.48 mmol, 100 mol%) dissolved in absolute dichloromethane (10 ml, 0.05M) under an 
athmosphere of argon, acryloyl chloride (47.8 mg, 0.53 mmol, 110 mol%), triethylamine 
(97.3 mg, 0.96 mmol, 200 mol%) and Pyridine (2.0 mg, 0.024 mmol, 5 mol%) were 
added in this order. The resulting reaction mixture was stirred for 17 hours at room 
temperature. After this time the solvent was removed in vacuo and the resulting residue 
was directly subjected to flash column chromatography (SiO2, hexanes, ethyl acetate 10:1 
-> 5:1) to furnish the title compound as a colorless viscous oil in 89 % yield (104 mg, 
0.48 mmol). According to the recorded NMR data the compound exists in solution as a 
4:1 mixture of rotamers. 
 
TLC (SiO2) Rf  = 0.43 (hexanes/ethyl acetate = 5:1).  
1H NMR (500 MHz, CDCl3): δ = 7.37-7.14 (m, 7.4H, major, minor), 6.60-6.49 (m, 0.4H, 
minor), 6.64-6.31 (m, 2.4H, major,minor), 5.87-5.75 (m, 1.4H, major, minor), 5.70-5.57 
(m, 1.4 H, major, minor), 5.35-5.15 (m, 2.8H, major, minor), 4.92 (d, J=15.4 Hz, 0.4H, 
minor), 4.67 (d, J=18.4 Hz, 1.0H, major), 4.59-4.49 (m, 2.0H, major), 4.49 (d, J =15.4 
Hz, 0.4H, minor), 3.66-3.56 (m, 0.3H, minor), 0.98-0.88 (m, 0.4 H, minor), 0.88-0.76 (m, 
 366 
1.0H, major), 0.66-0.54 (m, 1.4H, major, minor), 0.47-0.38 (m, 1.0H, major), 0.33-0.17 
(m, 2.8H, major, minor), 0.15-0.7 (m, 0.4H, minor).  
13C NMR (125 MHz, CDCl3): δ = 167.6 (minor), 167.2 (major), 139.2 (minor), 138.6 
(major), 136.7 (major), 136.6 (minor), 129.1 (major, minor), 128.7 (major), 128.5 
(major), 128.4 (minor), 128.1 (minor), 127.7 (minor), 127.3 (major), 126.9 (minor), 126.4 
(major), 117.1 (major), 116.9 (minor), 65.5 (minor), 61.5 (major), 47.8 (major), 47.1 
(minor), 14.3 (minor), 12.8 (major), 6.0 (minor), 5.5 (major), 4.6 (major), 4.5 (minor). 
HRMS (ESI): Calculated for C16H19N [M+Na
+] = 264.1359, Found 264.1355. 
FTIR (neat): 3083, 3004, 1647, 1609, 1495, 1452, 1419, 1358, 1322, 1289, 1234, 1199, 
1161, 1078, 1058, 1021, 978, 956, 923, 832, 794, 732, 697 cm–1. 
 [𝛼]𝐷
24 = +3.9 (c 1.4, CHCl3,). 

























To a round bottomed flask equipped with a magnetic stir bar and charged with Grubbs II 
(4.1 mg, 0.005 mmol, 5 mol%) 1.0 ml of a 0.1 M solution of 4j* in toluene is added 
under an atmosphere of argon. (Caution: The substrate solution was degassed by 
bubbling argon through the solution for 3 minutes before usage.) The resulting reaction 
mixture is heated to 60 °C for 17 h. After this time the reaction mixture is directly 
subjected to flash column chromatography (SiO2, hexanes, ethyl acetate 5:1–2:1) to 
furnish the compound as a pale violet oil in 65 % yield (15.6 mg, 0.065 mmol).  
TLC (SiO2) Rf  = 0.15 (hexanes/ethyl acetate = 2:1).  
1H NMR (400 MHz, CDCl3): δ = 7.34-7.16 (m, 5H), 6.99 (dd, J = 1.8, 5.9 Hz, 1H ), 6.19 
(dd, J = 1.8, 5.9 Hz, 1H), 5.15 (d, J = 15.4 Hz, 1H), 4.31 (d, J = 15.4 Hz, 1H ), 3.14 (td, J 
= 1.8, 9.1 Hz ), 0.71-0.44 (m, 3H), 0.31-0.23 (m, 1H),0.17-0.10 (m, 1H).  
13C NMR (125 MHz, CDCl3): δ = 171.3, 147.7, 138.1, 128.8, 127.8, 127.5, 127.1, 66.9, 
43.9, 11.9, 5.1, 0.2, 0.1. 
HRMS (ESI): Calculated for C14H15N [M+H
+] =214.1226, Found 214.1222. 
FTIR (neat): 3004, 2922, 1683, 1495, 1433, 1403, 1358, 1338, 1270, 1223, 1078, 1026, 
969, 867, 852, 807, 703 cm–1. 
 [𝛼]𝐷
24 = +4.5 (c 1.7, CHCl3). 















An oven-dried sealed tube under an atmosphere of N2 was charged with tert-butyl (4-
(hydroxymethyl)benzyl)carbamate (5) (150 mg, 0.63 mmol, 100 mol%), (R)-IrLn (32.5 mg, 0.03 mmol, 5 
mol%), K3PO4 (67 mg, 0.32 mmol 50 mol%),  THF (0.31 ml, 2.0 M) and H2O (57 µl, 3.2 mmol, 500 
mol%). But-3-en-2-yl acetate (144mg, 1.26 mmol, 200 mol%) was added and the reaction mixture was 
allowed to stir at ambient temperature for 0.5 h. The reaction vessel was placed in an oil bath preheated to 
60 °C. The reaction was stirred at this temperature for 48 h. After this time the reaction muxture was 
concentrated in vacuo. Purification of the remaining residue by column chromatography (SiO2; hexanes: 
ethyl acetate 4:1) provided 6 as a colorless viscous oil in 83 % yield (152 mg, 0.52 mmol, 8:1 dr). 
 
TLC (SiO2) Rf  = 0.30 (hexanes:ethyl acetate 1:1).  
1H NMR (500 MHz, CDCl3): δ = 7.32-7.21 (m, 4H), 5.77 (ddd, J= 17.2, 10.3, 8.3 Hz, 
1H), 5.24-5.14 (m, 2H), 4.36-4.25 (m, 3H), 2.51-2.39 (m, 1H), 1.44 (s, 9H), 0.84 (d, J = 
6.9 Hz, 3H).  
13C NMR (125 MHz, CDCl3): δ = 156.1, 141.7, 140.7, 138.5, 127.6 (2C), 127.3 (2C), 
117.2, 79.7, 77.5, 46.6, 44.6, 28.6 (3C), 16.73. 
HRMS (ESI): Calculated for C17H25NO3 [M+Na
+] = 314.1727, Found 314.1720. 
 373 
FTIR (neat) 3359, 2976, 2929, 1687, 1513, 1455, 1421, 1391, 1365, 1271, 1249, 1211, 
1164, 1046, 1017, 915, 864, 82:5, 783, 676 cm–1. 
 [𝛼]𝐷
24 = –34.3 (c 1.1, CHCl3,). 


























To a round bottomed flask equipped with a magnetic stir bar charged with 6 (140 mg, 
0.48 mmol, 100 mol%) was added DCM (0.4 ml) and afterwards TFA (80 µl). The 
resulting reaction mixture (0.1 M) was stirred for two hours at room temperature. After 
this time water (5 ml) and NaOH (20 ml of an 0.1 M aqueous solution) were added. The 
phases were separated and the aqueous phase was extracted with DCM (3x 20 ml). The 
combined organic extracts were dried over MgSO4, filtered and the solvent was removed 
in vacuo. The resulting residue was subjected to flash column chromatography (SiO2, 
hexanes, ethyl acetate 1:1) to furnish the title compound as a colorless oil in 84 % yield 
(77.0 mg, 0.40 mmol, 8:1 dr). 
 
TLC (SiO2) Rf  = 0.12 (hexanes: ethyl acetate 1:1).  
1H NMR (500 MHz, CDCl3): δ =  7.31-7.25 (m, 4H), 5.77 (ddd, J= 17.1, 10.4, 8.3 Hz, 
1H), 5.23-5.14 (m, 2H), 4.33 (d, J= 7.8 Hz, 1H), 3.84 (s, 2H), 2.51-2.41 (m, 1H),1.64 (bs, 
3H),  0.85 (d, J = 6.8 Hz, 3H). 
13C NMR (125 MHz, CDCl3): δ = 141.00, 140.7, 140.3, 127.1 (2C), 127.0 (2C), 117.0, 
77.7, 46.4, 46.2, 16.6. 
 377 
HRMS (ESI): Calculated for C12H17NO [M+H
+] =192.1383, Found 192.1385. 
FTIR (neat): 3293, 3076, 2971, 2928, 2868, 1737, 1638, 1511, 1455, 1438, 1415, 1371, 
1262, 1228, 1175, 1097, 1034, 1017, 995, 914, 821, 735, 300 cm–1. 
 [𝛼]𝐷





















Synthesis starting from compound 4.6’ 
Using General Procedure 1: the title compound was afforded after purification by flash 
column chromatography (ethyl acetate) to give 57.3 mg, 0.23 mmol (78%) as a pale 
orange oil. According to recorded NMR data the compound consisted of a 8:1 mixture of 
diastereomers. 
 
Synthesis starting from (4-(aminomethyl)phenyl)methanol (4.5’) 
[(R)-(+)-5,5'-bis(diphenylphosphino)-4,4'-bi-1,3-benzodioxole][4-cyano-3-
nitrobenzenecarboxylato] [1,2,3-eta-2-propenyl Ir(III)] (20.7 mg, 0.02 mmol, 10 mol%), 
cesium carbonate (197 mg, 0.6 mmol, 300 mol%), and 5’ (27.4 mg, 0.2 mmol, 100 mol%) 
were added to an oven-dried resealable pressure tube equipped with a magnetic stir bar. 
The tube was purged with argon for 5 minutes. Afterwards THF 0.2 ml, (1.0 M) was 
added followed by the addition of but-3-en-2-yl acetate (91.3 mg, 0.8 mmol, 400 
mol%).  The tube was sealed with a PTFE lined cap and heated at 80°C for 48 h.  After 
reaching ambient temperature, the crude reaction mixture was directly subjected to flash 
column chromatography (SiO2, ethyl acetate) to give 18 mg, 0.073 mmol (36 %) of the 
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title compound as a pale orange oil. According to recorded NMR data the compound 
consisted of a 2:1 mixture of diastereomers.  
 
TLC (SiO2) Rf  = 0.18 (ethyl acetate).  
1H NMR (500 MHz, CDCl3): δ =  7.25-7.19 (m, 4H), 5.79-5.59 (m, 2H), 5.17-4.99 (m, 
4H), 4.27 (d, J = 7.9 Hz, 1H), 3.72 (d, J = 12.8 Hz, 1H), 3.60 (d, J = 12.8 Hz, 1H), 3.18-
3.11 (m, 1H), 2.45-2.35 (m, 1H), 1.77 (bs, 2H), 1.11 (d, J = 6.5 Hz, 3H), 0.79 (d, J = 6.8 
Hz, 3H). 
13C NMR (125 MHz, CDCl3): δ = 142.6, 141.3, 140.9, 140.1, 128.3, 127.1, 117.1, 115.1, 
77.8, 56.3, 51.2, 46.5, 22.0, 16.8. 
HRMS (ESI): Calculated for C16H23NO [M+H
+] = 246.1852, Found 246.1842. 
FTIR (neat): 3339, 3076, 3025, 3002, 2815, 1640, 1603, 1494, 1453, 1428, 1413, 1358, 
1302, 1172, 1101, 1074, 1046, 1018, 993, 917, 859, 822, 733, 697, 672 cm–1. 
 [𝛼]𝐷














Single Crystal Diffraction Data for 4.3j’ 
Empirical formula  C13 H18 Cl N 
Formula weight  223.73 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  monoclinic 
Space group  P 21 
  Unit cell dimensions    a = 10.993(2) Å  = 90°. 
 b = 9.035(3) Å   = 109.866(7)°. 
 c = 13.737(4) Å   = 90°. 
Volume 1283.2(6) Å3 
Z 4 
Density (calculated) 1.158 Mg/m3 
Absorption coefficient 0.268 mm-1 
F(000) 480 
Crystal size 0.510 x 0.130 x 0.030 mm3 
Theta range for data collection 3.056 to 27.480°. 
Index ranges -14<=h<=14, -11<=k<=11, -17<=l<=17 
Reflections collected 21792 
Independent reflections 5883 [R(int) = 0.0393] 
Completeness to theta = 25.242° 99.8 %  
Absorption correction Semi-empirical from equivalents 
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Max. and min. transmission 1.00 and 0.783 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5883 / 1 / 288 
Goodness-of-fit on F2 1.038 
Final R indices [I>2sigma(I)] R1 = 0.0451, wR2 = 0.1108 
R indices (all data) R1 = 0.0533, wR2 = 0.1160 
Absolute structure parameter 0.00(10) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.529 and -0.213 e.Å-3 
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Figure S1.  View of the cation 1 of 4.3j’ showing the atom labeling scheme.  









Figure S2.  View of the cation 2 of 4.3j’ showing the atom labeling scheme.  










Chapter 5:  Regio- and Enantioselective Iridium-Catalyzed Amination 
of Branched Alkyl-Substituted Allylic Acetates with Primary and 
Secondary Aromatic and Heteroaromatic Amines* 
 
5.1 Introduction 
Cyclometallated π-allyliridium C,O-benzoate complexes have been shown to 
catalyze diverse alcohol-mediated carbonyl allylations using allyl carboxylates as 
pronucleophiles.1 In these umpoled allylations,2 the C,O-benzoate moiety assists in 
maintaining neutrality and, hence, nucleophilicity of the π-allyliridium intermediate. 
Neutral iridium complexes that are not cyclometallated also display nucleophilic 
properties.3 In contrast, as illustrated by enantioselective Tsuji-Trost-type allylic 
aminations developed by Takeuchi,4,5 Helmchen,6,7 Hartwig,8,9 Carreira10 and You,11,12 
cationic π-allyliridium species invariably serve as electrophiles. In this latter context, two 
distinct classes of iridium catalysts have emerged. Type I catalysts are used under basic 
conditions in combination with linear allyl proelectrophiles (as branched allyl 
proelectrophiles react stereospecifically).13 Type II catalysts are used under acidic 
conditions in combination with branched allyl proelectrophiles, which react in a non-
stereospecific fashion, perhaps due to displacement of the π-bond of (σ+π)-allyl (enyl) 
iridium intermediates by the tethered olefin of the phosphoramidite ligand (Figure 5.1).14 
The present authors recently found that neutral π-allyliridium C,O-benzoate 
complexes, which typically act as nucleophiles, can also display electrophilic behavior, 
representing the first examples of amphiphilic reactivity in the context of transition metal 
catalysis.  
 
*This chapter is based on the published work: 




Figure 5.1 Cationic vs neutral chiral iridium complexes for regio- and 
enantioselective allylic amination. 
 
In the initial communication of these findings, enantioselective allylic aminations of 
branched allylic acetates bearing linear alkyl groups with primary aliphatic amines were 
disclosed.15 These aminations proceed with complete branched regioselectivity, 
overcoming a significant limitation associated with Type I and II catalysts, which display 
incomplete regioselectivity for π-allyl precursors bearing linear alkyl groups.16,17 With 
regard to the amine nucleophile, the Type III SEGPHOS-modified π-allyliridium 
complexes used in our initial study enforced high enantioselectivities in reactions of 
primary aliphatic amines (Figure 5.1). Here, we show that the corresponding tol-BINAP-
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modified iridium catalyst avail a significant expansion in scope, enabling highly 
enantioselective aminations of branched alkyl substituted allylic acetates with 
electronically diverse primary and secondary aryl amines, including site-selective 
reactions of bis(amine) nucleophiles. Additionally, we report deuterium labelling studies 
that corroborate C-N bond formation through an outer-sphere mechanism. 
 
5.2 Reaction Development and Scope 
To develop highly regio- and enantioselective allylic aminations mediated by aryl 
amines, a series of π-allyliridium C,O-benzoate complexes were evaluated in reactions of 
α-methyl allyl acetate (100 mol%) and aniline (200 mol%) under conditions previously 
optimized for primary aliphatic amines.15 The iridium catalyst modified by tol-BINAP, 
(S)-Ir-II, delivered the product of allylic amination 5.4a with significantly higher levels of 
enantioselectivity than the corresponding SEGPHOS-modified catalyst, (S)-Ir-I, but a 
lower isolated yield of 5.4a was observed (eq. 5.1). Changing the solvent from THF to 
DME improved the isolated yield of 5.4a, and by decreasing the reaction temperature 
from 80 oC to 70 oC 5.4a could be formed in 82% yield and 89% enantiomeric excess 





Table 5.1 Iridium-catalyzed amination of α-methyl allyl acetate 5.1a with primary 
aromatic and heteroaromatic amines 5.2a-5.2l to form enantiomerically 
enriched allylic amines 5.4a-5.4l.a 
 
 
aYields of material isolated by silica gel chromatography. Enantioselectivities were determined by chiral 





Table 5.2 Iridium-catalyzed amination of α-methyl allyl acetate 5.1a with secondary 
aromatic and heteroaromatic amines 5.3a-5.3l to form enantiomerically 
enriched allylic amines 5.5a-5.5l.a 
 
 
aYields of material isolated by silica gel chromatography. Enantioselectivities were determined by chiral 






Deviation from these reaction parameters did not avail further improvement, and 
given the low cost of tol-BINAP these conditions were adopted to explore the scope of 
primary aromatic and heteroaromatic amine nucleophiles 5.2a-5.2l in aminations of α-
methyl allyl acetate (Table 5.1). Amine nucleophiles containing a diverse array of 
functional groups were examined to mirror challenges faced in medicinal chemistry. In 
each case, the targeted products of allylic amination 5.4a-5.4l were formed with complete 
branched regioselectivity and uniformly high levels of enantioselectivity. As illustrated in 
the formation of 5.4d, which incorporates a pinacol boronate moiety, the reaction 
conditions tolerate rather sensitive functional groups. The tolerance of ortho-substituted 
anilines, as demonstrated by the formation of 5.4e, is also noteworthy. Perhaps the most 
striking feature, however, is the compatibility of the catalyst with electronically diverse 
aryl amine partners and the tolerance of Lewis basic N-heterocycles, as illustrated by the 
formation 5.4k and 5.4l. The absolute stereochemical assignment of adducts 5.4b-5.4l is 
made in analogy to that determined for compound 5.4a, which has been prepared in 
enantiomerically enriched form in two separate reports.8d,18  
In a further exploration of scope, optimized conditions were applied to the 
amination of α-methyl allyl acetate using secondary aromatic and heteroaromatic amine 
nucleophiles 5.3a-5.3l (Table 5.2). Indoline 5.3a, 6- and 7-aza-indolines 5.3b and 5.3c 
and the 3,3-spirocyclic indoline 5.3d each underwent asymmetric allylation with 
complete branched regioselectivity and high levels of enantioselectivity. Pronounced 
match-mismatched effects were observed in the conversion of chiral nonracemic (S)- and 
(R)-2-methyl indolines 5.3e and 5.3f to adducts 5.5e and 5.5f, respectively, suggesting the 
potential for kinetic resolution. The amination of 5.1a using N-methyl aniline 5.3g and 
related compounds 5.3h and 5.3i bearing electron withdrawing and donating groups at the 
para-position proceeded smoothly to form adducts 5.5g-5.5i, respectively. Among these 
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three N-methyl aniline derivatives (5.3g-5.3i), amination using the more electron rich N-
methyl-para-anisidine 5.3i occurred with notably higher levels of enantioselectivity. As 
illustrated by the formation of 5.5j and 5.5k, N-methyl anilines containing bromide (5.3j) 
and chloride (5.3k) functional groups are tolerated. Finally, amination of 5.1a using N-
Methyl-2-(methylamino)benzimidazole 5.3l is remarkably efficient, providing adduct 5.5l 
in 94% yield with complete selectivity for allylation of the extranuclear 2-(methylamino) 
moiety. 
To assess how structural variation of the π-allyliridium intermediate impacts 
reactivity, regio- and stereoselectivity, a set of branched allylic acetates 5.1a-5.1g were 
explored in aminations mediated by 2-(methylamino)benzoxazole 5.3m (Table 5.3). In 
addition to α-methyl allyl acetate 5.1a, linear alkyl substituted allylic acetates 5.1b and 
5.1c smoothly underwent amination to form adducts 5.6a-5.6c as single regioisomers 
with high levels of enantiomeric enrichment. Allylic acetates 5.1d-5.1f, which 
incorporate cycloalkyl-substituents, delivered adducts 5.6d-5.6f as single regioisomers, 
although an erosion in enantioselectivity is observed using the larger cyclopentyl-
substituted allyl acetate 5.1f. Finally, using the enantiomeric iridium catalysts (S)-Ir-II 
and (R)-Ir-II, the (S)-citronellol-derived allylic acetate 5.1g reacts with 5.3m to form 5.6g 









Table 5.3 Iridium-catalyzed amination of α-substituted allyl acetates 5.1a-5.1g with 
secondary heteroaromatic amine 5.3m to form enantiomerically enriched 
allylic amines 5.6a-5.6g.a 
 
aYields of material isolated by silica gel chromatography. Enantioselectivities were determined by chiral 
stationary phase HPLC analysis. See Supporting Information for further experimental details. 
 
Having established the ability to functionalize both primary and secondary 
aromatic amines, the site-selective modification of reactants 5.3n-5.3p, which incorporate 
both primary and secondary aromatic amines, was attempted using the branched allylic 
acetate 5.1a (eq. 5.2-5.4). Upon exposure to standard conditions, 5-aminoindole 5.3n 
undergoes completely chemoselective functionalization at the primary amine to form 
 394 
adduct 5.7a as a single constitutional isomer with excellent levels of enantioselectivity 
(eq. 5.2). Similarly, in the conversion of 5.3o to adduct 5.7b, complete control of regio- 
and site-selectivity is accompanied by high levels of enantioselectivity (eq. 5.3). The 
structure of adduct 5.7b was verified by single crystal X-ray diffraction analysis, further 
corroborating the absolute stereochemical assignment of adducts 5.4a-5.4l, 5.5a-5.5l and 
5.6a-5.6g. Finally, N-cyclohexyl-1,2-diaminobenzene 5.3p reacts with 5.1a to deliver 
adduct 5.7c, which is modified exclusively at the primary amine (eq. 5.4). The ability to 
engage diamines in site-selective regio- and enantioselective amination enhances step 







Scheme 5.1 Iridium-catalyzed amination of enantiomerically enriched deuterated 
allylic acetate 5.1h with the enantiomeric catalysts (S)-Ir-II and (R)-Ir-II.a 
 
 
aYields of material isolated by silica gel chromatography. Enantioselectivities were determined by chiral 
stationary phase HPLC analysis. See Supporting Information for further experimental details. 
 
5.3 Discussion 
To better understand the nature of the C-N bond forming event, asymmetric 
amination of the enantiomerically enriched (Z)-deuterated allylic acetate 5.1h was 
conducted under standard conditions using (S)-Ir-II (Scheme 5.1, eq. 5.5).19 Compound 
5.8a is formed with complete alkene (Z)-stereoselectivity, as determined by 1H NMR. 
Assuming formation of the π-allyliridium occurs with inversion of stereochemistry, as 
established in analogous iridium phosphoramidite catalyzed processes,4-12 the 
stereochemistry of the amination product 5.8a is consistent with outer-sphere addition of 
the nitrogen nucleophile. To corroborate the veracity of this experiment, the amination of 
allylic acetate 5.1h was conducted using the enantiomeric iridium catalyst, (R)-Ir-II 
(Scheme 1, eq. 5.6). The amination product 5.8b is formed with complete alkene (E)-
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stereoselectivity, as de-termined by 1H NMR. The stereochemistry of 5.8a is again 
consistent with outer-sphere C-N bond formation.  
Based on the collective data, a general catalytic mechanism and stereochemical 
model were proposed (Scheme 5.2). The π-allyliridium(I) complex I is subject to outer-
sphere amine addition amine to form the C-N bond and the zwitterionic iridium(I) olefin 
complex II. Deprotonation of ammonium moiety of complex II mediated by cesium 
carbonate generates the anionic iridium(I) species III. Alkene exchange with the allylic 
acetate releases the product of allylic amination and forms the olefin complex IV. Loss of 
acetate ion regenerates the π-allyliridium(I) complex I to close the catalytic cycle. The 
indicated stereochemical model accounts for the observed sense of absolute 
stereoinduction for outer sphere addition of a nucleophile to the neutral iridium π-allyl 
complex I. This model is based upon the coordination mode revealed in closely related 
crystal structures.20 Orientation of the π-allyl is controlled through alleviation of steric 
clashes between the naphthyl and tolyl substituents of the phosphine ligand with the R-











Scheme 5.2 General catalytic mechanism and stereochemical model for 





Previously reported enantioselective allylic aminations are largely restricted to 
chiral iridium-phosphoramidite catalysts.4-12 We have shown that air and water stable π-
allyliridium C,O-benzoates, which are well-known for their ability to catalyze 
nucleophilic carbonyl allylation,1,2 also promote highly regio- and enantioselective 
electrophilic allylation of aliphatic amines15 and, as demonstrated here, primary and 
secondary  aromatic or heteroaromatic amines. These π-allyliridium C,O-benzoate 
catalyzed processes overcome a longstanding limitation associated with all known 
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catalytic systems for asymmetric allylic amination - the ability to promote highly 
enantioselective aminations of branched allylic acetates bearing n-alkyl groups with 
complete levels of regioselectivitity.4-12,16 Another notable feature of these catalysts 
involves the ability to promote site-selective N-allylations of reactants that incorporate 
both primary and secondary aromatic amines. Mechanistic studies establish an outer-
sphere mechanism for C-N bond formation. This work, along with our initially 
communicated studies,15 significantly expands the scope of catalytic asymmetric allylic 
amination methodology, broadening access to chiral α-stereogenic amines.  
 
5.5 Experimental Details 
 
General Information 
All  reactions were carried out under inert gas atmosphere (nitrogen or argon) 
unless otherwise indicated. Resealable pressure tubes (13x100 mm) were purchased from 
Fischer Scientific (catalog number 14-959-35C) and were flame dried followed by 
cooling in a desiccator or under a stream of inter gas prior to use. All commercial 
reagents and anhydrous solvents were used as received from vendors (Fischer Scientific, 
Sigma Aldrich and Combi Blocks) without further purification. The used Iridium catalyst 
(S)-Ir-II and (R)-Ir-II was prepared according to literature known procedures.1 Cesium 
carbonate was used as received from Rockwell Lithium. Preparative column 
chromatography employing Silicycle silica gel (40-63 μm) was performed according to 
the method of Still2 or on a Teledyne Isco Combiflash Rf utilizing Silicycle HP columns 
using a mobile phase composed of either heptane/isopropyl acetate, heptanes/ethyl 
acetate or dichloromethane/methanol. Reactions were monitored by a Shimadzu 
LCMS/UV system with LC-30AD solvent pump, 2020 MS, Sil-30AC autosampler, SPD-
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M30A UV detector, CTO-20A column oven, using a 2-98% acetonitrile/0.1% formic acid 
(or 0.001% ammonia) gradient over 2.5 minutes. Analytical thin-layer chromatography 
(TLC) was carried out using 0.25 mm commercial silica gel plates (Dynamic Absorbents 
F). Visualization was accomplished with UV light followed by dipping in CAM, p- 
Anisaldehyde (PAA), or KMnO4 stain solution followed by heating. 
 
Spectroscopy, Spectrometry and Data Collection  
Infrared spectra were recorded on a Perkin-Elmer 1600 spectrometer using a 
diamond ATR unit. High-resolution mass spectra (HRMS) were obtained on a Karatos 
MS9 and are reported as m/z (relative intensity). Accurate masses are reported for the 
molecular ion (M+H, M+Na), or a suitable fragment ion. Nuclear magnetic resonance 
(1H, 13C, 19F NMR) spectra were recorded with a Bruker BioSpin GmbG, Varian Gemini 
(400 MHz) or Varian INOVA (500 MHz) spectrometer equipped with a Bruker 
cryoprobe. The chemical shifts are given as parts per million (ppm) and were referenced 
to the residual solvent signal (CDCl3: δH = 7.26 ppm, δC = 77.16 ppm). Specific optical 
rotations were recorded on an Atago AP-300 automatic polarimeter at the sodium line 










Experimental Details and Spectral Data 
Synthesis of Allylic Acetates 5.1e-5.1g 
General procedure for the synthesis of allylic acetates. The allylic acetates 5.1e, 5.1f, and 
5.1g were prepared by the Grignard reaction and acetylation of the as shown below. The 
allylic acetates 5.1b,3 5.1c,4 and 5.1d5 were identical in all respects to the reported 
materials. 
 
To a round-bottomed flask charged with the corresponding aldehyde under an argon 
atmosphere was added THF (0.2 M). The reaction flask was placed an ice batch. After 10 
minutes, vinyl magnesium bromide solution (120 mol%, 1.0 M in THF) was added 
slowly and the mixture was stirred at room temperature for 1 hour, at which point acetic 
anhydride (150 mol%) and triethylamine (200 mol%) were added and the reaction was 
stirred vigorously overnight. After water was added, the mixture was transferred to a 
separatory funnel. The organic layer was extracted with diethyl ether and the combined 
organic layers were washed with 1 N HCl, dried (MgSO4), filtered and concentrated 
under reduced pressure. The resulting oily residue was subjected to flash column 







1-cyclobutylallyl acetate (5.1e) 
 
 
The title compound was prepared by the general procedure. 
 
TLC (SiO2) Rf  = 0.61 (heptanes: isopropyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 5.70 (ddd, J = 17.2, 10.5, 6.3 Hz, 1H), 5.25 – 5.13 (m, 
3H), 2.58 – 2.45 (m, 1H), 2.07 (s, 3H), 1.97 (dddd, J = 18.3, 9.9, 8.0, 4.7 Hz, 2H), 1.90 – 
1.74 (m, 4H). 
13C NMR (125 MHz, CDCl3): δ = 170.6, 134.6, 116.9, 77.9, 38.3, 24.3, 24.0, 21.2, 18.0. 
LRMS (CI): Calculated for C7H11 [M–OAc]
+ = 95, Found 95. 















1-cyclopentylallyl acetate (5.1f) 
 
 
The title compound was prepared by the general procedure. 
 
TLC (SiO2) Rf  = 0.61 (heptanes: isopropyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 5.70 (ddd, J = 17.2, 10.5, 6.7 Hz, 1H), 5.16 (dt, J = 
17.2, 1.4 Hz, 1H), 5.09 (dt, J = 10.6, 1.3 Hz, 1H), 5.07 – 5.02 (m, 1H), 2.07 – 1.94 (m, 
4H), 1.70 – 1.41 (m, 6H), 1.30 – 1.14 (m, 2H). 
13C NMR (125 MHz, CDCl3): δ = 170.4, 135.9, 116.9, 78.4, 43.5, 28.8, 28.6, 25.5, 25.3, 
21.3. 
LRMS (CI): Calculated for C8H13 [M–OAc]
+ = 109, Found 109. 








The title compound was prepared by the general procedure. 
 
TLC (SiO2) Rf  = 0.46 (heptane: isopropyl acetate = 9:1).  
1H NMR (400 MHz, CDCl3): δ = 5.76 (dddd, J = 17.2, 13.3, 10.5, 6.5 Hz, 1H), 5.38 – 
5.27 (m, 1H), 5.23 (ddt, J = 17.2, 8.7, 1.3 Hz, 1H), 5.14 (tt, J = 10.5, 1.2 Hz, 1H), 5.08 
(tdd, J = 8.4, 4.9, 3.5 Hz, 1H), 2.05 (d, J = 3.9 Hz, 3H), 2.02-1.87 (m, 2H), 1.67 (s, 3H), 
1.60 (d, J = 3.1 Hz, 3H), 1.55-1.45 (m, 2H), 1.40-1.10(m, 3H), 0.91 (t, J = 6.4 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 170.3 (d, J = 14.9 Hz), 136.9 (d, J = 48.9 Hz), 131.3 
(d, J = 2.2 Hz), 124.6 (d, J = 5.1 Hz), 116.4 (d, J = 76.0 Hz), 73.2 (d, J = 68.0 Hz), 41.4 
(d, J = 28.2 Hz), 37.0 (d, J = 48.7 Hz), 28.8 (d, J = 18.5 Hz), 25.7, 25.3 (d, J = 8.3 Hz), 
21.3 (d, J = 8.2 Hz), 19.6 (d, J = 29.8 Hz), 17.7. 
HRMS (CI): Calculated for C14H24O2 [M–OAc]
+ = 165.1643, Found 165.1635. 
FTIR (neat): 2965, 2917, 2367, 1741, 1338, 1372, 1237, 1020, 988, 929, 668 cm–1. 
[α]
D









Procedures and Spectral Data for Synthesis of Allylic Amines 5.4a-5.4l, 5.5a-5.5l, 
5.6a-5.6g, 5.7a-5.7c 






An pressure tube equipped with a magnetic stir bar was charged with cesium carbonate 
(200 mol%), (S)-Ir-II (5 mol%). The tube was purged with argon for 5 minutes. DME 
(1.0 M) was added followed by the allylic acetate (100 mol%) and the amine (200 
mol%). The tube was sealed with a PTFE lined cap and was placed in an oil bath at the 
indicated temperature and stirred for the indicated period of time. After reaching ambient 











The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (81.6 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The 
title compound was obtained in 82% yield (53.1 mg, 0.36 mmol) as a light yellow oil 
after purification by flash column chromatography (4g SiO2, Isopropyl Acetate / Heptane 
= 0% - 10% over 20 min). 
 
TLC (SiO2) Rf  = 0.40 (heptanes: isopropyl acetate = 4:1).  
1H NMR (400 MHz, CDCl3): δ = 7.20 – 7.09 (m, 2H), 6.68 (tt, J = 7.4, 1.1 Hz, 1H), 6.63 
– 6.57 (m, 2H), 5.83 (ddd, J = 17.2, 10.3, 5.6 Hz, 1H), 5.21 (dt, J = 17.2, 1.4 Hz, 1H), 
5.08 (dt, J = 10.4, 1.4 Hz, 1H), 3.98 (dddd, J = 9.5, 6.6, 4.8, 3.3 Hz, 1H), 3.59 (s, 1H), 
1.31 (d, J = 6.6 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 147.4, 141.3, 129.1, 117.3, 114.1, 113.4, 51.1, 21.6. 
HRMS (ESI): Calculated for C10H13N [M+H
+] = 148.1126, Found 148.1122. 
FTIR (neat): 3404, 2975, 1601, 1504, 1317, 1254, 992, 919, 748, 692 cm–1. 
[α]
D
𝟐𝟖= –3.9 (c 0.2, CHCl3). 
















The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (133.0 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (60 oC, 24 hr). The 
title compound was obtained in 85% yield (76.5 mg, 0.37 mmol) as a light yellow oil 
after purification by flash column chromatography (12g SiO2, Isopropyl Acetate / 
Heptane = 0% - 10% over 20 min). 
 
TLC (SiO2) Rf  = 0.23 (heptanes: isopropyl acetate = 4:1).  
1H NMR (400 MHz, CDCl3): δ = 6.68 (dd, J = 8.5, 0.4 Hz, 1H), 6.17 (d, J = 2.7 Hz, 
1H), 6.14 (dd, J = 8.5, 2.7 Hz, 1H), 5.81 (ddd, J = 17.2, 10.3, 5.7 Hz, 1H), 5.20 (dt, J = 
17.3, 1.4 Hz, 1H), 5.07 (dt, J = 10.3, 1.4 Hz, 1H), 4.34 – 4.18 (m, 2H), 4.21 – 4.13 (m, 
2H), 4.00 – 3.77 (m, 1H), 3.33 (br, 1H), 1.28 (d, J = 6.6 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 143.9, 142.4, 141.5, 135.5, 117.5, 114.1, 107.4, 102.3, 
64.8, 64.2, 51.9, 21.7. 
HRMS (ESI): Calculated for C12H15NO2 [M+H
+] = 206.1176, Found 206.1183. 
FTIR (neat): 3394, 2973, 1507, 1207, 1068, 915, 884, 794, 740 cm–1. 
[α]
D
𝟐𝟖= –0.87 (c 0.2, CHCl3). 














The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (97.8 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (60 oC, 24 hr). The 
title compound was obtained in 83% yield (60.3 mg, 0.37 mmol) as a light yellow oil 
after purification by flash column chromatography (12g SiO2, Isopropyl Acetate / 
Heptane = 0% - 10% over 20 min). 
 
 415 
TLC (SiO2) Rf  = 0.36 (heptanes: isopropyl acetate = 4:1).  
1H NMR (400 MHz, CDCl3): δ = 1H NMR (400 MHz, Chloroform-d) δ 6.91 – 6.81 (m, 
2H), 6.58 – 6.49 (m, 2H), 5.81 (ddd, J = 17.2, 10.3, 5.7 Hz, 1H), 5.20 (dt, J = 17.2, 1.4 
Hz, 1H), 5.09 (dt, J = 10.4, 1.3 Hz, 1H), 4.01 – 3.83 (m, 1H), 3.48 (br, 1H), 1.31 (d, J = 
6.6 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 156.9, 154.5, 143.7, 141.2, 115.6, 115.4, 114.3, 114.2, 
51.8, 21.7. 
19F NMR (376 MHz, CDCl3): δ = –128.3. 
HRMS (ESI): Calculated for C10H12NF [M+H
+] = 166.1027, Found 166.1028. 
FTIR (neat): 2975, 1505, 1309, 1213, 1155, 991, 918, 815, 770, 506 cm–1. 
[α]
D
𝟐𝟖= +1.78 (c 0.2, CHCl3). 























The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (205.1 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 40 hr). The 
title compound was obtained in 85% yield (98.6 mg, 0.34 mmol) as a light yellow oil 
after purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 20:1–
10:1). 
 
TLC (SiO2) Rf  = 0.58 (hexanes: ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 7.61 (d, J = 8.7 Hz, 1H), 6.40 (d, J = 7.0 Hz, 2H), 5.83 
(ddd, J = 17.2, 10.4, 5.3 Hz, 1H), 5.20 (dt, J = 17.2, 1.4 Hz, 1H), 5.08 (dt, J = 10.4, 1.3 
Hz, 1H), 4.04 (p, J = 6.5 Hz, 1H), 3.74 (br, 1H), 2.47 (s, 3H), 1.33 – 1.29 (m, 15H). 
13C NMR (100 MHz, CDCl3): δ = 149.5, 146.7, 140.8, 137.8, 114.5, 114.1, 109.6, 82.7, 
50.4, 24.9, 24.9, 22.5, 21.5. 
HRMS (ESI): Calculated for C17H26NO2 [M+H
+] = 288.2132, Found 288.2138. 
FTIR (neat): 2978, 2362, 1602, 1349, 1215, 1146, 754 cm–1. 
[α]
D
𝟐𝟖= –1.0 (c 1.0, CHCl3). 













The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (124.2 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The 
title compound was obtained in 78% yield (67.1 mg, 0.34 mmol) as a light yellow oil 
after purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 20:1–
10:1). 
TLC (SiO2) Rf  = 0.58 (hexanes: ethyl acetate = 4:1).  
1H NMR (400 MHz, CDCl3): δ = 6.69 – 6.60 (m, 2H), 6.56 (dd, J = 8.9, 2.7 Hz, 1H), 
5.82 (ddd, J = 16.7, 10.3, 5.8 Hz, 1H), 5.20 (dd, J = 17.3, 1.4 Hz, 1H), 5.08 (dd, J = 
10.4, 1.4 Hz, 1H), 3.91 (p, J = 6.5 Hz, 1H), 3.73 (s, 3H), 3.52 (br, 1H), 1.33 (d, J = 6.6 
Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 153.08, 151.5 (d, J = 9.9 Hz), 150.71, 141.28, 129.7 
(d, J = 12.1 Hz), 114.4 (d, J = 4.6 Hz), 114.19, 109.1 (d, J = 3.3 Hz), 102.38 (d, J = 22.7 
Hz), 55.8, 51.9, 21.7. 
19F NMR (471 MHz, CDCl3): δ = –133.0 (dd, J = 12.9, 9.8 Hz, 1F). 
HRMS (ESI): Calculated for C11H14FNO [M+H
+] = 196.1132, Found 196.1129. 
FTIR (neat): 2964, 1515, 1279, 1214, 1152, 1035, 923, 755 cm–1. 
[α]
D
𝟐𝟖= +6.3 (c 1.0, CHCl3). 














The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (120.0 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The 
title compound was obtained in 89% yield (74.5 mg, 0.39 mmol) as a light yellow oil 
after purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 10:1–
4:1). 
 
TLC (SiO2) Rf  = 0.34 (hexanes: ethyl acetate = 2:1).  
1H NMR (400 MHz, CDCl3): δ = 6.74 – 6.68 (m, 2H), 6.64 – 6.57 (m, 2H), 5.84 (ddd, J 
= 17.2, 10.3, 5.7 Hz, 1H), 5.20 (dt, J = 17.2, 1.4 Hz, 1H), 5.06 (dt, J = 10.4, 1.4 Hz, 1H), 
3.90 (ttd, J = 6.6, 5.3, 1.3 Hz, 1H), 3.25 (br, 1H), 2.81 (s, 6H), 1.28 (d, J = 6.6 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 144.1, 142.0, 139.9, 115.7, 115.2, 113.9, 52.2, 42.2, 
21.7. 
HRMS (ESI): Calculated for C12H18N2 [M+H
+] = 191.1543, Found 191.1535. 
FTIR (neat): 2979, 2361, 1515, 1216, 814, 753 cm–1. 
[α]
D
𝟐𝟖= –26.3 (c 0.2, CHCl3). 















The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (129.5 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 30 hr). The 
title compound was obtained in 81% yield (71.7 mg, 0.36 mmol) as a light yellow oil 
after purification by flash column chromatography (4g SiO2, Isopropyl Acetate / Heptane 
= 0% - 30% over 20 min). 
 
TLC (SiO2) Rf  = 0.38 (hexanes: ethyl acetate = 2:1).  
1H NMR (400 MHz, CDCl3): δ = 7.76 (d, J = 1.0 Hz, 1H), 7.43 (dd, J = 8.6, 0.6 Hz, 
1H), 6.49 (dd, J = 8.7, 1.9 Hz, 1H), 6.33 (dt, J = 1.7, 0.8 Hz, 1H), 5.88 (ddd, J = 17.2, 
10.3, 5.5 Hz, 1H), 5.27 (dt, J = 17.2, 1.4 Hz, 1H), 5.13 (dt, J = 10.4, 1.3 Hz, 1H), 4.07 
(dtd, J = 8.1, 6.7, 5.2 Hz, 1H), 3.93 (s, 3H), 3.91 – 3.82 (m, 1H), 1.37 (d, J = 6.6 Hz, 
3H). 
13C NMR (100 MHz, CDCl3): δ = 146.6, 141.8, 140.8, 132.6, 121.5, 117.0, 114.3, 112.4, 
88.6, 51.3, 35.2, 21.6. 
HRMS (ESI): Calculated for C12H15N3 [M+H
+] = 202.1339, Found 202.1339. 
FTIR (neat): 3312, 2973, 1624, 1492, 1254, 1098, 982, 919, 732, 620 cm–1. 
[α]
D
𝟐𝟖= –60.3 (c 0.2, CHCl3). 












The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (158.6 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The 
title compound was obtained in 82% yield (84.5 mg, 0.36 mmol) as a light yellow oil 
after purification by flash column chromatography (12g SiO2, Isopropyl Acetate / 
Heptane = 0% - 80% over 20 min). 
 
TLC (SiO2) Rf  = 0.37 (hexanes: ethyl acetate = 1:1).  
1H NMR (400 MHz, CDCl3): δ = 7.92 (s, 2H), 5.76 (ddd, J = 17.2, 10.3, 6.2 Hz, 1H), 
5.18 (dt, J = 17.2, 1.3 Hz, 1H), 5.11 (dt, J = 10.3, 1.2 Hz, 1H), 3.87 – 3.80 (m, 1H), 3.79 
– 3.76 (m, 4H), 3.63 (dd, J = 5.7, 4.0 Hz, 4H), 1.31 (d, J = 6.6 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 157.2, 145.2, 140.6, 133.4, 115.1, 66.9, 52.8, 45.2, 
21.7. 
HRMS (ESI): Calculated for C12H18N4O [M+H
+] = 235.1553, Found 235.1555. 
FTIR (neat): 2968, 1480, 1444, 1264, 1116, 954, 731 cm–1. 
[α]
D
𝟐𝟖= +9.92 (c 1.0, CHCl3). 














The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (132.2 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 30 hr). The 
title compound was obtained in 81% yield (72.8 mg, 0.36 mmol) as a light yellow oil 
after purification by flash column chromatography (4g SiO2, Isopropyl Acetate / Heptane 
= 0% - 30% over 20 min). 
 
TLC (SiO2) Rf  = 0.52 (hexanes: ethyl acetate = 2:1).  
1H NMR (400 MHz, CDCl3): δ = 8.92 (s, 1H), 7.57 (dd, J = 8.1, 0.9 Hz, 1H), 7.38 (t, J = 
8.0 Hz, 1H), 6.67 (d, J = 7.9 Hz, 1H), 5.90 (ddd, J = 17.2, 10.4, 5.6 Hz, 1H), 5.26 (dt, J 
= 17.3, 1.4 Hz, 1H), 5.13 (dt, J = 10.3, 1.3 Hz, 1H), 4.20 (dtd, J = 8.2, 6.7, 1.5 Hz, 1H), 
3.60 (d, J = 6.7 Hz, 1H), 1.42 (d, J = 6.6 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 154.4, 151.9, 142.0, 140.5, 127.3, 120.5, 114.6, 113.3, 
107.1, 51.6, 21.7. 
HRMS (ESI): Calculated for C11H12N2S [M+H
+] = 205.0794, Found 205.0802. 
FTIR (neat): 3292, 2974, 1575, 1472, 1287, 1145, 1049, 920, 774, 717 cm–1. 
[α]
D
𝟐𝟖= +31.68 (c 0.2, CHCl3). 













The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (150.7 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (60 oC, 40 hr). The 
title compound was obtained in 76% yield (75.3 mg, 0.33 mmol) as a light yellow oil 
after purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 10:1–
4:1). 
 
TLC (SiO2) Rf  = 0.41 (hexanes: ethyl acetate = 2:1).  
1H NMR (500 MHz, CDCl3): δ = 7.30 (t, J = 7.9 Hz, 1H), 7.18 (ddd, J = 7.7, 1.7, 0.9 
Hz, 1H), 7.10 (t, J = 2.1 Hz, 1H), 6.84 – 6.74 (m, 1H), 5.79 (ddd, J = 17.0, 10.3, 5.4 Hz, 
1H), 5.22 (dd, J = 17.3, 1.3 Hz, 1H), 5.12 (dt, J = 10.3, 1.2 Hz, 1H), 4.13 – 3.90 (m, 2H), 
3.01 (s, 3H), 1.34 (d, J = 6.3 Hz, 3H). 
13C NMR (125 MHz, CDCl3): δ = 148.0, 141.3, 140.0, 130.1, 118.0, 115.3, 114.8, 111.0, 
51.0, 44.4, 21.5. 
HRMS (ESI): Calculated for C11H15NO2S [M+H
+] = 226.0896, Found 226.0900. 
FTIR (neat): 3379, 1599, 1487, 1296, 1141, 961, 757, 683 cm–1. 
[α]
D
𝟐𝟖= –33.3 (c 1.0, CHCl3). 
HPLC (Two connected chiralcel AD-H column, hexanes:i-PrOH = 95:5, 1.00 mL/min, 












The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (82.8 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The 
title compound was obtained in 74% yield (48.3 mg, 0.33 mmol) as a light yellow oil 
after purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 10:1–
4:1). 
 
TLC (SiO2) Rf  = 0.45 (hexanes: ethyl acetate = 2:1).  
1H NMR (500 MHz, CDCl3): δ = 8.07 (ddd, J = 5.0, 2.0, 0.9 Hz, 1H), 7.40 (ddd, J = 8.8, 
7.1, 1.9 Hz, 1H), 6.56 (ddd, J = 7.1, 5.0, 1.0 Hz, 1H), 6.36 (dt, J = 8.4, 1.0 Hz, 1H), 5.87 
(ddd, J = 17.2, 10.4, 5.3 Hz, 1H), 5.21 (dt, J = 17.2, 1.4 Hz, 1H), 5.08 (dt, J = 10.4, 1.4 
Hz, 1H), 4.48 (br, 1H), 4.32 – 4.20 (m, 1H), 1.33 (d, J = 6.7 Hz, 3H). 
13C NMR (125 MHz, CDCl3): δ = 158.1, 148.2, 140.7, 137.4, 113.9, 112.9, 106.9, 49.4, 
21.3. 
HRMS (ESI): Calculated for C9H12N2 [M+H
+] = 149.1073, Found 149.1073. 
FTIR (neat): 3528, 2974, 1599, 1445, 1330, 1154, 987, 920, 751 cm–1. 
[α]
D
𝟐𝟖= +6.3 (c 1.0, CHCl3). 













The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (82.8 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 30 hr). The 
title compound was obtained in 87% yield (56.7 mg, 0.38 mmol) as a light yellow oil 
after purification by flash column chromatography (4g SiO2, Isopropyl Acetate / Heptane 
= 0% - 50% over 20 min). 
 
TLC (SiO2) Rf  = 0.22 (hexanes: ethyl acetate = 1:1).  
1H NMR (400 MHz, CDCl3): δ = 8.02 (dd, J = 2.9, 0.7 Hz, 1H), 7.93 (dd, J = 4.7, 1.4 
Hz, 1H), 7.05 (ddd, J = 8.3, 4.7, 0.7 Hz, 1H), 6.86 (ddd, J = 8.3, 2.9, 1.4 Hz, 1H), 5.80 
(ddd, J = 17.2, 10.3, 5.6 Hz, 1H), 5.21 (dt, J = 17.2, 1.3 Hz, 1H), 5.11 (dt, J = 10.4, 1.3 
Hz, 1H), 3.97 (s, 1H), 3.69 (br, 1H), 1.34 (d, J = 6.7 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 143.3, 140.3, 138.7, 136.6, 123.6, 119.1, 114.7, 51.0, 
21.6. 
HRMS (ESI): Calculated for C9H12N2 [M+H
+] = 149.1073, Found 149.1075. 
FTIR (neat): 3253, 2973, 1578, 1481, 1414, 1241, 991, 917, 791, 706 cm–1. 
[α]
D
𝟐𝟖= –12.7 (c 0.2, CHCl3). 














The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (104.9 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The 
title compound was obtained in 92% yield (70.1 mg, 0.40 mmol) as a light purple oil after 
purification by flash column chromatography (4g SiO2, Isopropyl Acetate / Heptane = 
0% - 10% over 10 min). 
 
TLC (SiO2) Rf  = 0.49 (heptane: isopropyl acetate = 9:1).  
1H NMR (400 MHz, CDCl3): δ = 7.10-7.02 (m, 2H), 6.63 (t, J = 7.3 Hz, 1H), 6.49 (d, J = 
7.8 Hz, 1H), 5.94 (ddd, J = 17.5, 10.5, 5.3 Hz, 1H), 5.26-5.15 (m, 2H), 4.22 (qd, J = 6.9, 
5.1 Hz, 1H), 3.44-3.30 (m, 2H), 2.96 (t, J =18.5 Hz, 2H), 1.32 (d, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 151.1, 138.4, 130.3, 127.2, 124.4, 117.2, 115.7, 107.6, 
52.6, 47.1, 28.2, 15.5. 
HRMS (ESI): Calculated for C12H15N [M+H
+] = 174.1277, Found 174.1227. 
FTIR (neat): 3047, 3024, 2973, 2933, 2845, 1606, 1487, 1473, 1458, 1257, 1185, 1023, 
919, 743 cm–1. 
[α]
D
𝟐𝟖= -551.36 (c 0.2, CHCl3). 












The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (105.7 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The 
title compound was obtained in 78% yield (59.8 mg, 0.34 mmol) as a light yellow oil 
after purification by flash column chromatography (4g SiO2, Isopropyl Acetate / Heptane 
= 0% - 20% over 20min). 
 
TLC (SiO2) Rf  = 0.25 (heptane: isopropyl acetate =1:1).  
1H NMR (400 MHz, CDCl3): δ = 7.89 (d, J = 4.6 Hz, 1H), 7.80 (d, J = 0.9 Hz, 1H), 6.97 
(dq, J = 4.6, 1.0 Hz, 1H), 5.88 (ddd, J = 17.4, 10.5, 5.5 Hz, 1H), 5.21 (dt, J = 12.2, 1.4 
Hz, 1H), 5.18 (dt, J = 5.3, 1.4 Hz, 1H), 4.18 (qdt, J =  7.0, 5.5, 1.6 Hz, 1H), 3.45-3.32 
(m, 2H), 2.98-2.91 (m, 2H), 1.31 (d, J = 6.9 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 147.7, 139.4, 139.2, 137.5, 129.5, 119.7, 116.2, 52.8, 
46.9, 28.0, 15.7. 
HRMS (ESI): Calculated for C11H14N2 [M+H
+] =175.1230, Found 175.1226. 




𝟐𝟖= –44.4 (c 0.2, CHCl3). 















The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (105.7 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The 
title compound was obtained in 74% yield (56.8 mg, 0.33 mmol) as a light yellow oil 
after purification by flash column chromatography (4g SiO2, Isopropyl Acetate / Heptane 
= 0% - 10% over 10 min). 
 
TLC (SiO2) Rf  = 0.25 (heptane: isopropyl acetate =9:1).  
1H NMR (400 MHz, CDCl3): δ = 7.85-7.83 (m, 1H), 7.13 (dq, J = 6.9, 1.4 Hz, 1H), 6.37 
(dd, J = 7.0, 5.3 Hz, 1H), 5.91 (ddd, J = 17.4, 10.5, 4.9 Hz, 1H), 5.20-5.14 (m, 2H), 4.86 
(qdt, J = 6.8, 4.9, 1.8 Hz, 1H), 3.46-3.41 (m, 2H), 2.95-2.91 (m, 2H), 1.28 (d, J = 6.9Hz, 
3H). 
13C NMR (100 MHz, CDCl3): δ = 162.5, 145.8, 138.4, 138.4, 130.7, 123.2, 115.4, 111.9, 
49.5, 43.6, 25.7, 15.5. 
HRMS (ESI): Calculated for C11H14N2 [M+H
+] = 175.1230, Found 175.1225. 




𝟐𝟖= –31.7 (c 0.2, CHCl3). 
 454 
HPLC (Two connected chiralcel OD-3 & OD-H column, hexanes:i-PrOH = 99:1, 1.00 








 (S)-1-(but-3-en-2-yl)-2’,3’,5’,6’-tetrahydrospiro[indoline-3,4’-pyran] (5.5d) 
 
Procedures  
The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (166.5 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The 
title compound was obtained in 85% yield (88.9 mg, 0.37 mmol) as a light yellow oil 
after purification by flash column chromatography (4g SiO2, Isopropyl Acetate / Heptane 
= 10%). 
TLC (SiO2) Rf  = 0.33 (heptane: isopropyl acetate =9:1).  
 457 
1H NMR (400 MHz, CDCl3): δ = 7.11-7.03 (m, 2H), 6.67 (td, J = 7.4, 1.0 Hz, 1H), 6.49 
(dd, J = 7.8, 0.9 Hz, 1H), 5.92 (ddd, J = 17.4, 10.5, 5.1 Hz, 1H), 5.22 (dt, J = 10.4, 1.5 
Hz, 1H), 5.18 (dt, J = 3.3, 1.5 Hz, 1H), 4.23 (qdt, J = 6.8, 5.1, 1.7 Hz, 1H), 3.97 (ddd, J 
= 11.8, 4.5, 2.2 Hz, 2H), 3.57 (tdd, J = 12.0, 7.7, 2.3 Hz, 2H), 3.39-3.29 (m, 2H), 1.97 
(dtd, J = 13.9, 12.2, 4.7 Hz, 2H), 1.69-1.59 (m, 2H), 1.32 (d, J = 6.9 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 150.0, 138.3, 137.3, 127.9, 122.4, 117.3, 115.7, 107.5, 
65.2, 56.4, 52.1, 41.7, 36.7, 36.6, 36.5, 15.5. 
HRMS (ESI): Calculated for C16H22NO [M+H
+] = 244.1696, Found 244.1699. 
FTIR (neat): 2936, 2848, 2360, 2341, 1660, 1482, 1462, 1251, 1104, 1027, 837, 750, 
668, 547, 464 cm–1. 
[α]
D
𝟐𝟖= –44.7 (c 0.2, CHCl3). 
HPLC (Two connected chiralcel AD-H column, hexanes:i-PrOH = 99:1, 1.00 mL/min, 













The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (117.2 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The 
title compound was obtained in 80% yield, >20:1 dr (69.2 mg, 0.37 mmol) as a light 
yellow oil after purification by flash column chromatography (4g SiO2, Heptane). 
 
TLC (SiO2) Rf  = 0.50 (heptane: isopropyl acetate = 9:1).  
1H NMR (400 MHz, CDCl3): δ = 7.03-6.96 (m, 2H), 6.63-6.54 (m, 2H), 6.07 (ddd, J = 
17.5, 10.6, 4.2 Hz, 1H), 5.26 (ddd, J = 17.5, 2.1, 1.5 Hz, 1H), 5.20, (ddd, J = 10.6, 2.2, 
1.5 Hz, 1H), 4.01 (qdt, J = 6.8, 4.3, 2.2 Hz, 1H), 3.79 (tq, J = 8.9, 6.1 Hz, 1H), 3.18 (dd, 
J = 15.6, 9.1 Hz, 1H), 2.61 (ddt, J = 15.7, 8.8, 1.2 Hz, 1H), 1.33 (d, J = 5.3 Hz, 3H), 1.31 
(d, J = 4.4 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 150.5, 140.5, 129.3, 126.8, 124.2, 117.0, 114.8, 108.9, 
57.7, 53.0, 37.6, 21.6, 14.1. 
HRMS (ESI): Calculated for C13H17N [M+H
+] =188.1434, Found 188.1427. 














The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (117.2mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The 
title compound was obtained in 48% yield, 5:1 dr (39.8 mg, 0.21 mmol) as a light orange 
oil after purification by flash column chromatography (4g SiO2, Heptane). 
 
TLC (SiO2) Rf  = 0.50 (heptane: isopropyl acetate = 9:1).  
1H NMR (400 MHz, CDCl3): δ = 7.07-6.98 (m, 2H), 6.66-6.54 (m, 1H), 6.48-6.46 (m, 
1H), 6.05 (ddd, J = 17.3, 10.5, 5.3 Hz, 1H), 5.19 (dt, J = 17.4, 1.7 Hz, 1H), 5.14 (dt, J = 
10.5, 1.6 Hz, 1H), 4.10-4.03 (m, 1H), 3.91-3.84 (m, 1H), 3.18 (ddt, J = 15.6, 9.2, 0.9 Hz, 
1H), 2.60 (ddt, J = 15.6, 7.9, 1.1 Hz, 1H), 1.42 (d, J = 7.0 Hz, 3H), 1.28 (d, J = 6.1 Hz, 
3H). 
13C NMR (100 MHz, CDCl3): δ = 150.8, 140.3, 128.9, 127.1, 124.3, 116.8, 114.7, 107.7, 
57.0, 53.4, 37.6, 22.0, 16.4. 
HRMS (ESI): Calculated for C13H17N [M+H
+] =188.1434, Found 188.1428. 














The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (94.3 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The 
title compound was obtained in 71% yield (50.3 mg, 0.31 mmol) as a light yellow oil 
after purification by flash column chromatography (4g SiO2, Heptane). 
 
TLC (SiO2) Rf  = 0.47 (heptane: isopropyl acetate = 10:1).  
1H NMR (400 MHz, CDCl3): δ = 7.25-7.19 (m, 2H), 6.82-6.77 (m, 2H), 6.70 (tt, J = 7.3, 
1.0 Hz, 1H), 5.91 (ddd, J = 17.2, 10.8, 4.2 Hz, 1H), 5.17 (p, J = 1.4 Hz, 1H), 5.13 (ddd, J 
= 9.3, 2.0, 1.4 Hz, 1H), 4.48 (qdt, J = 6.6, 4.1, 2.0 Hz, 1H), 2.73 (s, 3H), 1.25 (d, J = 6.8 
Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 150.0, 139.6, 129.1, 116.7, 115.0, 133.3, 55.1, 31.4, 
15.5. 
HRMS (ESI): Calculated for C11H15N [M+H
+] = 162.1277, Found 162.1278. 
FTIR (neat): 3061, 2973, 2812, 2360, 2341, 1597, 1501, 1308, 1137, 1035, 990, 917, 
746, 690, 518cm–1. 
[α]
D
𝟐𝟖= –185.6 (c 0.2, CHCl3). 













The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (116.3 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The 
title compound was obtained in 79% yield (64.7 mg, 0.35 mmol) as a light yellow oil 
after purification by flash column chromatography (4g SiO2, Isopropyl Acetate / Heptane 
= 0% - 10% over 10 min). 
 
TLC (SiO2) Rf  = 0.25 (heptane: isopropyl acetate = 9:1).  
1H NMR (400 MHz, CDCl3): δ = 7.48-7.43 (m, 2H), 6.74-6.69 (m, 2H), 5.86 (ddd, J = 
17.3, 10.6, 4.0 Hz, 1H), 5.21 (ddd, J = 10.6, 2.0, 1.1 Hz, 1H), 5.14 (ddd, J = 17.4, 2.0, 
1.1, 1H), 4.53 (qdt, J = 6.7, 4.1, 2.0 Hz, 1H), 2.81 (s, 3H), 1.32 (d, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 152.3, 137.9, 133.5, 120.6, 115.8, 112.0, 97.6, 54.5, 
31.5, 16.1. 
HRMS (ESI): Calculated for C12H14N2 [M+H
+] = 187.1230, Found 187.1231. 
FTIR (neat): 3726, 3627, 2360, 2341, 2111, 1602, 1517, 1383, 1179, 1111, 922, 816, 
669, 543 cm–1. 
[α]
D
𝟐𝟖= –207.8 (c 0.2, CHCl3). 
HPLC (Two connected chiralcel OD-3 & OD-H column, hexanes:i-PrOH = 99:1, 1.00 













The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the secondary amine (120.7 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The 
title compound was obtained in 89% yield (74.9 mg, 0.39 mmol) as a light yellow oil 
after purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 25:1–
10:1). 
 
TLC (SiO2) Rf  = 0.38 (hexanes: ethyl acetate = 10:1).  
1H NMR (500 MHz, CDCl3): δ = 6.86 – 6.77 (m, 4H), 5.92 (ddd, J = 17.2, 10.7, 4.6 Hz, 
1H), 5.18 – 5.09 (m, 2H), 4.28 (dtdd, J = 8.5, 6.6, 3.9, 1.8 Hz, 1H), 3.77 (s, 3H), 2.67 (s, 
3H), 1.21 (d, J = 6.7 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 152.1, 144.7, 139.8, 116.4, 115.0, 114.5, 57.1, 55.7, 
32.5, 15.2. 
HRMS (ESI): Calculated for C12H17NO [M+H
+] = 192.1383, Found 192.1381. 
FTIR (neat): 2975, 1509, 1464, 1242, 1110, 1039, 919, 815, 754 cm–1. 
[α]
D
𝟐𝟖= –112.0 (c 1.0, CHCl3). 













The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the secondary amine (163.7 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 60 hr). The 
title compound was obtained in 64% yield (67.6 mg, 0.28 mmol) as a light yellow oil 
after purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 40:1–
20:1). 
 
TLC (SiO2) Rf  = 0.59 (hexanes: ethyl acetate = 10:1).  
1H NMR (500 MHz, CDCl3): δ = 7.06 (t, J = 8.1 Hz, 1H), 6.89 (t, J = 2.2 Hz, 1H), 6.81 
(dd, J = 7.6, 1.7 Hz, 1H), 6.69 (dd, J = 8.5, 2.5 Hz, 1H), 5.88 (ddd, J = 17.4, 10.6, 4.1 
Hz, 1H), 5.20 – 5.11 (m, 2H), 4.44 (qdt, J = 6.5, 4.0, 2.0 Hz, 1H), 2.72 (s, 3H), 1.27 (d, J 
= 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 151.1, 138.8, 130.2, 123.4, 119.2, 115.7, 115.3, 111.5, 
54.9, 31.4, 15.7. 
HRMS (ESI): Calculated for C11H14BrN [M+H
+] = 240.0382, Found 240.0382. 
FTIR (neat): 1590, 1554, 1487, 1215, 1114, 981, 925, 752, 681 cm–1. 
[α]
D
𝟐𝟖= –95.8 (c 1.0, CHCl3). 













The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the secondary amine (154.9 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 60 hr). The 
title compound was obtained in 76% yield (76.9 mg, 0.33 mmol) as a light yellow oil 
after purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 40:1–
20:1). 
 
TLC (SiO2) Rf  = 0.59 (hexanes: ethyl acetate = 10:1).  
1H NMR (500 MHz, CDCl3): δ = 7.22 (d, J = 9.0 Hz, 1H), 6.81 (d, J = 2.9 Hz, 1H), 6.60 
(dd, J = 9.0, 3.0 Hz, 1H), 5.86 (ddd, J = 17.4, 10.6, 4.1 Hz, 1H), 5.18 (ddd, J = 10.6, 2.0, 
1.2 Hz, 1H), 5.13 (ddd, J = 17.4, 2.0, 1.2 Hz, 1H), 4.39 (qdt, J = 6.5, 4.1, 2.1 Hz, 1H), 
2.71 (s, 3H), 1.26 (d, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 149.3, 138.4, 132.7, 130.3, 118.9, 115.5, 114.3, 112.5, 
55.2, 31.5, 15.7. 
HRMS (ESI): Calculated for C11H13Cl2N [M+H
+] = 230.0498, Found 230.0496. 
FTIR (neat): 2976, 1593, 1487, 1371, 1214, 1112, 997, 924 cm–1. 
[α]
D
𝟐𝟖= –100.0 (c 1.0, CHCl3). 
HPLC (Two connected chiralcel OD-3 & OD-H column, hexanes:i-PrOH = 99.5:0.5, 











The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the primary amine (141.9 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The 
title compound was obtained in 94% yield (89.1 mg, 0.41 mmol) as a light orange oil 
after purification by flash column chromatography (4g SiO2, Isopropyl Acetate / Heptane 
= 20%). 
 
TLC (SiO2) Rf  = 0.25 (heptane: isopropyl acetate = 8:2).  
1H NMR (400 MHz, CDCl3): δ = 7.61-7.58 (m, 1H), 7.20-7.14 (m, 4H), 6.02 (ddd, J = 
17.4, 10.5, 4.9 Hz, 1H), 5.29-5.25 (m, 1H), 5.25-5.23 (m, 1H), 4.16 (qdt, J = 6.8, 4.9, 1.8 
Hz, 1H), 3.61 (d, 3H), 2.84 (s, 3H), 1.32 (d, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 141.7, 138.6, 135.8, 121.5, 120.8, 117.8, 116.2, 108.3, 
58.6, 33.1, 30.8, 15.7. 
HRMS (ESI): Calculated for C13H17N3 [M+H
+] = 216.1495, Found 216.1498. 
FTIR (neat): 2972, 2360, 2341, 1615, 1594, 1524, 1463, 1390, 1285, 1116, 922, 800, 
741, 669 cm–1. 
[α]
D
𝟐𝟖= –129.9 (c 0.2, CHCl3). 
















The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the secondary amine (130.3 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The 
title compound was obtained in 94% yield (83.7 mg, 0.41 mmol) as a light yellow oil 
after purification by flash column chromatography (SiO2, heptanes: ethyl acetate = 20:1–
10:1). 
 
TLC (SiO2) Rf  = 0.63 (hexanes: ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 7.35 (d, J = 7.8 Hz, 1H), 7.25 (d, J = 7.7 Hz, 1H), 7.15 
(t, J = 7.7 Hz, 1H), 7.03 – 6.96 (m, 1H), 5.91 (ddd, J = 17.3, 10.7, 4.5 Hz, 1H), 5.28 – 
5.20 (m, 2H), 5.04 (dqd, J = 8.8, 6.4, 5.6, 2.0 Hz, 1H), 3.02 (s, 3H), 1.38 (d, J = 6.9 Hz, 
3H). 
13C NMR (125 MHz, CDCl3): δ = 162.8, 148.8, 143.4, 137.2, 123.9, 120.2, 116.4, 116.0, 
108.6, 54.1, 29.5, 15.9. 
HRMS (ESI): Calculated for C12H14N2O [M+H
+] = 203.1179, Found 203.1180. 
FTIR (neat): 2975, 1632, 1575, 1459, 1424, 1246, 1127, 1001, 925, 793, 740 cm–1. 
[α]
D
𝟐𝟖= –94.5 (c 1.0, CHCl3). 












The allylic acetate (103.1 mg, 0.44 mmol, 100 mol%) and the secondary amine (130.3 
mg, 0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). 
The title compound was obtained in 93% yield (131.9 mg, 0.41 mmol) as a light yellow 
oil after purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 
20:1–10:1). 
TLC (SiO2) Rf  = 0.44 (hexanes: ethyl acetate = 2:1).  
1H NMR (500 MHz, CDCl3): δ = 7.43 – 7.37 (m, 1H), 7.30 – 7.23 (m, 6H), 7.19 (td, J = 
7.7, 1.1 Hz, 1H), 7.03 (td, J = 7.7, 1.2 Hz, 1H), 5.92 (ddd, J = 17.6, 10.4, 5.2 Hz, 1H), 
5.30 – 5.27 (m, 1H), 5.25 (dt, J = 3.5, 1.3 Hz, 1H), 5.07 (ddd, J = 13.2, 7.0, 3.6 Hz, 1H), 
4.44 (d, J = 2.8 Hz, 2H), 3.58 (dt, J = 9.5, 5.8 Hz, 1H), 3.52 (dt, J = 9.4, 6.7 Hz, 1H), 
3.06 (s, 3H), 2.15 – 2.00 (m, 2H). 
13C NMR (125 MHz, CDCl3): δ = 163.0, 148.8, 143.4, 138.1, 135.8, 128.3, 127.7, 127.6, 
123.9, 120.3, 117.0, 116.1, 108.7, 73.3, 66.9, 56.4, 31.0, 30.4. 
HRMS (ESI): Calculated for C20H22N2O2 [M+H
+] = 323.1754, Found 323.1757. 
FTIR (neat): 2857, 1631, 1575, 1459, 1414, 1284, 1246, 1098, 1002, 907, 736, 697 cm–1. 
[α]
D
𝟐𝟖= –78.3 (c 1.0, CHCl3). 













The allylic acetate (89.8 mg, 0.44 mmol, 100 mol%) and the secondary amine (130.3 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The 
title compound was obtained in 92% yield (118.3 mg, 0.40 mmol) as a light yellow oil 
after purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 20:1–
10:1). 
 
TLC (SiO2) Rf  = 0.44 (hexanes: ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 7.40 (dd, J = 7.8, 1.2 Hz, 1H), 7.30 – 7.25 (m, 3H), 
7.24 – 7.14 (m, 4H), 7.04 (td, J = 7.8, 1.2 Hz, 1H), 5.91 (ddd, J = 17.6, 10.3, 5.2 Hz, 
1H), 5.29 (t, J = 1.4 Hz, 1H), 5.26 (dt, J = 5.2, 1.3 Hz, 1H), 4.94 – 4.85 (m, 1H), 3.08 (s, 
3H), 2.70 (t, J = 8.0 Hz, 2H), 2.15 – 2.00 (m, 2H). 
13C NMR (125 MHz, CDCl3): δ = 163.1, 148.8, 143.4, 141.2, 135.8, 128.5, 128.3, 126.1, 
123.9, 120.3, 117.1, 116.1, 108.7, 58.7, 32.8, 32.5, 29.8. 
HRMS (ESI): Calculated for C19H20N2O [M+H
+] = 293.1648, Found 293.1656. 
FTIR (neat): 2941, 1630, 1574, 1496, 1458, 1245, 1125, 1000, 926, 738, 698 cm–1. 
[α]
D
𝟐𝟖= –29.5 (c 1.0, CHCl3). 













The allylic acetate (61.7 mg, 0.44 mmol, 100 mol%) and the secondary amine (130.3 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (60 oC, 48 hr). The 
title compound was obtained in 81% yield (81.3 mg, 0.36 mmol) as a light yellow oil 
after purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 30:1–
15:1). 
TLC (SiO2) Rf  = 0.56 (hexanes: ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 7.34 (dd, J = 7.8, 1.3 Hz, 1H), 7.23 (dd, J = 7.9, 1.1 
Hz, 1H), 7.14 (td, J = 7.6, 1.2 Hz, 1H), 6.99 (td, J = 7.8, 1.3 Hz, 1H), 5.93 (ddd, J = 
17.4, 10.5, 4.4 Hz, 1H), 5.36 (dt, J = 17.3, 1.6 Hz, 1H), 5.26 (dt, J = 10.5, 1.6 Hz, 1H), 
4.16 – 4.04 (m, 1H), 3.16 (s, 3H), 1.14 (dtt, J = 9.6, 8.0, 4.9 Hz, 1H), 0.74 (dddd, J = 8.0, 
6.7, 4.7, 3.3 Hz, 1H), 0.54 (tdd, J = 10.2, 4.3, 3.2 Hz, 1H), 0.48 – 0.35 (m, 2H). 
13C NMR (125 MHz, CDCl3): δ = 163.0, 148.7, 143.5, 135.5, 123.9, 120.1, 116.9, 115.9, 
108.6, 64.2, 30.6, 12.2, 5.0, 3.0. 
HRMS (ESI): Calculated for C14H16N2O [M+H
+] = 229.1335, Found 229.1337. 
FTIR (neat): 3007, 1629, 1573, 1458, 1423, 1245, 1124, 992, 908, 815, 738 cm–1. 
[α]
D
𝟐𝟖= –35.3 (c 1.0, CHCl3). 














The allylic acetate (67.9 mg, 0.44 mmol, 100 mol%) and the secondary amine (130.3 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 48 hr). The 
title compound was obtained in 71% yield (75.7 mg, 0.31 mmol) as a light yellow oil 
after purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 20:1–
10:1). 
 
TLC (SiO2) Rf  = 0.44 (hexanes: ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 7.39 – 7.32 (m, 1H), 7.25 (d, J = 5.9 Hz, 1H), 7.15 (td, 
J = 7.7, 1.2 Hz, 1H), 7.00 (td, J = 7.7, 1.3 Hz, 1H), 5.79 (ddd, J = 17.4, 10.7, 5.2 Hz, 
1H), 5.26 – 5.14 (m, 2H), 4.82 – 4.69 (m, 1H), 2.99 (s, 3H), 2.71 (dq, J = 11.0, 7.7 Hz, 
1H), 2.15 (dt, J = 12.6, 7.7 Hz, 1H), 2.05 – 1.77 (m, 5H). 
13C NMR (125 MHz, CDCl3): δ = 163.3, 148.7, 143.5, 133.6, 123.9, 120.1, 117.0, 116.0, 
108.6, 64.4, 35.9, 30.1, 26.3, 25.2, 17.7. 
HRMS (ESI): Calculated for C15H18N2O [M+H
+] = 243.1492, Found 243.1495. 
FTIR (neat): 2938, 1629, 1573, 1458, 1416, 1245, 1122, 990, 917, 821, 738 cm–1. 
[α]
D
𝟐𝟖= –98.8 (c 1.0, CHCl3). 














The allylic acetate (74.0 mg, 0.44 mmol, 100 mol%) and the secondary amine (130.3 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (60 oC, 60 hr). The 
title compound was obtained in 81% yield (91.3 mg, 0.36 mmol) as a light yellow oil 
after purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 20:1–
10:1). 
TLC (SiO2) Rf  = 0.44 (hexanes: ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 7.35 (dd, J = 7.8, 1.1 Hz, 1H), 7.25 (d, J = 7.7 Hz, 
1H), 7.14 (td, J = 7.7, 1.2 Hz, 1H), 6.99 (td, J = 7.7, 1.2 Hz, 1H), 5.89 (ddd, J = 17.0, 
10.5, 6.0 Hz, 1H), 5.30 – 5.18 (m, 2H), 4.56 – 4.45 (m, 1H), 3.06 (s, 3H), 2.25 (dp, J = 
10.9, 8.0 Hz, 1H), 1.82 (dp, J = 12.5, 4.5, 3.8 Hz, 1H), 1.74 – 1.50 (m, 5H), 1.33 (dddd, J 
= 16.2, 10.9, 7.9, 2.4 Hz, 2H). 
13C NMR (125 MHz, CDCl3): δ = 163.2, 148.7, 143.6, 135.1, 123.8, 120.1, 117.3, 116.0, 
108.6, 64.6, 41.0, 30.5, 30.3, 30.0, 25.6, 25.3. 
HRMS (ESI): Calculated for C16H20N2O [M+H
+] = 257.1648, Found 257.1650. 
FTIR (neat): 2951, 1629, 1573, 1458, 1245, 1123, 990, 921, 819, 738 cm–1. 
[α]
D
𝟐𝟖= –92.0 (c 1.0, CHCl3). 














The allylic acetate (98.7 mg, 0.44 mmol, 100 mol%) and the primary amine (130.4 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 60 hr). The 
title compound was obtained in 80% yield, 10:1 dr (110.2 mg, 0.35 mmol) as a light 
yellow oil after purification by flash column chromatography (4g SiO2, Isopropyl Acetate 
/ Heptane = 0% - 10% over 10 min). 
 
TLC (SiO2) Rf  = 0.33 (heptane: isopropyl acetate = 9:1).  
1H NMR (400 MHz, CDCl3): δ = 7.35 (ddd, J = 7.8, 1.3, 0.6 Hz, 1H), 7.24 (ddd, J = 7.9, 
1.2, 0.6 Hz, 1H), 7.14 (td, J = 7.7, 1.1 Hz, 1H), 6.99 (td, J = 7.7, 1.2 Hz, 1H), 5.85 (ddd, 
J = 172., 10.6, 5.4 Hz, 1H), 5.24 (dt, J = 7.5, 1.3 Hz, 1H), 5.20 (d, J = 1.5 Hz, 1H), 4.99 
(ddq, J = 8.5, 5.6, 1.4 Hz, 1H), 4.93 (dddt, J = 8.4, 6.9, 5.4, 1.6 Hz, 1H), 3.02 (s, 3H), 
2.03-1.93 (m, 1H), 1.89 (dt, J = 14.7, 7.1 Hz, 1H), 1.65-1.57 (m, 2H), 1.56 (d, J = 1.4 
Hz, 3H), 1.52 (d, J = 1.3 Hz, 3H), 1.50-1.23 (m, 2H), 1.21-1.11 (m, 1H), 0.96 (d, J = 6.6 
Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 163.0, 148.8, 143.6, 136.2, 131.4, 124.4, 123.8, 120.1, 
116.8, 116.1, 108.6, 56.9, 38.5, 36.3, 29.9, 29.0, 25.5, 25.3, 20.0, 17.6. 
HRMS (ESI): Calculated for C20H28N2O [M+H
+] = 313.2274, Found 313.2276. 
FTIR (neat): 3726, 2961, 2914, 2360, 2341, 1632, 1575, 1459, 1246, 1125, 922, 754, 









The allylic acetate (98.7 mg, 0.44 mmol, 100 mol%) and the primary amine (130.4 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 60 hr) with 
(R)-Ir-II. The title compound was obtained in 76% yield, 20:1 dr (104.4 mg, 0.33 mmol) 
as a light yellow oil after purification by flash column chromatography (4g SiO2, 
Isopropyl Acetate / Heptane = 0% - 10% over 10 min). 
 
TLC (SiO2) Rf  = 0.33 (heptane: isopropyl acetate = 9:1).  
1H NMR (400 MHz, CDCl3): δ = 7.36 (ddd, J = 7.8, 1.3, 0.6 Hz, 1H), 7.26-7.23 (m, 1H), 
7.15 (td, J =7.7, 1.2 Hz, 1H), 7.02-6.96 (m, 1H), 5.85 (ddd, J = 17.5, 10.4, 5.0 Hz, 1H), 
5.22 (ddd, J = 5.3, 1.7, 1.2 Hz, 1H), 5.19 (td, J = 1.8, 1.2 Hz, 1H), 5.07 (ddq, J = 8.5, 
5.7, 1.3 Hz, 1H), 4.97 (dtt, J = 11.1, 4.5, 1.7 Hz, 1H), 3.00 (s, 2H), 1.98 (p, J =7.3 Hz, 
2H), 1.83 (ddd, J = 13.6, 10.9, 2.9 Hz, 1H), 1.66 (d, J = 1.3 Hz, 3H), 1.60-1.56 (m, 3H), 
1.47-1.24(m, 4H), 0.96 (d, J = 6.2 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 163.2, 148.8, 143.6, 136.6, 131.5, 134.5, 123.9, 120.1, 
116.3, 116.0, 108.6, 56.5, 37.9, 37.7, 29.6, 29.0, 25.7, 25.5, 19.4, 17.7. 
HRMS (ESI): Calculated for C20H28N2O [M+H
+] = 313.2274, Found 313.2278. 










The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the amine (116.3 mg, 0.88 
mmol, 200 mol%) were subject to standard reaction conditions (60 oC, 24 hr). The title 
compound was obtained in 91% yield (74.5 mg, 0.40 mmol) as a light yellow oil after 
purification by flash column chromatography (12g SiO2, Isopropyl Acetate / Heptane = 
0% - 40% over 20 min). 
 
TLC (SiO2) Rf  = 0.32 (heptanes: ethyl acetate = 2:1).  
1H NMR (400 MHz, CDCl3): δ = 7.91 (br, 1H), 7.19 (dt, J = 8.6, 0.8 Hz, 1H), 7.12 – 
7.08 (m, 1H), 6.86 (d, J = 2.3 Hz, 1H), 6.63 (ddd, J = 8.7, 2.3, 0.4 Hz, 1H), 6.39 (ddd, J 
= 3.1, 2.0, 0.9 Hz, 1H), 5.90 (ddd, J = 17.3, 10.4, 5.7 Hz, 1H), 5.25 (dt, J = 17.2, 1.4 Hz, 
1H), 5.08 (dt, J = 10.3, 1.4 Hz, 1H), 4.07 – 3.97 (m, 1H), 1.34 (d, J = 6.6 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 142.1, 141.4, 130.1, 128.8, 124.4, 113.9, 112.8, 111.5, 
103.7, 101.8, 52.5, 21.7. 
HRMS (ESI): Calculated for C12H15N2 [M+H
+] = 187.1230, Found 187.1230. 
FTIR (neat): 3404, 2975, 1626, 1581, 1469, 1231, 1167, 919, 797, 724, 602 cm–1. 
[α]
D
𝟐𝟖= –5.0 (c 0.2, CHCl3). 










The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the amine (213.9 mg, 0.88 
mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The title 
compound was obtained in 61% yield (79.8 mg, 0.27 mmol) as a light yellow oil after 
purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 10:1–5:1). 
TLC (SiO2) Rf  = 0.24 (hexanes: ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 6.53 (d, J = 2.2 Hz, 1H), 6.46 (d, J = 2.2 Hz, 1H), 5.81 
(ddd, J = 17.2, 10.3, 5.6 Hz, 1H), 5.17 (dt, J = 17.2, 1.3 Hz, 1H), 5.09 (dt, J = 10.3, 1.3 
Hz, 1H), 4.50 (d, J = 6.3 Hz, 1H), 4.13 (t, J = 5.5 Hz, 2H), 3.85 (q, J = 6.3 Hz, 1H), 3.25 
– 3.08 (m, 2H), 2.60 (br, 1H), 2.01 (ddd, J = 10.0, 6.5, 4.8 Hz, 2H), 1.31 (d, J = 6.6 Hz, 
3H). 
13C NMR (125 MHz, CDCl3): δ = 156.5, 144.5, 140.8, 126.4, 116.5, 114.3, 113.5, 110.6, 
71.9, 51.5, 45.6, 33.5, 21.6. 
HRMS (ESI): Calculated for C13H17BrN2O [M+H
+] = 297.0597, Found 297.0581. 




𝟐𝟖= –1.8 (c 1.0, CHCl3). 















The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the amine (167.4 mg, 0.88 
mmol, 200 mol%) were subject to standard reaction conditions (60 oC, 24 hr). The title 
compound was obtained in 86% yield (92.5 mg, 0.38 mmol) as a light yellow oil after 
purification by flash column chromatography (12g SiO2, Isopropyl Acetate / Heptane = 
0% - 5% over 20 min). 
TLC (SiO2) Rf  = 0.46 (hexanes: ethyl acetate = 10:1).  
1H NMR (500 MHz, CDCl3): δ = 6.80 – 6.65 (m, 4H), 6.01 – 5.76 (m, 1H), 5.21 (dd, J = 
17.2, 1.7 Hz, 1H), 5.08 (dd, J = 10.4, 1.6 Hz, 1H), 3.93 (p, J = 6.5 Hz, 1H), 3.38 – 3.11 
(m, 3H), 2.12 – 1.99 (m, 2H), 1.84 – 1.72 (m, 2H), 1.66 (dt, J = 13.1, 3.9 Hz, 1H), 1.39 
(dd, J = 14.7, 11.5 Hz, 2H), 1.34 (d, J = 6.6 Hz, 3H), 1.31 – 1.14 (m, 3H). 
13C NMR (125 MHz, CDCl3): δ = 141.8, 136.7, 136.5, 119.2, 118.8, 114.0, 113.9, 113.4, 
52.1, 51.5, 33.7 (d), 26.10, 25.0 (d), 21.87. 
HRMS (ESI): Calculated for C16H24N2 [M+H
+] = 245.2012, Found 245.2016. 
FTIR (neat): 3330, 2926, 1598, 1508, 1448, 1304, 1252, 1148, 916, 733 cm–1. 
[α]
D
𝟐𝟖= +30.0 (c 0.1, CHCl3). 









Procedures and Spectral Data for the deuterium labelling experiments 
Preparation of (S,Z)-oct-1-en-3-yl-1-d acetate (5.1h). 5.1h synthesized from 





To a round-bottomed flask charged with potassium carbonate (380.1 mg, 2.8 mmol, 110 
mol%) was added deuterium oxide (6.8 mL, 0.37 M, 99.9 atom % D), followed by (S)-(-
)-1-Octyn-3-ol (315 mg, 2.5 mmol, 100 mol%). The mixture was stirred at room 
temperature overnight. After anhydrous CH2Cl2 (10 mL) were added to the reaction 
mixture, the mixture was transferred to a separatory funnel. The organic layer was 
extracted with CH2Cl2 (5 mL × 2) and the combined organic layers were washed with 
H2O (20 mL), dried (MgSO4), filtered and concentrated under reduced pressure. The 
resulting oily residue was subjected to the next step without further purification. 
To a round-bottomed flask charged with the crude substrate under an argon atmosphere 
was added anhydrous CH2Cl2 (10 mL, 0.25 M with respect to propargylic alcohol). The 
reaction vessel was placed in an ice batch. After 5 minutes DIBAL (3 mL, 3.0 mmol, 1 M 
in hexanes) was added slowly and the solution was stirred at room temperature for 30 
minutes. After the reaction vessel was placed in an ice batch, Schwartz’s reagent (773.6 
mg, 3.0 mmol, 120 mol%) was added to the reaction mixture. The mixture was stirred at 
room temperature for 2 hours, at which point saturated aqueous sodium bicarbonate (5 
mL) were added and the reaction was stirred vigorously. After 2 hours, the reaction 
mixture was filtered (celite) with the aid of CH2Cl2 (10 mL) and the filtrate was 
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transferred to a separatory funnel. The organic layer was extracted with CH2Cl2 (10 mL × 
2) and the combined organic layers were washed with H2O (20 mL), dried (MgSO4), 
filtered and concentrated under reduced pressure. The resulting oily residue was 
subjected to the next step without further purification. 
To a round-bottomed flask charged with the crude substrate and 4-
dimethylaminopyridine (15.2 mg, 0.13 mmol, 5 mol%) under an argon atmosphere was 
added CH2Cl2 (12.5 mL, 0.25 M with respect to propargylic alcohol), followed by acetic 
anhydride (0.28 mL, 3.0 mmol, 120 mol%) and triethylamine (0.41 mL, 3.0 mmol, 120 
mol%). After 1 hour, saturated aqueous sodium bicarbonate (10 mL) was added and the 
mixture was transferred to a separatory funnel. The organic layer was extracted with 
CH2Cl2 (10 mL × 2) and the combined organic layers were washed with 1 N HCl (10 
mL), dried (MgSO4), filtered and concentrated under reduced pressure. The resulting oily 
residue was subjected to flash column chromatography (SiO2, hexanes: ethyl acetate = 
30:1) to furnish the title compound as a light yellow oil (240 mg, 1.40 mmol) in 56% 
yield over 3 steps. 
TLC (SiO2) Rf  = 0.72 (hexanes: ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 5.76 (ddt, J = 10.4, 6.3, 2.6 Hz, 1H), 5.25 – 5.19 (m, 
1H), 5.14 (dd, J = 10.5, 1.1 Hz, 1H), 2.06 (s, 3H), 1.66 – 1.52 (m, 2H), 1.34 – 1.25 (m, 
6H), 0.91 – 0.84 (m, 3H). 
2H NMR (92 MHz, CHCl3): δ = 5.28 (s, 1D). 
13C NMR (125 MHz, CDCl3): δ = 170.4, 136.6, 116.2 (t), 74.9, 34.2, 31.6, 24.7, 22.5, 
21.3, 14.0. 
LRMS (CI): Calculated for C8H14D [M–OAc]
+ = 112, Found 112. 
FTIR (neat): 2932, 1731, 1372, 1247, 1021, 756, 667 cm–1. 
[α]
D






















An pressure tube equipped with a magnetic stir bar was charged with the amine 5.3m 
(59.3 mg, 0.4 mmol, 200 mol%), cesium carbonate (130.3 mg, 0.4 mmol, 200 mol%) and 
(S)-Ir-II (11.1 mg, 0.01 mmol, 5 mol%). The tube was purged with argon for 5 minutes. 
DME (0.2 mL, 1.0 M) was added followed by the deuterated allylic acetate 5.1h (34.3 
mg, 0.2 mmol, 100 mol%). The tube was sealed with a PTFE lined cap and was placed in 
an oil bath at 70 oC for 24 hours. After reaching ambient temperature, the crude reaction 
mixture was directly subjected to flash column chromatography (SiO2, hexanes: ethyl 
acetate = 25:1–15:1). The title compound was obtained in 89% yield (46.2 mg, 0.18 
mmol) as a colorless oil. 
TLC (SiO2) Rf   
= 0.55 (hexanes: ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 7.35 (dd, J = 7.8, 1.1 Hz, 1H), 7.25 (d, J = 8.0 Hz, 1H), 
7.15 (td, J = 7.7, 1.1 Hz, 1H), 6.99 (td, J = 7.7, 1.2 Hz, 1H), 5.85 (ddd, J = 10.5, 5.1, 2.4 
Hz, 1H), 5.20 (dd, J = 10.6, 1.6 Hz, 1H), 4.86 – 4.77 (m, 1H), 3.02 (s, 3H), 1.74 – 1.66 
(m, 2H), 1.36 – 1.27 (m, 6H), 0.86 (t, J = 6.9 Hz, 3H). 
2H NMR (92 MHz, CHCl3): δ = 5.28 (s, 1D). 
13C NMR (125 MHz, CDCl3): δ = 163.2, 148.8, 143.5, 136.1, 123.8, 120.1, 116.4 (t), 
116.0, 108.6, 58.9, 31.6, 30.9, 29.7, 25.8, 22.5, 14.0. 
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HRMS (ESI): Calculated for C16H21DN2O [M+H
+] = 260.1868, Found 260.1870. 
FTIR (neat): 2930, 1636, 1577, 1460, 1246, 1216, 748 cm–1. 
[α]
D
𝟐𝟖= –71.3 (c 1.0, CHCl3). 


















An pressure tube equipped with a magnetic stir bar was charged with the amine 5.3m 
(59.3 mg, 0.4 mmol, 200 mol%), cesium carbonate (130.3 mg, 0.4 mmol, 200 mol%) and 
(R)-Ir-II (11.1 mg, 0.01 mmol, 5 mol%). The tube was purged with argon for 5 minutes. 
DME (0.2 mL, 1.0 M) was added followed by the deuterated allylic acetate 5.1h (34.3 
mg, 0.2 mmol, 100 mol%). The tube was sealed with a PTFE lined cap and was placed in 
an oil bath at 70 oC for 24 hours. After reaching ambient temperature, the crude reaction 
mixture was directly subjected to flash column chromatography (SiO2, hexanes: ethyl 
acetate = 25:1–15:1). The title compound was obtained in 85% yield (44.1 mg, 0.17 
mmol) as a colorless oil. 
 
TLC (SiO2) Rf  = 0.55 (hexanes: ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 7.35 (dd, J = 7.8, 1.1 Hz, 1H), 7.26 – 7.22 (m, 1H), 
7.15 (td, J = 7.7, 1.1 Hz, 1H), 6.99 (td, J = 7.8, 1.2 Hz, 1H), 5.86 (dd, J = 17.3, 5.3 Hz, 
1H), 5.21 (dd, J = 17.4, 1.7 Hz, 1H), 4.82 (dddd, J = 8.6, 6.8, 5.3, 1.7 Hz, 1H), 3.02 (s, 
3H), 1.76 – 1.63 (m, 2H), 1.41 – 1.21 (m, 6H), 0.87 (t, J = 7.0 Hz, 3H). 
2H NMR (92 MHz, CHCl3): δ = 5.28 (s, 1D). 
13C NMR (125 MHz, CDCl3): δ = 163.2, 148.8, 143.5, 136.2, 136.0, 123.8, 120.1, 116.6, 
116.4, 116.2, 116.0, 108.6, 58.9, 31.6, 30.9, 29.7, 25.8, 22.5, 14.0. 
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HRMS (ESI): Calculated for C16H21DN2O [M+H
+] = 260.1868, Found 260.1872. 
FTIR (neat): 2930, 1636, 1577, 1460, 1246, 1216, 753 cm–1. 
[α]
D
𝟐𝟖= +70.8 (c 1.0, CHCl3). 











Single Crystal Diffraction Data for 5.7b 
 
Empirical formula  C13 H18 Br Cl N2 O 
Formula weight  333.65 
Temperature  100(2) K 
Wavelength  1.54184 Å 
Crystal system  monoclinic 
Space group  P 21 
  Unit cell dimensions a = 7.1967(3) Å = 90°. 
 b = 19.2597(4) Å = 105.491(5)°. 
 c = 10.4450(4) Å  = 90°. 
Volume 1395.15(9) Å3 
Z 4 
Density (calculated) 1.588 Mg/m3 
Absorption coefficient 5.697 mm-1 
F(000) 680 
Crystal size 0.160 x 0.070 x 0.030 mm3 
Theta range for data collection 4.393 to 75.594°. 
Index ranges -8<=h<=8, -23<=k<=23, -12<=l<=12 
Reflections collected 21291 
Independent reflections 5628 [R(int) = 0.0497] 
Completeness to theta = 67.684° 100.0 %  
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5628 / 2 / 351 
Goodness-of-fit on F2 1.063 
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Final R indices [I>2sigma(I)] R1 = 0.0362, wR2 = 0.0947 
R indices (all data) R1 = 0.0369, wR2 = 0.0955 
Absolute structure parameter -0.009(15) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.701 and -0.579 e.Å-3 
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Figure 1.  View of cation 1 in 5.7b showing the atom labeling scheme.  Displacement 











Figure 2.  View of cation 2 in 5.7b showing the atom labeling scheme.  Displacement 











Chapter 6:  Regio- and Enantioselective Iridium-Catalyzed N-Allylation 
of Indoles and Related Azoles with Racemic Branched Alkyl-
Substituted Allylic Acetates * 
 
6.1 Introduction 
Iridium-catalyzed allylic amination has emerged as an important method for 
enantioselective C-N bond formation.1-9 Pursuant to the pioneering work of Takeuchi,1,2 
studies from the laboratories of Helmchen,3,4 Hartwig,5,6 Carreira7 and You8,9 have shown 
that chiral phosphoramidite-modified iridium complexes are especially effective in this 
regard (Figure 6.1). Like the parent palladium-catalyzed Tsuji-Trost reactions,10 the 
iridium-phosphoramidite-catalyzed allylic alkylations occur by way of cationic π-
allylmetal intermediates. Recently, we found that π-allyliridium-C,O-benzoates, which 
are well-known to promote nucleophilic allylation of carbonyl compounds,11,12 are also 
effective catalysts for highly regio- and enantioselective electrophilic allylation of 
amines.13 These π-allyliridium-C,O-benzoates react by way of neutral π-allylmetal 
intermediates, which may account for their amphiphilic character. One advantage of the 
π-allyliridium-C,O-benzoate catalysts relates to their facile preparation and remarkable 
stability toward air, water and SiO2.
14 Using SEGPHOS-modified π-allyliridium-C,O-
benzoate catalysts, allylic aminations mediated by aliphatic amine nucleophiles occur 
with high levels of regio- and enantioselectivity.13a It was later found that the tol-BINAP-
modified π-allyliridium-C,O-benzoate (S)-Ir-I is a superior catalyst, enabling highly 
regio- and enantioselective allylation of electronically diverse primary and secondary 
(hetero)aryl amines.13b 
 
*This chapter is based on the published work: 
Kim, S. W.; Schempp, T. T.; Zbieg, J. R.; Stivala, C. E.; Krische, M. J. Angew. Chem. Int. Ed. 2019, 58, 
7762. 
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Figure 6.1 Iridium catalysts for asymmetric allylic amination and chiral indole-




6.2 Reaction Development and Scope 
In the latter study, it was shown that 5-amino-indole (5-N)-6.1a undergoes allylic 
alkylation at the 5-amino moiety to furnish (5-N)-6.3a with complete site-selectivity (eq. 
6.1), suggesting indoles may not be subject to π-allyliridium-C,O-benzoate-catalyzed N-
allylation. To challenge this assumption, the parent indole 6.1a was exposed to 
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essentially identical conditions for allylic alkylation (eq. 6.2). To our delight, the product 
6.3a was obtained in excellent yield as a single regioisomer in 93% enantiomeric excess. 
These results were deemed significant, as indoles and related azoles are prevalent 
structural motifs in clinical candidates and FDA approved drugs (Figure 6.1),15,16 and 
allylation at C3 is the major product observed in the intermolecular allylation of 
structurally and electronically unbiased indoles using palladium,17 ruthenium18 or 
iridium19 catalysts. For example, to enforce N-allylation, use of electron deficient 
indoles17j,19c or heteroatom substituted π-allylmetal species (from alkoxyallenes) is 
required.17o These limitations have necessitated the development of indirect methods for 
the synthesis of enantiomerically enriched N-allyl indoles (Figure 6.1).20 As the 
development of enantioselective methods for intermolecular indole allylation that are 
completely N-selective and display exclusive branched regioselectivity remains an unmet 
challenge,17-20 an effort to assess the scope the π-allyliridium-C,O-benzoate-catalyzed 
indole allylation was undertaken. Here, we show that the tol-BINAP-modified iridium 
complex (S)-Ir-I catalyzes highly enantioselective allylation of diverse indoles and azoles 





Table 6.1 Regio- and enantioselective iridium-catalyzed allylic alkylation of indoles 
and related azoles 6.1a-6.1s using α-methyl allyl acetate 6.2a.a 
 
 
aYields of material isolated by silica gel chromatography. Regio- and diastereoselectivities were determined 
by 1H NMR analysis of crude reaction mixtures. Enantioselectivities were determined by chiral stationary 
phase HPLC analysis. See Supporting Information for further experimental details. 
 
To assess the generality of indole allylation catalyzed by (S)-Ir-I, the reaction 
conditions utilized in equation 6.2 were applied to structural diverse indoles and azoles 
6.1a-6.1p (Table 6.1). Beyond the parent indole 6.1a, electronically diverse indoles 
substituted at the 2-position (6.1b), 4-position (6.1e), 5-position (6.1f), 6-position (6.1g, 
6.1h) and 7-position (6.1i-6.1k) each underwent efficient allylation to deliver the 
respective adducts (6.3b, 6.3e-6.3k) with complete N-regioselectivity, complete branched 
 535 
regioselectivity and uniformly high levels of enantioselectivity. The structurally related 
azoles tetrahydro-carbazole 6.1c, the “homo-tetrahydro-carbazole” 6.1d, 3-methyl-
indazole 6.1l, 2-ethyl- benzimidazole 6.1m, 6-azaindole 6.1n, 7-azaindole 6.1o, carbazole 
6.1p and 2-methyl-3-carboxypyrrole ethyl ester 6.1q also underwent efficient N-
allylation to form adducts 6.3c, 6.3d and 6.3l-6.3q, respectively, as single constitutional 
isomers with high levels of enantiomeric enrichment. Of relevance to medicinal 
chemistry applications, the formation of adduct 6.3o demonstrates tolerance of a pinacol 
boronate moiety under the conditions of asymmetric N-allylation. Additionally, to further 
test the limits of our method, catalyst-directed diastereoselectivity was explored in the 
allylation of the structurally complex chiral azole 6.1r, which is related to AZD-9496, a 
clinical stage non-steroidal oral estrogen receptor inhibitor.21 Remarkably, the 
enantiomeric iridium catalysts (S)-Ir-I and (R)-Ir-I deliver the diastereomeric adducts 6.3r 
and 6.3s in >95% yield with complete levels of catalyst-directed stereoinduction.  
Using diverse α-substituted allyl acetates 6.2b-6.2j, the scope of the electrophilic 
partner was subsequently evaluated in N-allylations of the parent indole 6.1a (Table 6.2). 
Branched allylic acetates bearing linear alkyl groups 6.2b-6.2d, which incorporate 
phenyl, benzyl ether and methyl sulfide moieties, respectively, were efficiently converted 
to adducts 6.4b-6.4d. As illustrated by the formation adduct 6.4e, branched alkyl groups 
are tolerated. Finally, the preparation of adducts 6.4f-6.4j highlight the tolerance of 
cycloalkyl substituents. All adducts 6.4b-6.4j were formed as single constitutional 
isomers and with high levels of enantiomeric enrichment. The absolute stereochemistry 
of adducts 6.3a-6.3s and 6.4b-6.4j was assigned in analogy to adduct 6.3a, which was 





Table 6.2 Regio- and enantioselective iridium-catalyzed allylic alkylation of indole 
6.1a using diverse α-substituted allyl acetates 6.2b-6.2j.a 
 
 
aYields of material isolated by silica gel chromatography. Regio- and diastereoselectivities were determined 
by 1H NMR analysis of crude reaction mixtures. Enantioselectivities were determined by chiral stationary 
phase HPLC analysis. See Supporting Information for further experimental details. 
 
To further assess the breadth of the present protocol for catalytic enantioselective 
N-allylation, the cyclization of racemic allylic acetate 6.5a was explored (eq. 6.3). The 
cyclization of 5a provides an opportunity to test the limits of stereoinduction, as the rate 
of enantiotopic π-facial interconversion must exceed the rate of 5-membered ring 
formation.22 The cyclization of 6.5a also provides another context to evaluate the fidelity 
of N- vs C3-regioselectivity. In the event, exposure of 6.5a to (S)-Ir-I under standard 
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conditions at 50 oC provided the product of N-cycloallylation 6.6a as single constitutional 
isomer without competing C3-cycloallylation. 
 
 
Scheme 6.1 Iridium-catalyzed amination of enantiomerically enriched deuterated 
allylic acetate 6.2k with the enantiomeric catalysts (S)-Ir-I and (R)-Ir-I.a 
 
 
aYields of material isolated by silica gel chromatography. Regio- and diastereoselectivities were determined 
by 1H NMR analysis of crude reaction mixtures. Enantioselectivities were determined by chiral stationary 








The basicity of the reaction conditions and the acidity of indoles suggest the 
active nucleophiles in the present protocol for iridium-catalyzed N-allylation are N-
centered anions. In previously reported allylic aminations catalyzed by π-allyliridium-
C,O-benzoates, significantly less acidic aliphatic and aromatic amines were utilized, 
which likely serve as neutral N-nucleophiles.13 Hence, although a mechanism involving 
outer-sphere addition was established in the previously reported allylic aminations of the 
less acidic aliphatic and aromatic amines, it was unclear whether inner- or outer-sphere 
addition pathways were operative in the present indole-mediated asymmetric aminations. 
To address this question, the enantiomerically enriched (Z)-deuterated allylic acetate 6.2k 
was subjected to standard conditions for allylic amination using indole 6.1a (Scheme 
1).[23] Using the enantiomeric catalysts (S)-Ir-I and (R)-Ir-I the stereoisomeric products 
6.4k and iso-6.4k are generated, which corroborates C-N bond formation through outer-
sphere addition.  
 
6.4 Conclusion 
In summary, using π-allyliridium-C,O-benzoate catalysts in combination with 
racemic branched alkyl-substituted allylic acetate proelectrophiles, we report the first 
highly enantioselective intermolecular Tsuji-Trost-type indole N-allylations wherein 
complete N-regioselectivity is accompanied by complete branched-regioselectivity. 
Future work will explore related electrophilic N- and C-allylations catalyzed by 
cyclometallated π-allyliridium C,O-benzoates. These efforts illustrate the effectiveness of 
 539 
academic-industrial collaboration vis-á-vis development of asymmetric methods for 
unmet challenges in synthetic chemistry of relevance to the drug discovery enterprise. 
 
6.5 Experimental Details 
 
General Information 
All reactions were carried out under inert gas atmosphere (nitrogen or argon) 
unless otherwise indicated. Resealable pressure tubes (13x100 mm) were purchased from 
Fischer Scientific (catalog number 14-959-35C) and were flame dried followed by 
cooling in a desiccator or under a stream of inter gas prior to use. All commercial 
reagents and anhydrous solvents were used as received from vendors (Fischer Scientific, 
Sigma Aldrich and Combi Blocks) without further purification. The used Iridium catalyst 
(S)-Ir-I and (R)-Ir-I was prepared according to literature known procedures.1 Cesium 
carbonate was used as received from Rockwell Lithium. Preparative column 
chromatography employing Silicycle silica gel (40-63 μm) was performed according to 
the method of Still2 or on a Teledyne Isco Combiflash Rf utilizing Silicycle HP columns 
using a mobile phase composed of either heptane/isopropyl acetate, heptanes/ethyl 
acetate or dichloromethane/methanol. Reactions were monitored by a Shimadzu 
LCMS/UV system with LC-30AD solvent pump, 2020 MS, Sil-30AC autosampler, SPD-
M30A UV detector, CTO-20A column oven, using a 2-98% acetonitrile/0.1% formic acid 
(or 0.001% ammonia) gradient over 2.5 minutes. Analytical thin-layer chromatography 
(TLC) was carried out using 0.25 mm commercial silica gel plates (Dynamic Absorbents 
F). Visualization was accomplished with UV light followed by dipping in CAM, p- 






Spectroscopy, Spectrometry and Data Collection  
Infrared spectra were recorded on a PerkiN-Elmer 1600 spectrometer using a 
diamond ATR unit. High-resolution mass spectra (HRMS) were obtained on a Karatos 
MS9 and are reported as m/z (relative intensity). Accurate masses are reported for the 
molecular ion (M+H, M+Na), or a suitable fragment ion. Nuclear magnetic resonance 
(1H, 13C, 19F NMR) spectra were recorded with a Bruker BioSpin GmbG, Varian Gemini 
(400 MHz) or Varian INOVA (500 MHz) spectrometer equipped with a Bruker 
cryoprobe. The chemical shifts are given as parts per million (ppm) and were referenced 
to the residual solvent signal (CDCl3: δH = 7.26 ppm, δC = 77.16 ppm). Specific optical 
rotations were recorded on an Atago AP-300 automatic polarimeter at the sodium line 
(589 nm) in CHCl3. Solution concentrations are given in the units of 10–2 g mL–1. 
 
Experimental Details and Spectral Data 
Synthesis of Allylic Acetates 6.2d, 6.2g, and 6.2h 
The allylic acetates 6.2d, 6.2g, and 6.2h were prepared by the Grignard reaction and 
acetylation of the as shown below. The allylic acetates 6.2b,3 6.2c,4 6.2e,5 6.2f,6 6.2i,7 







(S)-5-(methylthio)pent-1-en-3-yl acetate (6.2d) 
 
Procedures  
To a round-bottomed flask charged with the corresponding aldehyde (1.04 g, 10.0 mmol, 
100 mol%) under an argon atmosphere was added THF (50.0 mL, 0.2 M). The reaction 
flask was placed an ice batch. After 10 minutes, vinyl magnesium bromide solution (12.0 
mL, 12.0 mmol, 120 mol%, 1.0 M in THF) was added slowly and the mixture was stirred 
at room temperature for 1 hour, at which point acetic anhydride (1.42 mL, 15.0 mmol, 
150 mol%) and triethylamine (2.79 mL, 20.0 mmol, 200 mol%) were added and the 
reaction was stirred vigorously overnight. After water (50 mL) was added, the mixture 
was transferred to a separatory funnel. The organic layer was extracted with diethyl ether 
(50 mL × 2) and the combined organic layers were washed with 1 N HCl (50 mL), dried 
(MgSO4), filtered and concentrated under reduced pressure. The resulting oily residue 
was subjected to flash column chromatography (SiO2, pentanes: diethyl ether = 40:1–
20:1) to furnish the title compound as a colorless oil (1.31 g, 4.58 mmol) in 75% yield 
over 2 steps. 
TLC (SiO2) Rf  = 0.40 (hexanes: ethyl acetate = 5:1). 
1H NMR (500 MHz, CDCl3): δ 5.77 (ddd, J = 17.0, 10.5, 6.4 Hz, 1H), 5.34 (dt, J = 7.3, 
1.0 Hz, 1H), 5.27 (dt, J = 17.2, 1.3 Hz, 1H), 5.20 (dt, J = 10.5, 1.2 Hz, 1H), 2.49 (ddd, J 
= 8.4, 6.7, 1.9 Hz, 2H), 2.10 (s, 3H), 2.07 (s, 3H), 2.01 – 1.81 (m, 2H). 
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13C NMR (125 MHz, CDCl3): δ 170.2, 135.8, 117.2, 73.6, 33.7, 29.6, 21.2, 15.5. 
HRMS (ESI): Calculated for C8H14O2S [M+Na
+] = 197.0607, Found 197.0607. 








To a round-bottomed flask charged with the corresponding aldehyde (0.90 g, 7.50 mmol, 
100 mol%) under an argon atmosphere was added THF (37.5 mL, 0.2 M). The reaction 
flask was placed an ice batch. After 10 minutes, vinyl magnesium bromide solution (9.0 
mL, 9.0 mmol, 120 mol%, 1.0 M in THF) was added slowly and the mixture was stirred 
at room temperature for 1 hour, at which point acetic anhydride (1.06 mL, 11.3 mmol, 
150 mol%) and triethylamine (2.09 mL, 15.0 mmol, 200 mol%) were added and the 
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reaction was stirred vigorously overnight. After water (50 mL) was added, the mixture 
was transferred to a separatory funnel. The organic layer was extracted with diethyl ether 
(50 mL × 2) and the combined organic layers were washed with 1 N HCl (50 mL), dried 
(MgSO4), filtered and concentrated under reduced pressure. The resulting oily residue 
was subjected to flash column chromatography (SiO2, pentanes: diethyl ether = 40:1–
20:1) to furnish the title compound as a colorless oil (0.87 g, 4.58 mmol) in 61% yield 
over 2 steps. 
 
 
TLC (SiO2) Rf  = 0.39 (hexanes: ethyl acetate = 10:1).  
1H NMR (500 MHz, CDCl3): δ = 5.73 (ddd, J = 17.1, 10.5, 6.6 Hz, 1H), 5.36 – 5.22 (m, 
3H), 2.61 (dtdd, J = 16.0, 10.7, 5.1, 3.0 Hz, 2H), 2.55 – 2.27 (m, 3H), 2.12 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ = 170.2, 133.6, 118.3, 75.89 – 75.81 (m), 37.34 – 36.70 
(m, 2C), 26.27 (dd, J = 13.7, 5.9 Hz), 21.01. 
19F NMR (376 MHz, CDCl3): δ = -83.1 – -83.8 (m, 1F), -95.6 – -96.3 (m, 1F). 
LRMS (CI): Calculated for C7H9F2 [M–OAc]
+ = 131, Found 131. 

































To a round-bottomed flask charged with the corresponding aldehyde (0.90 g, 7.50 mmol, 
100 mol%) under an argon atmosphere was added THF (37.5 mL, 0.2 M). The reaction 
flask was placed an ice batch. After 10 minutes, vinyl magnesium bromide solution (9.0 
mL, 9.0 mmol, 120 mol%, 1.0 M in THF) was added slowly and the mixture was stirred 
at room temperature for 1 hour, at which point acetic anhydride (1.06 mL, 11.3 mmol, 
150 mol%) and triethylamine (2.09 mL, 15.0 mmol, 200 mol%) were added and the 
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reaction was stirred vigorously overnight. After water (50 mL) was added, the mixture 
was transferred to a separatory funnel. The organic layer was extracted with diethyl ether 
(50 mL × 2) and the combined organic layers were washed with 1 N HCl (50 mL), dried 
(MgSO4), filtered and concentrated under reduced pressure. The resulting oily residue 
was subjected to flash column chromatography (SiO2, pentanes: diethyl ether = 40:1–
20:1) to furnish the title compound as a colorless oil (1.09 g, 4.28 mmol) in 57% yield 
over 2 steps. 
 
TLC (SiO2) Rf  = 0.24 (hexanes: ethyl acetate = 4:1). 
1H NMR (400 MHz, CDCl3): δ = 5.69 (ddd, J = 17.1, 10.5, 6.4 Hz, 1H), 5.38 – 5.32 (m, 
1H), 5.31 – 5.20 (m, 2H), 3.91 (td, J = 8.6, 2.5 Hz, 2H), 3.72 (dd, J = 8.8, 5.5 Hz, 1H), 
3.62 (dd, J = 8.9, 5.6 Hz, 1H), 2.82 – 2.66 (m, 1H), 2.06 (s, 3H), 1.41 (s, 9H). 
13C NMR (125 MHz, CDCl3): δ = 170.2, 156.2, 133.2, 118.7, 79.5, 75.2, 50.7 (d, J = 
72.7 Hz), 31.6, 28.4, 21.1. 
HRMS (ESI): Calculated for C13H21NO4 [M+Na
+] = 278.1363, Found 278.1371. 




Procedures and Spectral Data for Synthesis of Allylic Amines 6.3a-6.3q, 6.4b-6.4j 






A pressure tube equipped with a magnetic stir bar was charged with cesium carbonate 
(200 mol%), (S)-Ir-I (5 mol%). The tube was purged with argon for 5 minutes. DME 
(1.0 M) was added followed by the allylic acetate (100 mol%) and the amine (200 
mol%). The tube was sealed with a PTFE lined cap and was placed in an oil bath at the 
indicated temperature and stirred for the indicated period of time. After reaching ambient 












The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the indole (103.1 mg, 0.88 
mmol, 200 mol%) were subject to standard reaction conditions (50 oC, 24 hr). The title 
compound was obtained in 78% yield (58.8 mg, 0.34 mmol) as a light yellow oil after 
purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 20:1–10:1). 
 
TLC (SiO2) Rf  = 0.44 (hexanes: ethyl acetate = 10:1).  
1H NMR (400 MHz, CDCl3): δ = 7.63 (dt, J = 7.9, 1.1 Hz, 1H), 7.36 (dd, J = 8.3, 0.9 
Hz, 1H), 7.22 – 7.16 (m, 2H), 7.10 (ddd, J = 7.9, 7.0, 1.0 Hz, 1H), 6.52 (dd, J = 3.2, 0.8 
Hz, 1H), 6.05 (ddd, J = 17.5, 10.4, 4.7 Hz, 1H), 5.18 (ddd, J = 10.4, 1.6, 0.9 Hz, 1H), 
5.12 – 5.04 (m, 2H), 1.65 (d, J = 6.9 Hz, 3H). 
13C NMR (125 MHz, CDCl3): δ = 138.8, 135.7, 128.7, 124.7, 121.3, 121.0, 119.4, 115.5, 
109.8, 101.4, 53.1, 19.7. 
HRMS (ESI): Calculated for C12H13N [M+H
+] = 172.1126, Found 172.1122. 
FTIR (neat): 2980, 1509, 1459, 1310, 1264, 1213, 926, 735 cm–1. 
[α]
D
𝟐𝟖= –20.6 (c 0.2, CHCl3). 


















The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the indole (170.1 mg, 0.88 
mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The title 
compound was obtained in 74% yield (80.5 mg, 0.33 mmol) as a light yellow oil after 
purification by flash column chromatography (12g SiO2, Isopropyl Acetate / Heptane = 
0% - 10% over 20 min). 
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TLC (SiO2) Rf  = 0.43 (hexanes: ethyl acetate = 10:1).  
1H NMR (400 MHz, CDCl3): δ = 7.67 – 7.62 (m, 1H), 7.52 – 7.39 (m, 6H), 7.14 (qdd, J 
= 8.1, 6.7, 1.2 Hz, 2H), 6.52 (d, J = 0.8 Hz, 1H), 6.22 (dddd, J = 17.3, 10.6, 3.7, 0.7 Hz, 
1H), 5.29 (ddd, J = 10.6, 2.3, 1.0 Hz, 1H), 5.20 (ddt, J = 17.3, 2.0, 0.9 Hz, 1H), 5.17 – 
5.10 (m, 1H), 1.62 (d, J = 7.1 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 141.5, 138.8, 135.9, 133.3, 129.4, 129.0, 128.5, 128.0, 
121.0, 120.7, 119.7, 115.6, 113.0, 102.4, 52.9, 18.2. 
HRMS (ESI): Calculated for C18H17N [M+H
+] = 248.1434, Found 248.1435. 
FTIR (neat): 2980, 1604, 1455, 1347, 1313, 1163, 921, 763, 700 cm–1. 
[α]
D
𝟐𝟖= –40.8 (c 0.2, CHCl3). 












The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the indole (150.7 mg, 0.88 
mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The title 
compound was obtained in 81% yield (80.3 mg, 0.36 mmol) as a light yellow oil after 
purification by flash column chromatography (12g SiO2, Isopropyl Acetate / Heptane = 
0% - 10% over 20 min). 
 
TLC (SiO2) Rf  = 0.46 (hexanes: ethyl acetate = 10:1).  
1H NMR (400 MHz, CDCl3): δ = 7.51 – 7.45 (m, 1H), 7.39 – 7.34 (m, 1H), 7.14 – 7.03 
(m, 2H), 6.19 (ddd, J = 17.3, 10.6, 4.0 Hz, 1H), 5.23 (ddd, J = 10.6, 2.3, 1.0 Hz, 1H), 
5.15 (ddd, J = 17.4, 2.2, 1.0 Hz, 1H), 5.04 (dddd, J = 11.1, 7.1, 4.8, 2.0 Hz, 1H), 2.77 – 
2.71 (m, 4H), 1.98 – 1.91 (m, 2H), 1.90 – 1.83 (m, 2H), 1.65 (d, J = 7.1 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 139.1, 135.2, 135.1, 127.9, 120.2, 118.4, 117.7, 115.2, 
110.7, 109.8, 51.5, 23.5, 23.2, 23.1, 21.1, 18.4. 
HRMS (ESI): Calculated for C16H19N [M+H
+] = 226.1596, Found 226.1605. 
FTIR (neat): 2933, 1462, 1368, 1264, 1175, 922, 732, 703 cm–1. 
[α]
D
𝟐𝟖= –7.7 (c 0.2, CHCl3). 













The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the indole (163.0 mg, 0.88 
mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The title 
compound was obtained in 83% yield (87.4 mg, 0.37 mmol) as a light yellow oil after 
purification by flash column chromatography (12g SiO2, Isopropyl Acetate / Heptane = 
0% - 10% over 20 min). 
TLC (SiO2) Rf  = 0.46 (hexanes: ethyl acetate = 10:1).  
1H NMR (400 MHz, CDCl3): δ = 7.53 – 7.46 (m, 1H), 7.37 – 7.31 (m, 1H), 7.11 – 7.04 
(m, 2H), 6.20 (ddd, J = 17.4, 10.5, 3.8 Hz, 1H), 5.24 (ddd, J = 10.7, 2.4, 0.9 Hz, 1H), 
5.22 – 5.13 (m, 2H), 2.92 – 2.82 (m, 4H), 1.94 – 1.87 (m, 2H), 1.80 – 1.74 (m, 4H), 1.63 
(d, J = 7.0 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 139.7, 138.9, 134.5, 128.2, 119.9, 118.5, 117.5, 115.0, 
114.5, 110.3, 51.2, 31.7, 28.1, 27.3, 26.9, 24.1, 18.9. 
HRMS (ESI): Calculated for C17H21N [M+H
+] = 240.1747, Found 240.1747. 
FTIR (neat): 2917, 2845, 1463, 1346, 1204, 1086, 919, 735 cm–1. 
[α]
D
𝟐𝟖= –8.8 (c 0.2, CHCl3). 












The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the indole (125.1 mg, 0.88 
mmol, 200 mol%) were subject to standard reaction conditions (50 oC, 24 hr). The title 
compound was obtained in 83% yield (72.0 mg, 0.37 mmol) as a light yellow oil after 
purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 10:1). 
 
TLC (SiO2) Rf  = 0.26 (hexanes: ethyl acetate = 5:1).  
1H NMR (500 MHz, CDCl3): δ 7.58 (d, J = 8.3 Hz, 1H), 7.47 (dd, J = 7.3, 0.8 Hz, 1H), 
7.36 (d, J = 3.3 Hz, 1H), 7.22 (dd, J = 8.3, 7.4 Hz, 1H), 6.77 – 6.70 (m, 1H), 6.03 (ddd, J 
= 17.1, 10.4, 5.1 Hz, 1H), 5.22 (dd, J = 10.5, 1.6 Hz, 1H), 5.14 – 5.03 (m, 2H), 1.68 (d, J 
= 6.9 Hz, 3H). 
13C NMR (125 MHz, CDCl3): δ 138.0, 135.4, 130.0, 127.5, 125.0, 121.0, 118.8, 116.2, 
114.6, 103.3, 100.6, 53.6, 19.8. 
HRMS (ESI): Calculated for C13H12N2 [M+H
+] = 219.0893, Found 219.0900. 
FTIR (neat): 2983, 2360, 2342, 2222, 1435, 1274, 1260, 750 cm–1. 
[α]
D
𝟐𝟖= –9.0 (c 1.0, CHCl3). 


















The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the indole (172.5 mg, 0.88 
mmol, 200 mol%) were subject to standard reaction conditions (50 oC, 24 hr). The title 
compound was obtained in 79% yield (87.0 mg, 0.35 mmol) as a light yellow oil after 
purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 20:1). 
 
TLC (SiO2) Rf  = 0.35 (hexanes: ethyl acetate = 10:1).  
1H NMR (500 MHz, CDCl3): δ 7.75 (dd, J = 1.9, 0.7 Hz, 1H), 7.27 (d, J = 9.0 Hz, 1H), 
7.25 – 7.14 (m, 2H), 6.47 (dd, J = 3.3, 0.8 Hz, 1H), 6.02 (ddd, J = 17.3, 10.4, 4.9 Hz, 
1H), 5.19 (ddd, J = 10.3, 1.6, 0.8 Hz, 1H), 5.09 – 4.98 (m, 2H), 1.64 (d, J = 6.9 Hz, 3H). 
 13C NMR (125 MHz, CDCl3): δ 138.3, 134.4, 130.3, 125.9, 124.1, 123.4, 115.8, 112.7, 
111.2, 101.0, 53.3, 19.7. 
HRMS (ESI): Calculated for C12H12BrN [M+H
+] = 250.0226, Found 250.0228. 
FTIR (neat): 2982, 2370, 2342, 1462, 1275, 1262, 1208, 751 cm–1. 
[α]
D
𝟐𝟖= –18.5 (c 1.0, CHCl3). 




















The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the indole (154.2 mg, 0.88 
mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The title 
compound was obtained in 82% yield (82.0 mg, 0.36 mmol) as a light yellow oil after 
purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 10:1). 
 
TLC (SiO2) Rf  = 0.38 (hexanes: ethyl acetate = 5:1).  
1H NMR (500 MHz, CDCl3): δ 8.14 (s, 1H), 7.80 (dd, J = 8.3, 1.5 Hz, 1H), 7.64 (d, J = 
8.3 Hz, 1H), 7.34 (d, J = 3.2 Hz, 1H), 6.59 – 6.53 (m, 1H), 6.07 (ddd, J = 17.2, 10.4, 5.0 
Hz, 1H), 5.19 (ddt, J = 13.9, 6.9, 1.6 Hz, 2H), 5.14 – 5.05 (m, 1H), 3.94 (s, 3H), 1.67 (d, 
J = 6.9 Hz, 3H). 
13C NMR (125 MHz, CDCl3): δ 168.3, 138.3, 135.1, 132.3, 128.0, 123.0, 120.5, 120.4, 
115.9, 112.1, 101.9, 53.1, 51.9, 19.9. 
HRMS (ESI): Calculated for C14H15NO2 [M+H
+] = 252.0995, Found 252.1003. 
FTIR (neat): 2983, 2950, 2359, 2342, 1708, 1242, 750, cm–1. 
[α]
D
𝟐𝟖= –46.3 (c 1.0, CHCl3). 

















The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the indole (118.9 mg, 0.88 
mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The title 
compound was obtained in 92% yield (77.0 mg, 0.41 mmol) as a light yellow oil after 
purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 20:1). 
 
TLC (SiO2) Rf  = 0.53 (hexanes: ethyl acetate = 10:1).  
1H NMR (500 MHz, CDCl3): δ 7.38 (d, J = 7.9 Hz, 1H), 7.19 (d, J = 3.2 Hz, 1H), 6.99 
(td, J = 7.8, 4.4 Hz, 1H), 6.91 – 6.84 (m, 1H), 6.57 – 6.49 (m, 1H), 6.16 – 6.07 (m, 1H), 
5.48 (tt, J = 5.3, 1.6 Hz, 1H), 5.18 (d, J = 10.4 Hz, 1H), 5.08 (d, J = 18.6 Hz, 1H), 1.64 
(d, J = 7.9 Hz, 3H). 
 13C NMR (125 MHz, CDCl3): δ 151.1, 149.2, 139.2, 132.5, 125.7, 123.8, 119.6, 116.7, 
115.4, 107.4, 102.4, 54.9, 54.9, 20.4. 
19F NMR (376 MHz, CDCl3): δ =
 -134.1. 
HRMS (ESI): Calculated for C12H12FN [M+H
+] = 190.1027, Found 190.1026. 
FTIR (neat): 2984, 2360, 2342, 1275, 1261, 1236, 750 cm–1. 
[α]
D
𝟐𝟖= –37.8 (c 1.0, CHCl3). 


















The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the indole (177.5 mg, 0.88 
mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The title 
compound was obtained in 77% yield (84.7 mg, 0.34 mmol) as a light yellow oil after 
purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 40:1). 
 
TLC (SiO2) Rf  = 0.60 (hexanes: ethyl acetate = 5:1).  
1H NMR (500 MHz, CDCl3): δ 7.56 (dd, J = 7.8, 1.1 Hz, 1H), 7.36 (dd, J = 7.6, 1.1 Hz, 
1H), 7.23 (d, J = 3.4 Hz, 1H), 6.93 (t, J = 7.7 Hz, 1H), 6.53 (d, J = 3.3 Hz, 1H), 6.36 
(ddt, J = 6.6, 4.2, 2.0 Hz, 1H), 6.14 (ddd, J = 17.3, 10.5, 4.4 Hz, 1H), 5.22 (ddd, J = 
10.5, 1.8, 0.9 Hz, 1H), 5.06 (ddd, J = 17.3, 2.0, 1.0 Hz, 1H), 1.61 (d, J = 6.8 Hz, 3H). 
 13C NMR (125 MHz, CDCl3): δ 139.4, 132.1, 132.0, 127.3, 126.6, 120.5, 120.4, 115.4, 
103.6, 102.4, 52.6, 20.5. 
 HRMS (ESI): Calculated for C12H12BrN [M+H
+] = 250.0226, Found 250.0223.  
FTIR (neat): 2980, 2360, 2342, 1333, 1301, 751, 718 cm–1. 
[α]
D
𝟐𝟖= –7.3 (c 1.0, CHCl3). 

















The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the indole (116.3 mg, 0.88 
mmol, 200 mol%) were subject to standard reaction conditions (60 oC, 24 hr). The title 
compound was obtained in 67% yield (55.9 mg, 0.30 mmol) as a light yellow oil after 
purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 40:1). 
 
TLC (SiO2) Rf  = 0.19 (hexanes: ethyl acetate = 10:1).  
1H NMR (500 MHz, CDCl3): δ 7.65 (dt, J = 8.1, 1.0 Hz, 1H), 7.38 (dt, J = 8.5, 1.0 Hz, 
1H), 7.33 (ddd, J = 8.4, 6.7, 1.1 Hz, 1H), 7.11 (ddd, J = 7.9, 6.7, 1.0 Hz, 1H), 6.20 – 6.06 
(m, 1H), 5.25 – 5.14 (m, 2H), 5.13 (dt, J = 17.2, 1.3 Hz, 1H), 2.59 (s, 3H), 1.72 (d, J = 
6.9 Hz, 3H). 
13C NMR (125 MHz, CDCl3): δ 141.4, 139.8, 138.6, 125.9, 123.7, 120.5, 119.7, 115.6, 
109.4, 56.5, 19.3, 12.0. 
HRMS (ESI): Calculated for C12H14N2 [M+H
+] = 187.1230, Found 187.1233.  
FTIR (neat): 2360, 2342, 1276, 1261, 764, 750 cm–1. 
[α]
D
𝟐𝟖= –10.2 (c 1.0, CHCl3). 
















The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the benzimidazole (128.6 mg, 
0.88 mmol, 200 mol%) were subject to standard reaction conditions (60 oC, 24 hr). The 
title compound was obtained in 85% yield (74.9 mg, 0.37 mmol) as a light yellow oil 
after purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 2:1). 
 
TLC (SiO2) Rf  = 0.26 (hexanes: ethyl acetate = 1:1). 
1H NMR (500 MHz, CDCl3): δ = 7.73 (dt, J = 8.0, 0.9 Hz, 1H), 7.37 (dt, J = 7.9, 0.9 Hz, 
1H), 7.18 (dddd, J = 22.6, 8.4, 7.2, 1.2 Hz, 2H), 6.14 (ddd, J = 17.3, 10.6, 4.0 Hz, 1H), 
5.30 (ddd, J = 10.5, 2.2, 0.7 Hz, 1H), 5.18 (ddd, J = 17.3, 2.2, 0.7 Hz, 1H), 5.11 (ttd, J = 
7.1, 4.7, 2.0 Hz, 1H), 2.92 (qd, J = 7.5, 1.3 Hz, 2H), 1.70 (d, J = 7.1 Hz, 3H), 1.45 (t, J = 
7.5 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 155.6, 143.0, 137.0, 133.7, 121.6, 121.5, 119.3, 116.6, 
111.6, 52.4, 21.5, 18.3, 12.2. 
HRMS (ESI): Calculated for C13H16N2 [M+H
+] = 201.1386, Found 201.1390. 
FTIR (neat): 2978, 1517, 1457, 1402, 1277, 927, 745 cm–1. 
[α]
D
𝟐𝟖= +13.3 (c 1.0, CHCl3). 














The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the indole (104.0 mg, 0.88 
mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The title 
compound was obtained in 71% yield (53.0 mg, 0.31 mmol) as a light yellow oil after 
purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 20:1–10:1). 
 
TLC (SiO2) Rf  = 0.31 (hexanes: ethyl acetate = 1:4).  
1H NMR (500 MHz, CDCl3): δ 8.80 (s, 1H), 8.23 (d, J = 5.5 Hz, 1H), 7.51 (dd, J = 5.5, 
1.1 Hz, 1H), 7.32 (d, J = 3.2 Hz, 1H), 6.52 (d, J = 3.1 Hz, 1H), 6.12 – 6.01 (m, 1H), 5.26 
– 5.20 (m, 1H), 5.17 (dd, J = 7.0, 5.2 Hz, 1H), 5.11 (dt, J = 17.2, 1.2 Hz, 1H), 1.69 (d, J 
= 7.0 Hz, 3H). 
13C NMR (125 MHz, CDCl3): δ 138.5, 138.1, 133.5, 133.3, 132.8, 128.5, 116.3, 115.4, 
100.9, 53.9, 19.9. 
HRMS (ESI): Calculated for C11H12N2 [M+H
+] = 173.1073, Found 173.1073. 




𝟐𝟖= –18.5 (c 1.0, CHCl3). 

















The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the indole (213.9 mg, 0.88 
mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The title 
compound was obtained in 76% yield (100 mg, 0.34 mmol) as a light yellow oil after 
purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 6:1). 
TLC (SiO2) Rf  = 0.39 (hexanes: ethyl acetate = 5:1).  
1H NMR (500 MHz, CDCl3): (d, J = 1.6 Hz, 1H), 8.35 (d, J = 1.7 Hz, 1H), 7.24 (d, J = 
3.6 Hz, 1H), 6.48 (d, J = 3.6 Hz, 1H), 6.10 (d, J = 2.0 Hz, 1H), 5.72 (d, J = 2.0 Hz, 1H), 
5.17 (dt, J = 10.5, 1.4 Hz, 1H), 5.11 – 4.98 (m, 1H), 1.60 (d, J = 7.0 Hz, 3H), 1.36 (s, 
12H). 
13C NMR (125 MHz, CDCl3): δ 149.0, 148.6, 138.8, 135.9, 125.0, 120.2, 115.5, 100.4, 
83.7, 50.4, 24.9, 19.8. 
HRMS (ESI): Calculated for C17H23BN2O2 [M+H
+] = 299.1928, Found 299.1937. 
FTIR (neat): 2978, 2360, 2342, 1363, 1348, 1275, 1261, 764, 750, cm–1. 
[α]
D
𝟐𝟖= –24.3 (c 1.0, CHCl3). 
















The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the carbazole (147.0 mg, 0.88 
mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The title 
compound was obtained in 91% yield (88.6 mg, 0.40 mmol) as a light yellow oil after 
purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 20:1). 
 
TLC (SiO2) Rf  = 0.43 (hexanes: ethyl acetate = 10:1).  
1H NMR (500 MHz, CDCl3): δ = 8.15 (dt, J = 7.8, 1.0 Hz, 2H), 7.52 (dt, J = 8.3, 0.9 Hz, 
2H), 7.46 (ddd, J = 8.2, 7.0, 1.2 Hz, 2H), 7.30 – 7.24 (m, 2H), 6.31 (ddd, J = 17.4, 10.6, 
3.7 Hz, 1H), 5.46 (ttd, J = 7.0, 4.5, 1.7 Hz, 1H), 5.39 – 5.31 (m, 2H), 1.77 (d, J = 7.1 Hz, 
3H). 
13C NMR (125 MHz, CDCl3): δ = δ 139.6, 138.3, 125.4, 123.4, 120.3, 118.8, 116.0, 
110.1, 51.5, 17.1. 
HRMS (ESI): Calculated for C16H15N [M+H
+] = 222.1277, Found 222.1279. 
FTIR (neat): 2982, 1595, 1481, 1452, 1328, 1223, 1155, 924, 747, 722 cm–1. 
[α]
D
𝟐𝟖= +2.0 (c 1.0, CHCl3). 
HPLC (Two connected chiralcel OJ-H column, hexanes:i-PrOH = 99:1, 1.00 mL/min, 














The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the indole (110.1 mg, 0.88 
mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The title 
compound was obtained in 74% yield (68 mg, 0.33 mmol) as a light yellow oil after 
purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 10:1). 
 
TLC (SiO2) Rf  = 0.39 (hexanes: ethyl acetate = 5:1).  
1H NMR (500 MHz, CDCl3): δ 6.56 (s, 2H), 5.93 (ddd, J = 17.2, 10.5, 4.8 Hz, 1H), 5.15 
(ddd, J = 10.5, 1.8, 0.9 Hz, 1H), 4.90 (ddd, J = 17.1, 1.9, 0.9 Hz, 1H), 4.73 (dd, J = 6.9, 
4.9 Hz, 1H), 4.26 (q, J = 7.1 Hz, 2H), 2.52 (s, 3H), 1.53 (d, J = 6.9 Hz, 3H), 1.33 (t, J = 
7.1 Hz, 3H). 
13C NMR (125 MHz, CDCl3): δ 165.7, 138.5, 135.4, 116.4 115.5, 112.1, 109.5, 59.2, 
53.0, 20.1, 14.6, 10.8. 
HRMS (ESI): Calculated for C12H17NO2 [M+H
+] = 208.1332, Found 208.1331. 
FTIR (neat): 2982, 2360, 2342, 1696, 1223, 929, 764, 750 cm–1. 
[α]
D
𝟐𝟖= –9.2 (c 1.0, CHCl3). 















The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the indole (445.5 mg, 0.88 
mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The title 
compound was obtained in 95% yield, >20:1 dr (234.2 mg, 0.42 mmol) as a light yellow 
oil after purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 
30:1). 
 
TLC (SiO2) Rf  = 0.43 (hexanes: ethyl acetate = 10:1).  
1H NMR (400 MHz, CDCl3): δ = 7.54 – 7.51 (m, 1H), 7.36 – 7.32 (m, 1H), 7.25 – 7.16 
(m, 2H), 7.16 – 7.07 (m, 2H), 5.87 (ddd, J = 17.4, 10.6, 4.0 Hz, 1H), 5.31 (s, 1H), 5.07 
(ddd, J = 10.6, 2.3, 0.9 Hz, 1H), 4.86 (ddd, J = 17.4, 2.3, 0.9 Hz, 1H), 4.64 – 4.54 (m, 
1H), 3.38 (dq, J = 12.3, 6.5 Hz, 1H), 3.25 (dq, J = 15.7, 9.9 Hz, 1H), 3.00 – 2.82 (m, 
2H), 2.61 (ddd, J = 16.2, 9.7, 1.3 Hz, 1H), 1.49 (d, J = 7.1 Hz, 3H), 1.20 (d, J = 6.7 Hz, 
3H). 
 599 
13C NMR (100 MHz, CDCl3): δ = 137.3, 135.6, 130.7, 127.5, 127.0, 124.3, 121.7 (d, J = 
25.9 Hz), 121.3, 119.05, 118.4, 116.8 (t, J = 14.5 Hz), 115.9, 111.9, 109.6, 91.9 (t, J = 
10.9 Hz), 54.1, 52.4, 49.5, 48.7 (q, J = 32.3 Hz), 25.5, 18.5, 18.4. 
19F NMR (376 MHz, CDCl3): δ = -70.77, -110.47. 
HRMS (ESI): Calculated for C24H22N2F5I [M+H
+] = 561.0821, Found 561.0821. 
FTIR (neat): 2982, 1606, 1569, 1409, 1195, 1140, 1051, 1022, 843, 739 cm–1. 
[α]
D
































The allylic acetate (50.2 mg, 0.44 mmol, 100 mol%) and the indole (445.5 mg, 0.88 
mmol, 200 mol%) were subject to standard reaction conditions with (R)-Ir-I (70 oC, 24 
hr). The title compound was obtained in 96% yield, >20:1 dr (236.7 mg, 0.42 mmol) as a 
light yellow oil after purification by flash column chromatography (SiO2, hexanes: ethyl 
acetate = 30:1). 
 
TLC (SiO2) Rf  = 0.43 (hexanes: ethyl acetate = 10:1).  
1H NMR (400 MHz, CDCl3): δ = 7.56 – 7.51 (m, 1H), 7.37 – 7.31 (m, 1H), 7.26 – 7.18 
(m, 2H), 7.12 (pd, J = 7.0, 1.4 Hz, 2H), 6.01 (ddd, J = 17.3, 10.6, 4.1 Hz, 1H), 5.27 (s, 
1H), 5.13 (ddd, J = 10.5, 2.2, 0.8 Hz, 1H), 5.05 (ddd, J = 17.3, 2.2, 0.9 Hz, 1H), 4.53 
(ttd, J = 7.0, 4.7, 2.0 Hz, 1H), 3.39 (dq, J = 12.2, 6.0 Hz, 1H), 3.24 (dq, J = 15.7, 9.8 Hz, 
1H), 2.97 – 2.83 (m, 2H), 2.61 (ddd, J = 16.1, 9.5, 1.3 Hz, 1H), 1.34 (d, J = 7.1 Hz, 3H), 
1.19 (d, J = 6.6 Hz, 3H). 
 603 
13C NMR (100 MHz, CDCl3): δ = 138.2, 135.4, 130.7, 127.6, 127.0, 124.2, 121.7 (d, J = 
26.5 Hz), 121.2, 119.0, 118.4, 116.8 (t, J = 14.5 Hz), 115.7, 112.0, 109.4, 92.0 (t, J = 
11.1 Hz), 54.1, 52.5, 50.0, 48.7 (q, J = 32.1 Hz), 25.5, 18.3, 17.7. 
19F NMR (376 MHz, CDCl3): δ = -70.9, -110.5. 
HRMS (ESI): Calculated for C24H22N2F5I [M+H
+] = 561.0821, Found 561.0828. 
FTIR (neat): 2981, 1606, 1569, 1408, 1264, 1139, 1049, 1021, 843, 735 cm–1. 
[α]
D















The allylic acetate (89.8 mg, 0.44 mmol, 100 mol%) and the indole (103.0 mg, 0.88 
mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The title 
compound was obtained in 79% yield (91.0 mg, 0.35 mmol) as a light yellow oil after 
purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 20:1). 
 
TLC (SiO2) Rf  = 0.36 (hexanes: ethyl acetate = 10:1).  
1H NMR (500 MHz, CDCl3): δ 7.65 (dq, J = 7.8, 1.0 Hz, 1H), 7.28 (dd, J = 6.9, 1.1 Hz, 
3H), 7.24 – 7.15 (m, 3H), 7.15 – 7.01 (m, 3H), 6.58 (dt, J = 3.2, 0.9 Hz, 1H), 6.02 (dddd, 
J = 16.8, 10.5, 5.6, 0.7 Hz, 1H), 5.16 (ddt, J = 10.5, 1.7, 0.8 Hz, 1H), 5.02 (ddt, J = 17.1, 
1.8, 0.9 Hz, 1H), 4.86 (d, J = 8.0 Hz, 1H), 2.56 (t, J = 7.7 Hz, 2H), 2.45 – 2.24 (m, 2H). 
 13C NMR (125 MHz, CDCl3): δ 140.9, 137.6, 136.1, 128.7, 128.5, 126.2, 124.9, 121.4, 
121.0, 119.5, 116.3, 109.9, 101.9, 57.3, 35.8, 32.3. 
HRMS (ESI): Calculated for C19H19N [M+H
+] = 262.1590, Found 262.1598. 
FTIR (neat): 3026, 2928, 2360, 2342, 1610, 1476, 1459, 740 cm–1.  
[α]
D
𝟐𝟖= +32.1 (c 1.0, CHCl3). 














The allylic acetate (103.1 mg, 0.44 mmol, 100 mol%) and the indole (103.1 mg, 0.88 
mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The title 
compound was obtained in 65% yield (67.0 mg, 0.29 mmol) as a light yellow oil after 
purification by flash column chromatography (12g SiO2, Isopropyl Acetate / Heptane = 
0% - 10% over 20 min). 
TLC (SiO2) Rf  = 0.53 (heptanes: isopropyl acetate = 5:1).  
1H NMR (400 MHz, CDCl3): δ = 7.65 (dt, J = 7.8, 1.1 Hz, 1H), 7.41 (dd, J = 8.3, 1.0 
Hz, 1H), 7.36 – 7.26 (m, 5H), 7.19 (ddd, J = 8.3, 7.0, 1.3 Hz, 1H), 7.15 – 7.09 (m, 2H), 
6.55 (dd, J = 3.2, 0.8 Hz, 1H), 6.07 (ddd, J = 17.2, 10.4, 5.3 Hz, 1H), 5.26 – 5.15 (m, 
2H), 5.09 (ddd, J = 17.3, 1.7, 1.0 Hz, 1H), 4.36 (s, 2H), 3.47 (dt, J = 9.8, 5.1 Hz, 1H), 
3.16 (ddd, J = 9.5, 8.5, 4.8 Hz, 1H), 2.38 – 2.22 (m, 2H). 
13C NMR (100 MHz, CDCl3): δ = 138.2, 137.6, 136.1, 128.6, 128.4, 127.7, 127.6, 125.3, 
121.3, 120.9, 119.4, 116.2, 110.1, 101.8, 73.1, 66.3, 54.7, 34.3. 
HRMS (ESI): Calculated for C20H21NO [M+H
+] = 292.1696, Found 292.1698. 
FTIR (neat): 2862, 1458, 1308, 1264, 1195, 1105, 734, 700 cm–1. 
[α]
D
𝟐𝟖= –20.7 (c 0.2, CHCl3). 












The allylic acetate (34.9 mg, 0.2 mmol, 100 mol%) and the indole (46.9 mg, 0.84 mmol, 
200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The title 
compound was obtained in 71% yield (33.0 mg, 0.14 mmol) as a light yellow oil after 
purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 20:1). 
 
TLC (SiO2) Rf  = 0.32 (hexanes: ethyl acetate = 10:1).  
1H NMR (500 MHz, CDCl3): δ 7.64 (d, J = 7.8 Hz, 1H), 7.41 (d, J = 8.3 Hz, 1H), 7.23 – 
7.17 (m, 1H), 7.16 (d, J = 3.3 Hz, 1H), 7.11 (td, J = 7.4, 7.0, 1.0 Hz, 1H), 6.56 (d, J = 3.2 
Hz, 1H), 6.05 (ddd, J = 17.2, 10.5, 5.6 Hz, 1H), 5.21 (dt, J = 10.5, 1.3 Hz, 1H), 5.18 – 
5.06 (m, 2H), 2.48 – 2.16 (m, 4H), 2.05 (s, 3H). 
13C NMR (125 MHz, CDCl3): δ 137.2, 136.1, 128.6, 125.0, 121.5, 121.0, 119.6, 116.6, 
109.9, 102.0, 56.6, 33.3, 30.7, 15.6. 
HRMS (ESI): Calculated for C14H17NS [M+H
+] = 232.1154, Found 232.1156. 




𝟐𝟖= – 37.5 (c 1.0, CHCl3). 
















The allylic acetate (31.2 mg, 0.2 mmol, 100 mol%) and the indole (46.9 mg, 0.4 mmol, 
200 mol%) were subject to standard reaction conditions (70 oC, 48 hr). The title 
compound was obtained in 68% yield (29.0 mg, 0.14 mmol) as a light yellow oil after 
purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 40:1). 
 
TLC (SiO2) Rf  = 0.63 (hexanes: ethyl acetate = 10:1).  
1H NMR (500 MHz, CDCl3): δ = 7.64 (dt, J = 7.9, 1.0 Hz, 1H), 7.37 (d, J = 8.1 Hz, 1H), 
7.23 – 7.15 (m, 2H), 7.10 (td, J = 7.4, 1.0 Hz, 1H), 6.55 (d, J = 3.1 Hz, 1H), 6.00 (ddd, J 
= 17.3, 10.4, 5.4 Hz, 1H), 5.16 – 5.09 (m, 1H), 5.02 – 4.95 (m, 2H), 2.00 (ddd, J = 13.8, 
9.4, 5.7 Hz, 1H), 1.79 (ddd, J = 14.0, 8.2, 5.9 Hz, 1H), 1.53 – 1.42 (m, 1H), 0.94 (d, J = 
6.6 Hz, 3H), 0.91 (d, J = 6.7 Hz, 3H). 
13C NMR (125 MHz, CDCl3): δ = 138.2, 136.0, 128.5, 124.9, 121.3, 120.9, 119.3, 115.6, 
109.6, 101.6, 56.0, 43.2, 24.6, 22.9, 22.2. 
HRMS (ESI): Calculated for C15H19N [M+H
+] = 214.1590, Found 214.1592. 
FTIR (neat): 2957, 1459, 1309, 1215, 923, 755, 739, 667 cm–1. 
[α]
D
𝟐𝟖= +10.3 (c 1.0, CHCl3). 










 (R)-1-(1-cyclopropylallyl)-1H-indole (6.4f) 
 
Procedures  
The allylic acetate (61.7 mg, 0.44 mmol, 100 mol%) and the indole (103.1 mg, 0.88 
mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The title 
compound was obtained in 74% yield (64.2 mg, 0.33 mmol) as a light yellow oil after 
purification by flash column chromatography (12g SiO2, Isopropyl Acetate / Heptane = 
0% - 10% over 20 min). 
TLC (SiO2) Rf  = 0.66 (heptanes: isopropyl acetate = 5:1).  
1H NMR (400 MHz, CDCl3): δ = 7.65 (ddd, J = 7.8, 1.3, 0.7 Hz, 1H), 7.36 (d, J = 3.2 
Hz, 1H), 7.34 – 7.30 (m, 1H), 7.18 (ddd, J = 8.3, 7.0, 1.3 Hz, 1H), 7.11 (ddd, J = 8.0, 
7.0, 1.1 Hz, 1H), 6.55 (dd, J = 3.2, 0.8 Hz, 1H), 6.03 (ddd, J = 17.2, 10.4, 5.3 Hz, 1H), 
5.20 (ddd, J = 10.4, 1.2 Hz, 1H), 5.12 (ddd, J = 17.2, 1.7, 1.2 Hz, 1H), 4.29 (ddt, J = 8.5, 
5.3, 1.7 Hz, 1H), 1.45 (qt, J = 8.2, 4.9 Hz, 1H), 0.86 – 0.75 (m, 1H), 0.62 (dddd, J = 9.1, 
8.0, 5.7, 4.7 Hz, 1H), 0.49 (ddt, J = 9.4, 5.8, 4.8 Hz, 1H), 0.38 (ddt, J = 9.4, 5.8, 4.9 Hz, 
1H). 
13C NMR (100 MHz, CDCl3): δ = 136.7, 136.0, 128.7, 125.6, 121.2, 120.9, 119.3, 116.4, 
109.9, 101.2, 62.6, 14.9, 4.4, 3.6. 
HRMS (ESI): Calculated for C14H15N [M+H
+] = 198.1283, Found 198.1279. 
FTIR (neat): 3007, 1458, 1308, 1264, 1218, 927, 737 cm–1. 
[α]
D
𝟐𝟖= +25.5 (c 1.0, CHCl3). 
HPLC (Two connected chiralcel OJ-H column, hexanes:i-PrOH = 95:5, 1.00 mL/min, 













The allylic acetate (83.7 mg, 0.44 mmol, 100 mol%) and the indole (103.1 mg, 0.88 
mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The title 
compound was obtained in 70% yield (76.2 mg, 0.31 mmol) as a light yellow oil after 
purification by flash column chromatography (12g SiO2, Isopropyl Acetate / Heptane = 
0% - 10% over 20 min). 
TLC (SiO2) Rf  = 0.60 (heptanes: isopropyl acetate = 5:1).  
1H NMR (400 MHz, CDCl3): δ = 7.63 (dt, J = 7.9, 1.0 Hz, 1H), 7.37 (dd, J = 8.3, 1.0 
Hz, 1H), 7.21 (ddd, J = 8.3, 7.0, 1.3 Hz, 1H), 7.15 – 7.10 (m, 1H), 7.09 (d, J = 3.3 Hz, 
1H), 6.55 (dd, J = 3.3, 0.8 Hz, 1H), 5.95 (ddd, J = 17.2, 10.4, 6.0 Hz, 1H), 5.24 (dt, J = 
10.4, 1.1 Hz, 1H), 5.12 (ddd, J = 17.2, 1.5, 0.9 Hz, 1H), 4.84 – 4.73 (m, 1H), 2.89 – 2.79 
(m, 2H), 2.59 – 2.42 (m, 2H), 2.29 – 2.15 (m, 1H). 
13C NMR (100 MHz, CDCl3): δ = 136.2, 134.6, 128.6, 124.6, 121.8, 121.1, 119.7, 
119.4(m), 117.8, 109.6, 102.4, 62.7 (d, J = 4.1 Hz), 38.9 (dt, J = 49.0, 23.0 Hz), 26.8 (dd, 
J = 11.2, 7.9 Hz). 
19F NMR (376 MHz, CDCl3): δ = -83.08 – -84.39 (m, 1F), -92.95 – -94.40 (m, 1F). 
HRMS (ESI): Calculated for C15H15NF2 [M+H
+] = 248.1245, Found 248.1247. 




𝟐𝟖= +14.0 (c 1.0, CHCl3). 

















tert-butyl (R)-3-(1-(1H-indol-1-yl)allyl)azetidine-1-carboxylate (6.4h) 
 
Procedures  
The allylic acetate (51.1 mg, 0.2 mmol, 100 mol%) and the indole (46.9 mg, 0.4 mmol, 
200 mol%) were subject to standard reaction conditions (70 oC, 24 hr). The title 
compound was obtained in 74% yield (46.2 mg, 0.15 mmol) as a light yellow oil after 
purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 6:1). 
 
TLC (SiO2) Rf  = 0.39 (hexanes: ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 7.64 (d, J = 7.8 Hz, 1H), 7.40 (d, J = 8.2 Hz, 1H), 7.22 
(ddd, J = 8.2, 6.9, 1.2 Hz, 1H), 7.16 – 7.08 (m, 1H), 7.05 (d, J = 3.3 Hz, 1H), 6.55 (d, J = 
3.1 Hz, 1H), 5.93 (ddd, J = 16.8, 10.4, 6.0 Hz, 1H), 5.25 (dt, J = 10.5, 1.1 Hz, 1H), 5.12 
(dt, J = 17.1, 1.1 Hz, 1H), 5.06 – 4.98 (m, 1H), 4.16 (t, J = 8.6 Hz, 1H), 3.90 (t, J = 8.6 
Hz, 1H), 3.83 (dd, J = 8.9, 5.2 Hz, 1H), 3.55 (dd, J = 9.1, 5.3 Hz, 1H), 3.22 (dtt, J = 
10.6, 8.1, 5.3 Hz, 1H), 1.43 (s, 9H). 
13C NMR (125 MHz, CDCl3): δ = 156.2, 136.1, 134.3, 128.6, 124.4, 121.7, 121.1, 119.7, 
117.9, 109.7, 102.4, 79.7, 61.6, 32.0, 28.3. 
HRMS (ESI): Calculated for C19H24N2O2 [M+Na
+] = 335.1730, Found 335.1738. 
FTIR (neat): 2973, 1693, 1405, 1366, 1216, 1143, 931, 741 cm–1. 
[α]
D
𝟐𝟖= +25.5 (c 1.0, CHCl3). 













The allylic acetate (33.6 mg, 0.2 mmol, 100 mol%) and the indole (46.9 mg, 0.4 mmol, 
200 mol%) were subject to standard reaction conditions (70 oC, 60 hr). The title 
compound was obtained in 64% yield (28.8 mg, 0.13 mmol) as a light yellow oil after 
purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 40:1). 
 
TLC (SiO2) Rf  = 0.63 (hexanes: ethyl acetate = 10:1).  
1H NMR (500 MHz, CDCl3): δ = 7.63 (dt, J = 7.9, 1.0 Hz, 1H), 7.36 (d, J = 8.3 Hz, 1H), 
7.22 – 7.16 (m, 2H), 7.09 (ddd, J = 7.9, 6.9, 1.0 Hz, 1H), 6.54 (d, J = 3.5 Hz, 1H), 6.06 
(ddd, J = 16.9, 10.4, 6.3 Hz, 1H), 5.12 (dt, J = 10.4, 1.3 Hz, 1H), 5.00 (dt, J = 17.1, 1.3 
Hz, 1H), 4.62 – 4.52 (m, 1H), 2.64 – 2.48 (m, 1H), 1.94 (dtd, J = 12.5, 7.6, 4.5 Hz, 1H), 
1.71 (dddd, J = 16.2, 10.2, 7.5, 3.0 Hz, 1H), 1.67 – 1.55 (m, 2H), 1.55 – 1.49 (m, 2H), 
1.43 (dq, J = 12.8, 8.4 Hz, 1H), 1.18 – 1.08 (m, 1H). 
13C NMR (125 MHz, CDCl3): δ = 137.1, 136.3, 128.4, 125.4, 121.2, 120.9, 119.3, 116.4, 
109.8, 101.5, 63.8, 44.2, 30.8, 30.3, 25.6, 25.1. 
HRMS (ESI): Calculated for C16H19N [M+H
+] = 226.1590, Found 226.1588. 
FTIR (neat): 2955, 1458, 1215, 987, 924, 754, 738, 667 cm–1. 
[α]
D
𝟐𝟖= +23.0 (c 1.0, CHCl3). 















The allylic acetate (80.2 mg, 0.44 mmol, 100 mol%) and the indole (103.1 mg, 0.88 
mmol, 200 mol%) were subject to standard reaction conditions (70 oC, 60 hr). The title 
compound was obtained in 60% yield (63.2 mg, 0.26 mmol) as a light yellow oil after 
purification by flash column chromatography (12g SiO2, Isopropyl Acetate / Heptane = 
0% - 10% over 20 min). 
TLC (SiO2) Rf  = 0.60 (hexanes: ethyl acetate = 10:1).  
1H NMR (400 MHz, CDCl3): δ = 7.63 (ddd, J = 7.8, 1.3, 0.8 Hz, 1H), 7.37 (dd, J = 8.4, 
1.0 Hz, 1H), 7.19 (ddd, J = 8.3, 7.0, 1.3 Hz, 1H), 7.16 (d, J = 3.2 Hz, 1H), 7.09 (ddd, J = 
8.0, 7.0, 1.0 Hz, 1H), 6.54 (dd, J = 3.2, 0.9 Hz, 1H), 6.11 (ddd, J = 17.0, 10.3, 7.5 Hz, 
1H), 5.23 – 5.08 (m, 2H), 4.56 – 4.47 (m, 1H), 1.99 – 1.89 (m, 2H), 1.80 (ddq, J = 13.2, 
3.4, 1.8 Hz, 1H), 1.70 – 1.57 (m, 2H), 1.36 – 1.00 (m, 5H), 0.93 – 0.82 (m, 1H). 
13C NMR (100 MHz, CDCl3): δ = 136.2, 136.0, 128.3, 125.3, 121.2, 120.9, 119.2, 117.6, 
109.8, 101.5, 64.4, 41.9, 30.6, 29.8, 26.3, 26.0, 25.8. 
HRMS (ESI): Calculated for C17H21N [M+H
+] = 240.1747, Found 240.1752. 
FTIR (neat): 2922, 2850, 1509, 1457, 1304, 1263, 1203, 986, 924, 734 cm–1. 
[α]
D
𝟐𝟖= +40.9 (c 0.2, CHCl3). 














To a round-bottomed flask charged with 2-Iodoaniline (527.8 mg, 2.41 mmol, 100 
mol%), hept-1-en-6-yn-3-ol8 (318.6 mg, 2.89 mmol, 120 mol%), copper iodide (50.1 mg, 
0.26 mmol, 10 mol%) and Tetrakis(triphenylphosphine)palladium (60.8 mg, 0.053 mmol, 
2 mol%) under an argon atmosphere was added triethylamine (4.8 mL, 0.5 M). The 
reaction was placed in an oil bath at 40 oC for 24 hours, at which point saturated aqueous 
ammonium chloride (5 mL) were added and the mixture was transferred to a separatory 
funnel. The organic layer was extracted with ethyl acetate (10 mL × 3) and the combined 
organic layers were washed with H2O (10 mL), dried (MgSO4), filtered and concentrated 
under reduced pressure. The resulting oily residue was subjected to flash column 
chromatography (SiO2, hexanes: ethyl acetate = 10:1–3:1) to furnish the title compound 
as a light yellow oil (408.6 mg, 2.03 mmol) in 84% yield. 
 
TLC (SiO2) Rf  = 0.33 (dichloromethane: diethyl ether = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 7.24 (dd, J = 7.6, 1.5 Hz, 1H), 7.08 (ddd, J = 8.7, 7.4, 
1.6 Hz, 1H), 6.70 – 6.63 (m, 2H), 5.91 (ddd, J = 17.1, 10.4, 6.0 Hz, 1H), 5.29 (dt, J = 
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17.2, 1.4 Hz, 1H), 5.16 (dt, J = 10.5, 1.3 Hz, 1H), 4.37 – 4.31 (m, 1H), 4.18 (br, 1H), 
2.68 – 2.52 (m, 2H), 1.84 (qd, J = 7.1, 1.9 Hz, 2H). 
13C NMR (125 MHz, CDCl3): δ = 147.7, 140.4, 132.0, 129.0, 117.8, 115.1, 114.2, 108.6, 
94.8, 77.6, 72.0, 35.8, 15.9. 
HRMS (ESI): Calculated for C13H15NO [M+H
+] = 202.1226, Found 202.1233. 










To a round-bottomed flask charged with 6.5a’ (408.6 mg, 2.03 mmol, 100 mol%) and 
zinc bromide (685.7 mg, 3.04 mmol, 150 mol%) under an argon atmosphere was added 
dimethylformamide (20.3 mL, 0.1 M). The reaction was placed in an oil bath at 150 oC 
for 24 hours. After reaching ambient temperature, the mixture was concentrated under 
reduced pressure, at which point ethyl acetate (10 mL) and H2O (10 mL) were added and 
the mixture was transferred to a separatory funnel. The organic layer was extracted with 
ethyl acetate (10 mL × 3) and the combined organic layers were washed with H2O (15 
mL), dried (MgSO4), filtered and concentrated under reduced pressure. The resulting oily 
residue was subjected to the next step without further purification. 
 
To a round-bottomed flask charged with the crude substrate and 4-
dimethylaminopyridine (12.4 mg, 0.10 mmol, 5 mol%) under an argon atmosphere was 
added CH2Cl2 (10.1 mL, 0.2 M with respect to 5a’), followed by acetic anhydride (0.23 
mL, 2.4 mmol, 120 mol%) and triethylamine (0.42 mL, 3.0 mmol, 150 mol%). After 1 
hour, saturated aqueous sodium bicarbonate (10 mL) was added and the mixture was 
transferred to a separatory funnel. The organic layer was extracted with CH2Cl2 (10 mL × 
2) and the combined organic layers were washed with 1 N HCl (10 mL), dried (MgSO4), 
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filtered and concentrated under reduced pressure. The resulting oily residue was 
subjected to flash column chromatography (SiO2, hexanes: ethyl acetate = 8:1–4:1) to 





TLC (SiO2) Rf  = 0.47 (hexanes: ethyl acetate = 2:1).  
1H NMR (500 MHz, CDCl3): δ = 8.20 (s, 1H), 7.54 (dd, J = 7.7, 1.1 Hz, 1H), 7.32 (dq, J 
= 8.1, 1.0 Hz, 1H), 7.13 (ddd, J = 8.1, 7.1, 1.3 Hz, 1H), 7.08 (ddd, J = 8.1, 7.1, 1.1 Hz, 
1H), 6.26 (dd, J = 2.1, 1.0 Hz, 1H), 5.82 (ddd, J = 17.0, 10.5, 6.3 Hz, 1H), 5.43 – 5.36 
(m, 1H), 5.29 (dt, J = 17.2, 1.3 Hz, 1H), 5.22 (dt, J = 10.5, 1.2 Hz, 1H), 2.87 – 2.80 (m, 
1H), 2.80 – 2.72 (m, 1H), 2.15 – 2.06 (m, 4H), 2.00 (dddd, J = 13.9, 8.6, 7.0, 5.3 Hz, 
1H). 
13C NMR (125 MHz, CDCl3): δ = 170.8, 138.5, 136.0 (2C), 128.8, 121.2, 119.8, 119.7, 
117.2, 110.5, 100.0, 74.2, 33.9, 23.9, 21.3. 
HRMS (ESI): Calculated for C15H17NO2 [M+Na
+] = 266.1151, Found 266.1160. 















A pressure tube equipped with a magnetic stir bar was charged with cesium carbonate 
(130.3 mg, 0.4 mmol, 200 mol%) and (S)-Ir-I (11.1 mg, 0.01 mmol, 5 mol%). The tube 
was purged with argon for 5 minutes. DME (0.5 mL, 0.4 M) was added followed by the 
allylic acetate 5a (48.7 mg, 0.2 mmol, 100 mol%). The tube was sealed with a PTFE 
lined cap and was placed in an oil bath at 70 oC for 24 hours. After reaching ambient 
temperature, the crude reaction mixture was directly subjected to flash column 
chromatography (SiO2, hexanes: ethyl acetate = 25:1–15:1). The title compound was 
obtained in 80% yield (29.3 mg, 0.16 mmol) as a colorless oil. 
TLC (SiO2) Rf  = 0.34 (hexanes: ethyl acetate = 20:1). 
1H NMR (500 MHz, CDCl3): δ = 7.58 – 7.49 (m, 1H), 7.32 – 7.27 (m, 1H), 7.12 – 7.02 
(m, 2H), 6.16 (s, 1H), 6.02 – 5.90 (m, 1H), 5.26 (s, 1H), 5.23 (dd, J = 6.1, 1.1 Hz, 1H), 
4.92 – 4.85 (m, 1H), 3.07 (dddd, J = 14.9, 8.6, 6.1, 1.1 Hz, 1H), 2.97 (dddd, J = 15.8, 
8.5, 5.9, 1.1 Hz, 1H), 2.85 – 2.75 (m, 1H), 2.36 (ddt, J = 12.5, 8.7, 5.6 Hz, 1H). 
13C NMR (125 MHz, CDCl3): δ = 144.3, 137.6, 133.4, 132.7, 120.3, 120.1, 119.2, 116.8, 
109.9, 92.5, 59.6, 35.7, 23.4. 
HRMS (ESI): Calculated for C13H13N [M+H
+] = 184.1121, Found 184.1127. 
FTIR (neat): 2952, 1454, 1264, 1217, 989, 924, 740, 702 cm–1. 
[α]
D
𝟐𝟖= –53.8 (c 1.0, CHCl3). 








Procedures and Spectral Data for Deuterium Labelling Experiments  




A pressure tube equipped with a magnetic stir bar was charged with the indole (46.9 mg, 
0.4 mmol, 200 mol%), cesium carbonate (130.3 mg, 0.4 mmol, 200 mol%) and (S)-Ir-I 
(11.1 mg, 0.01 mmol, 5 mol%). The tube was purged with argon for 5 minutes. DME (0.2 
mL, 1.0 M) was added followed by the deuterated allylic acetate 2k7 (34.3 mg, 0.2 mmol, 
100 mol%). The tube was sealed with a PTFE lined cap and was placed in an oil bath at 
70 oC for 24 hours. After reaching ambient temperature, the crude reaction mixture was 
directly subjected to flash column chromatography (SiO2, hexanes: ethyl acetate = 25:1–
15:1). The title compound was obtained in 75% yield (34.2 mg, 0.15 mmol) as a colorless 
oil. 
 
TLC (SiO2) Rf  = 0.63 (hexanes: ethyl acetate = 10:1).  
1H NMR (500 MHz, CDCl3): δ = 7.63 (dt, J = 7.8, 1.0 Hz, 1H), 7.35 (d, J = 8.3 Hz, 1H), 
7.22 – 7.14 (m, 2H), 7.10 (ddd, J = 7.9, 6.9, 1.0 Hz, 1H), 6.54 (d, J = 3.2 Hz, 1H), 6.01 
(ddd, J = 10.4, 5.5, 2.6 Hz, 1H), 5.13 (dd, J = 10.5, 1.5 Hz, 1H), 4.91 – 4.82 (m, 1H), 
2.08 – 1.92 (m, 2H), 1.32 – 1.21 (m, 6H), 0.84 (t, J = 6.9 Hz, 3H). 
2H NMR (92 MHz, CHCl3): δ = 5.07 (s, 1D). 
13C NMR (100 MHz, CDCl3): δ = 137.9, 136.1, 128.6, 124.9, 121.2, 120.9, 119.3, 115.9 
– 115.3 (m), 109.8, 101.5, 58.2, 34.2, 31.5, 25.9, 22.5, 14.0. 
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HRMS (ESI): Calculated for C16H20DN [M+H
+] = 229.1810, Found 229.1813. 
FTIR (neat): 2931, 1459, 1309, 1214, 750, 668 cm–1. 
[α]
D
𝟐𝟖= +19.8 (c 1.0, CHCl3). 





















A pressure tube equipped with a magnetic stir bar was charged with the indole (46.9 mg, 
0.4 mmol, 200 mol%), cesium carbonate (130.3 mg, 0.4 mmol, 200 mol%) and (R)-Ir-I 
(11.1 mg, 0.01 mmol, 5 mol%). The tube was purged with argon for 5 minutes. DME (0.2 
mL, 1.0 M) was added followed by the deuterated allylic acetate 2k (34.3 mg, 0.2 mmol, 
100 mol%). The tube was sealed with a PTFE lined cap and was placed in an oil bath at 
70 oC for 24 hours. After reaching ambient temperature, the crude reaction mixture was 
directly subjected to flash column chromatography (SiO2, hexanes: ethyl acetate = 25:1–
15:1). The title compound was obtained in 76% yield (34.7 mg, 0.15 mmol) as a colorless 
oil. 
 
TLC (SiO2) Rf  = 0.63 (hexanes: ethyl acetate = 10:1).  
1H NMR (500 MHz, CDCl3): δ = 7.63 (dt, J = 7.8, 1.0 Hz, 1H), 7.35 (d, J = 8.2 Hz, 1H), 
7.22 – 7.15 (m, 2H), 7.10 (ddd, J = 7.9, 6.9, 1.0 Hz, 1H), 6.54 (dd, J = 3.2, 0.8 Hz, 1H), 
6.01 (dd, J = 17.1, 5.8 Hz, 1H), 5.01 (dd, J = 17.2, 1.6 Hz, 1H), 4.86 (dtd, J = 8.0, 6.1, 
1.5 Hz, 1H), 2.10 – 1.91 (m, 2H), 1.32 – 1.23 (m, 6H), 0.84 (t, J = 6.9 Hz, 3H). 
2H NMR (92 MHz, CHCl3): δ = 5.19 (s, 1D). 
13C NMR (100 MHz, CDCl3): δ = 137.9, 136.1, 128.5, 124.9, 121.2, 120.9, 119.3, 115.9 
– 115.3 (m), 109.8, 101.5, 58.2, 34.2, 31.5, 25.9, 22.5, 14.0. 
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HRMS (ESI): Calculated for C16H20DN [M+H
+] = 229.1810, Found 229.1814. 
FTIR (neat): 2932, 1459, 1309, 1215, 754, 668 cm–1. 
[α]
D
𝟐𝟖= –22.8 (c 1.0, CHCl3). 

















Single Crystal Diffraction Data for 6.3p 
 
Empirical formula  C24 H24 Cl2 F5 I N2 
Formula weight  633.25 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  orthorhombic 
Space group  P 21 21 21 
  Unit cell dimensions a = 11.5320(11) Å = 90°. 
 b = 11.5452(11) Å = 90°. 
 c = 18.4648(19) Å  = 90°. 
Volume 2458.4(4) Å3 
Z 4 
Density (calculated) 1.711 Mg/m3 
Absorption coefficient 1.574 mm-1 
F(000) 1256 
Crystal size 0.342 x 0.146 x 0.107 mm3 
Theta range for data collection 2.082 to 30.656°. 
Index ranges -16<=h<=16, -16<=k<=16, -26<=l<=26 
Reflections collected 45429 
Independent reflections 7552 [R(int) = 0.0574] 
Completeness to theta = 25.242° 100.0 %  
Absorption correction Numerical 
Max. and min. transmission 0.9878 and 0.6732 
Refinement method Full-matrix least-squares on F2 
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Data / restraints / parameters 7552 / 0 / 318 
Goodness-of-fit on F2 1.025 
Final R indices [I>2sigma(I)] R1 = 0.0336, wR2 = 0.0772 
R indices (all data) R1 = 0.0428, wR2 = 0.0796 
Absolute structure parameter -0.003(17) 
Extinction coefficient n/a 
Largest diff. peak and hole 1.229 and -0.621 e.Å-3 
 
Figure 1.  View of the cation in 1 showing the atom labeling scheme. Displacement 
ellipsoids are scaled to the 50% probability level. 
 
 652 
Figure 2.  View of 1 showing the heteroatom labeling scheme. Displacement ellipsoids 











Chapter 7:  Hydroamination versus Allylic Amination in Iridium 
Catalyzed Reactions of Allylic Acetates with Amines: 1,3-Aminoalcohols 
via Ester-Directed Regioselectivity* 
 
7.1 Introduction 
The importance of nitrogen-containing compounds in pharmaceutical and 
agrochemical research continues to inspire efforts toward the development of metal 
catalysts for alkene hydroamination.1,2 Among late transition metal catalysts,1g those 
based on rhodium3,4 and iridium5,6 have shown great promise, however, despite decades 
of research, significant challenges remain. Many hydroaminations are limited to 
intramolecular processes.4,6 Intermolecular variants often require highly activated 
alkenes,3b,5a-d are accompanied by oxidative amination side-products3c-i,5f or exploit 
specialized directing groups to control regioselectivity.3j,k Further, the mechanisms of 
these processes are obfuscated by the fact that simple brønsted acids – even ammonium 
salts7b,f – catalyze hydroamination with levels of efficiency equal to or greater than the 
corresponding metal catalyzed reactions.7,8 Here, we report the first hydroaminations of 
allylic acetates. Specifically, using a neutral dppf-modified iridium catalyst in the 
presence of Cs2CO3, linear allylic acetates react with primary amines to form products of 
hydroamination with complete 1,3-regioselectivity. These results are remarkable, as 
iridium complexes are well-known to catalyze the substitution of allylic acetates with 
amines to form products of allylic amination (Figure 7.1).9 
 
 
*This chapter is based on the published work: 
Kim, S. W.; Wurm, T.; Brito, G. A.; Jung, W.-O.; Zbieg, J. R.; Stivala, C. E.; Krische, M. J. J. Am. Chem. 
Soc. 2018, 140, 9087. 
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Recently, in a collaborative endeavor, we reported that commercially available π-
allyliridium C,O-benzoates catalyze highly enantioselective substitutions of branched al-
lylic acetates with primary amines.10 In the course of developing this process, significant 
quantities (30-40% yield) of hydroamination product were formed as single regioisomers 
in attempted substitutions of linear allylic acetates. Both iridium C,O-benzoates and non-
cyclometallated phosphine-modified iridium complexes derived in situ from [Ir(cod)Cl]2 
displayed roughly equivalent efficiencies. In both cases, chiral ligands did not induce 
asymmetry, so the simpler non-cyclometallated complexes were chosen for further 
optimization. From a survey of achiral phosphine ligands, the phosphine ligand dppf, 
1,1'-bis(diphenylphosphino)ferrocene, was found to be most effective. Hydroamination 





Figure 7.1 Cationic vs neutral iridium catalysts promote Tsuji-Trost allylic amination 





7.2 Reaction Development and Scope 
The effect of base was systematically investigated (Table 7.1, entries 1-5). In the 
presence of [Ir(cod)Cl]2 (2.5 mol%), dppf (5 mol%) and Cs2CO3 (200 mol%) at 90 °C in 
THF (1 M), cinnamyl acetate 7.1a (100 mol%) and benzyl amine 7.2a (200 mol%) were 
converted the hydroamination products 7.3a and the deactylated compound 7.3a′ in a 2:1 
ratio and a combined 66% yield along with trace amounts of cinnamyl alcohol. In an 
attempt to minimize formation of 7.3a, lower loadings of Cs2CO3 were explored (Table 
7.1, entries 1-3), however, although the reaction is heterogeneous, the combined yield 
hydroamination products 7.3a and 7.3a’ declined.11 Other bases were explored (Table 
7.1, entries 4,5), but Cs2CO3 provided superior results. The use of cinnamic esters less 
prone to saponification were explored (Table 7.1, entries 6-10), but this also led to a 
decrease in the combined yield of hydroamination products 7.3a and 7.3a’. In all 
experiments, products of acyl transfer to benzyl amine were not observed. 
Acute sensitivity to the steric features of the cinnamic ester (cf. Table 7.1, entries 
1 and 7) along with the regioselectivity of hydroamination suggested chelation of iridium 
by the acetate carbonyl and olefin moieties might play an integral role in the mechanism. 
To perhaps favor chelation of iridium and minimize formation of 7.3a′ the stoichiometry 
of cinnamyl acetate 7.1a and benzyl amine 7.2a was altered (Table 7.1, entries 11-13). 
Using cinnamyl acetate 7.1a (300 mol%) and benzyl amine 7.2a (100 mol%), the 
hydroamination product 7.3a was obtained in 76% yield accompanied by only trace 
quantities of the 7.3a′ (Table 7.1, entry 13). To mitigate solvent evaporation, a number of 
higher boiling solvents were evaluated and it was found that 1,2-dimethoxyethane 
(DME), provided 7.3a with equivalent efficiencies (Table 7.1, entry 14). Finally, 
although this effect was not pronounced in reactions of cinnamyl acetate 7.1a, it was also 
found that in certain cases milled Cs2CO3 led to higher and more reproducible yields.
11 
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Table 7.1 Selected optimization experiments in the reaction of cinnamyl acetate 7.1a 
with benzyl amine 7.2a to form hydroamination product 7.3a.a 
 
 
aAll reactions were performed on 0.2 mmol scale. All yields are of material isolated by silica gel 
chromatography. See Supporting In-formation for further experimental details. 
 
To illustrate scope, optimal conditions for hydroamination were applied across a 
diverse set of reactants (Table 7.2). As demonstrated by the formation of hydroamination 
products 7.3a-7.3g, primary benzylic amines are effective partners for hydroamination. 
Saturated primary amines provide moderate yields of hydroamination product (7.3h). A 
range of aryl-substituted linear allylic acetates also were evaluated (7.3i-7.3p). These 
experiments, which were all conducted using benzyl amine, reveal that both electron rich 
and electron deficient aryl groups, as well as heteroaryl groups, are tolerated. The 
formation of adduct 7.3p, derived from AZD-9496 (a non-steroidal oral estrogen receptor 
inhibitor),12 which incorporates an unprotected indole moiety, highlights the functional 
group tolerance of the present hydroamination method. As illustrated by formation of 
7.3q and 7.3r, alkyl-substituted allylic acetates provide modest yields of hydroamination 
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product as single regioisomers. The regioselective formation 7.3r is noteworthy, as it 
provides strong evidence of the directing influence of the acetate moiety. Indeed, as 
cinnamyl methyl ether, trans-β-methyl styrene and 1-octene do engage in hydroamination 
under these conditions, it would appear that the acetate moiety not only directs 
regioselectivity, but is required for hydroamination to proceed. 
 




aYields of material isolated by silica gel chromatography. Standard conditions: [Ir(cod)Cl]2 (2.5 mol%), 
dppf (5 mol%), Cs2CO3 (200 mol%), amine (100 mol%), DME (1 M), 90 oC. All yields are of material 









To gain insight into the reaction mechanism, mono- and di-deuterated cinnamyl 
acetates d1-7.1a and d2-7.1a were exposed to standard hydroamination conditions 
(Scheme 7.1). To facilitate assignment of relative stereochemistry, the reaction products 
were converted to the cyclic carbamates d1-7.3a and d2-7.3a. Axial disposition of the 
phenyl moiety was corroborated by nOe experiments and is presumably due to 
nonbonded interactions with the N-benzyl moiety. As determined by 1H NMR, 2H NMR 
and HRMS, both compounds d1-7.3a and d2-7.3a, completely retain deuterium and were 
each generated as 1.7:1 mixtures of diastereomers. Guided by the results of deuterium 
labeling, a general catalytic mechanism for iridium catalyzed hydroamination of linear 
allylic acetates was proposed (Scheme 7.2). Base-induced formation of amidoiridium 
species I enables entry into the catalytic cycle.11 Association of d1-7.1a provides the 
chelated olefin complex II, which undergoes rapid and reversible inner- or outer-sphere 
alkene aminoiridation to form the σ-alkyliridium species cis-III and trans-III, 
respectively. Equilibration between cis-III and trans-III occurs in advance of turn-over 
limiting proto-demetalation mediated by benzyl amine to release the product d1-7.3a and 
regenerate amidoiridium species I to close the catalytic cycle. Consistent with this 
mechanistic interpretation, chiral iridium complexes do not deliver enantiomerically 
enriched hydroamination product. Additionally, using cis-cinnamyl acetate, low 
conversion to hydroamination product is observed (15% yield) and recovered cinnamyl 
acetate is partially isomerized to the trans-isomer (8:1, cis:trans). These data suggest the 
small quantity of hydroamination product observed in reactions of cis-cinnamyl acetate 
are likely formed by way of the trans-isomer and, for cis-cinnamyl acetate, allylic strain 
may prevent acetate-mediated chelation of the olefin by iridium. On the basis of these 
data, mechanisms involving alkene isomerization appear less plausible.  
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Scheme 7.1 Deuterium labelling experiments.a 
 
 
aReactants and products characterized by 1H NMR, 2H NMR and HRMS. See Supporting Information for 




Scheme 7.2 General catalytic mechanism for iridium catalyzed hydroamination of 










To summarize, allylic acetates are well-known to undergo Tsuji-Trost amination 
upon exposure to amines in the presence of iridium catalysts with cationic character. 
Here, using neutral iridium catalysts under basic conditions, we report the first examples 
of allylic acetates hydroamination. The collective data, including deuterium labeling 
studies, corroborate a catalytic mechanism involving rapid, reversible acetate-directed 
aminoiridation with inner sphere/outer-sphere crossover in advance of turn-over limiting 
amine-mediated proto-demetalation. The present studies establish a new mechanistic 
pathway for alkene hydroamination under basic conditions, broadening access to 1,3-
aminoalcohols and related N-containing compounds.13 More broadly, this study and prior  
collaborative work from the present authors10 demonstrate the effectiveness of academic-
industrial cooperation for the discovery of useful and robust methods for chemical 
synthesis. 
 
7.5 Experimental Details 
 
General Information 
All reactions were carried out under inert gas atmosphere (nitrogen or argon) 
unless otherwise indicated. Resealable pressure tubes (13x100 mm) were purchased from 
Fischer Scientific (catalog number 14-959-35C) and were flame dried followed by 
cooling in a desiccator or under a stream of inter gas prior to use. All commercial 
reagents and anhydrous solvents were used as received from vendors (Fischer Scientific, 
Sigma Aldrich and Combi Blocks) without further purification. [Ir(cod)Cl]2 and dppf 
were used as received from Strem Chemicals Inc. Cs2CO3 was used as received from 
Rockwell Lithium. The compounds (4-(pentafluoro-λ6-sulfaneyl)phenyl)methanamine1 
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was prepared according to literature procedures. Preparative column chromatography 
employing Silicycle silica gel (40-63 μm) was performed according to the method of 
Still2 or on a Teledyne Isco Combiflash Rf utilizing Silicycle HP columns using a mobile 
phase composed of either heptane/isopropyl acetate, hexanes/ethyl acetate or 
dichloromethane/methanol. Reactions were monitored by a Shimadzu LCMS/UV system 
with LC-30AD solvent pump, 2020 MS, Sil-30AC autosampler, SPD-M30A UV 
detector, CTO-20A column oven, using a 2-98% acetonitrile/0.1% formic acid (or 
0.001% ammonia) gradient over 2.5 minutes. Analytical thin-layer chromatography 
(TLC) was carried out using 0.25 mm commercial silica gel plates (Dynamic Absorbents 
F). Visualization was accomplished with UV light followed by dipping in CAM, p- 
Anisaldehyde (PAA), or KMnO4 stain solution followed by heating. Specific optical 
rotations were recorded on an Atago AP-300 automatic polarimeter at the sodium line 
(589.3 nm) in CHCl3 Solution concentrations are given in the units of 10-2 g ml
-1.  
 
Spectroscopy, Spectrometry and Data Collection  
Infrared spectra were recorded on a Perkin-Elmer 1600 spectrometer. High-
resolution mass spectra (HRMS) were obtained on a Karatos MS9 and are reported as 
m/z (relative intensity). Accurate masses are reported for the molecular ion (M+H, 
M+Na), or a suitable fragment ion. Proton nuclear magnetic resonance (1H NMR) spectra 
were recorded with a Bruker BioSpin GmbG, Varian Gemini (400 MHz) or Varian 
INOVA (500 MHz) spectrometer equipped with a Bruker cryoprobe. Chemical shifts are 
reported in delta (δ) units, parts per million (ppm) downfield from tetramethylsilane or 
ppm relative to the center of the singlet at 7.26 ppm for deuteriochloroform. Data 
reported as multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet). 
Integration and coupling constants were reported in Hertz (Hz). Carbon-13 nuclear 
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magnetic resonance (13C NMR) spectra were recorded with a Bruker BioSpin GmbG, 
Varian Gemini (100 MHz) or Varian INOVA (125 MHz) spectrometer and were 
routinely run with broadband decoupling. Chemical shifts are reported in delta (δ) units, 
ppm relative to the center of the triplet at 77.16 ppm for deuteriochloroform. Fluorine-19 




Experimental Details and Spectral Data 
General procedure for the synthesis of allylic acetates. The allylic acetate 7.1i, 7.1j, 
7.1k, and 7.1o were prepared by the Horner–Wadsworth–Emmons reaction, DIBAL 
reduction, and acetylation of the corresponding aldehyde as shown below. The allylic 
acetate 7.1l and 7.1r were prepared by the acetylation of the corresponding allylic alcohol 
as shown below. The allylic acetates 7.1m,3 7.1n,4 and 7.1q5 were prepared according to 




To a round-bottomed flask charged with sodium hydride (140 mol%, 60% in mineral oil) 
under an argon atmosphere was added THF (0.3 M), followed by triethyl 
phosphonoacetate (150 mol%). After 10 minutes, the corresponding aldehyde was added 
and the mixture was stirred at room temperature overnight. After water was added, the 
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mixture was transferred to a separatory funnel. The organic layer was extracted with ethyl 
acetate and the combined organic layers were washed with brine, dried (MgSO4), filtered 
and concentrated under reduced pressure. The resulting oily residue was subjected to the 
next step without further purification. 
To a round-bottomed flask charged with the crude substrate under an argon atmosphere 
was added CH2Cl2 (0.3 M). The reaction flask was placed an ice batch. After 10 minutes, 
diisobutylaluminum hydride (400 mol%, 1.0 M in hexanes) was added slowly and the 
mixture was stirred at room temperature for 1 hour, at which point saturated aqueous 
Rochelle salts were added and the reaction was stirred vigorously overnight. After water 
was added, the mixture was transferred to a separatory funnel. The organic layer was 
extracted with ethyl acetate and the combined organic layers were washed with brine, 
dried (MgSO4), filtered and concentrated under reduced pressure. The resulting oily 
residue was subjected to the next step without further purification. 
To a round-bottomed flask charged with the crude substrate and 4-
dimethylaminopyridine (5 mol%) under an argon atmosphere was added CH2Cl2 (0.3 M), 
followed by acetic anhydride (150 mol%) and triethylamine (300 mol%). After 1 hour, 
saturated aqueous sodium bicarbonate was added and the mixture was transferred to a 
separatory funnel. The organic layer was extracted with CH2Cl2 and the combined 
organic layers were washed with 1 N HCl, dried (MgSO4), filtered and concentrated 
under reduced pressure. The resulting oily residue was subjected to flash column 










The title compound was prepared by the general procedure (Horner–Wadsworth–
Emmons reaction, DIBAL reduction, and acetylation of the corresponding aldehyde). The 
spectral data were consistent with those reported.6 
1H NMR (400 MHz, CDCl3): δ = 7.36 – 7.29 (m, 2H), 6.88 – 6.83 (m, 2H), 6.60 (dd, J = 
16.0, 1.4 Hz, 1H), 6.15 (dt, J = 15.8, 6.6 Hz, 1H), 4.70 (dd, J = 6.6, 1.3 Hz, 2H), 3.80 (s, 
3H), 2.08 (s, 3H). 


















The title compound was prepared by the general procedure (Horner–Wadsworth–
Emmons reaction, DIBAL reduction, and acetylation of the corresponding aldehyde). The 
spectral data were consistent with those reported.7 
 
1H NMR (400 MHz, CDCl3): δ = 6.90 (d, J = 1.7 Hz, 1H), 6.79 (dd, J = 8.0, 1.7 Hz, 
1H), 6.72 (d, J = 8.0 Hz, 1H), 6.52 (dt, J = 15.8, 1.4 Hz, 1H), 6.08 (dt, J = 15.8, 6.6 Hz, 
1H), 5.91 (s, 2H), 4.66 (dd, J = 6.6, 1.4 Hz, 2H), 2.06 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ = 170.6, 147.9, 147.5, 133.8, 130.5, 121.3, 121.1, 108.1, 




















The title compound was prepared by the general procedure (Horner–Wadsworth–
Emmons reaction, DIBAL reduction, and acetylation of the corresponding aldehyde). The 
spectral data were consistent with those reported.8 
 
1H NMR (400 MHz, CDCl3): δ = 7.47 (d, J = 2.0 Hz, 1H), 7.39 (d, J = 8.3 Hz, 1H), 7.20 
(dd, J = 8.3, 2.1 Hz, 1H), 6.55 (dt, J = 16.1, 1.5 Hz, 1H), 6.28 (dt, J = 16.0, 6.2 Hz, 1H), 
4.72 (dd, J = 6.2, 1.4 Hz, 2H), 2.11 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ = 170.7, 136.4, 132.8, 131.8, 131.4, 130.5, 128.3, 125.7, 



















The title compound was prepared by the general procedure (acetylation of the 
corresponding allylic alcohol). The spectral data were consistent with those reported.9 
 
1H NMR (400 MHz, CDCl3): δ = 7.14 (ddd, J = 8.9, 5.8, 3.1 Hz, 1H), 7.00 (td, J = 9.4, 
4.6 Hz, 1H), 6.96 – 6.86 (m, 1H), 6.75 (dq, J = 16.1, 1.5 Hz, 1H), 6.35 (dt, J = 16.1, 6.1 
Hz, 1H), 4.75 (dd, J = 6.2, 1.5 Hz, 2H), 2.12 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ = 170.7, 158.7 (dd, J = 242.0, 2.1 Hz), 156.3 (dd, J = 
245.8, 2.3 Hz), 127.3 – 127.1 (m), 125.4 (dd, J = 14.8, 8.0 Hz), 125.2 (t, J = 2.6 Hz), 
116.8 (dd, J = 25.1, 8.7 Hz), 115.7 (dd, J = 24.3, 8.8 Hz), 113.4 (dd, J = 24.6, 4.0 Hz), 
64.6, 20.9. 






























The title compound was prepared by the general procedure (Horner–Wadsworth–
Emmons reaction, DIBAL reduction, and acetylation of the corresponding aldehyde). 
 
TLC (SiO2) Rf  = 0.56 (hexanes: ethyl acetate = 2:1). 
1H NMR (400 MHz, CDCl3): δ = 8.80 (s, 2H), 8.47 – 8.38 (m, 2H), 7.53 – 7.43 (m, 3H), 
6.66 – 6.54 (m, 1H), 6.44 (dt, J = 16.1, 5.9 Hz, 1H), 4.77 (dd, J = 5.9, 1.4 Hz, 2H), 2.13 
(s, 3H). 
13C NMR (100 MHz, CDCl3): δ = 170.6, 163.7, 154.8, 137.2, 130.8, 128.6, 128.1, 127.3, 
126.8, 126.7, 64.4, 20.9. 
HRMS (ESI): Calculated for C15H14N2O2 [M+H
+] = 255.1128, found 255.1128. 
FTIR (neat): 3036, 2939, 1731,1662, 1582, 1540, 1450, 1432, 1385, 1366, 1328, 1316, 
1297, 1250, 1228, 1170, 1077, 1065, 1021, 967, 942, 930, 906, 848, 820, 780, 747, 730, 
697, 651 cm–1. 






























Step 1: Borane-tetrahydrofuran complex (2.0 M in tetrahydrofuran, 16 mL, 33 mmol) 
was added to a solution of (E)-3-[3,5-difluoro-4-[(1R,3R)-2-(2-fluoro-2-methyl-propyl)-
3-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]phenyl]prop-2-enoic acid (3.6 g, 8.1 
mmol) in THF (16 mL) at rt.  After 3 h, methanol was added and the reaction was 
allowed to stir for 20 minutes. The reaction was concentrated under reduced pressure, and 
the crude residue was purified by flash column chromatography (silica, 0% to 40% 
isopropyl acetate - heptane) to give (E)-3-[3,5-difluoro-4-[(1R,3R)-2-(2-fluoro-2-methyl-
propyl)-3-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]phenyl]prop-2-en-1-ol (1.60 
g, 3.73 mmol, 46% Yield). 
 
TLC (SiO2) Rf  = 0.48 (hexanes: ethyl acetate = 1:1).   
1H NMR (400 MHz, CDCl3): δ = 7.58 – 7.50 (m, 2H), 7.27 – 7.18 (m, 1H), 7.17 – 7.06 
(m, 2H), 6.91 – 6.83 (m, 2H), 6.56 – 6.47 (m, 1H), 6.35 (dt, J = 15.9, 5.2 Hz, 1H), 5.28 
(s, 1H), 4.34 – 4.28 (m, 2H), 3.74 – 3.62 (m, 1H), 3.11 (ddd, J = 15.2, 5.2, 2.0 Hz, 1H), 
2.90 (dd, J = 20.0, 15.0 Hz, 1H), 2.64 (ddd, J = 15.1, 4.1, 1.5 Hz, 1H), 2.43 (dd, J = 
25.0, 14.9 Hz, 1H), 1.23 (dd, J = 21.6, 18.1 Hz, 6H), 1.13 (d, J = 6.6 Hz, 3H). 
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13C NMR (100 MHz, CDCl3): δ = 162.3 (dd, J = 251.5, 8.3 Hz), 139.2 (t, J = 10.3 Hz), 
136.3, 131.9, 131.6, 128.2 (t, J = 2.6 Hz), 127.7, 121.4, 119.3, 118.2, 116.3 (t, J = 15.0 
Hz), 110.8, 109.5 (d, J = 22.1 Hz), 108.7, 98.1, 96.5, 63.0, 57.0 (d, J = 21.4 Hz), 51.2 (d, 
J = 3.7 Hz), 50.9, 27.1, 25.2 (d, J = 24.9 Hz), 24.6 (d, J = 24.6 Hz). 
19F NMR (376 MHz, CDCl3): δ = –139.4 (m).  
HRMS (ESI): Calculated for C25H28ON2F3 [M+H
+] = 429.2148, found 429.2146. 

















Step 2: 4-Dimethylaminopyridine (45.6 mg, 0.373 mmol) was added to a solution of (E)-
3-[3,5-difluoro-4-[(1R,3R)-2-(2-fluoro-2-methyl-propyl)-3-methyl-1,3,4,9-
tetrahydropyrido[3,4-b]indol-1-yl]phenyl]prop-2-en-1-ol (1.60 g, 3.73 mmol) and acetic 
anhydride (0.420 mL, 4.48 mmol) in dichloromethane (75 mL) at rt.  After 30 min, the 
reaction was concentrated under reduced pressure and the crude residue was purified by 
flash column chromatography (silica 0% to 30% isopropyl acetate - heptane) to give [(E)-
3-[3,5-difluoro-4-[(1R,3R)-2-(2-fluoro-2-methyl-propyl)-3-methyl-1,3,4,9-
tetrahydropyrido[3,4-b]indol-1-yl]phenyl]allyl] acetate (1.64 g, 3.49 mmol, 93% Yield). 
 
TLC (SiO2) Rf  = 0.61 (hexanes: ethyl acetate = 2:1).   
1H NMR (400 MHz, CDCl3): δ = 7.55 – 7.49 (m, 1H), 7.43 (s, 1H), 7.23 – 7.17 (m, 1H), 
7.14 – 7.05 (m, 2H), 6.86 (d, J = 9.9 Hz, 2H), 6.52 (d, J = 16.0 Hz, 1H), 6.28 (dt, J = 
15.9, 6.1 Hz, 1H), 5.26 (s, 1H), 4.71 (dd, J = 6.1, 1.4 Hz, 2H), 3.72 – 3.63 (m, 1H), 3.09 
(ddd, J = 15.2, 5.0, 1.9 Hz, 1H), 2.88 (dd, J = 19.9, 15.0 Hz, 1H), 2.61 (ddd, J = 15.1, 
4.1, 1.4 Hz, 1H), 2.39 (dd, J = 25.1, 15.0 Hz, 1H),1.23 (d, J = 18.2 Hz, 3H), 1.17 (d, J = 
18.4 Hz, 3H), 1.10 (d, J = 6.5 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 170.7 , 162.3 (dd, J = 251.8, 8.2 Hz), 138.6 (t, J = 
10.3 Hz), 136.3, 131.7, 131.2 (d, J = 2.7 Hz), 127.7 , 126.4 , 121.4 , 119.3 , 118.2 , 116.7 
(t, J = 14.9 Hz), 110.7 , 109.7 (dd, J = 23.8, 3.3 Hz), 108.8, 98.0, 96.4, 64.3, 57.1 (d, J = 
21.7 Hz), 51.2 (d, J = 3.9 Hz), 50.9, 27.1, 25.2 (d, J = 24.9 Hz), 24.5 (d, J = 24.8 Hz), 
20.9. 
19F NMR (376 MHz, CDCl3): δ = –139.3 (m).  
HRMS (ESI): Calculated for C27H29O2N2F3 [M+H
+] = 471.2254, found 471.2247. 






















The title compound was prepared by the acetylation of the corresponding allylic 
alcohol.10 
 
TLC (SiO2) Rf  = 0.45 (hexanes: ethyl acetate = 4:1).  
1H NMR (400 MHz, CDCl3): δ = 7.38 – 7.24 (m, 5H), 5.94 – 5.78 (m, 2H), 4.60 – 4.53 
(m, 2H), 4.51 (s, 2H), 4.02 (dt, J = 3.9, 1.1 Hz, 2H), 2.05 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ = 170.6, 138.0, 130.9, 128.3, 127.7, 127.6, 126.5, 72.3, 
69.7, 64.2, 20.9. 
HRMS (ESI): Calculated for C13H16O3 [M+NH4
+] = 238.1438, found 238.1442. 














Procedures and Spectral Data for Synthesis of OAc-Amino Alcohols 7.3a-7.3r: 






An oven-dried pressure tube equipped with a magnetic stir bar was charged with cesium 
carbonate (200 mol%), [Ir(cod)Cl]2 (2.5 mol%), and dppf (5 mol%). The tube was purged 
with argon for 5 minutes. DME (1.0 M) was added followed by the allylic acetate (300 
mol%) and the amine (100 mol%). The tube was sealed with a PTFE lined cap and was 
placed in an oil bath at 90 oC and stirred for 24 hours. After reaching ambient 
temperature, the crude reaction mixture was directly subjected to flash column 












The allylic acetate (105.7 mg, 0.6 mmol, 300 mol%) and the primary amine (21.4 mg, 0.2 
mmol, 100 mol%) were subject to standard reaction conditions. The title compound was 
obtained in 77% yield (43.6 mg, 0.15 mmol) as a light yellow oil after purification by 
flash column chromatography (SiO2, dichloromethane: diethyl ether = 20:1–10:1). 
 
TLC (SiO2) Rf  = 0.22 (dichloromethane: diethyl ether = 5:1).  
1H NMR (400 MHz, CDCl3): δ = 7.40 – 7.19 (m, 10H), 4.12 (dt, J = 11.1, 6.4 Hz, 1H), 
3.97 (dt, J = 11.1, 6.6 Hz, 1H), 3.73 (t, J = 7.0 Hz, 1H), 3.65 (d, J = 13.1 Hz, 1H), 3.53 
(d, J = 13.1 Hz, 1H), 2.05 (dq, J = 13.5, 6.7 Hz, 1H), 1.97 (s, 3H), 1.97 – 1.89 (m, 1H), 
1.66 (br, 1H). 
13C NMR (100 MHz, CDCl3): δ = 170.9, 143.2, 140.4, 128.6, 128.3, 128.1, 127.3, 127.1, 
126.8, 62.0, 59.4, 51.3, 36.8, 20.9. 
HRMS (ESI): Calculated for C18H21NO2 [M+H
+] = 284.1654, found 284.1651. 












The allylic acetate (105.7 mg, 0.6 mmol, 300 mol%) and the primary amine (46.6 mg, 0.2 
mmol, 100 mol%) were subject to standard reaction conditions. The title compound was 
obtained in 63% yield (51.6 mg, 0.13 mmol) as a light yellow oil after purification by 
flash column chromatography (SiO2, dichloromethane: diethyl ether = 1:0–5:1). 
 
TLC (SiO2) Rf  = 0.52 (dichloromethane: diethyl ether = 5:1).  
1H NMR (400 MHz, CDCl3): δ = 7.70 – 7.65 (m, 2H), 7.40 – 7.34 (m, 4H), 7.31 – 7.26 
(m, 3H), 4.17 (dt, J = 11.1, 6.5 Hz, 1H), 3.99 (dt, J = 11.1, 6.5 Hz, 1H), 3.73 – 3.64 (m, 
2H), 3.58 (d, J = 13.9 Hz, 1H), 2.10 – 2.01 (m, 1H), 1.98 (s, 3H), 1.98 – 1.91 (m, 1H), 
1.69 (br, 1H). 
13C NMR (100 MHz, CDCl3): δ = 171.0, 144.5, 142.8, 128.7, 128.2, 127.5, 126.99, 
125.87(t), 61.8, 59.4, 50.3, 36.9, 20.9. 
19F NMR (376 MHz, CDCl3): δ = 86.52 – 83.38 (m, 1F), 63.03 (d, J = 149.7 Hz, 4F). 
HRMS (ESI): Calculated for C18H20F5NO2S [M+H
+] = 410.1208, found 410.1210. 

























The allylic acetate (105.7 mg, 0.6 mmol, 300 mol%) and the primary amine (37.2 mg, 0.2 
mmol, 100 mol%) were subject to standard reaction conditions. The title compound was 
obtained in 65% yield (51.2 mg, 0.13 mmol) as a yellow oil after purification by flash 
column chromatography (SiO2, hexanes: ethyl acetate = 4:1). 
 
TLC (SiO2) Rf  = 0.20 (hexanes: ethyl acetate = 3:1).  
1H NMR (400 MHz, CDCl3): δ = 7.45 – 7.43 (m, 1H), 7.38 – 7.33 (m, 3H), 7.29 (dt, J = 
7.8, 1.2 Hz, 3H), 7.20 – 7.14 (m, 2H), 4.14 (dt, J = 11.1, 6.4 Hz, 1H), 3.98 (ddd, J = 
11.1, 7.0, 6.2 Hz, 1H), 3.71 (t, J = 7.0 Hz, 1H), 3.64 – 3.59 (m, 1H), 3.50 (d, J = 13.5 Hz, 
1H), 2.06 (ddd, J = 14.0, 6.9, 6.2 Hz, 1H), 2.00 (s, 3H), 1.98 – 1.90 (m, 1H). 
13C NMR (100 MHz, CDCl3): δ = 171.0, 142.9, 142.9, 131.1, 130.0, 129.9, 128.7, 128.7, 
128.7, 128.6, 127.5, 127.1, 126.7, 126.5, 122.5, 61.9, 59.5, 50.7, 36.9, 21.0. 
HRMS (ESI): Calculated for C18H20BrNO2 [M+H
+] = 362.0750, Found 362.0754. 
FTIR (neat): 3025, 2921, 1735, 1568, 1452, 1364, 1236, 1091, 1068, 1030, 996, 968,763, 












The allylic acetate (105.7 mg, 0.6 mmol, 300 mol%) and the primary amine (30.2 mg, 0.2 
mmol, 100 mol%) were subject to standard reaction conditions. The title compound was 
obtained in 74% yield (48.5 mg, 0.15 mmol) as a light yellow oil after purification by 
flash column chromatography (SiO2, dichloromethane: diethyl ether = 20:1–5:1). 
 
TLC (SiO2) Rf  = 0.19 (dichloromethane: diethyl ether = 5:1).  
1H NMR (400 MHz, CDCl3): δ = 7.37 – 7.22 (m, 5H), 6.78 (d, J = 1.6 Hz, 1H), 6.72 (d, 
J = 7.9 Hz, 1H), 6.67 (d, J = 7.9 Hz, 1H), 5.90 (s, 2H), 4.11 (dt, J = 11.1, 6.4 Hz, 1H), 
3.96 (dt, J = 11.1, 6.7 Hz, 1H), 3.70 (t, J = 7.0 Hz, 1H), 3.54 (d, J = 13.0 Hz, 1H), 3.42 
(d, J = 13.0 Hz, 1H), 2.04 (dt, J = 13.7, 6.8 Hz, 1H), 1.97 (s, 3H), 1.91 (dt, J = 13.7, 6.8 
Hz, 1H), 1.63 (br, 1H). 
13C NMR (100 MHz, CDCl3): δ = 170.9, 147.5, 146.3, 143.1, 134.3, 128.5, 127.2, 127.1, 
121.1, 108.6, 107.9, 100.8, 61.9, 59.2, 51.0, 36.8, 20.8. 
HRMS (ESI): Calculated for C19H21NO4 [M+H
+] = 328.1543, found 328.1551. 










The allylic acetate (105.7 mg, 0.6 mmol, 300 mol%) and the primary amine (19.4 mg, 0.2 
mmol, 100 mol%) were subject to standard reaction conditions. The title compound was 
obtained in 68% yield (37.1 mg, 0.14 mmol) as a light yellow oil after purification by 
flash column chromatography (SiO2, dichloromethane: diethyl ether = 30:1–10:1). 
 
TLC (SiO2) Rf  = 0.33 (dichloromethane: diethyl ether = 5:1).  
1H NMR (400 MHz, CDCl3): δ = 7.36 – 7.21 (m, 6H), 6.27 (dd, J = 3.2, 1.9 Hz, 1H), 
6.12 – 6.02 (m, 1H), 4.05 (dt, J = 11.1, 6.2 Hz, 1H), 3.91 (dt, J = 11.1, 6.2 Hz, 1H), 3.70 
(t, J = 6.8 Hz, 1H), 3.63 (d, J = 14.5 Hz, 1H), 3.50 (d, J = 14.5 Hz, 1H), 2.05 (td, J = 
13.8, 6.3 Hz, 1H), 1.96 (s, 3H), 1.95 – 1.87 (m, 1H), 1.82 (br, 1H). 
13C NMR (100 MHz, CDCl3): δ = 170.9, 153.7, 142.6, 141.7, 128.5, 127.4, 127.2, 110.0, 
106.8, 76.7, 61.9, 59.2, 43.7, 36.6, 20.8. 
HRMS (ESI): Calculated for C16H19NO3 [M+H
+] = 274.1438, found 274.1445. 













The allylic acetate (105.7 mg, 0.6 mmol, 300 mol%) and the primary amine (22.6 mg, 0.2 
mmol, 100 mol%) were subject to standard reaction conditions. The title compound was 
obtained in 71% yield (41.1 mg, 0.14 mmol) as a light yellow oil after purification by 
flash column chromatography (SiO2, dichloromethane: diethyl ether = 20:1–10:1). 
 
TLC (SiO2) Rf  = 0.52 (dichloromethane: diethyl ether = 5:1).  
1H NMR (400 MHz, CDCl3): δ = 7.38 – 7.25 (m, 5H), 7.18 (dd, J = 5.1, 1.2 Hz, 1H), 
6.91 (dd, J = 5.1, 3.4 Hz, 1H), 6.82 (dd, J = 3.4, 1.0 Hz, 1H), 4.11 (dt, J = 11.1, 6.4 Hz, 
1H), 3.97 (dt, J = 11.1, 6.6 Hz, 1H), 3.86 – 3.68 (m, 3H), 2.04 (dq, J = 13.5, 6.9 Hz, 1H), 
1.97 (s, 3H), 1.93 (dd, J = 13.9, 7.2 Hz, 1H), 1.70 (br, 1H). 
13C NMR (100 MHz, CDCl3): δ = 171.0, 144.3, 142.8, 128.6, 128.6, 127.4, 127.2, 126.5, 
124.7, 124.3, 62.0, 59.1, 45.8, 36.8, 20.9. 
HRMS (ESI): Calculated for C16H19NO2S [M+H
+] = 290.1209, found 290.1213. 




































The allylic acetate (105.7 mg, 0.6 mmol, 300 mol%) and the primary amine (21.6 mg, 0.2 
mmol, 100 mol%) were subject to standard reaction conditions. The title compound was 
obtained in 67% yield (38 mg, 0.14 mmol) as a light yellow oil after purification by flash 
column chromatography (4g SiO2, Isopropyl Acetate / Heptane = 0% - 100% over 30 
min). 
 
TLC (SiO2) Rf  = 0.30 (ethyl acetate: methanol = 15:1). 
1H NMR (400 MHz, CDCl3): δ = 8.52 – 8.45 (m, 2H), 7.64 (dt, J = 7.7, 2.0 Hz, 1H), 
7.42 – 7.33 (m, 2H), 7.33 – 7.24 (m, 3H), 7.23 (dd, J = 7.8, 4.7 Hz, 1H), 4.13 (dt, J = 
11.1, 6.4 Hz, 1H), 3.97 (dt, J = 11.2, 6.6 Hz, 1H), 3.72 (t, J = 7.0 Hz, 1H), 3.66 (d, J = 
13.5 Hz, 1H), 3.56 (d, J = 13.5 Hz, 1H), 2.08 (dt, J = 13.7, 6.7 Hz, 1H), 2.05 – 1.89 (m, 
1H), 1.98 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ = 170.8, 149.5, 149.2, 134.8, 128.5, 128.3, 127.4, 123.8, 
61.4, 57.2, 51.1, 36.3 20.8. 
HRMS (ESI): Calculated for C17H21N2O2 [M+H
+] =285.1598, found 285.1595. 










The cinnamyl acetate (105.7 mg, 0.6 mmol, 300 mol%) and the cyclohexylmethanamine 
(22.6 mg, 0.2 mmol, 100 mol%) were subject to standard reaction conditions (90 oC, 24 
hr). The title compound was obtained in 54% yield (31.2 mg, 0.11 mmol) as a yellow oil 
after purification by flash column chromatography (SiO2, hexanes: ethylacetate = 3:1). 
 
TLC (SiO2) Rf  = 0.19 (hexanes: ethyl acetate = 2:1).   
1H NMR (400 MHz, CDCl3): δ = 7.35 – 7.21 (m, 7H), 4.10 (dt, J = 11.1, 6.3 Hz, 1H), 
3.95 (dt, J = 11.1, 6.8 Hz, 1H), 3.66 (t, J = 6.9 Hz, 1H), 2.25 (qd, J = 11.5, 6.6 Hz, 2H), 
2.01 (s, 4H), 1.97 – 1.86 (m, 1H), 1.71 – 1.61 (m, 6H), 1.38 (ddt, J = 11.1, 7.6, 3.4 Hz, 
1H), 1.28 – 1.08 (m, 6H), 0.90 – 0.80 (m, 2H). 
13C NMR (100 MHz, CDCl3): δ = 171.0, 143.7, 128.5, 127.1, 127.0, 62.1, 60.6, 54.3, 
38.2, 36.9, 31.5, 26.7, 26.1, 20.9. 
HRMS (ESI): Calculated for C18H27NO2 [M+H
+] = 290.2115, Found 290.2119. 















The allylic acetate (123.7 mg, 0.6 mmol, 300 mol%) and the benzyl amine (21 mg, 0.2 
mmol, 100 mol%) were subject to standard reaction conditions (90 oC, 24 hr). The title 
compound was obtained in 64% yield (40.1 mg, 0.13 mmol) as a yellow oil after 
purification by flash column chromatography (SiO2, hexanes: ethylacetate = 2:1). 
 
TLC (SiO2) Rf  = 0.17 (hexanes: ethyl acetate = 2:1).   
1H NMR (400 MHz, CDCl3): δ = 7.33 – 7.18 (m, 11H), 6.90 – 6.85 (m, 2H), 4.08 (dt, J 
= 11.0, 6.3 Hz, 1H), 3.93 (dt, J = 11.1, 6.7 Hz, 1H), 3.80 (d, J = 0.5 Hz, 3H), 3.70 – 3.60 
(m, 2H), 3.50 (d, J = 13.1 Hz, 1H), 2.08 – 1.95 (m, 4H), 1.90 (dt, J = 14.0, 6.9 Hz, 1H). 
13C NMR (125 MHz, CDCl3): δ = 171.0, 158.8, 140.5, 135.1, 128.4, 128. 2, 128.2, 126.9, 
114.0, 62.1, 58.8, 55.3, 51.3, 36.9, 21.0. 
HRMS (ESI): Calculated for C19H23NO3 [M+H
+] = 314.1751, Found 313.1751. 














The allylic acetate (132.1 mg, 0.6 mmol, 300 mol%) and the primary amine (21.4 mg, 0.2 
mmol, 100 mol%) were subject to standard reaction conditions for 48 h. The title 
compound was obtained in 67% yield (43.9 mg, 0.13 mmol) as a light yellow oil after 
purification by flash column chromatography (SiO2, dichloromethane: diethyl ether = 
25:1–5:1). 
 
TLC (SiO2) Rf  = 0.30 (dichloromethane: diethyl ether = 3:1).  
1H NMR (400 MHz, CDCl3): δ = 7.34 – 7.15 (m, 5H), 6.85 (d, J = 1.6 Hz, 1H), 6.76 (d, 
J = 7.8 Hz, 1H), 6.72 (dd, J = 7.9, 1.7 Hz, 1H), 5.94 (d, J = 0.8 Hz, 2H), 4.09 (dt, J = 
11.1, 6.3 Hz, 1H), 3.93 (dt, J = 11.1, 6.3 Hz, 1H), 3.68 – 3.61 (m, 2H), 3.51 (d, J = 13.2 
Hz, 1H), 2.05 – 1.95 (m, 1H), 1.98 (s, 3H), 1.87 (ddt, J = 13.8, 7.5, 6.3 Hz, 1H), 1.59 (br, 
1H). 
13C NMR (100 MHz, CDCl3): δ = 170.9, 148.0, 146.7, 140.4, 137.1, 128.3, 128.1, 126.8, 
120.6, 108.0, 107.0, 100.9, 61.9, 59.2, 51.2, 36.9, 20.9. 
HRMS (ESI): Calculated for C19H21NO4 [M+H
+] = 328.1543, found 328.1551. 









The allylic acetate (147 mg, 0.6 mmol, 300 mol%) and the primary amine (21.6 mg, 0.2 
mmol, 100 mol%) were subject to standard reaction conditions. The title compound was 
obtained in 78% yield (55 mg, 0.16 mmol) as a light yellow oil after purification by flash 
column chromatography (4g SiO2, Isopropyl Acetate / Heptane = 0% - 100% over 30 
min). 
 
TLC (SiO2) Rf  = 0.42 (hexanes: ethyl acetate = 2:1).   
1H NMR (400 MHz, CDCl3): δ = 7.47 – 7.39 (m, 2H), 7.34 – 7.28 (m, 2H), 7.24 (td, J = 
4.8, 2.8 Hz, 3H), 7.16 (dd, J = 8.2, 2.0 Hz, 1H), 4.13 (dt, J = 11.2, 6.5 Hz, 1H), 3.95 (dt, 
J = 11.2, 6.5 Hz, 1H), 3.71 (t, J = 6.9 Hz, 1H), 3.64 (d, J = 13.2 Hz, 1H), 3.51 (d, J = 
13.2 Hz, 1H), 2.05-1.95 (m, 4H), 1.95 – 1.84 (m, 1H). 
13C NMR (100 MHz, CDCl3): δ = 170.9, 143.9, 139.9, 132.7, 131.1, 130.6, 129.2, 128.5, 
128.1, 127.1, 126.6, 61.5, 58.7, 51.4, 36.8, 20.9. 
HRMS (ESI): Calculated for C18H19Cl2NO2 [M+H
+] = 352.0866, found 352.0858. 










The allylic acetate (127 mg, 0.6 mmol, 300 mol%) and the primary amine (21.6 mg, 0.2 
mmol, 100 mol%) were subject to standard reaction conditions. The title compound was 
obtained in 52% yield (33 mg, 0.10 mmol) as a light yellow oil after purification by flash 
column chromatography (4g SiO2, Isopropyl Acetate / Heptane = 0% - 100% over 30 
min). 
TLC (SiO2) Rf  = 0.61 (hexanes: ethyl acetate = 2:1).   
1H NMR (400 MHz, CDCl3): δ = 7.36 – 7.20 (m, 5H), 7.12 (ddd, J = 8.8, 5.5, 3.1 Hz, 
1H), 7.00 (td, J = 9.2, 4.4 Hz, 1H), 6.99 – 6.87 (m, 1H), 4.16 (dt, J = 11.1, 6.4 Hz, 1H), 
4.11 – 3.99 (m, 2H), 3.67 (d, J = 13.0 Hz, 1H), 3.56 (d, J = 13.1 Hz, 1H), 2.14 – 2.02 (m, 
1H), 1.97 (s, 3H), 2.05 – 1.90 (m, 1H). 
13C NMR (100 MHz, CDCl3): δ = 170.9, 159.3 (dd, J = 210, 2.3 Hz, 1C), 156.9 (dd, J= 
210, 2.3 Hz, 1C) 140.0, 132.2 (dd, J = 15.7, 6.5 Hz, 1C), 128.4, 128.1, 127.1, 116.7 (dd, 
J =25.5, 8.4, 1C), 115.1-114.7 (m, 2C), 61.7, 53.3, 51.5, 35.6, 20.8. 
19F NMR (376 MHz, CDCl3): δ = -121.9 (dd, J = 2644, 18.5 Hz, 1F), -278.1 (dd, 
J=2244, 18.5 Hz, 1F). 
HRMS (ESI): Calculated for C18H19F2NO2 [M+H
+] = 320.1457, found 320.1452. 






















The allylic acetate (106 mg, 0.6 mmol, 300 mol%) and the primary amine (21.6 mg, 0.2 
mmol, 100 mol%) were subject to standard reaction conditions. The title compound was 
obtained in 81% yield (46 mg, 0.16 mmol) as a light yellow oil after purification by flash 
column chromatography (4g SiO2, Methanol / DCM = 0% - 10% over 30 min). 
 
TLC (SiO2) Rf  = 0.45 (ethyl acetate: methanol = 15:1). 
1H NMR (400 MHz, CDCl3): δ = 8.59 – 8.51 (m, 2H), 7.76 (d, J = 7.8 Hz, 1H), 7.36 – 
7.21 (m, 6H), 4.15 (dt, J = 11.3, 6.3 Hz, 1H), 3.94 (dt, J = 11.5, 6.4 Hz, 1H), 3.82 (t, J = 
7.0 Hz, 1H), 3.67 (d, J = 13.2 Hz, 1H), 3.54 (d, J = 13.2 Hz, 1H), 2.14 (dt, J = 13.4, 6.9 
Hz, 1H), 2.08 – 1.96 (m, 1H), 1.96 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ = 170.8, 149.5, 149.2, 134.8, 128.5, 128.3, 127.4, 123.8, 
61.4, 57.2, 51.1, 36.3 20.8. 
HRMS (ESI): Calculated for C17H21N2O2 [M+H
+] =285.1598, found 285.1598. 












The allylic acetate (109.3 mg, 0.6 mmol, 300 mol%) and the primary amine (21.4 mg, 0.2 
mmol, 100 mol%) were subject to standard reaction conditions for 48 h. The title 
compound was obtained in 71% yield (41.1 mg, 0.14 mmol) as a light yellow oil after 
purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 10:1–5:1). 
 
TLC (SiO2) Rf  = 0.40 (hexanes: ethyl acetate = 2:1).  
1H NMR (400 MHz, CDCl3): δ = 7.34 – 7.19 (m, 6H), 6.95 (dd, J = 5.1, 3.4 Hz, 1H), 
6.91 (ddd, J = 3.4, 1.3, 0.5 Hz, 1H), 4.16 (dt, J = 11.1, 6.2 Hz, 1H), 4.07 – 3.96 (m, 2H), 
3.77 (d, J = 13.2 Hz, 1H), 3.61 (d, J = 13.1 Hz, 1H), 2.11 (dtd, J = 14.0, 7.0, 6.1 Hz, 
1H), 2.02 (dt, J = 7.5, 6.2 Hz, 1H), 1.98 (s, 3H), 1.63 (s, 1H). 
13C NMR (100 MHz, CDCl3): δ = 170.9, 148.1, 140.1, 128.3, 128.2, 127.0, 126.5, 124.7, 
124.2, 61.8, 54.8, 51.1, 37.4, 20.9. 
HRMS (ESI): Calculated for C16H19NO2S [M+H
+] = 290.1209, found 290.1211. 













The allylic acetate (152.1 mg, 0.6 mmol, 300 mol%) and the primary amine (21.4 mg, 0.2 
mmol, 100 mol%) were subject to standard reaction conditions with Cs2CO3 (300 mol%). 
The title compound was obtained in 52% yield (37.6 mg, 0.10 mmol) as a light yellow oil 
after purification by flash column chromatography (SiO2, toluene: ethyl acetate = 10:1–
3:1). 
 
TLC (SiO2) Rf  = 0.55 (toluene: ethyl acetate = 1:1).  
1H NMR (400 MHz, CDCl3): δ = 8.77 (s, 2H), 8.49 – 8.40 (m, 3H), 7.50 (dd, J = 5.2, 2.1 
Hz, 4H), 7.35 – 7.23 (m, 6H), 4.28 – 4.18 (m, 1H), 4.08 – 3.98 (m, 1H), 3.83 (t, J = 6.9 
Hz, 1H), 3.71 (d, J = 13.2 Hz, 1H), 3.58 (d, J = 13.2 Hz, 1H), 2.19 – 2.08 (m, 1H), 2.03 
(dd, J = 12.7, 7.0 Hz, 1H), 1.98 (s, 3H), 1.73 (br, 1H). 
13C NMR (100 MHz, CDCl3): δ = 170.8, 164.2, 156.7, 139.5, 137.4, 133.6, 130.7, 128.7, 
128.6, 128.1, 128.1, 127.3, 61.3, 55.3, 51.4, 36.5, 20.9. 
HRMS (ESI): Calculated for C22H23N3O2 [M+H
+] = 362.1863, found 362.1867. 
FTIR (neat): 3026, 2926, 1737, 1583, 1543, 1494, 1428, 1322, 1240, 1172, 1025, 927, 











The allylic acetate (282 mg, 0.6 mmol, 300 mol%) and the primary amine (21.4 mg, 0.2 
mmol, 100 mol%) were subject to standard reaction conditions with Cs2CO3 (300 mol%). 
The title compound was obtained in 53% yield (61 mg, 0.11 mmol) as a light yellow oil 
after purification by flash column chromatography (12g SiO2, Isopropyl Acetate / 
Heptane = 0% - 100% over 30 min). 
 
TLC (SiO2) Rf  = 0.30 (hexanes: ethyl acetate = 2:1).   
1H NMR (400 MHz, CDCl3): δ = 7.58 – 7.49 (m, 2H), 7.37 – 7.30 (m, 2H), 7.30 – 7.21 
(m, 3H), 7.17 – 7.05 (m, 2H), 6.91 – 6.83 (m, 2H), 5.31 (s, 1H), 4.19 – 4.06 (m, 1H), 3.98 
– 3.86 (m, 1H), 3.76 – 3.60 (m, 3H), 3.59 – 3.51 (m, 1H), 3.14 – 3.04 (m, 1H), 2.95 – 
2.79 (m, 1H), 2.68 – 2.57 (m, 1H), 2.52 – 2.35 (m, 1H), 2.08 - 1.89 (m, 5H), 1.32 – 1.06 
(m, 9H). 
13C NMR (100 MHz, CDCl3): δ = 170.9, 162.4 (dd, J = 252.4, 7.8 Hz), 136.3, 131.9, 
128.6, 128.3, 127.7, 127.4, 121.4, 119.3, 118.2, 110.8, 110.5, 108.8, 97.9, 96.2, 61.3, 58.8 
(d, J = 8.0 Hz), 57.1 (d, J = 22.1 Hz), 51.6 – 50.8 (m, 2C), 36.2, 29.7, 27.0, 25.1 (d, J = 
24.7 Hz), 24.7 (d, J = 24.9 Hz), 22.6, 21.8, 20.9. 
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19F NMR (376 MHz, CDCl3): δ = –139.7 (m).  
HRMS (ESI): Calculated for C34H39N3O2F3 [M+H
+] = 578.2989, found 578.2984. 



















The allylic acetate (68.5 mg, 0.6 mmol, 300 mol%) and the primary amine (21.4 mg, 0.2 
mmol, 100 mol%) were subject to standard reaction conditions. The title compound was 
obtained in 30% yield (13.3 mg, 0.06 mmol) as a light yellow oil after purification by 
flash column chrmmatography (SiO2, hexanes: ethyl acetate = 5:1–1:1). 
 
TLC (SiO2) Rf  = 0.24 (ethyl acetate: methanol = 10:1).  
1H NMR (400 MHz, CDCl3): δ = 7.33 – 7.18 (m, 5H), 4.19 (dt, J = 11.1, 6.6 Hz, 1H), 
4.11 (dt, J = 11.1, 6.7 Hz, 1H), 3.82 (d, J = 13.0 Hz, 1H), 3.72 (d, J = 13.0 Hz, 1H), 2.78 
(h, J = 6.3 Hz, 1H), 1.99 (s, 3H), 1.83 – 1.72 (m, 1H), 1.71 – 1.61 (m, 1H), 1.40 (br, 1H), 
1.11 (d, J = 6.3 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ = 171.1, 140.6, 128.3, 128.1, 126.8, 62.1, 51.2, 49.7, 
35.7, 21.0, 20.4. 
HRMS (ESI): Calculated for C13H19NO2 [M+H
+] = 222.1489, found 222.1495. 












The allylic acetate (132.2 mg, 0.6 mmol, 300 mol%) and the primary amine (21.4 mg, 0.2 
mmol, 100 mol%) were subject to standard reaction conditions with Cs2CO3 (300 mol%). 
The title compound was obtained in 53% yield (34.7 mg, 0.11 mmol) as a light yellow oil 
after purification by flash column chromatography (SiO2, hexanes: ethyl acetate = 5:1–
2:1). 
 
TLC (SiO2) Rf  = 0.30 (hexanes: ethyl acetate = 1:1).  
1H NMR (400 MHz, CDCl3): δ = 7.37 – 7.19 (m, 10H), 4.50 (s, 2H), 4.17 (qt, J = 11.0, 
6.6 Hz, 2H), 3.77 (d, J = 1.5 Hz, 2H), 3.54 (dd, J = 9.4, 4.3 Hz, 1H), 3.41 (dd, J = 9.4, 
5.8 Hz, 1H), 2.88 (qd, J = 6.2, 4.3 Hz, 1H), 1.98 (s, 3H), 1.80 (q, J = 6.6 Hz, 2H), 1.70 
(s, 1H). 
13C NMR (100 MHz, CDCl3): δ = 171.0, 140.5, 138.2, 128.4, 128.3, 128.1, 127.6, 127.6, 
126.8, 73.2, 71.7, 62.0, 53.9, 51.1, 30.9, 21.0. 
HRMS (ESI): Calculated for C20H25NO3 [M+H
+] = 328.1907, found 328.1907. 








Procedures and Spectral Data for Deuterium Labelling Experiments 
(E)-3-phenylallyl-2-d acetate (d1-7.1a) 
 
To a flame dried round-bottomed flask charged with LiAlD4 (210 mg, 5 mmol, 100 
mol%) under an argon atmosphere was added THF (15 mL, 0.33 M with respect to 
propargylic alcohol). The reaction vessel was placed in an ice batch. After 5 minutes a 
solution of 3-phenyl-2-propyn-1-ol (660 mg, 5 mmol, 100 mol%) in dry THF (5 mL, 1.0 
M with respect to propargylic alcohol) was added slowly and the mixture was stirred at 
room temperature for 3 hours. After the reaction vessel was placed in an ice batch, water 
(1 mL), NaOH (1 mL, 10% aqueous solution) and water (3 mL) were added to the 
reaction mixture. After 10 minutes MgSO4 was added, the reaction mixture was filtered 
(celite) with the aid of CH2Cl2 (10 mL) and the filtrate was concentrated under reduced 
pressure. The resulting oily residue was subjected to the next step without further 
purification. 
To a round-bottomed flask charged with the crude substrate and 4-
dimethylaminopyridine (30 mg, 0.25 mmol, 5 mol%) under an argon atmosphere was 
added CH2Cl2 (12.5 mL, 0.4 M), followed by acetic anhydride (0.52 mL, 5.5 mmol, 110 
mol%) and triethylamine (1.0 mL, 7.5 mmol, 150 mol%). After 1 hour, saturated aqueous 
sodium bicarbonate (10 mL) was added and the mixture was transferred to a separatory 
funnel. The organic layer was extracted with CH2Cl2 (10 mL × 2) and the combined 
organic layers were washed with 1 N HCl (30 mL), dried (MgSO4), filtered and 
concentrated under reduced pressure. The resulting oily residue was subjected to flash 
column chromatography (SiO2, hexanes: ethyl acetate = 30:1) to furnish the title 
compound as a colorless oil (790 mg, 4.46 mmol) in 89% yield. 
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TLC (SiO2) Rf  = 0.38 (hexanes: ethyl acetate = 10:1).  
1H NMR (400 MHz, CDCl3): δ = 7.40 – 7.22 (m, 5H), 6.63 (t, J = 2.1 Hz, 1H), 4.72 (s, 
2H), 2.09 (s, 3H). 
2H NMR (92 MHz, CDCl3) δ = 6.34 (s, 1D) 
13C NMR (100 MHz, CDCl3): δ = 170.8, 136.1, 134.1, 128.5, 128.0, 126.5, 122.8 (t), 
64.9, 20.9. 
HRMS (ESI): Calculated for C11H11DO2 [M+Na
+] = 200.0792, found 200.0794. 














To a flame dried round-bottomed flask charged with LiAlD4 (210 mg, 5 mmol, 100 
mol%) under an argon atmosphere was added THF (15 mL, 0.33 M with respect to 
propargylic alcohol). The reaction vessel was placed in an ice batch. After 5 minutes a 
solution of 3-phenyl-2-propyn-1-ol (660 mg, 5 mmol, 100 mol%) in dry THF (5 mL, 1.0 
M with respect to propargylic alcohol) was added slowly and the mixture was stirred at 
room temperature for 3 hours. After the reaction vessel was placed in an ice batch, D2O 
(1 mL), NaOH (1 mL, 10% aqueous solution) and water (3 mL) were added to the 
reaction mixture. After 10 minutes MgSO4 was added, the reaction mixture was filtered 
(celite) with the aid of CH2Cl2 (10 mL) and the filtrate was concentrated under reduced 
pressure. The resulting oily residue was subjected to the next step without further 
purification. 
To a round-bottomed flask charged with the crude substrate and 4-
dimethylaminopyridine (30 mg, 0.25 mmol, 5 mol%) under an argon atmosphere was 
added CH2Cl2 (12.5 mL, 0.4 M), followed by acetic anhydride (0.52 mL, 5.5 mmol, 110 
mol%) and triethylamine (1.0 mL, 7.5 mmol, 150 mol%). After 1 hour, saturated aqueous 
sodium bicarbonate (10 mL) was added and the mixture was transferred to a separatory 
funnel. The organic layer was extracted with CH2Cl2 (10 mL × 2) and the combined 
organic layers were washed with 1 N HCl (30 mL), dried (MgSO4), filtered and 
concentrated under reduced pressure. The resulting oily residue was subjected to flash 
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column chromatography (SiO2, hexanes: ethyl acetate = 30:1) to furnish the title 
compound as a colorless oil (802 mg, 4.50 mmol) in 90% yield. 
 
TLC (SiO2) Rf  = 0.38 (hexanes: ethyl acetate = 10:1).  
1H NMR (400 MHz, CDCl3): δ = 7.40 – 7.22 (m, 5H), 4.71 (s, 2H), 2.09 (s, 3H). 
2H NMR (92 MHz, CHCl3) δ = 6.70 (s, 1D), 6.33 (s, 1D). 
13C NMR (100 MHz, CDCl3): δ = 170.8, 136.0, 133.7 (m), 128.5, 128.0, 126.5, 122.7 
(m), 64.9, 20.9. 
HRMS (ESI): Calculated for C11H10D2O2 [M+Na
+] = 201.0855, found 201.0849. 





















An oven-dried pressure tube equipped with a magnetic stir bar was charged with cesium 
carbonate (200 mol%), [Ir(cod)Cl]2 (2.5 mol%), and dppf (5 mol%). The tube was purged 
with argon for 5 minutes. DME (1.0 M) was added followed by the deuterated cinnamyl 
acetate (300 mol%) and the amine (100 mol%). The tube was sealed with a PTFE lined 
cap and was placed in an oil bath at 90 oC and stirred for 24 hours. After reaching 
ambient temperature, the crude reaction mixture was directly subjected to flash column 
chromatography. 
To a round-bottomed flask charged with the purified substrate under an argon atmosphere 
was added MeOH (0.2 M), followed by potassium carbonate (150 mol%). After 3 hours, 
the reaction mixture was filtered (celite) with the aid of CH2Cl2 (5 mL) and the filtrate 
was concentrated under reduced pressure. The crude reaction mixture was subjected to 
the next step without further purification 
To a round-bottomed flask charged with the crude substrate under an argon atmosphere 
was added toluene (1.0 M), followed by carbonyldiimidazole (150 mol%). The reaction 
flask was placed an oil bath at 40 oC and stirred for 24 hours. After reaching ambient 
temperature, the reaction mixture was concentrated under reduced pressure and the crude 







The title compound was prepared by the general procedure. 
 
TLC (SiO2) Rf  = 0.24 (hexanes: ethyl acetate = 2:1).  
1H NMR (500 MHz, CDCl3): δ = 7.46 – 7.27 (m, 6H), 7.24 (dt, J = 8.8, 3.1 Hz, 4H), 
5.38 (d, J = 15.0 Hz, 1H), 4.50 (dd, J = 5.9, 4.0 Hz, 1H), 4.29 – 4.17 (m, 2H), 3.63 (d, J 
= 15.1 Hz, 1H), 2.37 (dddd, J = 14.5, 10.4, 6.0, 4.2 Hz, 1H), 1.96 (dtd, J = 14.1, 4.1, 2.9 
Hz, 1H). 
13C NMR (100 MHz, CDCl3): δ 154.4, 139.8, 136.7, 129.0, 128.6, 128.2, 128.1, 127.6, 
126.5, 62.9, 56.8, 50.2, 30.6. 
HRMS (ESI): Calculated for C17H17NO2 [M+H
+] = 268.1332, found 268.1339. 





















The title compound was prepared by the general procedure. 
 
TLC (SiO2) Rf  = 0.24 (hexanes: ethyl acetate = 2:1).  
1H NMR (400 MHz, CDCl3): δ = 7.42 – 7.36 (m, 2H), 7.35 – 7.23 (m, 4H), 7.19 (ddd, J 
= 7.4, 4.0, 1.6 Hz, 4H), 5.34 (d, J = 15.1 Hz, 1H), 4.45 (d, J = 4.7 Hz, 1H), 4.26 – 4.10 
(m, 2H), 3.59 (d, J = 15.1 Hz, 1H), 2.37 – 2.26 (m, 0.42H), 1.95 – 1.86 (m, 0.66H). 
2H NMR (92 MHz, CHCl3) δ = 2.35 (s, 0.63H), 1.94 (s, 0.37H). 
13C NMR (100 MHz, CDCl3): δ = 154.4, 139.7, 136.7, 129.0, 128.6, 128.1, 128.0, 127.6, 
126.4, 62.8 (d, J = 2.7 Hz), 56.7 (d, J = 3.3 Hz), 50.1 (d, J = 1.7 Hz), 30.2 (m). 
HRMS (ESI): Calculated for C17H16DNO2 [M+H
+] = 269.1395, found 269.1396. 




























The title compound was prepared by the general procedure. 
 
TLC (SiO2) Rf  = 0.24 (hexanes: ethyl acetate = 2:1).  
1H NMR (400 MHz, CDCl3): δ = 7.46 – 7.27 (m, 6H), 7.21 (ddd, J = 7.2, 4.0, 1.6 Hz, 
4H), 5.36 (d, J = 15.1 Hz, 1H), 4.27 – 4.14 (m, 2H), 3.60 (d, J = 15.1 Hz, 1H), 2.38 – 
2.28 (m, 0.43H) 1.92 (ddd, J = 14.2, 4.3, 2.8 Hz, 0.66H).  
2H NMR (92 MHz, CHCl3) δ = 4.46 (s, 1H), 2.34 (s, 0.57H), 1.92 (s, 0.33H) 
13C NMR (100 MHz, CDCl3): δ = 154.4, 139.7, 136.7, 129.0, 128.6, 128.1, 128.0, 127.6, 
126.4, 62.8, 56.4 (m), 50.1 (d, J = 1.7 Hz), 30.2 (dd, J = 37.4, 17.2 Hz). 
HRMS (ESI): Calculated for C17H15D2NO2 [M+H
+] = 270.1459, found 270.1458. 























Chapter 8:  Inversion of Enantioselectivity in Allene Gas versus Allyl 
Acetate Reductive Aldehyde Allylation Guided by Metal-Centered 
Stereogenicity: An Experimental and Computational Study* 
 
8.1 Introduction 
In connection with longstanding efforts to use abundant chemical feedstocks as 
pronucleophiles in metal-catalyzed carbonyl reductive coupling,1f a diverse suite of 
enantioselective C-C couplings was developed in our laboratory.1,2 A distinguishing 
feature of these processes resides in the use of inexpensive terminal reductants (e.g. H2, 
2-PrOH) or, more ideally, dual use of alcohols as carbonyl proelectrophiles and 
reductants in carbonyl addition via hydrogen auto-transfer.1 Given the high occurrence of 
allenes as constituents in the C3, C4 and C5 petroleum cracking fractions (Figure 8.1), 
these patterns of reactivity were applied to the first (2007) allene-carbonyl reductive 




Figure 8.1 Allene feedstocks formed in petroleum cracking.  
 
 
*This chapter is based on the published work: 




Figure 8.2 Milestones in metal-catalyzed allene-carbonyl reductive coupling and 
related hydrogen auto-transfer processes.  
 
Using allene, methylallene and dimethylallene as pronucleophiles, products of 
carbonyl allylation, crotylation and tert-prenylation were obtained in reactions conducted 
from either the alcohol or aldehyde oxidation level.3 Shortly thereafter (2009), we 
reported the first enantioselective reactions of this type using dimethyl allene.4a 
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Following this and other catalytic enantioselective allene-carbonyl additions developed in 
our laboratory,4,5 Buchwald reported an allene-ketone reductive coupling mediated by 
(MeO)2MeSiH.
6 In this account, we report the first enantioselective allene-aldehyde 
reductive couplings.7 Additionally, we demonstrate that using the same antipode of chiral 
ligand, (S)-tol-BINAP, an inversion of enantioselectivity is observed for carbonyl 
allylations that employ gaseous allene vs allyl acetate as pronucleophile solely in 
response to stereogenicity at iridium.8,9 Experimental and computational studies 
corroborate intervention of diastereomeric π-allyliridium-C,O-benzoate complexes, 
which arise via allene hydrometalation (from a pentacoordinate iridium hydride) vs 
ionization of allyl acetate (from a square planar iridium species). 
 
8.2 Reaction Development and Scope 
An initial series of experiments were conducted in which a sealed reaction vessel 
back-filled with gaseous allene 8.1a and charged with aldehyde 8.2a (100 mol%), 2-
propanol (200 mol%), THF (0.4 M) and an iridium catalyst (5 mol%) were heated to 60 
oC (Table 1) for 24 hours. It was determined that the (S)-tol-BINAP-modified iridium 
catalyst, Ir-V, delivered the desired product 8.3a with the highest levels of 
enantioselectivity as the (R)-enantiomer, which is the opposite enantiomer observed in 
corresponding carbonyl allylations mediated by allyl acetate 8.1b.10 This surprising result 
compelled us to evaluate the diastereomeric composition of the iridium catalyst Ir-V, 
which is easily accomplished via LCMS due to the chromatographic stability of π-
allyliridium-C,O-benzoates (Figure 8.3). The catalyst prepared from allyl acetate is 
enriched in diastereomer D, which, as indicated by experiment and computation, is the 
thermodynamically most stable isomer. In contrast, the catalyst recovered from the 
reaction mixture using allene or prepared from allene itself is enriched in diastereomer C. 
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It was posited that use of Ir-V derived from allene would improve enantioselectivity in 
the allene-mediated allylation of aldehyde 8.2a. Indeed, an increase from 86% to 92% ee 
in the formation of homoallylic alcohol 8.3a was observed (Table 8.1). Using catalyst 
(S)-Ir-V derived from allene, the scope of the allene-mediated reductive aldehyde 
allylation mediated by 2-propanol was explored (Table 2). Diverse aryl aldehydes 8.2a-
8.2i and heteroaryl aldehydes 8.2j-8.2p were converted to the corresponding homoallylic 
alcohols 8.3a-8.3p in good yield with uniformly high levels of enantioselectivity. As 
illustrated by the formation of adduct 8.3d, due to the mild reaction conditions, sensitive 
functional groups such as pinacol boronates are tolerated. The formation of 8.3l, which 
incorporates an unprotected indole nitrogen, also is notable. The α,β-unsaturated 
aldehyde 8.2q, as well as linear and branched aliphatic aldehydes 8.2r and 8.2s also 
participate in highly enantioselective allylation. Allene-mediated allylation of 8.2a 
mediated by d8-2-propanol delivers deuterio-8.3a (eq. 8.1).
11 The pattern of deuterium 
incorporation corroborates reversible allene hydrometalation with incomplete 
regiocontrol. The relatively low levels of deuterium incorporation are attributed to 











Table 8.1 Selected optimization experiments in the enantioselective reductive 
coupling of allene 8.1a with aldehyde 8.2a and divergent 





aYields are of material isolated by silica gel chromatography. Enantioselectivities were determined by 
chiral stationary phase HPLC analysis. bPhMe (0.4 M). cPhMe (0.1 M). d(S)-Ir-V derived from allene. See 



























Table 8.2 Enantioselective iridium-catalyzed reductive coupling of gaseous allene 
8.1a with aldehydes 8.2a-8.2s mediated by 2-propanol.a 
 
aYields of material isolated by silica gel chromatography. The catalyst (S)-Ir-V prepared from allene was 
used. Enantioselectivities were determined by chiral stationary phase HPLC analysis. See Supporting 





The experimental data suggest that the observed divergence in enantioselectivity 
in reactions of allene vs allyl acetate is due to intervention of diastereomeric π-
allyliridium-C,O-benzoate complexes C and D, which arise via allene hydrometalation 
(from an pentacoordinate iridium hydride) vs ionization of allyl acetate (from a square 




Figure 8.4 Hypothesis for enantiodivergence in aldehyde allylations mediated by 
gaseous allene vs allyl acetate. 
 
To challenge the veracity of our hypothesis, we then turned our efforts to density 
functional theory (DFT) calculations.15 The reaction pathways to form the π-allyliridium 
complexes under the different experimental conditions were first computed. When allyl 
acetate pronucleophile is used, the π-allyliridium is formed via coordination of allyl 
acetate to the C,O-benzoate complex 4 followed by ionization (TS1, Figure 8.5A). 
Although the common intermediate 4 can potentially lead to all four diastereomeric π-
allyl complexes, formation of D is kinetically and thermodynamically favored (see Figure 
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S2 for less favorable pathways to A and B). The relatively low barrier of TS1D suggests 
a reversible ionization process. The thermodynamically more stable complex D is 
operative in the subsequent aldehyde addition step (vide infra). On the other hand, π-
allyliridium complexes derived from allene are formed via hydrometalation from a square 
pyramidal iridium hydride (6C or 6D, Figure 8.5B). DFT calculations suggest 6C is 
thermodynamically more stable than 6D, and subsequent allene coordination to form 7C 
and hydrometalation via TS3C are both very facile. Therefore, π-allyl complex C is 
formed preferentially from allene hydrometalation. The calculated transition states for 
allylation of aldehyde 8.2a by the diastereomeric complexes C and D provide further 
insight into the origins of enantiodivergence. Complexes C and D are supported by the 
same antipode of the (S)-tol-BINAP ligand, but their stereogenicity at iridium is opposite. 
Therefore, examination of the transition states for carbonyl addition will reveal whether 
enantioselectivity is influenced more by the chirality of the metal center16 or the 
bisphosphine ligand. The aldehyde addition with C and D occurs by way of Zimmerman-
Traxler-type transition states that place the Ar group of the aldehyde in a pseudo-
equatorial position (Figure 8.6).17 In the reaction with D, addition to the (Si)-face of the 
aldehyde (TS2D-S) to form (S)-8.3a is 2.2 kcal/mol more favorable than the (Re)-face 
addition (TS2D-R) to form (R)-8.3a. TS2D-R is destabilized by the 1,3-diaxial 
interactions between the aldehyde hydrogen and the benzene ring of the benzoate, which 
is co-planar with the aldehyde. In TS2D-S, the axial aldehyde hydrogen and the benzoate 
are on opposite faces of the chair, which relieves steric repulsion. In the allylation 
transition states with complex C (Figure 8.6B), because the stereogenicity at iridium is 
inverted, the (S)-selective transition state (TS2C-S) is now destabilized by the 1,3-diaxial 
interactions be-tween the aldehyde hydrogen and the benzoate. As such, the most 
 750 
favorable transition state from C is TS2C-R, which eventually leads to the (R)-




Figure 8.5 Computed energy profiles of the kinetic pathways leading to 





Figure 8.6 Enantioselectivity determining aldehyde allylation transition states with π-
allyliridium complexes D and C. Activation free energies are with respect 




In summary, we report the first catalytic enantioselective aldehyde allylations 
mediated by gaseous allene. These processes exploit a feedstock pronucleophile (allene) 
in combination with a feedstock reductant (2-propanol) under non-cryogenic conditions 
with acetone as the sole stoichiometric byproduct. Remarkably, use of allene vs allyl 
acetate as pronucleophile results in an inversion of enantioselectivity using the same 
antipode of chiral ligand, (S)-tol-BINAP. The collective experimental and computational 
data corroborate intervention of diastereomeric π-allyliridium-C,O-benzoate complexes, 
which arise via allene hydrometalation (from a pentacoordinate iridium hydride) vs allyl 
acetate ionization (from a square planar iridium species). These data should facilitate the 
(B) aldehyde allylation transition states from complex 6C
TS2C-R (favored)
∆G‡ = 25.2 kcal/mol
TS2C-S
∆G‡ = 26.4 kcal/mol
TS2D-R
∆G‡ = 28.0 kcal/mol
TS2D-S (favored)
∆G‡ = 25.8 kcal/mol




design of related chiral-at-metal complexes for enantioselective catalysis by providing 
insight into the structural and interactions features of the catalyst that influence 
enantioselectivity. More broadly, these studies and other work from our laboratory 
demonstrate how reactions that traditionally have employed organometallic reagents may 






















8.5 Experimental Details 
 
General Information 
All  reactions were carried out under inert gas atmosphere (nitrogen or argon) 
unless otherwise indicated. Resealable pressure tubes (13x100 mm) were purchased from 
Fischer Scientific (catalog number 14-959-35C) and were oven dried followed by cooling 
in a desiccator or under a stream of inter gas prior to use. All commercial reagents and 
anhydrous solvents were used as received from vendors (Fischer Scientific, Sigma 
Aldrich, and Combi Blocks) without further purification. Preparative column 
chromatography employing Silicycle silica gel (40-63 μm) was performed according to 
the method of Still1 or on a Teledyne Isco Combiflash Rf utilizing Silicycle HP column 
using a mobile phase composed of either hexanes/ethyl acetate, hexanes/acetone, or 
dichloromethane/methanol. Reactions were monitored by analytical thin-layer 
chromatography (TLC) using 0.25 mm commercial silica gel plates (Dynamic 
Absorbents F). Visualization was accomplished with UV light followed by dipping in 
CAM, p-Anisaldehyde (PAA), or KMnO4 stain solution followed by heating. 
 
Spectroscopy, Spectrometry and Data Collection  
Infrared spectra were recorded on a Perkin-Elmer 1600 spectrometer using a 
diamond ATR unit. High-resolution mass spectra (HRMS) were obtained on a Karatos 
MS9 and are reported as m/z (relative intensity). Accurate masses are reported for the 
molecular ion (M+H, M+Na), or a suitable fragment ion. Nuclear magnetic resonance 
(1H, 13C, 19F NMR) spectra were recorded with a Bruker BioSpin GmbG, Varian Gemini 
(400 MHz) or Varian INOVA (500 MHz) spectrometer equipped with a Bruker 
cryoprobe. The chemical shifts are given as parts per million (ppm) and were referenced 
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to the residual solvent signal (CDCl3: δH = 7.26 ppm, δC = 77.16 ppm). Specific optical 
rotations were recorded on an Azzota Corp AP45 (589 nm) in CHCl3. Solution 
concentrations are given in the units of 10–2 g mL–1. 
 
Experimental Details and Spectral Data 
Detailed Procedure for Preparation of Iridium Complexes 




To a sealed tube equipped with a magnetic stir bar was added Cs2CO3 (977.5 mg, 3.0 
mmol, 200 mol%), 3,4-dinitrobenzoic acid (636.4 mg, 3.0 mmol, 200 mol%), (S)-
TolBINAP (1.02 g, 1.5 mmol, 100 mol%) and [Ir(cod)Cl]2 (503.8 mg, 0.75 mmol, 50 
mol%). The reaction vessel was purged with argon and THF (15.0 mL, 0.1 M) was added 
followed by allyl acetate (0.40 mL, 3.75 mmol, 250 mol%). The resulting mixture was 
stirred at room temperature for 30 min, and at 80 ˚C for another 90 min. After cooling to 
ambient temperature, the mixture was filtered through a celite plug with the aid of DCM 
(45 mL). The combined filtrate was concentrated in vacuo and subjected to flash column 
chromatography (DCM:THF = 10:1). The resulting gum-like residue was dissolved in 
THF (2.0 mL). Addition of HPLC grade hexanes (20 mL) led to formation of a 
precipitate. The product was filtered and washed with HPLC grade hexanes, followed by 
removal of trace amount of solvent in vacuo, to provide a light yellow powder (1.4 g, 
1.25 mmol) in 83% yield as a mixture of stereoisomers. The yellow powder was 
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dissolved in toluene and hexanes was allowed to diffuse into the toluene solution at room 
temperature via slow vapor diffusion, resulting in formation of crystals. 
 
Spectral data is reported for the major isomer. 
 
31P NMR (202 MHz, CDCl3): δ = -13.78 (d, J = 22.5 Hz), -16.62 (d, J = 22.5 Hz). 
HRMS (ESI): Calculated for C58H47IrN2O6P2 [M+H
+] = 1123.2616, Found 1123.2624. 
[α]
D
𝟐𝟖= –100.8 (c 0.3, CHCl3). 










To a sealed tube equipped with a magnetic stir bar was added K2CO3 (110.6 mg, 0.8 
mmol, 200 mol%), 3,4-dinitrobenzoic acid (169.7 mg, 0.8 mmol, 200 mol%), (S)-
TolBINAP (271.5 mg, 0.4 mmol, 100 mol%) and [Ir(cod)Cl]2 (134.3 mg, 0.2 mmol, 50 
mol%). The tube was fit with a rubber septum before being evacuated by piercing the 
septum with a needle connected to a Schlenk line. Immediately after evacuation, an 
allene balloon fitted with a needle was used to pierce the septum and refill the tube with 
allene gas. Under the allene balloon, THF (4.0 mL, 0.1 M) was added. The septum was 
quickly removed and the tube was sealed with a PTFE lined cap. The resulting mixture 
was stirred at room temperature for 30 min, and at 80 ˚C for another 90 min. After 
cooling to ambient temperature, the mixture was filtered through a celite plug with the 
aid of DCM (45 mL). The combined filtrate was concentrated in vacuo and subjected to 
flash column chromatography (DCM:THF = 10:1). The resulting gum-like residue was 
dissolved in THF (1.0 mL). Addition of HPLC grade hexanes (20 mL) led to formation of 
a precipitate. The product was filtered and washed with HPLC grade hexanes, followed 
by removal of trace amount of solvent in vacuo, to provide a light yellow powder (358.0 





Spectral data is reported for the major isomer. 
 
31P NMR (202 MHz, CDCl3): δ = -4.26 (d, J = 18.7 Hz), -13.67 (d, J = 19.8 Hz). 
HRMS (ESI): Calculated for C58H47IrN2O6P2 [M+H
+] = 1123.2616, Found 1123.2624. 
[α]
D
𝟐𝟖= –282.7 (c 0.3, CHCl3). 








(S)-Ir-V recovered from Allylation - It was prepared according to the following 
procedures and was identical in all respects to the (S)-Ir-V made from allene gas. 
 
A pressure tube equipped with a magnetic stir bar was charged with aldehyde 2a (37.0 
mg, 0.2 mmol, 100 mol%) and (S)-Ir-V made from allyl acetate (11.2 mg, 0.01 mmol, 5 
mol%). The tube was fit with a rubber septum and was evacuated by piercing the septum 
with a needle connected to a Schlenk line. Immediately after evacuation, an allene-filled 
balloon equipped with a needle was used to pierce the septum and refill the tube with 
allene gas. Under the allene balloon, toluene (2.0 mL, 0.1 M) was added followed by 2-
propanol (31 µL, 0.4 mmol, 200 mol%). The septum was removed quickly and the tube 
was sealed with a PTFE lined cap. The tube was placed at 60 oC for 24 hours. The 
solution was allowed to reach ambient temperature before being concentrated in vacuo. 
The residue was directly subjected to flash column chromatography. The title compound 
was obtained in 54% yield (6.1 mg, 5.4 µmol) as a light yellow solid after isolation by 





Spectral data is reported for the major isomer. 

















A pressure tube equipped with a magnetic stir bar was charged with aldehyde (0.2 mmol, 
100 mol%) and (S)-Ir-V (11.2 mg, 0.01 mmol, 5 mol%). The tube was fit with a rubber 
septum and was evacuated by piercing the septum with a needle connected to a Schlenk 
line. Immediately after evacuation, an allene-filled balloon equipped with a needle was 
used to pierce the septum and refill the tube with allene gas. Under the allene balloon, 
toluene (2.0 mL, 0.1 M) was added followed by 2-propanol (31 µL, 0.4 mmol, 200 
mol%). The septum was removed quickly and the tube was sealed with a PTFE lined cap. 
The tube was placed in an oil bath at the indicated temperature and stirred for the 
indicated time period. The solution was allowed to reach ambient temperature before 












The aldehyde (37.0 mg, 0.20 mmol, 100 mol%) was subjected to standard reaction 
conditions (60 oC, 24 hr). The title compound was obtained in 90% yield (41.0 mg, 0.18 
mmol) as a light yellow oil after isolation by flash column chromatography (SiO2, 
hexanes: ethyl acetate = 25:1–10:1). 
 
TLC (SiO2) Rf  = 0.48 (hexanes: ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 7.47 (d, J = 8.4 Hz, 2H), 7.24 (d, J = 8.3 Hz, 2H), 5.86 
– 5.66 (m, 1H), 5.19 – 5.13 (m, 2H), 4.71 (ddd, J = 7.9, 4.8, 2.9 Hz, 1H), 2.54 – 2.41 (m, 
2H), 2.06 (t, J = 2.8 Hz, 1H). 
13C NMR (125 MHz, CDCl3): δ = 142.8, 133.9, 131.5, 127.5, 121.2, 118.9, 72.5, 43.8. 
HRMS (EI): Calculated for C10H11BrO [M
+] = 225.9993, Found 225.9990. 




𝟐𝟖= +48.0 (c 0.25, CHCl3). 














The aldehyde (26.2 mg, 0.20 mmol, 100 mol%) was subjected to standard reaction 
conditions (60 oC, 24 hr). The title compound was obtained in 82% yield (28.4 mg, 0.16 
mmol) as a yellow oil after isolation by flash column chromatography (SiO2, hexanes: 
ethyl acetate = 20:1–10:1). 
 
TLC (SiO2) Rf  = 0.28 (hexanes: ethyl acetate = 3:1).  
1H NMR (500 MHz, CDCl3): δ = 7.63 (d, J = 8.2 Hz, 2H), 7.47 (d, J = 8.3 Hz, 2H), 5.87 
– 5.65 (m, 1H), 5.29 – 5.05 (m, 2H), 4.80 (dd, J = 8.0, 4.7 Hz, 1H), 2.57 – 2.49 (m, 1H), 
2.43 (dt, J = 14.7, 7.9 Hz, 1H), 2.10 (s, 1H). 
13C NMR (125 MHz, CDCl3): δ = 149.2, 133.4, 132.2, 126.5, 119.5, 118.9, 111.2, 72.4, 
43.9. 
HRMS (ESI): Calculated for C11H11NO [M+Na
+] = 196.0733, Found 196.0738. 
FTIR (neat): 3405, 3077, 2979, 2922, 2228, 1641, 1609, 1604, 1412, 1198, 1055, 990, 
919, 838 cm–1. 
[α]
D
𝟐𝟖= +46.2 (c 0.1, CHCl3). 













The aldehyde (32.8 mg, 0.20 mmol, 100 mol%) was subjected to standard reaction 
conditions (60 oC, 24 hr). The title compound was obtained in 88% yield (36.3 mg, 0.18 
mmol) as a light yellow oil after isolation by flash column chromatography (SiO2, 
hexanes: ethyl acetate = 25:1–10:1). 
 
TLC (SiO2) Rf  = 0.27 (hexanes: ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 8.07 – 7.95 (m, 2H), 7.43 (d, J = 8.3 Hz, 2H), 5.79 
(dddd, J = 17.9, 9.8, 7.7, 6.5 Hz, 1H), 5.24 – 5.10 (m, 2H), 4.81 (dd, J = 8.0, 4.8 Hz, 
1H), 3.91 (s, 3H), 2.59 – 2.51 (m, 1H), 2.51 – 2.42 (m, 1H), 2.22 – 2.09 (m, 1H). 
13C NMR (125 MHz, CDCl3): δ = 166.9, 148.9, 133.8, 129.7, 129.3, 125.7, 119.1, 72.7, 
52.1, 43.8. 
HRMS (ESI): Calculated for C12H14O3 [M+Na
+] = 229.0835, Found 229.0844. 
FTIR (neat): 3436, 2952, 1720, 1611, 1436, 1276, 1192, 1111, 1054, 1018, 917, 957, 
768, 707 cm–1. 
[α]
D
𝟐𝟖= +45.0 (c 0.3, CHCl3). 














The aldehyde (46.4 mg, 0.20 mmol, 100 mol%) was subjected to standard reaction 
conditions (60 oC, 48 hr). The title compound was obtained in 85% yield (46.6 mg, 0.17 
mmol) as a light yellow oil after isolation by flash column chromatography (SiO2, 
hexanes: ethyl acetate = 25:1–5:1). 
 
TLC (SiO2) Rf  = 0.28 (hexanes: ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 7.85 – 7.76 (m, 2H), 7.41 – 7.31 (m, 2H), 5.79 (ddt, J 
= 17.1, 10.0, 7.1 Hz, 1H), 5.21 – 5.09 (m, 2H), 4.76 (ddd, J = 8.0, 5.0, 3.2 Hz, 1H), 2.60 
– 2.41 (m, 2H), 2.06 (d, J = 3.3 Hz, 1H), 1.34 (s, 12H). 
13C NMR (125 MHz, CDCl3): δ = 147.0, 134.9, 134.3, 125.1, 118.5, 83.8, 73.2, 43.8, 
24.9. 
HRMS (ESI): Calculated for C16H23BO3 [M+Na
+] = 297.1625, Found 297.1643. 
FTIR (neat): 3318, 2980, 2921, 1613, 1359, 1324, 1142, 1090, 1017, 859, 843, 660 cm–1. 
[α]
D
𝟐𝟖= +22.5 (c 0.4, CHCl3). 















The aldehyde (28.8 μL, 0.20 mmol, 100 mol%) was subjected to standard reaction 
conditions (60 oC, 24 hr). The title compound was obtained in 74% yield (37.1 mg, 0.15 
mmol) as a pale yellow oil after isolation by flash column chromatography (SiO2, 
hexanes: ethyl acetate = 20:1–10:1). 
 
TLC (SiO2) Rf  = 0.38 (hexanes: ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 7.69 (s, 1H), 7.47 (d, J = 2.6 Hz, 2H), 5.86 – 5.68 (m, 
1H), 5.24 – 5.13 (m, 2H), 4.77 (dd, J = 8.2, 4.6 Hz, 1H), 2.59 – 2.35 (m, 2H), 2.10 (s, 
1H). 
13C NMR (125 MHz, CDCl3): δ = 142.9, 133.3, 131.4, 131.1, 130.2, 125.0 (q, J = 4.0 
Hz), 124.0, 121.8, 119.6, 71.9, 43.9. 
19F NMR (471 MHz, CDCl3): δ = -62.6 
HRMS (EI): Calculated for C11H10ClF3O [M
+] = 250.0372, Found 250.0368. 




𝟐𝟖= +46.0 (c 0.2, CHCl3). 

















The aldehyde (30.0 mg, 0.20 mmol, 100 mol%) was subjected to standard reaction 
conditions (60 oC, 24 hr). The title compound was obtained in 84% yield (32.7 mg, 0.17 
mmol) as a brown oil after isolation by flash column chromatography (SiO2, hexanes: 
ethyl acetate = 20:1–10:1). 
 
TLC (SiO2) Rf  = 0.38 (hexanes: ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 6.87 (s, 1H), 6.78 (q, J = 8.0 Hz, 2H), 5.94 (d, J = 1.3 
Hz, 2H), 5.78 (ddt, J = 14.2, 10.1, 7.2 Hz, 1H), 5.24 – 5.02 (m, 2H), 4.64 (t, J = 6.4 Hz, 
1H), 2.47 (t, J = 6.6 Hz, 2H), 2.04 (s, 1H). 
13C NMR (125 MHz, CDCl3): δ = 147.7, 146.9, 138.0, 134.4, 119.2, 118.4, 108.1, 106.4, 
101.0, 73.2, 43.8. 
HRMS (EI): Calculated for C11H12O3 [M
+] = 192.0786, Found 192.0791. 
FTIR (neat): 3391, 2899, 1640, 1503, 1486, 1441, 1239, 1093, 1036, 919, 865, 810 cm–1. 
[α]
D
𝟐𝟖= +42.4 (c 0.2, CHCl3). 














The aldehyde (35.0 mg, 0.20 mmol, 100 mol%) was subjected to standard reaction 
conditions (60 oC, 24 hr). The title compound was obtained in 82% yield (35.7 mg, 0.16 
mmol) as a pale brown solid after isolation by flash column chromatography (SiO2, 
hexanes: ethyl acetate = 20:1–10:1). 
 
TLC (SiO2) Rf  = 0.45 (hexanes: ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 7.50 (dd, J = 7.8, 1.6 Hz, 1H), 7.39 (dd, J = 8.0, 1.6 
Hz, 1H), 7.24 (t, J = 7.8 Hz, 1H), 5.86 (dddd, J = 17.5, 9.6, 7.8, 6.4 Hz, 1H), 5.23 – 5.20 
(m, 1H), 5.20 – 5.15 (m, 2H), 2.71 – 2.55 (m, 1H), 2.42 – 2.26 (m, 1H), 1.95 (s, 1H). 
13C NMR (125 MHz, CDCl3): δ = 143.8, 134.0, 133.1, 129.9, 129.3, 127.6, 125.4, 119.3, 70.1, 
42.0. 
HRMS (EI): Calculated for C10H10OCl2 [M
+] = 216.0109, Found 216.0110. 
FTIR (neat): 3288, 3074, 2942, 1640, 1421, 1181, 1103, 918, 779, 718 cm–1. 
[α]
D
𝟐𝟖= +92.9 (c 0.3, CHCl3). 















The aldehyde (33.2 mg, 0.20 mmol, 100 mol%) was subjected to standard reaction 
conditions (60 oC, 24 hr). The title compound was obtained in 84% yield (35.0 mg, 0.17 
mmol) as a light yellow oil after isolation by flash column chromatography (SiO2, 
hexanes: ethyl acetate = 15:1–4:1). 
 
TLC (SiO2) Rf  = 0.35 (hexanes: ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 6.94 (d, J = 3.1 Hz, 1H), 6.80 (d, J = 8.8 Hz, 1H), 6.76 
(dd, J = 8.8, 3.0 Hz, 1H), 5.93 – 5.75 (m, 1H), 5.20 – 5.06 (m, 2H), 4.93 (dt, J = 8.1, 5.0 
Hz, 1H), 3.81 (s, 3H), 3.77 (s, 3H), 2.63 – 2.54 (m, 2H), 2.53 – 2.43 (m, 1H). 
13C NMR (125 MHz, CDCl3): δ = 153.7, 150.5, 135.1, 132.9, 117.7, 112.9, 112.5, 111.4, 
69.7, 55.8, 55.7, 41.9. 
HRMS (ESI): Calculated for C12H13N [M+H
+] = 231.0992, Found 231.0991. 
FTIR (neat): 3440, 2941, 2834, 1494, 1464, 1429, 1276, 1213, 1178, 1157, 1043, 914, 
803, 708 cm–1. 
[α]
D
𝟐𝟖= +36.7 (c 0.3, CHCl3). 














The aldehyde (55.0 mg, 0.20 mmol, 100 mol%) was subjected to standard reaction 
conditions (60 oC, 24 hr). The title compound was obtained in 92% yield (58.1 mg, 0.18 
mmol) as a pale yellow oil after isolation by flash column chromatography (SiO2, 
hexanes: ethyl acetate = 20:1–10:1). 
 
TLC (SiO2) Rf  = 0.28 (hexanes: ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 6.97 (s, 1H), 5.99 – 5.82 (m, 1H), 5.28 – 5.14 (m, 2H), 
5.09 (dd, J = 8.7, 3.4 Hz, 1H), 3.89 (s, 3H), 3.88 (s, 3H), 3.87 (s, 3H), 2.63 (dt, J = 13.9, 
4.6 Hz, 1H), 2.30 (dt, J = 15.2, 8.3 Hz, 1H), 1.99 (s, 1H). 
13C NMR (125 MHz, CDCl3): δ = 153.1, 150.6, 142.3, 138.6, 134.6, 118.8, 108.0, 105.9, 72.0, 
61.2, 61.2, 56.3, 42.3. 
HRMS (ESI): Calculated for C13H17BrO4 [M+Na
+] = 339.0202, Found 339.0206. 
FTIR (neat): 3471, 2937, 1569, 1480, 1393, 1323, 1195, 1161, 1103, 1038, 1006, 919, 
851, 816 cm–1. 
[α]
D
𝟐𝟖= +56.8 (c 0.4, CHCl3). 














The aldehyde (27.4 mg, 0.20 mmol, 100 mol%) was subjected to standard reaction 
conditions (60 oC, 24 hr). The title compound was obtained in 91% yield (32.7 mg, 0.18 
mmol) as a yellow oil after isolation by flash column chromatography (SiO2, hexanes: 
ethyl acetate = 20:1–5:1). 
 
TLC (SiO2) Rf  = 0.23 (hexanes: ethyl acetate = 3:1).  
1H NMR (500 MHz, CDCl3): δ = 8.19 – 7.99 (m, 1H), 7.60 (dd, J = 8.5, 2.3 Hz, 1H), 
6.72 (d, J = 8.5 Hz, 1H), 5.89 – 5.65 (m, 1H), 5.24 – 5.04 (m, 2H), 4.69 (t, J = 6.4 Hz, 
1H), 3.91 (d, J = 2.1 Hz, 3H), 2.48 (t, J = 6.6 Hz, 2H), 2.33 (s, 1H). 
13C NMR (125 MHz, CDCl3): δ = 163.8, 144.5, 136.8, 133.9, 132.0, 118.8, 110.8, 70.8, 
53.6, 43.5. 
HRMS (ESI): Calculated for C10H13NO2 [M+Na
+] = 202.0838, Found 202.0841. 
FTIR (neat): 3337, 3077, 2979, 2946, 1608, 1574, 1493, 1395, 1331, 1256, 1125, 1026, 
917, 831 cm–1. 
[α]
D
𝟐𝟖= +61.3 (c 0.4, CHCl3). 















The aldehyde (30.2 mg, 0.20 mmol, 100 mol%) was subjected to standard reaction 
conditions (60 oC, 24 hr). The title compound was obtained in 76% yield (29.2 mg, 0.15 
mmol) as a yellow oil after isolation by flash column chromatography (SiO2, hexanes: 
acetone = 15:1). 
 
TLC (SiO2) Rf  = 0.22 (hexanes: ethyl acetate = 1:1).  
1H NMR (500 MHz, CDCl3): δ = 8.29 (s, 2H), 5.86 – 5.69 (m, 1H), 5.20 – 5.06 (m, 2H), 
4.60 (t, J = 6.6 Hz, 1H), 3.18 (s, 6H), 2.49 (h, J = 6.9 Hz, 2H), 2.26 (s, 1H). 
13C NMR (125 MHz, CDCl3): δ = 161.9, 156.2, 133.9, 123.5, 119.1, 69.7, 43.2, 37.4. 
HRMS (ESI): Calculated for C10H15N3O [M+Na
+] = 194.1288, Found 194.1285. 
FTIR (neat): 3345, 2929, 1604, 1537, 1405, 1335, 1310, 1192, 1175, 1054, 973, 916, 
799, 659 cm–1. 
[α]
D
𝟐𝟖= +39.1 (c 0.2, CHCl3). 
HPLC (two connected Chiralcel OD-H columns, hexanes:i-PrOH = 97:3, 1.00 mL/min, 














The aldehyde (29.0 mg, 0.20 mmol, 100 mol%) was subjected to standard reaction 
conditions (50 oC, 48 hr). The title compound was obtained in 79% yield (29.6 mg, 0.16 
mmol) as a light yellow oil after isolation by flash column chromatography (SiO2, 
dichloromethane: diethyl ether = 1:0–10:1). 
 
TLC (SiO2) Rf  = 0.28 (dichloromethane: diethyl ether = 10:1).  
1H NMR (500 MHz, CDCl3): δ = δ 8.24 (s, 1H), 7.62 (d, J = 8.1 Hz, 1H), 7.35 (s, 1H), 
7.18 (t, J = 2.8 Hz, 1H), 7.11 (dd, J = 8.1, 1.4 Hz, 1H), 6.54 (t, J = 2.5 Hz, 1H), 5.84 
(ddt, J = 17.2, 10.1, 7.1 Hz, 1H), 5.22 – 5.09 (m, 2H), 4.84 (t, J = 6.5 Hz, 1H), 2.59 (t, J 
= 6.6 Hz, 2H), 2.23 (s, 1H). 
13C NMR (125 MHz, CDCl3): δ = δ 138.0, 135.8, 134.9, 127.3, 124.5, 120.6, 118.1, 
118.0, 108.3, 102.3, 74.0, 44.0.  
HRMS (ESI): Calculated for C12H13NO [M+Na
+] = 210.0889, Found 210.0884. 




𝟐𝟖= +39.0 (c 0.3, CHCl3). 













The aldehyde (31.4 mg, 0.20 mmol, 100 mol%) was subjected to standard reaction 
conditions (60 oC, 48 hr). The title compound was obtained in 88% yield (35.1 mg, 0.18 
mmol) as a light yellow oil after isolation by flash column chromatography (SiO2, 
hexanes: ethyl acetate = 25:1–5:1). 
 
TLC (SiO2) Rf  = 0.27 (hexanes: ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 8.15 (d, J = 8.5 Hz, 1H), 8.08 (d, J = 8.4 Hz, 1H), 7.83 
(dd, J = 8.1, 1.4 Hz, 1H), 7.73 (ddd, J = 8.4, 6.9, 1.5 Hz, 1H), 7.54 (ddd, J = 8.1, 6.8, 1.2 
Hz, 1H), 7.37 (d, J = 8.4 Hz, 1H), 5.89 (ddt, J = 17.2, 10.2, 7.0 Hz, 1H), 5.17 – 5.05 (m, 
2H), 4.99 (t, J = 6.0 Hz, 1H), 4.89 (s, 1H), 2.75 (dddt, J = 14.2, 7.0, 4.6, 1.3 Hz, 1H), 
2.56 (dtt, J = 14.3, 7.1, 1.3 Hz, 1H). 
13C NMR (125 MHz, CDCl3): δ = 161.3, 146.5, 136.8, 134.1, 129.8, 128.8, 127.6, 127.5, 
126.4, 118.4, 117.9, 72.2, 42.6.  
HRMS (ESI): Calculated for C13H13NO [M+Na
+] = 222.0889, Found 222.0896. 
FTIR (neat): 3261, 2921, 2895, 1618, 1599, 1502, 1430, 1304, 1069, 919, 793, 757 cm–1. 
[α]
D
𝟐𝟖= –18.0 (c 0.3, CHCl3). 













The aldehyde (38.4 mg, 0.20 mmol, 100 mol%) was subjected to standard reaction 
conditions (60 oC, 24 hr). The title compound was obtained in 71% yield (33.1 mg, 0.14 
mmol) as a light yellow oil after isolation by flash column chromatography (SiO2, 
hexanes: ethyl acetate = 20:1–4:1). 
 
TLC (SiO2) Rf  = 0.32 (hexanes: ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 7.15 (s, 1H), 5.80 (ddt, J = 17.2, 10.2, 7.1 Hz, 1H), 
5.21 – 5.14 (m, 2H), 4.85 (dt, J = 7.8, 4.9 Hz, 1H), 2.71 (dddt, J = 14.1, 6.2, 4.6, 1.3 Hz, 
1H), 2.61 – 2.50 (m, 1H), 2.45 (d, J = 5.3 Hz, 1H). 
13C NMR (125 MHz, CDCl3): δ = 159.2, 135.9, 133.5, 119.0, 117.6, 69.7, 41.6. 
HRMS (ESI): Calculated for C7H8BrNOS [M+Na
+] = 257.9381, Found 257.9391. 
FTIR (neat): 3350, 3076, 2907, 1640, 1519, 1416, 1317, 1243, 1012, 916, 758 cm–1. 
[α]
D
𝟐𝟖= +75.0 (c 1.0, CHCl3). 

















The aldehyde (47.3 mg, 0.20 mmol, 100 mol%) was subjected to standard reaction 
conditions (60 oC, 48 hr). The title compound was obtained in 79% yield (44.0 mg, 0.16 
mmol) as a light yellow oil after isolation by flash column chromatography (SiO2, 
hexanes: dichloromethane = 1:1–0:1). 
 
TLC (SiO2) Rf  = 0.55 (dichloromethane). 
1H NMR (500 MHz, CDCl3): δ = 7.66 (d, J = 2.2 Hz, 1H), 7.50 (dd, J = 8.6, 2.2 Hz, 
1H), 6.92 (d, J = 8.6 Hz, 1H), 6.47 (d, J = 3.3 Hz, 1H), 6.32 (d, J = 3.3 Hz, 1H), 5.85 
(ddt, J = 17.1, 10.2, 7.0 Hz, 1H), 5.25 – 5.10 (m, 2H), 4.79 (dt, J = 9.6, 4.9 Hz, 1H), 3.92 
(s, 3H), 2.68 (qt, J = 7.1, 1.3 Hz, 2H), 2.13 (d, J = 4.4 Hz, 1H). 
13C NMR (125 MHz, CDCl3): δ = 155.4, 154.2, 152.0, 133.6, 125.7, 124.6, 123.2, 122.8, 
118.7, 112.1, 108.3, 104.9, 67.0, 56.2, 40.1. 
HRMS (ESI): Calculated for C15H15ClO3 [M+Na
+] = 301.0602, Found 301.0601. 
FTIR (neat): 3377, 2939, 1490, 1440, 1289, 1267, 1062, 1019, 909, 787, 730, 708 cm–1. 
[α]
D
𝟐𝟖= +30.0 (c 0.3, CHCl3). 














The aldehyde (32.4 mg, 0.20 mmol, 100 mol%) was subjected to standard reaction 
conditions (60 oC, 24 hr). The title compound was obtained in 81% yield (33.1 mg, 0.16 
mmol) as a light yellow oil after isolation by flash column chromatography (SiO2, 
hexanes: ethyl acetate = 25:1–8:1). 
 
TLC (SiO2) Rf  = 0.45 (hexanes: ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 7.88 (ddd, J = 7.4, 5.4, 1.4 Hz, 2H), 7.45 – 7.30 (m, 
3H), 5.96 – 5.83 (m, 1H), 5.26 – 5.17 (m, 2H), 5.15 (dt, J = 8.0, 3.9 Hz, 1H), 2.77 (dddt, 
J = 14.0, 6.2, 4.6, 1.4 Hz, 1H), 2.71 – 2.60 (m, 1H), 2.15 (d, J = 3.5 Hz, 1H). 
13C NMR (125 MHz, CDCl3): δ = 140.9, 138.8, 137.2, 134.2, 124.4, 124.0, 122.9, 122.2, 
122.2, 118.7, 68.9, 41.8. 
HRMS (ESI): Calculated for C12H12OS [M+Na
+] =227.0501, Found 227.0507. 
FTIR (neat): 3373, 3075, 2906, 1640, 1459, 1427, 1256, 1140, 1057, 1022, 915, 868, 
834, 759, 732 cm–1. 
[α]
D
𝟐𝟖= +48.2 (c 0.3, CHCl3). 















The aldehyde (29.2 mg, 0.20 mmol, 100 mol%) was subjected to standard reaction 
conditions (60 oC, 24 hr). The title compound was obtained in 61% yield (23.1 mg, 0.12 
mmol) as a light yellow oil after isolation by flash column chromatography (SiO2, 
hexanes: ethyl acetate = 20:1–10:1). 
 
TLC (SiO2) Rf  = 0.39 (hexanes: ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 7.33 (t, J = 7.6 Hz, 2H), 7.30 – 7.26 (m, 2H), 7.24 – 
7.19 (m, 1H), 6.53 (s, 1H), 5.84 (ddt, J = 17.2, 10.2, 7.1 Hz, 1H), 5.23 – 5.13 (m, 2H), 
4.27 – 4.18 (m, 1H), 2.50 – 2.43 (m, 1H), 2.43 – 2.36 (m, 1H), 1.89 (d, J = 1.3 Hz, 3H), 
1.80 (d, J = 3.0 Hz, 1H). 
13C NMR (125 MHz, CDCl3): δ = 139.5, 137.5, 134.5, 129.0, 128.1, 126.4, 125.7, 118.1, 
76.5, 40.1, 13.7. 
HRMS (EI): Calculated for C13H16O [M
+] = 188.1201, Found 188.1205. 
FTIR (neat): 3366, 3079, 2919, 1641, 1442, 992, 915, 867, 747, 697 cm–1. 
[α]
D
𝟐𝟖= –4.5 (c 0.2, CHCl3). 















The aldehyde (26.8 mg, 0.20 mmol, 100 mol%) was subjected to standard reaction 
conditions (60 oC, 48 hr). The title compound was obtained in 65% yield (22.9 mg, 0.13 
mmol) as a light yellow oil after isolation by flash column chromatography (SiO2, 
hexanes: ethyl acetate = 20:1–10:1). 
 
TLC (SiO2) Rf  = 0.45 (hexanes: ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 7.29 (t, J = 7.6 Hz, 2H), 7.23 – 7.17 (m, 3H), 5.96 – 
5.66 (m, 1H), 5.19 – 5.10 (m, 2H), 3.68 (tt, J = 7.7, 4.6 Hz, 1H), 2.82 (ddd, J = 13.8, 8.9, 
6.6 Hz, 1H), 2.70 (dt, J = 13.8, 7.8 Hz, 1H), 2.33 (dddt, J = 13.7, 5.8, 4.3, 1.3 Hz, 1H), 
2.19 (dt, J = 13.9, 7.9 Hz, 1H), 1.84 – 1.73 (m, 2H). 
13C NMR (125 MHz, CDCl3): δ = 142.0, 134.6 128.4, 128.4, 125.8, 118.3, 69.9, 42.1, 
38.4, 32.0. 
HRMS (ESI): Calculated for C12H16O [M+Na
+] = 199.1093, Found 199.1096. 




𝟐𝟖= –6.0 (c 0.2, CHCl3). 













The aldehyde (42.7 mg, 0.20 mmol, 100 mol%) was subjected to standard reaction 
conditions (60 oC, 48 hr). The title compound was obtained in 71% yield (36.3 mg, 0.14 
mmol) as a light yellow oil after isolation by flash column chromatography (SiO2, 
hexanes: ethyl acetate = 15:1–4:1). 
TLC (SiO2) Rf  = 0.29 (hexanes: ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = 5.76 (dddd, J = 15.5, 11.5, 8.4, 6.1 Hz, 1H), 5.14 – 
5.05 (m, 2H), 4.08 (s, 2H), 3.35 (ddd, J = 9.2, 6.1, 3.4 Hz, 1H), 2.59 (s, 2H), 2.29 (dddd, 
J = 14.1, 6.3, 3.2, 1.5 Hz, 1H), 2.06 (dt, J = 14.0, 8.4 Hz, 1H), 1.75 (dq, J = 11.3, 2.8 Hz, 
1H), 1.54 (dt, J = 13.0, 3.0 Hz, 1H), 1.45 (ddq, J = 11.8, 5.7, 3.2 Hz, 1H), 1.39 (s, 9H), 
1.26 – 1.14 (m, 2H). 
13C NMR (125 MHz, CDCl3): δ = 154.8, 134.8, 118.6, 79.3, 73.7, 43.8, 41.5, 38.8, 28.5, 
28.1. 
HRMS (ESI): Calculated for C14H25NO3 [M+Na
+] = 278.1727, Found 2788.1726. 
FTIR (neat): 3429, 2976, 2930, 2858, 1668, 1424, 1365, 1277, 1235, 1164, 982, 911, 
866, 769 cm–1. 
[α]
D
𝟐𝟖= –10.6 (c 0.2, CHCl3). 
HPLC Enantiomeric excess was determined by HPLC analysis of the p-nitrobenzoyl 
derivative of the product (Chiralcel OJ-H column, hexanes:i-PrOH = 97:3, 1.00 mL/min, 















A pressure tube equipped with a magnetic stir bar was charged with aldehyde (32.4 mg, 
0.20 mmol, 100 mol%) and (S)-Ir-V (11.2 mg, 0.01 mmol, 5 mol%). The tube was fit 
with a rubber septum. The tube was evacuated by piercing the septum with a needle 
connected to a Schlenk line. Immediately after evacuation, an allene balloon fitted with a 
needle was used to pierce the septum and refill the tube with allene gas. Under the allene 
balloon, toluene (2.0 mL, 0.1 M) was added followed by d8-isopropylalcohol (31 µL, 0.4 
mmol, 200 mol%). The septum was quickly removed and the tube was sealed with a 
PTFE lined cap. The tube was placed in an oil bath at 60 oC for 24 hours. The reaction 
was allowed to reach ambient temperature and concentrated in vacuo. The title compound 
was obtained in 86% yield (39.2 mg, 0.17 mmol) as a light yellow oil after isolation by 
flash column chromatography (SiO2, hexanes: ethyl acetate = 25:1–8:1). 
 
TLC (SiO2) Rf  = 0.45 (hexanes: ethyl acetate = 4:1).  
1H NMR (500 MHz, CDCl3): δ = δ 7.50 – 7.44 (m, 2H), 7.25 – 7.20 (m, 2H), 5.91 – 5.64 
(m, 1H), 5.23 – 5.08 (m, 2H), 4.70 (dd, J = 7.9, 5.0 Hz, 1H), 2.54 – 2.39 (m, 2H), 2.09 (s, 
1H). 
 821 
13C NMR (125 MHz, CDCl3): δ = 142.8, 133.9, 131.5, 127.5, 121.2, 118.8 (d, J = 17.0 
Hz), 72.5, 43.8 (d, J = 15.1 Hz). 
2H NMR (92 MHz, CHCl3): δ = 5.82, 5.20, 2.48 (d, J = 3.9 Hz) 
HRMS (EI): Calculated for C10H10DBrO [M
+] = 227.0056, Found 227.0063. 




𝟐𝟖= +30.0 (c 0.2, CHCl3). 





















Single Crystal Diffraction Data for (S)-Ir-V Made from Allyl Acetate 
 
Empirical formula  C72 H63 Ir N2 O6 P2 
Formula weight  1306.38 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  orthorhombic 
Space group  P 21 21 21 
  Unit cell dimensions a = 15.155(2) Å = 90°. 
 b = 17.531(3) Å = 90°. 
 c = 22.268(3) Å  = 90°. 
Volume 5916.2(15) Å3 
Z 4 
Density (calculated) 1.467 Mg/m3 
Absorption coefficient 2.368 mm-1 
F(000) 2656 
Crystal size 0.410 x 0.250 x 0.140 mm3 
Theta range for data collection 1.776 to 27.877°. 
Index ranges -19<=h<=19, -23<=k<=22, -29<=l<=29 
Reflections collected 168850 
Independent reflections 14106 [R(int) = 0.0595] 
Completeness to theta = 25.242° 99.9 %  
Absorption correction Numerical 
Max. and min. transmission 0.7723 and 0.5359 
Refinement method Full-matrix least-squares on F2 
 826 
Data / restraints / parameters 14106 / 777 / 819 
Goodness-of-fit on F2 1.045 
Final R indices [I>2sigma(I)] R1 = 0.0215, wR2 = 0.0353 
R indices (all data) R1 = 0.0261, wR2 = 0.0357 
Absolute structure parameter -0.0019(16) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.648 and -0.642 e.Å-3 
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Figure S1.  View of the Ir complex in 1 showing the heteroatom labeling scheme.  
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